data_2jzm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jzm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.3 tp . . . . . 0 CA--C 1.552 1.024 0 CA-C-O 122.95 1.357 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.839 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 96.6 m -111.38 33.7 4.54 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-O 122.004 0.907 . . . . 0.0 111.405 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -79.62 145.8 32.86 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.189 -1.369 . . . . 0.0 107.526 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -146.93 168.31 21.8 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -66.9 -28.3 68.2 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.4 t -68.32 -43.03 78.45 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.74 -2.5 23.63 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.328 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.42 161.75 54.33 Favored Glycine 0 N--CA 1.425 -2.093 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.576 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.1 m -116.32 122.55 45.22 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 122.528 0.331 . . . . 0.0 110.72 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 3.2 tttp -43.13 132.4 4.18 Favored 'General case' 0 C--O 1.247 0.973 0 C-N-CA 124.677 1.191 . . . . 0.0 111.464 175.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.98 -28.32 15.22 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.98 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.8 m -103.92 133.37 49.01 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 122.537 -0.39 . . . . 0.0 110.299 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HG3' ' HE1' ' A' ' 23' ' ' PHE . 12.6 mptt -84.62 118.47 24.39 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.815 -177.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -88.56 105.97 18.0 Favored 'General case' 0 CA--C 1.492 -1.284 0 CA-C-O 123.2 1.476 . . . . 0.0 108.727 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -123.09 146.98 47.24 Favored 'General case' 0 C--N 1.269 -2.933 0 CA-C-N 111.959 -2.382 . . . . 0.0 111.589 -165.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.437 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 19.4 p -94.91 145.7 24.74 Favored 'General case' 0 N--CA 1.408 -2.531 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.587 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.2 -12.99 57.09 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.964 0.905 . . . . 0.0 112.911 -173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -71.53 -20.09 62.09 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.87 30.6 2.95 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.128 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.0 m -123.85 136.76 54.57 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.342 0.592 . . . . 0.0 112.494 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.449 ' HE1' ' HG3' ' A' ' 15' ' ' LYS . 62.2 t80 -79.95 115.19 19.39 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.6 t -85.75 -61.55 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.9 p -164.38 154.73 14.64 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.434 ' HG3' ' HD2' ' A' ' 15' ' ' LYS . 13.2 tt0 -89.65 155.53 19.17 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 174.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -54.55 113.13 3.18 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.592 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -83.37 -10.53 58.4 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.5 m -95.78 125.72 40.55 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-O 121.403 0.62 . . . . 0.0 110.338 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.71 134.66 37.06 Favored Pre-proline 0 C--N 1.293 -1.89 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.038 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.88 -8.21 17.28 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.074 2.516 . . . . 0.0 114.72 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -63.66 -46.66 84.58 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 117.839 0.29 . . . . 0.0 110.823 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -90.14 138.14 27.54 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.02 95.88 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.882 2.388 . . . . 0.0 110.727 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -88.92 118.94 28.99 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.077 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.8 78.48 1.72 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 96.8 m -79.16 169.16 18.58 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.859 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.414 ' HB ' ' OD1' ' A' ' 40' ' ' ASN . 0.3 OUTLIER -61.73 155.83 21.82 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.61 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.4 mt -94.77 40.87 1.09 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.907 0.861 . . . . 0.0 109.563 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.414 ' OD1' ' HB ' ' A' ' 38' ' ' THR . 8.4 m120 -62.47 122.57 16.07 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 113.793 -1.548 . . . . 0.0 109.307 175.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.839 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 5.2 m -81.26 112.04 18.21 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.186 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -111.09 85.09 4.97 Favored Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 24.4 Cg_exo -63.19 -19.89 69.66 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 123.614 2.876 . . . . 0.0 113.695 -171.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 18' ' ' SER . 3.4 tmm_? -73.36 -9.64 58.91 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.277 0.561 . . . . 0.0 110.486 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.5 mt -101.24 124.49 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 172.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.84 -59.09 1.93 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.643 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -157.36 163.66 38.38 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.469 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.06 127.75 9.2 Favored Glycine 0 N--CA 1.407 -3.292 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.2 t -105.77 103.37 15.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 14.0 m -85.1 152.48 58.7 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo . . . . . 0 C--N 1.364 1.372 0 C-N-CA 123.26 2.64 . . . . 0.0 112.6 -178.664 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 tt . . . . . 0 C--O 1.244 0.773 0 CA-C-O 121.594 0.711 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.87 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 22.2 m -119.73 43.21 2.71 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.62 ' HB ' HG23 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -90.74 163.81 14.35 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 170.29 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.633 ' HA ' ' HB3' ' A' ' 42' ' ' ASP . 7.9 p30 -151.42 136.13 17.15 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 119.116 0.871 . . . . 0.0 110.309 170.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 t -60.69 -34.51 74.45 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.277 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 t -74.45 -26.81 60.28 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.328 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.54 -54.39 4.59 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 18.76 -137.38 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 118.669 2.227 . . . . 0.0 118.669 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.506 ' H ' ' HE1' ' A' ' 16' ' ' TYR . 80.4 m -159.98 102.26 1.46 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.743 1.217 . . . . 0.0 109.789 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -46.75 128.11 10.38 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 125.136 1.375 . . . . 0.0 109.979 171.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.42 ' O ' ' HD2' ' A' ' 51' ' ' PRO . . . 111.49 -10.01 28.35 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 30.9 m -132.39 141.66 48.97 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.629 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 55.7 mmtt -82.56 131.02 35.22 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.506 ' HE1' ' H ' ' A' ' 11' ' ' THR . 12.3 m-85 -83.99 119.72 25.26 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.76 144.69 32.73 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.828 0.823 . . . . 0.0 112.369 -169.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.652 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 34.3 p -92.79 139.27 30.72 Favored 'General case' 0 N--CA 1.407 -2.623 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.017 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -62.74 -13.57 34.34 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -171.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -72.61 -15.16 61.74 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 120.833 0.349 . . . . 0.0 110.707 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.31 34.33 2.53 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.964 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.417 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 85.3 m -125.52 124.65 41.78 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.023 0.439 . . . . 0.0 110.88 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.629 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 69.0 t80 -76.97 132.61 39.11 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 175.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.9 t -106.18 -58.57 3.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.223 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.38 154.01 35.84 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.37 0.605 . . . . 0.0 112.46 -176.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -79.85 152.92 29.42 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.113 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.471 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -69.04 93.26 0.32 Allowed Glycine 0 N--CA 1.436 -1.308 0 O-C-N 123.927 0.767 . . . . 0.0 113.752 -175.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -100.25 -41.37 7.11 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.424 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 5.0 m -71.87 102.54 2.91 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -164.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -78.81 124.23 85.07 Favored Pre-proline 0 C--N 1.304 -1.394 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.794 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -87.9 1.9 6.65 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.911 2.407 . . . . 0.0 113.289 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -82.96 -46.59 12.73 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -86.23 156.85 57.0 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 173.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.71 55.8 4.98 Favored 'Trans proline' 0 C--O 1.246 0.91 0 C-N-CA 122.411 2.074 . . . . 0.0 113.426 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.424 ' HE2' ' HA ' ' A' ' 29' ' ' SER . 7.5 ttpt -88.75 97.28 11.05 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.415 0.626 . . . . 0.0 110.356 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.01 146.16 48.77 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.024 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.0 m -125.89 149.66 48.53 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.373 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.0 60.63 0.4 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.858 0.863 . . . . 0.0 112.271 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 tp -137.57 44.15 2.25 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 175.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -62.92 141.05 58.86 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 113.495 -1.684 . . . . 0.0 109.986 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.87 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 35.9 m 63.45 59.64 1.21 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.04 0.924 . . . . 0.0 110.328 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.633 ' HB3' ' HA ' ' A' ' 6' ' ' ASN . 61.3 t0 -82.8 109.43 16.64 Favored Pre-proline 0 C--N 1.312 -1.054 0 C-N-CA 125.45 1.5 . . . . 0.0 108.821 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 11.8 Cg_exo -69.68 -4.47 14.03 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 123.204 2.603 . . . . 0.0 113.616 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.652 ' O ' ' HB3' ' A' ' 18' ' ' SER . 1.6 mmp_? -85.17 -30.48 23.89 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.396 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.62 HG23 ' HB ' ' A' ' 5' ' ' THR . 7.3 tt -99.16 105.4 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.753 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.79 -42.71 23.87 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -167.54 176.44 6.51 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.919 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -109.07 124.74 7.45 Favored Glycine 0 C--N 1.285 -2.275 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.213 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.1 t -94.88 107.65 19.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 13.9 m -80.32 117.41 67.52 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.53 ' HG3' ' HE2' ' A' ' 15' ' ' LYS . 21.0 Cg_endo . . . . . 0 C--O 1.24 0.613 0 C-N-CA 123.117 2.544 . . . . 0.0 113.614 -175.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 tp . . . . . 0 N--CA 1.435 -1.186 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 m -115.11 20.66 14.83 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.405 ' HA ' HD13 ' A' ' 39' ' ' LEU . 1.2 m -90.69 172.79 8.41 Favored 'General case' 0 C--N 1.273 -2.744 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.608 177.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.834 HD21 HD12 ' A' ' 39' ' ' LEU . 9.1 p30 -133.31 156.81 46.93 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.4 t -73.72 -35.59 65.11 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 123.791 0.836 . . . . 0.0 113.105 -174.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 45.7 t -59.5 -56.91 15.99 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.578 0.704 . . . . 0.0 109.801 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.633 ' HB1' ' HB2' ' A' ' 37' ' ' CYS . . . -90.53 26.38 2.01 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.55 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.15 163.68 26.77 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.606 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -53.77 110.83 0.63 Allowed 'General case' 0 C--O 1.241 0.646 0 C-N-CA 125.708 1.603 . . . . 0.0 113.111 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.603 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 27.1 ttpp -55.02 112.96 1.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.215 1.006 . . . . 0.0 111.627 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.01 -26.51 10.45 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.17 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.9 m -87.15 122.09 30.48 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -77.8 113.16 15.4 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.764 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.613 ' HD2' HG22 ' A' ' 45' ' ' ILE . 60.5 m-85 -72.91 106.65 4.92 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.85 145.11 44.03 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.499 -1.682 . . . . 0.0 111.154 -167.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.479 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 4.9 p -92.87 145.57 24.29 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.556 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -64.45 -14.7 58.37 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -170.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.71 8.27 20.36 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.405 0.622 . . . . 0.0 110.444 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.27 28.37 9.87 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 115.522 -0.763 . . . . 0.0 114.251 171.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.479 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 5.3 m -115.74 114.14 24.4 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 118.007 0.903 . . . . 0.0 112.027 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -67.44 116.78 8.57 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 171.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.68 -47.29 16.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.1 p -178.59 -175.58 0.44 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -125.6 144.3 50.64 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -66.36 146.09 48.31 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -130.75 1.75 4.42 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.42 0.629 . . . . 0.0 111.035 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.7 m -121.46 169.39 10.69 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-O 121.974 0.892 . . . . 0.0 112.127 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.482 ' HB3' ' OD1' ' A' ' 33' ' ' ASN . 30.6 t70 -114.43 116.98 43.51 Favored Pre-proline 0 C--N 1.287 -2.132 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 173.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 19.6 Cg_exo -67.79 26.98 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 124.018 3.145 . . . . 0.0 115.334 -173.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -116.79 -32.58 5.08 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.482 ' OD1' ' HB3' ' A' ' 30' ' ' ASP . 3.0 p-10 -90.54 152.14 44.88 Favored Pre-proline 0 C--O 1.245 0.851 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.179 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.79 103.55 0.72 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.228 2.618 . . . . 0.0 112.815 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.18 114.18 19.94 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.57 64.63 4.5 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.552 0.691 . . . . 0.0 112.845 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.633 ' HB2' ' HB1' ' A' ' 9' ' ' ALA . 58.8 m -113.18 118.15 33.91 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 172.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.9 p -65.03 141.01 58.91 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 123.565 0.54 . . . . 0.0 111.226 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.834 HD12 HD21 ' A' ' 6' ' ' ASN . 4.1 mm? -79.54 -74.14 0.31 Allowed 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 60.7 7.65 1.49 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.408 1.483 . . . . 0.0 113.643 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.524 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 60.6 m 58.83 123.58 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 125.416 1.486 . . . . 0.0 111.789 -173.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -110.62 83.64 3.54 Favored Pre-proline 0 C--N 1.323 -0.579 0 O-C-N 121.115 -0.991 . . . . 0.0 109.547 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 23.4 Cg_exo -65.46 -14.09 43.13 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 123.616 2.877 . . . . 0.0 114.11 -172.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -73.71 -25.09 60.04 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.567 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.613 HG22 ' HD2' ' A' ' 16' ' ' TYR . 87.3 mt -82.56 144.33 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.06 -59.69 2.13 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.6 174.04 11.28 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.176 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.73 99.13 2.02 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.94 107.26 12.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.343 0.592 . . . . 0.0 110.876 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.7 m -85.73 136.86 36.36 Favored Pre-proline 0 C--N 1.291 -1.953 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 170.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 16.9 Cg_exo . . . . . 0 CA--C 1.539 0.734 0 C-N-CA 123.446 2.764 . . . . 0.0 113.52 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 tt . . . . . 0 N--CA 1.427 -1.591 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.453 ' HA ' ' CB ' ' A' ' 41' ' ' CYS 0.252 98.7 m -88.66 19.32 4.03 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -174.156 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.7 m -90.64 136.14 33.25 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 171.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -119.3 158.06 26.83 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.611 ' HB2' HD12 ' A' ' 45' ' ' ILE . 6.9 t -84.86 -17.25 38.56 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.287 -174.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.3 t -67.9 -46.1 72.57 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.53 22.58 3.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.239 0.542 . . . . 0.0 109.593 173.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.71 152.91 37.81 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 115.738 -0.665 . . . . 0.0 114.75 -172.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 m -79.36 114.26 18.16 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 124.768 1.227 . . . . 0.0 110.277 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 26' ' ' GLU . 2.3 tmtp? -64.84 127.34 31.16 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.44 ' H ' ' HG2' ' A' ' 26' ' ' GLU . . . 113.48 -10.11 24.04 Favored Glycine 0 C--N 1.301 -1.372 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -176.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.5 m -105.75 127.54 53.15 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.403 ' HA ' ' HE1' ' A' ' 23' ' ' PHE . 20.7 mmmt -84.84 94.02 8.63 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -178.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -72.51 111.22 7.49 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 175.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -140.91 151.69 44.44 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.794 -164.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.9 t -97.17 138.96 33.86 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.537 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.441 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 3.5 p30 -69.12 -3.59 13.99 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.732 0.813 . . . . 0.0 112.894 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.07 -8.88 59.0 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.765 176.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.45 25.05 6.48 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.93 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 m -122.02 114.91 21.6 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 122.565 -0.374 . . . . 0.0 111.662 -177.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.491 ' HZ ' ' HB2' ' A' ' 26' ' ' GLU . 73.6 t80 -73.34 130.8 40.95 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.91 -62.05 2.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.895 -175.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 p -162.73 155.51 19.34 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.598 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 20.0 tt0 -103.76 44.82 0.99 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.517 0.675 . . . . 0.0 110.461 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.89 -162.8 49.0 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.872 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -112.26 -69.74 0.85 Allowed 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 120.974 0.416 . . . . 0.0 109.988 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.4 m -144.56 -166.49 2.4 Favored 'General case' 0 N--CA 1.407 -2.62 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -177.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.48 133.74 59.28 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.66 1.54 0.39 Allowed 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 123.505 2.803 . . . . 0.0 115.205 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -61.39 -47.91 83.62 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -91.81 117.56 67.81 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 172.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -76.63 121.52 6.0 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 121.551 1.501 . . . . 0.0 111.081 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.93 116.21 24.84 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.59 113.16 20.11 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.376 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.6 m -141.96 -177.68 5.33 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.32 157.39 29.26 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 120.867 0.365 . . . . 0.0 110.616 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.49 32.92 1.9 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.898 0.856 . . . . 0.0 109.838 -175.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -78.14 136.16 37.8 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.188 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.475 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 19.6 m -76.27 123.48 25.97 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -83.78 105.27 5.31 Favored Pre-proline 0 N--CA 1.468 0.454 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.699 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 68.1 Cg_endo -83.45 1.72 8.8 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.929 2.419 . . . . 0.0 111.725 -174.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 ttp-105 -83.04 -20.55 34.78 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.611 HD12 ' HB2' ' A' ' 7' ' ' CYS . 71.8 mt -108.02 152.64 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.491 -1.232 . . . . 0.0 109.018 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.26 -50.58 3.12 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 19' ' ' ASP . 15.9 p90 -159.16 175.54 13.33 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -114.62 112.16 2.71 Favored Glycine 0 N--CA 1.428 -1.894 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.339 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.529 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 56.2 t -82.29 106.29 13.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 85.7 m -105.67 99.29 20.89 Favored Pre-proline 0 C--N 1.298 -1.657 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.231 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 49' ' ' VAL . 3.6 Cg_exo . . . . . 0 N--CA 1.456 -0.703 0 C-N-CA 123.296 2.664 . . . . 0.0 109.594 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 tp . . . . . 0 CA--C 1.551 0.996 0 CA-C-O 122.911 1.339 . . . . 0.0 109.769 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.949 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.8 m -88.58 40.83 0.98 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.991 0.901 . . . . 0.0 112.282 -176.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -90.83 127.25 36.29 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 171.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -146.27 178.8 7.97 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.524 -0.871 . . . . 0.0 112.548 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -85.17 -32.93 22.44 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.6 t -66.1 -50.43 64.07 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.933 0.873 . . . . 0.0 108.976 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.37 33.25 0.9 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.527 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.23 136.11 13.06 Favored Glycine 0 N--CA 1.41 -3.076 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.804 HG22 ' HA ' ' A' ' 31' ' ' PRO . 7.2 p -83.85 111.46 19.24 Favored 'General case' 0 C--N 1.268 -2.955 0 CA-C-N 113.924 -1.138 . . . . 0.0 111.834 -175.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -45.79 115.57 1.0 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.704 0.802 . . . . 0.0 110.854 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.49 -36.59 2.53 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 m -95.52 134.71 38.05 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.53 ' HG3' ' HG3' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -88.42 119.96 29.34 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -83.86 105.24 14.59 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 122.896 1.331 . . . . 0.0 108.142 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.593 ' HE1' ' HA2' ' A' ' 21' ' ' GLY . 0.5 OUTLIER -126.52 147.95 49.78 Favored 'General case' 0 N--CA 1.405 -2.684 0 CA-C-N 112.868 -1.969 . . . . 0.0 112.207 -164.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.7 142.58 29.31 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.113 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -58.18 -19.05 30.21 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.867 1.267 . . . . 0.0 114.208 -172.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.07 -8.03 59.17 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.131 0.491 . . . . 0.0 111.02 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.593 ' HA2' ' HE1' ' A' ' 17' ' ' PHE . . . 106.14 24.27 6.95 Favored Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.324 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.2 m -107.04 123.32 48.05 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.291 -0.563 . . . . 0.0 112.142 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -77.94 109.65 12.18 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.21 -52.09 15.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.9 p -174.46 169.54 3.71 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.53 ' HG3' ' HG3' ' A' ' 15' ' ' LYS . 15.8 tt0 -108.27 171.3 7.49 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.67 112.3 1.56 Allowed Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -83.08 -22.67 33.4 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.666 -0.267 . . . . 0.0 111.705 -172.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -130.36 -176.94 4.12 Favored 'General case' 0 N--CA 1.4 -2.962 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.472 -174.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -78.0 140.59 62.27 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.804 ' HA ' HG22 ' A' ' 11' ' ' THR . 1.0 OUTLIER -42.92 -27.07 0.8 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 124.922 3.748 . . . . 0.0 115.725 -179.501 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.465 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 19.5 mmt85 -122.64 46.09 2.23 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 118.409 0.549 . . . . 0.0 110.492 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -73.57 119.9 78.37 Favored Pre-proline 0 C--N 1.304 -1.382 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.525 175.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -87.25 94.21 0.48 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.787 2.324 . . . . 0.0 111.575 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -158.67 155.32 27.92 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.263 0.554 . . . . 0.0 111.478 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.16 131.53 45.13 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 173.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.2 m -115.28 135.51 54.07 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.208 0.528 . . . . 0.0 112.278 -174.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -18.26 62.9 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 123.573 0.749 . . . . 0.0 110.814 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 tp -86.33 25.31 1.21 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.099 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -53.67 121.09 7.13 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.937 176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.949 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 14.9 m 67.36 86.58 0.13 Allowed 'General case' 0 C--N 1.321 -0.661 0 O-C-N 124.504 1.128 . . . . 0.0 111.421 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -96.28 104.5 17.6 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.49 3.87 6.83 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.782 2.321 . . . . 0.0 113.041 -172.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -90.41 -15.57 30.73 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.49 0.662 . . . . 0.0 109.331 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 93.2 mt -101.18 140.94 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.49 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.95 -54.35 3.49 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -167.23 173.3 9.11 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.423 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.43 121.23 7.14 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.5 t -94.14 114.09 30.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 123.021 0.529 . . . . 0.0 109.582 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.6 m -99.84 129.39 28.72 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 32.2 Cg_exo . . . . . 0 C--O 1.246 0.883 0 C-N-CA 123.324 2.683 . . . . 0.0 112.114 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.417 ' O ' ' HB3' ' A' ' 41' ' ' CYS . 6.1 tp . . . . . 0 N--CA 1.445 -0.682 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 69.4 m -113.6 40.37 2.42 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.97 0.891 . . . . 0.0 112.781 -173.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 t -90.82 165.81 13.43 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 172.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -160.17 175.86 12.43 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 118.435 0.561 . . . . 0.0 111.11 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.4 t -69.11 -21.2 64.06 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.563 0.745 . . . . 0.0 112.275 -174.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.3 t -91.03 -54.82 3.79 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.56 -0.713 . . . . 0.0 109.965 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.22 37.43 0.1 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.21 175.3 30.67 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 175.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 m -109.48 124.74 51.58 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 117.037 0.419 . . . . 0.0 111.251 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.542 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -54.36 122.58 10.71 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.9 175.152 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.56 -35.52 2.65 Favored Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -176.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.1 m -105.75 151.15 24.82 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -88.28 123.99 33.44 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.515 ' CZ ' ' HA2' ' A' ' 27' ' ' GLY . 1.2 m-30 -77.45 106.89 9.51 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.416 ' CE1' ' HA ' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -141.01 151.74 44.35 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.599 0.714 . . . . 0.0 112.77 -167.192 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.526 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 43.4 p -96.24 129.61 43.52 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 175.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.416 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 4.1 p-10 -62.64 -9.8 10.23 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -20.23 63.79 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.16 -0.19 6.51 Favored Glycine 0 N--CA 1.429 -1.812 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.404 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.526 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 3.8 m -97.45 118.07 33.12 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -76.56 121.77 23.65 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.417 HG22 HG12 ' A' ' 45' ' ' ILE . 23.5 t -95.53 -65.86 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.837 -176.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.56 155.75 43.81 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.964 0.412 . . . . 0.0 111.849 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.07 169.02 10.57 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.542 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -62.48 118.78 15.31 Favored Glycine 0 N--CA 1.439 -1.105 0 O-C-N 123.53 0.519 . . . . 0.0 113.306 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -131.24 1.52 4.19 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.01 0.433 . . . . 0.0 111.638 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.2 m -121.29 115.41 22.92 Favored 'General case' 0 N--CA 1.403 -2.779 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -114.12 140.83 25.42 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.74 -21.02 7.47 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.634 2.889 . . . . 0.0 114.958 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -90.94 -24.99 19.99 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.495 ' HA ' ' HD3' ' A' ' 34' ' ' PRO 0.254 28.5 p30 -91.4 115.28 64.12 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.344 0.592 . . . . 0.0 112.484 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 17.2 Cg_exo -65.43 111.74 1.93 Allowed 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 123.313 2.675 . . . . 0.0 111.573 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -139.45 120.29 14.39 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.61 92.92 7.23 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.525 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.6 m -88.7 165.66 14.6 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.804 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.08 149.68 42.93 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.952 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -95.88 33.22 1.72 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.13 147.19 40.73 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.995 -1.457 . . . . 0.0 111.443 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 35.0 m -106.99 93.77 4.74 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.529 ' OD1' ' HB3' ' A' ' 44' ' ' ARG . 9.9 t70 -80.65 103.2 1.66 Allowed Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 123.871 0.868 . . . . 0.0 110.572 -175.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 52.6 Cg_endo -72.79 -7.12 20.25 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.637 2.225 . . . . 0.0 112.464 -174.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.529 ' HB3' ' OD1' ' A' ' 42' ' ' ASP . 16.9 ttp180 -82.81 -45.94 13.69 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.417 HG12 HG22 ' A' ' 24' ' ' VAL . 79.6 mt -79.72 128.95 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 CA-C-O 121.538 0.685 . . . . 0.0 109.965 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.05 -55.41 3.95 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.898 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -171.38 171.24 5.62 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.03 117.06 4.93 Favored Glycine 0 N--CA 1.423 -2.199 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.7 t -93.08 117.32 36.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.35 0.595 . . . . 0.0 111.419 -176.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.3 m -105.73 102.34 37.89 Favored Pre-proline 0 C--N 1.285 -2.198 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 171.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo . . . . . 0 C--N 1.367 1.527 0 C-N-CA 125.092 3.861 . . . . 0.0 114.513 -174.737 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.457 HG13 ' OG1' ' A' ' 5' ' ' THR . 6.5 tp . . . . . 0 N--CA 1.428 -1.543 0 CA-C-O 121.624 0.726 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.48 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 19.3 m -136.38 47.16 2.22 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 121.972 0.892 . . . . 0.0 110.3 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.457 ' OG1' HG13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -72.17 160.41 32.49 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.961 178.153 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -158.93 149.25 19.56 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 t -105.79 18.36 22.27 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.357 0.598 . . . . 0.0 112.048 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 t -85.84 -46.01 11.02 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.527 ' HA ' ' OG ' ' A' ' 29' ' ' SER . . . -91.05 -100.01 0.11 Allowed 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.386 173.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.62 -140.3 28.98 Favored Glycine 0 N--CA 1.414 -2.779 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.563 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 m -154.0 119.3 5.12 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.568 ' HD3' ' HB2' ' A' ' 30' ' ' ASP . 15.0 ttpt -57.26 127.05 30.0 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 123.704 0.627 . . . . 0.0 110.613 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.19 -12.83 65.2 Favored Glycine 0 C--N 1.304 -1.201 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.391 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.9 m -99.06 128.65 45.24 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -80.13 92.2 5.63 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.988 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.595 ' HD2' HG23 ' A' ' 45' ' ' ILE . 27.9 m-85 -71.21 115.5 10.44 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.426 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -146.5 151.64 37.71 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.009 -161.747 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.3 t -86.86 137.19 32.61 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.427 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -57.98 -22.45 49.45 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.6 -18.61 60.54 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.181 0.515 . . . . 0.0 110.888 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.426 ' HA2' ' CE2' ' A' ' 17' ' ' PHE . . . 118.65 20.29 4.26 Favored Glycine 0 N--CA 1.425 -2.076 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.404 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 m -104.8 108.33 19.75 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 117.312 0.556 . . . . 0.0 110.173 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.492 ' CZ ' ' HG3' ' A' ' 26' ' ' GLU . 75.1 t80 -68.92 137.15 53.57 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.6 t -108.23 -64.56 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.713 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.3 p -163.35 155.34 17.69 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.492 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 18.3 mt-10 -97.52 39.19 1.21 Allowed 'General case' 0 C--O 1.242 0.676 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -175.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.21 127.74 0.27 Allowed Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.446 -0.797 . . . . 0.0 114.165 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -105.4 27.81 7.97 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 122.377 -0.484 . . . . 0.0 111.036 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.527 ' OG ' ' HA ' ' A' ' 9' ' ' ALA . 4.3 m -141.74 109.1 5.56 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.568 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 21.0 t70 -96.18 130.45 31.08 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 167.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -59.44 50.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.511 2.51 0 C-N-CA 124.859 3.706 . . . . 0.0 116.189 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -128.56 -56.12 1.22 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -90.5 130.06 42.81 Favored Pre-proline 0 N--CA 1.442 -0.85 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 175.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.28 147.75 11.5 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.258 1.972 . . . . 0.0 110.853 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.526 ' HB3' ' SG ' ' A' ' 37' ' ' CYS . 27.6 mmtp -120.28 89.7 3.18 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.477 0.656 . . . . 0.0 109.893 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.99 59.51 5.67 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.178 0.99 . . . . 0.0 110.041 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.526 ' SG ' ' HB3' ' A' ' 35' ' ' LYS . 3.4 m -88.46 -178.79 5.94 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.808 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.45 ' C ' ' H ' ' A' ' 40' ' ' ASN . 0.2 OUTLIER -80.48 137.49 36.47 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 174.277 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.9 tp -89.1 43.72 1.16 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.377 1.084 . . . . 0.0 110.105 -174.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.45 ' H ' ' C ' ' A' ' 38' ' ' THR . 3.1 m120 -53.17 122.54 9.67 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 112.837 -1.983 . . . . 0.0 110.926 172.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.524 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 34.8 m -71.94 108.67 5.31 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 175.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -104.88 91.57 4.44 Favored Pre-proline 0 C--N 1.31 -1.123 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 22.9 Cg_exo -64.66 -17.2 58.78 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 124.43 3.42 . . . . 0.0 114.818 -172.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.4 ttp-105 -59.68 -23.65 63.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.564 0.697 . . . . 0.0 110.139 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.595 HG23 ' HD2' ' A' ' 16' ' ' TYR . 95.1 mt -103.82 122.27 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.73 -46.56 8.52 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.143 -177.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -161.09 175.15 12.72 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.965 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -109.59 111.78 3.24 Favored Glycine 0 N--CA 1.415 -2.754 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.7 t -86.31 98.68 7.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.7 m -87.74 157.49 52.03 Favored Pre-proline 0 C--N 1.285 -2.212 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo . . . . . 0 CA--C 1.532 0.376 0 C-N-CA 122.636 2.224 . . . . 0.0 109.709 175.921 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 tp . . . . . 0 N--CA 1.426 -1.669 0 CA-C-O 121.949 0.881 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.546 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 90.8 m -96.36 25.65 4.86 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 122.218 1.008 . . . . 0.0 112.317 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.7 m -90.82 141.94 28.28 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 173.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -136.84 167.15 22.02 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.97 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.497 ' HA ' ' CD2' ' A' ' 16' ' ' TYR . 6.4 t -70.95 -34.57 71.59 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 123.447 0.699 . . . . 0.0 112.695 -171.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 1.8 t -77.89 -36.43 49.69 Favored 'General case' 0 N--CA 1.424 -1.754 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.767 -177.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.58 34.28 0.32 Allowed 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.482 0.658 . . . . 0.0 111.09 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.523 ' HA3' ' HE2' ' A' ' 16' ' ' TYR . . . -119.29 168.75 13.49 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.36 143.25 30.77 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 116.929 0.365 . . . . 0.0 111.009 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -50.81 138.66 18.26 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.694 172.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.91 -33.08 6.66 Favored Glycine 0 C--N 1.3 -1.456 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 64.0 m -99.11 138.83 35.65 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.736 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 37.0 mtmt -110.94 127.76 55.59 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -175.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.523 ' HE2' ' HA3' ' A' ' 10' ' ' GLY . 28.6 m-85 -76.47 128.28 34.48 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.335 0.588 . . . . 0.0 110.443 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -148.07 147.05 29.13 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.162 -171.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.547 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 31.5 p -97.74 144.22 27.58 Favored 'General case' 0 N--CA 1.407 -2.588 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.889 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.0 -11.47 57.1 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.737 0.815 . . . . 0.0 113.14 -170.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -74.1 -14.12 60.93 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.68 48.74 1.25 Allowed Glycine 0 N--CA 1.427 -1.962 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.547 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 84.9 m -134.68 121.61 21.06 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.077 0.465 . . . . 0.0 110.803 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.736 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 78.1 t80 -69.67 120.23 15.12 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.3 t -89.57 -53.22 9.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.327 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.4 p -172.33 164.87 5.85 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.986 0.422 . . . . 0.0 110.458 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -88.87 146.05 25.19 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 123.765 0.826 . . . . 0.0 109.265 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.61 109.65 2.49 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 1.1 mm-40 -101.49 23.49 11.03 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 10' ' ' GLY . 5.5 m -113.32 102.7 10.59 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-O 121.285 0.564 . . . . 0.0 111.779 176.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.539 ' HB3' ' ND2' ' A' ' 33' ' ' ASN . 4.6 t70 -113.98 138.7 22.94 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 173.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.34 -19.83 5.06 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.981 3.121 . . . . 0.0 115.549 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -86.88 -37.75 17.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.91 -0.494 . . . . 0.0 111.345 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.539 ' ND2' ' HB3' ' A' ' 30' ' ' ASP . 14.9 p30 -90.44 116.9 67.44 Favored Pre-proline 0 C--N 1.317 -0.834 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.094 -177.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -80.85 117.91 3.35 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.237 1.958 . . . . 0.0 109.208 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.461 ' HE2' ' HB3' ' A' ' 28' ' ' GLU . 25.5 mmtm -109.36 139.89 43.75 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -171.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.55 125.05 30.04 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 166.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 73.0 m -128.94 150.47 50.36 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.785 -170.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 t -68.06 140.88 56.3 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 29.3 mt -106.85 -10.46 16.03 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.07 0.462 . . . . 0.0 110.833 -172.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -110.92 163.95 13.29 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.348 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 2.7 m -45.28 135.33 5.95 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 126.082 1.753 . . . . 0.0 112.596 -177.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -119.85 88.98 41.17 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.4 2.79 2.08 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 123.884 3.056 . . . . 0.0 115.214 -172.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -76.0 -24.54 55.32 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.865 0.84 . . . . 0.0 108.856 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.3 mt -95.89 149.47 4.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.023 -175.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.88 -53.01 2.84 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.42 170.7 18.33 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.883 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -102.45 98.17 1.66 Allowed Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.4 t -79.69 109.2 14.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.292 0.568 . . . . 0.0 109.882 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 3.4 m -80.66 115.08 52.97 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 106.131 -1.804 . . . . 0.0 106.131 173.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.609 ' HG3' ' HE2' ' A' ' 15' ' ' LYS . 24.5 Cg_exo . . . . . 0 C--O 1.24 0.615 0 C-N-CA 123.365 2.71 . . . . 0.0 114.169 -171.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 tt . . . . . 0 CA--C 1.543 0.705 0 CA-C-O 122.793 1.282 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.739 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 78.2 m -124.37 43.66 2.95 Favored 'General case' 0 N--CA 1.406 -2.631 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.918 -175.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.401 ' HB ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -77.97 148.64 34.36 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 173.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -128.61 142.97 50.87 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 118.871 -1.131 . . . . 0.0 113.501 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.7 t -98.97 13.03 34.16 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.321 1.057 . . . . 0.0 108.619 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.7 t -85.92 -70.39 0.6 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.773 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.1 -71.5 0.64 Allowed 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.33 -159.62 53.76 Favored Glycine 0 N--CA 1.415 -2.714 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.604 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 m -122.08 98.17 5.81 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.741 ' HE3' ' HB2' ' A' ' 30' ' ' ASP . 0.5 OUTLIER -40.18 122.22 1.49 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.031 0.932 . . . . 0.0 112.103 175.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.02 -42.01 1.92 Allowed Glycine 0 N--CA 1.435 -1.414 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.601 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 70.0 m -89.42 147.43 24.04 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.554 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 18.4 mtpp -97.36 116.19 29.1 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -175.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.826 ' HB3' HG13 ' A' ' 45' ' ' ILE . 10.9 m-85 -77.61 115.94 17.77 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.025 0.917 . . . . 0.0 108.85 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.452 ' HE2' ' HA2' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -135.67 149.05 49.16 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.498 -166.09 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.81 134.06 37.84 Favored 'General case' 0 N--CA 1.41 -2.466 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.42 -20.45 19.74 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -169.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -76.03 -13.77 60.22 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.907 0.385 . . . . 0.0 111.669 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.452 ' HA2' ' HE2' ' A' ' 17' ' ' PHE . . . 114.8 19.11 6.16 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.054 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.6 m -104.53 110.2 22.39 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.837 0.351 . . . . 0.0 110.86 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.554 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 50.3 t80 -73.14 126.14 29.34 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.1 t -96.34 -61.14 2.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 120.842 0.353 . . . . 0.0 110.328 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.4 p -161.63 160.07 28.32 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -176.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -97.3 145.46 26.08 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 174.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -46.65 122.09 6.31 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 124.165 0.916 . . . . 0.0 112.133 -178.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.56 -52.75 6.54 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.898 0.38 . . . . 0.0 111.13 -173.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.7 m -102.69 145.16 30.11 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-O 121.684 0.754 . . . . 0.0 111.963 -170.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.741 ' HB2' ' HE3' ' A' ' 12' ' ' LYS . 11.3 t70 -87.91 139.07 30.9 Favored Pre-proline 0 C--N 1.288 -2.077 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 172.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -49.79 -20.18 4.42 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.233 2.622 . . . . 0.0 114.512 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -83.23 -21.59 33.35 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.28 2.8 p-10 -90.58 118.86 69.02 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.823 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -75.27 73.51 4.45 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 123.637 2.892 . . . . 0.0 116.161 -170.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -130.37 49.91 2.25 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 122.551 1.167 . . . . 0.0 109.639 170.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.47 123.26 27.38 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.439 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.3 m -81.49 171.11 15.1 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.382 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 m -50.18 -64.76 0.71 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.85 -53.6 0.09 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 59.91 79.33 0.24 Allowed 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 124.578 1.174 . . . . 0.0 111.88 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.739 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 61.7 m -81.18 89.8 6.03 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 173.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.601 ' HB3' HG23 ' A' ' 45' ' ' ILE . 7.0 t0 -91.3 108.58 29.79 Favored Pre-proline 0 C--N 1.306 -1.283 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.544 -170.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -71.44 -5.59 17.36 Favored 'Trans proline' 0 C--O 1.24 0.594 0 C-N-CA 123.184 2.589 . . . . 0.0 112.424 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.568 ' HD3' ' OD1' ' A' ' 42' ' ' ASP . 25.8 mtp180 -75.26 -36.59 61.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.025 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.826 HG13 ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -108.98 136.66 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 CA-C-O 121.752 0.787 . . . . 0.0 112.943 -171.552 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.7 -60.53 1.68 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.387 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -153.75 165.22 36.69 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.012 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -98.41 114.56 5.05 Favored Glycine 0 C--N 1.29 -2.003 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t -92.85 114.12 29.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 14.7 m -79.67 137.43 54.8 Favored Pre-proline 0 C--N 1.284 -2.25 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo . . . . . 0 CA--C 1.54 0.821 0 C-N-CA 124.278 3.318 . . . . 0.0 114.466 -175.652 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 tp . . . . . 0 CA--C 1.539 0.555 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.991 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 69.3 m -101.47 34.39 2.61 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-O 122.206 1.003 . . . . 0.0 113.18 -173.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.8 m -91.34 147.07 23.3 Favored 'General case' 0 N--CA 1.408 -2.525 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.44 ' HA ' HD12 ' A' ' 45' ' ' ILE . 8.7 t-20 -159.01 -172.64 3.87 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.476 ' O ' ' HA3' ' A' ' 27' ' ' GLY . 1.1 t -74.14 -30.5 62.31 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 122.055 0.931 . . . . 0.0 108.925 -175.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.518 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 34.3 t -80.32 -44.28 19.79 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.972 176.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.27 49.43 0.2 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.471 1.108 . . . . 0.0 113.375 -176.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.437 ' C ' ' HG1' ' A' ' 11' ' ' THR . . . -151.86 -121.52 0.94 Allowed Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.335 -0.936 . . . . 0.0 111.322 176.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.437 ' HG1' ' C ' ' A' ' 10' ' ' GLY . 7.7 m -159.9 138.17 10.29 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 27' ' ' GLY . 14.9 mtpp -57.4 130.71 47.5 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.72 -32.66 6.24 Favored Glycine 0 C--N 1.291 -1.95 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -174.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.3 m -80.81 123.94 28.66 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 121.1 0.476 . . . . 0.0 109.838 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.683 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 62.0 mttm -87.34 109.91 19.87 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.495 ' HE2' ' N ' ' A' ' 27' ' ' GLY . 51.5 m-85 -71.7 125.68 27.76 Favored 'General case' 0 CA--C 1.472 -2.056 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.48 146.16 32.28 Favored 'General case' 0 N--CA 1.393 -3.314 0 CA-C-N 114.385 -1.28 . . . . 0.0 111.541 -167.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.628 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 28.1 t -93.62 130.47 39.52 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.09 -17.12 50.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.101 0.96 . . . . 0.0 113.038 -172.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.72 -10.19 59.43 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.988 0.423 . . . . 0.0 110.387 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.08 6.05 16.65 Favored Glycine 0 N--CA 1.432 -1.612 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.96 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 8.5 m -90.95 122.66 33.82 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 117.046 0.423 . . . . 0.0 111.694 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.683 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 72.3 t80 -79.04 138.53 38.03 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 174.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.461 HG23 HG12 ' A' ' 45' ' ' ILE . 59.8 t -108.58 -64.51 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.532 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 p -173.02 168.27 4.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.646 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -112.54 117.47 32.44 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 170.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.599 ' O ' ' HG2' ' A' ' 12' ' ' LYS . . . -79.17 176.29 54.76 Favored Glycine 0 C--N 1.296 -1.657 0 N-CA-C 115.351 0.9 . . . . 0.0 115.351 -169.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -103.21 29.02 5.82 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 123.365 0.666 . . . . 0.0 110.96 -176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.431 ' HB3' ' HA ' ' A' ' 11' ' ' THR . 10.0 t -81.94 72.11 8.98 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 122.335 1.064 . . . . 0.0 109.084 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.69 140.33 31.5 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.119 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -35.46 -44.7 0.65 Allowed 'Trans proline' 0 CA--C 1.548 1.196 0 C-N-CA 124.791 3.661 . . . . 0.0 115.892 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.72 9.46 37.13 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -174.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.42 158.07 43.79 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -83.41 85.29 1.53 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.261 1.974 . . . . 0.0 111.072 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.12 55.01 3.14 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 122.143 0.973 . . . . 0.0 111.86 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.32 83.51 1.77 Allowed 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.951 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.2 m -109.99 123.74 50.18 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.387 -175.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.08 46.36 1.38 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.211 0.529 . . . . 0.0 111.359 -175.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.32 23.19 0.48 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.518 ' OD1' ' HB3' ' A' ' 8' ' ' CYS . 37.2 m-20 -90.21 57.14 3.63 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -167.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.991 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 71.0 m -148.29 74.34 1.28 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 173.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -92.82 112.94 58.14 Favored Pre-proline 0 CA--C 1.515 -0.394 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.54 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.76 -11.69 28.05 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 123.053 2.502 . . . . 0.0 113.862 -174.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.9 ptt-85 -90.7 -12.44 36.68 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.55 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.461 HG12 HG23 ' A' ' 24' ' ' VAL . 85.1 mt -97.82 138.0 23.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.82 -59.61 1.7 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.374 0.607 . . . . 0.0 109.622 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.35 161.51 41.04 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -95.51 106.75 3.43 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.3 t -86.91 107.43 16.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.433 0.635 . . . . 0.0 110.931 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.6 m -92.43 124.12 60.2 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 173.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 2.6 Cg_exo . . . . . 0 N--CA 1.457 -0.637 0 C-N-CA 123.086 2.524 . . . . 0.0 113.291 -175.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.662 HG12 ' HA ' ' A' ' 43' ' ' PRO . 7.1 tp . . . . . 0 CA--C 1.567 1.605 0 CA-C-O 122.832 1.301 . . . . 0.0 113.072 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.426 ' HA ' ' CB ' ' A' ' 41' ' ' CYS . 3.3 m -102.45 32.55 3.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.238 1.018 . . . . 0.0 111.162 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.93 162.85 17.46 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 113.921 -1.491 . . . . 0.0 108.222 176.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -132.42 156.58 46.45 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.208 0.528 . . . . 0.0 110.3 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 t -85.09 -16.13 41.64 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 124.263 1.025 . . . . 0.0 112.407 -173.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 8.4 t -90.86 -66.61 0.91 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.594 -1.242 . . . . 0.0 113.788 -175.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.05 48.9 0.42 Allowed 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -167.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.2 -95.13 2.38 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 174.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.4 m -163.78 132.17 3.69 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 123.957 0.903 . . . . 0.0 109.088 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.915 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 19.8 pttp -64.34 143.05 58.18 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.48 -35.47 4.79 Favored Glycine 0 C--N 1.297 -1.619 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.504 -175.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.4 m -80.49 146.33 31.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.692 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 2.1 mmpt? -97.19 113.89 25.54 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.685 ' HE2' ' HA2' ' A' ' 27' ' ' GLY . 90.6 m-85 -71.28 117.6 13.01 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.51 ' CE2' ' HA ' ' A' ' 22' ' ' THR . 16.0 t80 -122.73 144.5 49.12 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-O 122.193 0.997 . . . . 0.0 113.138 -163.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.452 ' HB2' ' CG2' ' A' ' 24' ' ' VAL . 6.4 t -97.19 123.3 40.92 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.4 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -66.76 -30.9 71.24 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -174.112 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -107.06 18.81 21.28 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.252 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -162.7 20.21 0.17 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 118.815 -1.66 . . . . 0.0 115.715 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.51 ' HA ' ' CE2' ' A' ' 17' ' ' PHE . 0.4 OUTLIER 55.91 -170.42 0.08 Allowed 'General case' 0 CA--C 1.587 2.387 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 177.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.692 ' HD1' ' HB3' ' A' ' 15' ' ' LYS . 72.9 t80 -39.79 126.06 1.92 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.253 1.421 . . . . 0.0 113.103 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.452 ' CG2' ' HB2' ' A' ' 18' ' ' SER . 40.2 t -106.49 -58.68 3.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.694 177.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 p -147.28 165.41 30.2 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.402 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 15.7 tt0 -111.21 165.08 12.22 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -178.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.915 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -51.85 134.87 35.17 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 115.976 1.15 . . . . 0.0 115.976 -176.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -123.52 8.85 8.98 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 122.404 1.097 . . . . 0.0 108.946 176.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.2 m -100.98 101.41 12.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.135 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -108.27 143.95 28.46 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.61 -29.0 77.58 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.504 2.136 . . . . 0.0 114.298 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -98.11 -41.67 7.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.503 0.192 . . . . 0.0 111.287 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -57.8 139.3 82.33 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -174.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -67.57 134.8 34.07 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.371 2.047 . . . . 0.0 109.561 175.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 ptpp? -123.51 111.13 15.92 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -173.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.45 81.53 1.56 Allowed 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 172.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 91.4 m -99.62 143.15 30.19 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -172.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.26 115.75 10.77 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 171.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mp -111.2 36.23 3.27 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.55 0.691 . . . . 0.0 110.138 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -92.98 158.98 15.52 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.753 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.426 ' CB ' ' HA ' ' A' ' 4' ' ' CYS . 33.6 m -67.01 105.35 1.62 Allowed 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.809 ' HB3' HG23 ' A' ' 45' ' ' ILE . 12.7 t70 -97.73 110.78 56.76 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.199 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.662 ' HA ' HG12 ' A' ' 3' ' ' ILE . 24.7 Cg_exo -63.56 -9.82 19.6 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.787 2.992 . . . . 0.0 114.854 -176.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.68 -34.97 15.2 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.675 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.809 HG23 ' HB3' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -87.59 100.26 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 122.001 0.905 . . . . 0.0 110.98 -176.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.86 -39.54 30.38 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.545 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -170.65 172.52 5.8 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.21 123.16 7.78 Favored Glycine 0 C--N 1.288 -2.138 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.0 t -96.32 100.83 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 73.1 m -80.94 153.66 72.57 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo . . . . . 0 C--N 1.35 0.614 0 C-N-CA 123.348 2.698 . . . . 0.0 113.269 -177.926 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 CA--C 1.552 1.039 0 CA-C-O 123.37 1.557 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.0 m -92.61 57.28 2.88 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.985 -178.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.592 ' HB ' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -90.65 -178.67 5.35 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 173.225 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -156.48 142.83 18.33 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 174.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.5 t -61.0 -46.66 89.87 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 123.758 0.661 . . . . 0.0 111.611 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.489 ' HA ' ' HB3' ' A' ' 28' ' ' GLU . 34.2 t -67.89 -51.16 51.18 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.885 -176.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.13 36.94 0.19 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.6 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . -109.35 170.66 14.6 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 176.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -74.77 122.47 23.35 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 117.008 0.404 . . . . 0.0 110.621 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.726 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -57.41 144.49 36.16 Favored 'General case' 0 C--O 1.241 0.606 0 O-C-N 121.902 -0.499 . . . . 0.0 110.048 173.613 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.08 -26.32 19.61 Favored Glycine 0 C--N 1.305 -1.171 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.5 m -91.28 130.92 37.09 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -84.13 103.67 13.53 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.584 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 17.0 m-85 -61.07 122.45 15.02 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.532 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -148.84 149.99 32.24 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.744 -167.214 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.594 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 33.6 t -89.88 133.61 34.66 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -47.46 -33.12 5.79 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.812 1.645 . . . . 0.0 114.155 -174.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -68.77 -19.71 64.33 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.532 ' HA2' ' CE2' ' A' ' 17' ' ' PHE . . . 122.61 18.79 3.22 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.326 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.594 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 69.1 m -103.5 125.49 50.09 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 117.197 0.498 . . . . 0.0 111.302 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -78.2 137.74 38.3 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 45' ' ' ILE . 21.7 t -111.29 -56.07 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.128 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.8 177.99 7.53 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.022 0.529 . . . . 0.0 109.687 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -147.51 103.9 3.58 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 118.776 0.716 . . . . 0.0 112.14 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.726 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . 73.55 84.98 0.26 Allowed Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.979 177.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.489 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 59.2 mm-40 -111.32 -37.38 5.3 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.6 ' HB2' ' O ' ' A' ' 10' ' ' GLY . 3.8 m -105.6 107.48 18.49 Favored 'General case' 0 C--O 1.248 0.992 0 O-C-N 121.877 -0.514 . . . . 0.0 111.331 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.406 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 56.4 t0 -139.88 129.82 13.92 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.406 ' HD2' ' OD1' ' A' ' 30' ' ' ASP . 21.1 Cg_endo -61.73 77.83 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.212 0 C-N-CA 123.004 2.47 . . . . 0.0 114.402 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -141.46 -56.96 0.48 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 173.263 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 1.2 p-10 -82.25 126.3 74.7 Favored Pre-proline 0 N--CA 1.432 -1.351 0 CA-C-O 121.37 0.605 . . . . 0.0 109.832 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 11.5 Cg_exo -70.37 166.26 28.96 Favored 'Trans proline' 0 C--O 1.253 1.271 0 C-N-CA 123.234 2.623 . . . . 0.0 111.534 175.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.747 ' HE3' ' HA ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER 83.09 142.69 0.07 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.311 1.844 . . . . 0.0 111.677 -179.439 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.3 157.75 17.5 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.3 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 24.0 m -85.88 164.4 17.51 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 t -65.66 156.51 32.68 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.309 0.576 . . . . 0.0 110.87 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.68 6.95 45.51 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.368 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -58.06 127.94 34.62 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.978 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 33.0 m -64.21 123.16 18.39 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.456 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -112.34 95.92 33.29 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -72.33 8.82 1.34 Allowed 'Trans proline' 0 N--CA 1.485 0.994 0 C-N-CA 123.267 2.645 . . . . 0.0 113.969 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.5 ttp-105 -90.45 -34.96 15.4 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.592 HG21 ' HB ' ' A' ' 5' ' ' THR . 1.6 tt -94.8 121.13 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.2 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.79 -47.66 8.45 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -167.76 169.3 11.79 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.694 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -97.03 120.35 6.68 Favored Glycine 0 C--N 1.284 -2.334 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.7 t -92.43 107.45 19.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 121.327 0.584 . . . . 0.0 110.364 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.74 153.87 64.59 Favored Pre-proline 0 C--N 1.296 -1.744 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo . . . . . 0 C--N 1.359 1.087 0 C-N-CA 123.457 2.771 . . . . 0.0 113.231 -178.684 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.4 tp . . . . . 0 N--CA 1.442 -0.831 0 CA-C-O 121.758 0.79 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.891 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 6.7 m -126.11 47.95 2.18 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-O 121.667 0.746 . . . . 0.0 112.876 -175.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.54 HG23 ' HA ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -90.24 116.33 28.14 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 172.156 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.452 HD22 ' HB1' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -126.5 156.53 40.6 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -178.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.491 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 45.0 t -88.72 -47.18 8.43 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -172.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.4 t -61.38 -53.93 50.2 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.262 0.553 . . . . 0.0 111.35 -174.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.452 ' HB1' HD22 ' A' ' 6' ' ' ASN . . . -90.48 24.83 2.46 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.588 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.532 ' HA3' ' CE1' ' A' ' 16' ' ' TYR . . . -90.77 149.97 20.35 Favored Glycine 0 N--CA 1.431 -1.671 0 C-N-CA 120.096 -1.05 . . . . 0.0 110.876 177.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.37 117.98 5.45 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 123.477 0.711 . . . . 0.0 111.48 -176.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.718 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 40.2 ttmt -53.31 107.46 0.24 Allowed 'General case' 0 C--O 1.238 0.49 0 O-C-N 123.882 0.738 . . . . 0.0 112.777 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.54 -30.8 3.07 Favored Glycine 0 C--N 1.303 -1.274 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.1 m -86.26 121.86 29.43 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 63.7 mmtt -80.75 108.1 14.12 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.592 ' HD2' HG21 ' A' ' 45' ' ' ILE . 43.1 m-85 -71.25 109.94 5.59 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.02 151.22 50.6 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.567 -165.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.429 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 6.3 t -87.87 129.55 35.18 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.08 -9.18 20.36 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -168.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -79.61 -10.17 59.75 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 122.997 0.519 . . . . 0.0 111.1 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.89 33.11 2.47 Favored Glycine 0 C--N 1.315 -0.611 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.2 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 52.5 m -124.94 106.45 9.98 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 121.021 0.439 . . . . 0.0 110.788 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.415 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 58.2 t80 -70.91 124.14 23.64 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.528 176.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.03 -64.72 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.9 p -170.73 157.74 5.75 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 30.6 tt0 -85.24 138.86 32.07 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.718 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -63.57 135.15 41.69 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 176.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -126.48 34.96 4.72 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.792 -175.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 t -82.96 113.37 20.5 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -104.35 133.41 20.22 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -53.57 -14.94 5.58 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.616 2.877 . . . . 0.0 114.442 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -103.07 -27.08 12.79 Favored 'General case' 0 N--CA 1.441 -0.895 0 O-C-N 121.622 -0.674 . . . . 0.0 111.693 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -91.14 137.42 26.4 Favored Pre-proline 0 C--O 1.239 0.552 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -172.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -82.6 124.08 3.96 Favored 'Trans proline' 0 N--CA 1.442 -1.548 0 C-N-CA 122.461 2.108 . . . . 0.0 110.038 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.9 138.25 47.53 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.656 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.5 93.3 3.9 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.451 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.9 m -142.67 167.2 22.65 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.9 138.11 54.39 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.4 47.65 1.97 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.806 0.812 . . . . 0.0 109.958 -176.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -97.83 18.89 14.75 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.321 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.891 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 55.7 m 65.23 156.72 0.09 Allowed 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 125.701 1.6 . . . . 0.0 112.124 177.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -122.52 112.31 31.14 Favored Pre-proline 0 N--CA 1.466 0.357 0 O-C-N 120.411 -1.431 . . . . 0.0 113.127 -178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.68 -2.88 12.83 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.975 2.45 . . . . 0.0 113.941 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -85.6 -21.75 28.34 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.4 0.619 . . . . 0.0 109.673 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.592 HG21 ' HD2' ' A' ' 16' ' ' TYR . 95.3 mt -95.73 132.47 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.083 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.09 -55.67 3.65 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.692 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.54 ' HA ' HG23 ' A' ' 5' ' ' THR . 2.2 p90 -164.77 164.8 21.08 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.767 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -92.95 111.58 4.12 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.2 t -87.81 115.92 29.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 120.996 0.427 . . . . 0.0 110.3 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.7 m -96.16 105.14 20.02 Favored Pre-proline 0 C--N 1.293 -1.856 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 4.3 Cg_exo . . . . . 0 C--N 1.35 0.629 0 C-N-CA 123.202 2.601 . . . . 0.0 112.079 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.7 tp . . . . . 0 N--CA 1.438 -1.058 0 CA-C-O 123.154 1.454 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.972 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.7 m -83.98 48.02 1.4 Allowed 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -176.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -91.17 164.12 14.02 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.455 ' HB3' HD22 ' A' ' 39' ' ' LEU . 1.1 t-20 -160.49 152.37 20.0 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.008 0.822 . . . . 0.0 111.811 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.8 t -67.8 -44.35 77.53 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 46.5 t -59.0 -52.22 66.68 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.163 0.506 . . . . 0.0 109.715 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.446 ' HB3' ' H ' ' A' ' 37' ' ' CYS . . . -86.16 25.58 1.15 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.783 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.51 156.11 22.48 Favored Glycine 0 N--CA 1.423 -2.193 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.911 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.2 m -83.01 109.41 17.08 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 123.008 0.523 . . . . 0.0 111.704 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -47.38 141.11 5.07 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.639 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.73 -44.11 1.56 Allowed Glycine 0 C--N 1.303 -1.298 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.3 m -103.23 140.43 37.39 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.77 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 69.8 mttt -100.01 129.39 46.06 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 121.392 0.615 . . . . 0.0 110.432 -173.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.414 ' HB3' ' CG1' ' A' ' 45' ' ' ILE . 48.7 m-85 -84.14 132.14 34.71 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.241 -176.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.46 148.45 37.76 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.227 -168.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.575 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 29.6 t -91.5 141.14 29.06 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.211 -1.358 . . . . 0.0 109.442 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.2 -14.4 60.55 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.796 1.239 . . . . 0.0 112.388 -176.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.29 -6.65 59.24 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.106 0.479 . . . . 0.0 110.527 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.71 34.17 3.61 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.505 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 25.2 m -118.75 120.03 36.17 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.261 -178.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.77 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 47.7 t80 -74.91 128.91 36.7 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -98.54 -71.71 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.504 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -172.11 165.96 6.12 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -178.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.755 ' HG3' ' HG2' ' A' ' 15' ' ' LYS . 12.0 tt0 -85.35 158.63 20.21 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.19 127.73 29.7 Favored Glycine 0 C--O 1.238 0.367 0 O-C-N 123.602 0.564 . . . . 0.0 112.905 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.595 ' HB2' ' HA ' ' A' ' 8' ' ' CYS . 4.4 mm-40 -79.76 -22.69 42.9 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.494 0.188 . . . . 0.0 111.315 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.3 m -95.89 128.62 42.93 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-O 121.088 0.47 . . . . 0.0 110.047 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -79.53 124.41 83.85 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.43 82.62 0.1 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.488 2.792 . . . . 0.0 112.944 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 mmm180 -146.17 -70.44 0.25 Allowed 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -90.44 151.7 44.6 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.82 66.27 5.86 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.62 2.214 . . . . 0.0 111.781 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -80.38 130.6 35.28 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.145 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -131.76 160.88 34.26 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.285 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.446 ' H ' ' HB3' ' A' ' 9' ' ' ALA . 59.8 m -137.53 166.56 23.58 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.6 m -59.28 110.51 1.09 Allowed 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.455 HD22 ' HB3' ' A' ' 6' ' ' ASN . 12.8 mt -79.39 -62.54 1.66 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.554 -175.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 56.34 31.53 18.82 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.026 0.93 . . . . 0.0 111.253 -177.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.972 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 68.4 m 49.29 76.83 0.12 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.064 -177.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 6.7 t0 -53.27 112.74 3.9 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 123.869 0.868 . . . . 0.0 111.357 -174.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 10.9 Cg_exo -71.35 -11.31 28.42 Favored 'Trans proline' 0 C--O 1.242 0.695 0 C-N-CA 123.0 2.466 . . . . 0.0 112.828 -176.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.754 ' HA ' ' HE ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -91.41 -14.13 31.15 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.513 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.414 ' CG1' ' HB3' ' A' ' 16' ' ' TYR . 1.7 mp -108.85 124.24 65.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.155 0.503 . . . . 0.0 110.765 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.07 -47.76 5.11 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -164.47 166.21 20.7 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.715 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.11 130.5 10.34 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.2 t -109.54 115.88 50.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 25.6 m -82.05 141.19 46.67 Favored Pre-proline 0 C--N 1.288 -2.071 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 12.6 Cg_exo . . . . . 0 CA--C 1.54 0.783 0 C-N-CA 123.65 2.9 . . . . 0.0 114.01 -174.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.542 HG21 ' HA ' ' A' ' 43' ' ' PRO . 6.7 tp . . . . . 0 CA--C 1.547 0.838 0 CA-C-O 122.297 1.046 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.669 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 1.8 m -121.64 22.27 10.62 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 122.015 0.912 . . . . 0.0 111.727 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.37 144.08 26.15 Favored 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.77 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -126.06 151.8 46.67 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 17.2 t -86.59 -16.37 36.97 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 123.743 0.817 . . . . 0.0 111.346 -173.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.0 t -66.31 -43.97 84.72 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.93 0.871 . . . . 0.0 108.764 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' A' ' 36' ' ' ALA . . . -90.9 -102.39 0.1 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.483 172.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.48 -151.16 48.97 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-O 121.521 0.512 . . . . 0.0 113.813 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.795 HG23 ' HD3' ' A' ' 31' ' ' PRO . 95.0 m -143.88 110.96 5.75 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 122.679 0.392 . . . . 0.0 110.189 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.434 ' HE3' ' O ' ' A' ' 27' ' ' GLY . 17.0 ttmt -51.34 116.52 2.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.136 176.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.59 -38.25 1.59 Allowed Glycine 0 N--CA 1.418 -2.544 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.2 m -106.56 112.43 25.43 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.502 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 37.0 mttp -87.47 113.24 23.0 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.755 -175.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -65.79 123.44 19.76 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.174 -177.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -125.06 152.79 43.85 Favored 'General case' 0 N--CA 1.407 -2.605 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.314 -166.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.744 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 1.0 OUTLIER -105.7 127.04 52.83 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 113.221 -1.809 . . . . 0.0 106.325 179.158 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.7 -14.34 20.33 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -167.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.6 -18.14 60.61 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.266 175.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.91 3.12 6.45 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.032 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.744 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 97.7 m -83.13 117.18 22.71 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.97 0.414 . . . . 0.0 111.674 -177.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.502 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 20.4 t80 -76.08 119.14 19.61 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 169.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.4 HG12 ' NH2' ' A' ' 44' ' ' ARG . 18.0 t -87.39 -63.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.497 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 p -169.14 172.58 7.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.866 0.365 . . . . 0.0 111.206 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -97.1 150.52 20.75 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.434 ' O ' ' HE3' ' A' ' 12' ' ' LYS . . . -62.61 118.59 14.69 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -79.91 3.02 21.19 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -175.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.4 m -121.38 141.22 51.17 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-O 121.601 0.715 . . . . 0.0 110.53 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -99.0 145.29 29.73 Favored Pre-proline 0 C--N 1.285 -2.237 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.795 ' HD3' HG23 ' A' ' 11' ' ' THR . 6.6 Cg_endo -50.53 -19.78 5.34 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.37 2.713 . . . . 0.0 115.071 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.458 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 0.8 OUTLIER -82.24 -25.62 33.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.52 138.48 25.31 Favored Pre-proline 0 C--N 1.319 -0.723 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.767 177.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -86.34 -164.18 0.21 Allowed 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.759 2.306 . . . . 0.0 111.195 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt 73.62 164.57 0.28 Allowed 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 125.37 1.468 . . . . 0.0 112.833 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.477 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . . . -155.58 143.28 19.69 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 178.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 55.7 m -79.85 125.19 29.39 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.42 79.44 0.26 Allowed 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 124.079 0.952 . . . . 0.0 112.249 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.6 tp -100.34 -18.91 16.56 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.884 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 65.63 55.12 1.03 Allowed 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 124.389 1.076 . . . . 0.0 110.19 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.669 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 20.7 m 74.78 138.04 0.06 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 125.686 1.594 . . . . 0.0 110.744 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -107.52 91.71 7.49 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.542 ' HA ' HG21 ' A' ' 3' ' ' ILE . 3.5 Cg_exo -77.25 0.67 9.51 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 123.117 2.545 . . . . 0.0 112.325 -175.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.4 ' NH2' HG12 ' A' ' 24' ' ' VAL . 15.3 ttp-105 -85.63 -19.13 31.44 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 74.1 mt -82.42 141.01 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.61 -57.96 2.32 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.433 0.635 . . . . 0.0 109.47 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -160.34 170.7 20.52 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.201 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.03 125.39 8.56 Favored Glycine 0 C--N 1.291 -1.92 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.7 t -95.95 106.19 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 m -93.96 111.9 54.93 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 177.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 C--O 1.236 0.409 0 C-N-CA 123.177 2.584 . . . . 0.0 112.225 -177.372 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 1.011 ' HB ' ' HA ' ' A' ' 43' ' ' PRO . 37.5 mm . . . . . 0 N--CA 1.428 -1.565 0 CA-C-O 121.293 0.568 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.6 m -97.32 32.33 2.25 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 122.284 1.04 . . . . 0.0 112.526 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.448 ' HB ' HG22 ' A' ' 45' ' ' ILE . 3.6 m -81.44 140.95 34.35 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 171.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -133.13 148.23 52.11 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.305 -174.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.7 t -83.77 -28.02 28.46 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.564 1.145 . . . . 0.0 110.815 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.1 t -62.94 -59.99 4.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.421 0.629 . . . . 0.0 110.828 -175.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.82 47.86 1.39 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.254 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.794 ' HA3' ' HE1' ' A' ' 16' ' ' TYR . . . -93.04 -110.07 1.95 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.73 175.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.9 m -162.86 127.65 3.11 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 123.857 0.863 . . . . 0.0 108.746 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 1.07 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -64.24 128.95 38.0 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.917 174.313 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.93 -26.42 11.56 Favored Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 m -89.68 127.53 35.94 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.508 ' HG2' ' HG3' ' A' ' 26' ' ' GLU . 43.9 mtpt -86.11 114.61 23.1 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.794 ' HE1' ' HA3' ' A' ' 10' ' ' GLY . 57.3 m-85 -72.85 111.95 8.44 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 178.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.561 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -134.94 147.74 49.85 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.871 -166.307 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.439 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 21.6 p -97.13 148.17 23.32 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.556 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -62.97 -16.7 60.48 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.663 1.185 . . . . 0.0 113.218 -172.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -77.6 -12.01 59.92 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.382 0.61 . . . . 0.0 109.72 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.561 ' HA2' ' CE2' ' A' ' 17' ' ' PHE . . . 101.59 40.93 2.63 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.393 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.439 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 41.6 m -127.26 131.92 50.46 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.612 0.72 . . . . 0.0 111.93 -178.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.601 ' HE1' ' HB2' ' A' ' 26' ' ' GLU . 78.1 t80 -72.51 130.24 40.18 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.245 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 t -106.07 -49.08 8.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 120.911 0.386 . . . . 0.0 109.993 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.1 p -164.77 174.39 10.73 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.601 ' HB2' ' HE1' ' A' ' 23' ' ' PHE . 2.2 tm-20 -153.51 140.78 19.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.834 0.743 . . . . 0.0 111.636 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 1.07 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . 57.27 55.57 29.66 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 116.684 1.433 . . . . 0.0 116.684 171.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -81.58 -44.98 16.52 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.605 0.716 . . . . 0.0 109.614 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.21 78.32 8.85 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.609 -174.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.614 ' HA ' ' HG2' ' A' ' 12' ' ' LYS . 18.8 t0 -89.69 129.29 47.31 Favored Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -64.28 51.19 0.18 Allowed 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 123.921 3.081 . . . . 0.0 113.721 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -147.18 -45.52 0.17 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 125.294 1.437 . . . . 0.0 107.721 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -84.26 124.38 74.01 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -86.88 106.36 0.69 Allowed 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.737 2.292 . . . . 0.0 110.333 173.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.403 ' HE2' ' HB2' ' A' ' 35' ' ' LYS . 17.5 mtmm -115.36 102.83 10.21 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.25 98.9 6.82 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.28 0.562 . . . . 0.0 110.106 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.4 m -114.77 124.69 52.41 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.37 -42.28 71.98 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.0 -175.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.5 tp -158.98 -64.82 0.08 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 m120 61.2 49.29 5.61 Favored 'General case' 0 C--O 1.245 0.867 0 O-C-N 124.197 0.936 . . . . 0.0 112.148 176.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 84.9 m -57.98 120.96 9.46 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.513 ' O ' HG23 ' A' ' 45' ' ' ILE . 2.2 t70 -116.21 100.51 53.55 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -177.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 1.011 ' HA ' ' HB ' ' A' ' 3' ' ' ILE . 44.2 Cg_endo -68.74 -6.48 18.04 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.858 2.372 . . . . 0.0 113.97 -174.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.428 ' O ' ' HB3' ' A' ' 18' ' ' SER . 0.7 OUTLIER -90.55 -25.4 20.24 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 111.755 0.279 . . . . 0.0 111.755 -178.572 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 42' ' ' ASP . 3.8 tt -88.39 147.13 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 121.411 0.624 . . . . 0.0 111.07 -177.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.91 -50.92 4.03 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.77 175.24 4.0 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.234 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.33 121.69 6.82 Favored Glycine 0 N--CA 1.429 -1.825 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.6 t -104.3 103.82 15.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.033 0.444 . . . . 0.0 110.446 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 17.3 m -79.89 112.67 31.69 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 170.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo . . . . . 0 C--N 1.354 0.859 0 C-N-CA 124.29 3.327 . . . . 0.0 114.272 -171.733 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.443 ' O ' ' HB3' ' A' ' 41' ' ' CYS . 19.3 tt . . . . . 0 CA--C 1.546 0.791 0 CA-C-O 122.207 1.003 . . . . 0.0 112.458 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 97.0 m -128.65 40.36 3.66 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.811 0.815 . . . . 0.0 110.792 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.459 HG21 ' HA ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -62.75 133.67 55.13 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.765 176.678 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -144.84 148.69 34.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.083 0.468 . . . . 0.0 110.164 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 t -75.22 -25.84 58.46 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.839 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.1 t -59.48 -56.06 26.71 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.361 0.601 . . . . 0.0 109.448 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . . . -90.74 23.29 3.15 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.309 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.62 141.85 31.44 Favored Glycine 0 N--CA 1.424 -2.132 0 C-N-CA 120.34 -0.933 . . . . 0.0 111.932 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.0 m -75.4 117.1 16.83 Favored 'General case' 0 C--N 1.273 -2.737 0 O-C-N 123.886 0.404 . . . . 0.0 111.451 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -53.03 120.63 6.1 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.51 0.724 . . . . 0.0 109.129 175.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.92 -31.27 6.16 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.8 m -91.0 126.82 36.2 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 178.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -90.09 109.39 20.44 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.623 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 18.8 m-85 -71.54 115.16 10.4 Favored 'General case' 0 CA--C 1.484 -1.569 0 CA-C-O 121.875 0.845 . . . . 0.0 109.287 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.463 ' HE1' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -133.81 145.19 49.52 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 113.281 -1.781 . . . . 0.0 111.612 -167.227 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.505 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 53.4 p -98.22 148.16 23.89 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -13.16 44.16 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -173.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.7 -0.99 40.75 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.213 0.53 . . . . 0.0 110.453 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.463 ' HA2' ' HE1' ' A' ' 17' ' ' PHE . . . 92.94 36.22 6.11 Favored Glycine 0 N--CA 1.43 -1.735 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.039 176.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.505 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 90.7 m -122.11 121.5 37.06 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.759 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -73.29 124.37 25.57 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.439 HG21 HG12 ' A' ' 45' ' ' ILE . 34.3 t -96.2 -60.76 2.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.515 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.8 p -161.95 161.05 28.49 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.675 -0.41 . . . . 0.0 112.074 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -81.45 149.31 28.83 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 174.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.5 127.38 45.05 Favored Glycine 0 CA--C 1.524 0.64 0 O-C-N 123.587 0.554 . . . . 0.0 113.046 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -83.53 -21.0 32.85 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.6 m -100.86 131.01 46.95 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 121.266 0.555 . . . . 0.0 111.609 -176.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.801 ' HB3' ' HB3' ' A' ' 33' ' ' ASN . 25.1 t70 -79.72 140.23 54.84 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -56.01 -12.41 7.22 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.286 2.657 . . . . 0.0 114.374 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -121.6 7.98 10.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 122.329 0.252 . . . . 0.0 111.325 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.801 ' HB3' ' HB3' ' A' ' 30' ' ' ASP . 2.4 p-10 -90.58 138.16 26.86 Favored Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.729 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -76.46 121.37 5.99 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.706 1.604 . . . . 0.0 108.686 171.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.7 pttm -128.84 162.46 27.43 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 120.822 0.344 . . . . 0.0 111.552 -173.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.41 45.62 1.73 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.103 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 9' ' ' ALA . 89.6 m -79.54 148.67 31.7 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.7 t -79.69 -175.7 4.97 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.488 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.51 39.95 1.88 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.339 0.656 . . . . 0.0 110.269 -175.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -66.08 106.21 1.56 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.156 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 3.3 m -73.08 112.59 9.26 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.447 -178.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -92.6 101.13 4.6 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 3.0 Cg_exo -74.22 -3.53 13.96 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 123.144 2.563 . . . . 0.0 112.526 -174.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -87.8 -34.59 18.23 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.172 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.439 HG12 HG21 ' A' ' 24' ' ' VAL . 79.4 mt -87.05 142.28 13.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.23 -65.46 1.0 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.459 ' HA ' HG21 ' A' ' 5' ' ' THR . 0.5 OUTLIER -161.02 169.17 23.05 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.077 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.623 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -96.11 103.51 2.96 Favored Glycine 0 N--CA 1.429 -1.799 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.515 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 71.4 t -79.9 113.75 19.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.69 102.87 2.92 Favored Pre-proline 0 C--N 1.308 -1.231 0 C-N-CA 122.988 0.515 . . . . 0.0 109.636 175.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 49' ' ' VAL . 9.5 Cg_endo . . . . . 0 N--CA 1.441 -1.56 0 C-N-CA 123.0 2.467 . . . . 0.0 111.567 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.7 tp . . . . . 0 CA--C 1.544 0.743 0 CA-C-O 122.148 0.975 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.813 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 22.4 m -105.26 29.36 6.49 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 122.227 1.013 . . . . 0.0 110.874 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -90.31 135.79 33.46 Favored 'General case' 0 N--CA 1.399 -2.981 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.393 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -126.25 154.75 42.92 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.57 ' HB2' HD12 ' A' ' 45' ' ' ILE . 17.5 t -88.81 -11.58 44.44 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.002 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.0 t -60.8 -49.43 77.5 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 120.91 0.386 . . . . 0.0 109.968 -178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.46 -87.34 0.17 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.06 -144.28 32.19 Favored Glycine 0 N--CA 1.438 -1.192 0 O-C-N 124.093 0.871 . . . . 0.0 114.182 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 4.6 t -147.06 115.44 6.66 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-O 120.951 0.405 . . . . 0.0 110.219 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -47.58 111.09 0.38 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.267 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.0 -35.31 2.32 Favored Glycine 0 N--CA 1.422 -2.292 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.362 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.4 m -96.9 131.59 43.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 117.534 0.667 . . . . 0.0 110.454 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.689 ' HE2' ' HB3' ' A' ' 51' ' ' PRO . 65.4 mttm -79.71 101.5 8.45 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.678 -174.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -70.98 112.32 7.05 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.0 147.97 42.83 Favored 'General case' 0 N--CA 1.407 -2.593 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.161 -167.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.01 137.12 32.62 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.684 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.61 -14.11 62.66 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -171.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.36 -15.18 60.02 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.958 0.409 . . . . 0.0 110.321 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.61 24.82 3.91 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.317 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -112.44 105.81 14.15 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.95 0.405 . . . . 0.0 111.522 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -71.01 130.32 41.26 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.5 t -99.09 -70.46 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -160.05 152.01 20.34 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 15.6 tt0 -93.86 43.26 1.11 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.563 0.697 . . . . 0.0 110.789 -175.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.84 127.39 0.95 Allowed Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.407 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -89.91 -24.88 21.22 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 120.705 -0.398 . . . . 0.0 112.014 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.32 157.91 44.84 Favored 'General case' 0 N--CA 1.424 -1.741 0 O-C-N 121.883 -0.511 . . . . 0.0 111.471 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.42 131.62 37.8 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 42.7 Cg_endo -65.43 -9.87 23.96 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.911 2.407 . . . . 0.0 115.15 -172.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.3 mtm180 -75.85 -23.74 55.73 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -91.25 146.12 32.85 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 172.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -74.1 84.77 1.45 Allowed 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.021 1.814 . . . . 0.0 112.408 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -95.25 127.87 41.64 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.21 100.45 6.97 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.41 0.624 . . . . 0.0 109.812 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.6 m -107.14 -172.9 2.17 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.446 ' C ' ' H ' ' A' ' 40' ' ' ASN . 0.2 OUTLIER -67.8 143.81 55.65 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 172.351 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.67 47.22 1.16 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 38' ' ' THR . 85.0 m-20 -54.0 112.95 1.06 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 112.288 -2.233 . . . . 0.0 110.236 177.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.813 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 60.4 m -81.79 78.42 8.52 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 170.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 45.3 t0 -70.64 111.91 11.26 Favored Pre-proline 0 CA--C 1.51 -0.579 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.377 -169.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 16.6 Cg_exo -70.97 -18.37 31.38 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.976 2.451 . . . . 0.0 110.986 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -70.76 -23.89 62.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.514 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.57 HD12 ' HB2' ' A' ' 7' ' ' CYS . 63.0 mt -95.76 125.62 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.87 -51.02 6.07 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -169.91 166.24 9.47 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.146 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.11 110.58 4.0 Favored Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -84.66 103.95 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 64.1 m -79.07 116.38 59.7 Favored Pre-proline 0 C--N 1.288 -2.076 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.689 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 37.3 Cg_endo . . . . . 0 N--CA 1.455 -0.787 0 C-N-CA 123.35 2.7 . . . . 0.0 114.992 -171.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.8 tp . . . . . 0 N--CA 1.436 -1.148 0 CA-C-O 121.527 0.68 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 71.6 m -99.2 56.62 1.03 Allowed 'General case' 0 N--CA 1.422 -1.87 0 CA-C-O 121.93 0.871 . . . . 0.0 111.763 -177.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.8 147.13 23.4 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.7 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -134.25 146.6 50.22 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.511 ' HB2' HD11 ' A' ' 45' ' ' ILE . 8.0 t -101.61 -4.17 27.08 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.033 0.444 . . . . 0.0 110.063 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.1 t -60.41 -54.45 45.5 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.31 -83.31 0.28 Allowed 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.44 175.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . 67.55 173.21 6.54 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.005 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.56 111.76 24.59 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 122.019 -0.695 . . . . 0.0 109.911 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.406 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 1.2 tmmt? -47.46 127.24 10.86 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.315 0.646 . . . . 0.0 110.35 176.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.94 -32.42 6.0 Favored Glycine 0 N--CA 1.436 -1.303 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.7 m -94.35 128.32 40.8 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.631 ' HG2' ' HG2' ' A' ' 26' ' ' GLU . 43.0 mtmt -88.76 112.11 22.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.534 ' HD2' HG23 ' A' ' 45' ' ' ILE . 81.8 m-85 -74.38 114.36 12.66 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.165 0.983 . . . . 0.0 109.279 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.05 147.51 38.74 Favored 'General case' 0 N--CA 1.407 -2.588 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.443 -167.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.451 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 43.1 t -89.0 141.97 28.03 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.955 -1.475 . . . . 0.0 109.014 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -72.89 -8.23 54.61 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.232 0.613 . . . . 0.0 112.335 -174.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.5 -3.37 57.56 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.76 43.47 3.11 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.353 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 13.6 m -131.24 123.38 28.28 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 122.514 -0.404 . . . . 0.0 110.952 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.666 ' HZ ' ' HG3' ' A' ' 26' ' ' GLU . 52.2 t80 -81.42 129.04 34.48 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.5 t -95.17 -67.62 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.99 174.48 4.72 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.666 ' HG3' ' HZ ' ' A' ' 23' ' ' PHE . 32.3 mt-10 -102.35 157.75 16.68 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.2 132.18 45.36 Favored Glycine 0 C--O 1.242 0.625 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -100.47 -27.48 13.42 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.064 0.459 . . . . 0.0 110.568 -175.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.485 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 47.6 m -80.94 128.12 33.33 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 122.355 1.074 . . . . 0.0 112.926 -176.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.87 138.67 13.14 Favored Pre-proline 0 C--N 1.293 -1.879 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -13.2 -51.89 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.247 1 C-N-CA 127.735 5.623 . . . . 0.0 119.31 -175.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.524 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 6.2 tpp180 -63.37 -44.95 93.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.506 0.594 . . . . 0.0 111.275 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.485 ' OD1' ' HA ' ' A' ' 29' ' ' SER . 6.5 p30 -92.8 107.56 25.34 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-O 121.593 0.711 . . . . 0.0 111.22 176.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 32' ' ' ARG . 65.5 Cg_endo -94.35 67.49 0.34 Allowed 'Trans proline' 0 N--CA 1.443 -1.488 0 C-N-CA 123.117 2.544 . . . . 0.0 110.273 175.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 55.2 mtpt -74.94 92.36 2.57 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.889 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.64 82.77 7.88 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.6 m -79.64 159.37 26.77 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.869 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.574 HG22 ' H ' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.18 175.37 1.66 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.138 0.575 . . . . 0.0 112.102 -175.85 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.574 ' H ' HG22 ' A' ' 38' ' ' THR . 3.3 mm? -86.75 37.85 0.77 Allowed 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.393 1.077 . . . . 0.0 110.193 -171.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.436 ' H ' ' C ' ' A' ' 38' ' ' THR . 3.9 m120 -61.88 119.06 8.07 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.649 176.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 24.3 m -96.83 104.01 15.98 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -96.5 104.45 17.86 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.614 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 5.2 Cg_exo -76.85 -3.59 13.96 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 123.483 2.789 . . . . 0.0 111.983 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 18' ' ' SER . 4.6 tpp180 -77.86 -10.84 59.77 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.534 HG23 ' HD2' ' A' ' 16' ' ' TYR . 83.3 mt -102.43 130.45 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.171 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.37 -40.58 9.86 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -176.75 174.01 1.87 Allowed 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.75 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.77 114.0 4.89 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.8 t -79.63 100.69 4.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 121.338 0.589 . . . . 0.0 109.89 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -97.82 150.15 36.47 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 173.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo . . . . . 0 CA--C 1.538 0.715 0 C-N-CA 122.825 2.35 . . . . 0.0 111.869 179.975 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 41' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.648 0 CA-C-O 121.935 0.874 . . . . 0.0 109.645 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.77 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 60.5 m -128.59 37.01 4.18 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-O 122.333 1.063 . . . . 0.0 109.684 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.401 HG22 ' HA ' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -81.91 151.7 27.14 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-N 113.788 -1.551 . . . . 0.0 108.704 176.832 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -150.45 175.67 11.65 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.7 t -70.49 -30.09 66.79 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 118.149 0.431 . . . . 0.0 111.809 -174.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 4.4 t -76.09 -41.33 50.71 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.368 -0.832 . . . . 0.0 109.837 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.3 46.24 0.25 Allowed 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.617 ' HA3' ' HE1' ' A' ' 16' ' ' TYR . . . -140.37 -141.23 4.0 Favored Glycine 0 N--CA 1.431 -1.689 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.85 178.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.2 m -151.91 133.34 14.59 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 122.483 -0.422 . . . . 0.0 110.412 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.696 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 29.9 mmtt -50.52 121.89 6.36 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.348 1.059 . . . . 0.0 110.364 175.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 119.57 -34.11 4.37 Favored Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.477 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.2 m -92.85 132.06 37.33 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.563 ' HD3' ' HG2' ' A' ' 26' ' ' GLU . 10.3 mmtp -87.04 117.68 25.92 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -177.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.617 ' HE1' ' HA3' ' A' ' 10' ' ' GLY . 66.0 m-85 -70.18 120.36 15.75 Favored 'General case' 0 CA--C 1.479 -1.777 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -134.57 147.58 50.29 Favored 'General case' 0 N--CA 1.399 -3.017 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.331 -168.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.474 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 12.1 t -93.11 131.96 37.68 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.93 -10.45 53.42 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -170.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.25 -1.9 54.29 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.948 0.404 . . . . 0.0 110.956 176.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.62 59.21 0.75 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.711 175.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 18.9 m -146.8 133.09 19.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 O-C-N 122.484 -0.421 . . . . 0.0 110.426 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -83.92 120.32 25.95 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.9 t -93.56 -51.14 11.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-O 120.699 0.285 . . . . 0.0 110.553 -177.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.4 p -169.85 165.32 9.77 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.563 ' HG2' ' HD3' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -94.44 171.87 8.54 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 176.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.696 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -52.5 128.87 36.51 Favored Glycine 0 N--CA 1.45 -0.431 0 O-C-N 123.703 0.627 . . . . 0.0 114.138 -175.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -100.82 -18.18 16.54 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.963 0.411 . . . . 0.0 110.374 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 m -120.07 107.22 12.79 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -175.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -82.41 109.01 13.63 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 165.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.01 21.94 0.37 Allowed 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 123.49 2.793 . . . . 0.0 115.185 -170.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -83.12 -51.93 7.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -90.34 126.73 55.64 Favored Pre-proline 0 C--O 1.254 1.306 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.81 139.7 81.55 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.606 2.871 . . . . 0.0 113.681 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.39 152.4 27.49 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.53 83.67 1.9 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.032 0.444 . . . . 0.0 111.394 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 78.5 m -83.25 123.2 29.36 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.99 167.53 3.79 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.176 0.99 . . . . 0.0 112.882 -175.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.7 mt -94.4 34.86 1.25 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -61.8 119.55 8.98 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.643 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.77 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 2.7 m -80.27 104.25 10.69 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.046 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -100.48 100.99 13.45 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 19.5 Cg_exo -69.04 -4.56 13.79 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.695 2.93 . . . . 0.0 113.453 -177.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.9 ttp-105 -75.61 -23.92 56.47 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 66.5 mt -110.84 161.6 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.489 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.45 -57.2 2.3 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 173.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.401 ' HA ' HG22 ' A' ' 5' ' ' THR . 0.2 OUTLIER -162.86 179.09 7.86 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.0 178.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -100.5 116.58 5.62 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 177.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.6 t -104.18 122.97 57.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.043 0.449 . . . . 0.0 110.426 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -96.09 104.79 18.21 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 171.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 C--O 1.241 0.642 0 C-N-CA 122.982 2.455 . . . . 0.0 113.396 -174.016 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 34.4 t70 . . . . . 0 CA--C 1.517 -0.3 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.476 ' HG3' ' SG ' ' A' ' 4' ' ' CYS . 2.1 tpm_? -151.97 91.84 1.66 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.3 tp -72.61 76.29 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-O 122.95 1.357 . . . . 0.0 111.861 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.839 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 96.6 m -111.38 33.7 4.54 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-O 122.004 0.907 . . . . 0.0 111.405 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -79.62 145.8 32.86 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.189 -1.369 . . . . 0.0 107.526 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -146.93 168.31 21.8 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -66.9 -28.3 68.2 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.4 t -68.32 -43.03 78.45 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.74 -2.5 23.63 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.328 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.42 161.75 54.33 Favored Glycine 0 N--CA 1.425 -2.093 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.576 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.1 m -116.32 122.55 45.22 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 122.528 0.331 . . . . 0.0 110.72 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 3.2 tttp -43.13 132.4 4.18 Favored 'General case' 0 C--O 1.247 0.973 0 C-N-CA 124.677 1.191 . . . . 0.0 111.464 175.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.98 -28.32 15.22 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.98 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.8 m -103.92 133.37 49.01 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 122.537 -0.39 . . . . 0.0 110.299 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HG3' ' HE1' ' A' ' 23' ' ' PHE . 12.6 mptt -84.62 118.47 24.39 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.815 -177.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -88.56 105.97 18.0 Favored 'General case' 0 CA--C 1.492 -1.284 0 CA-C-O 123.2 1.476 . . . . 0.0 108.727 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -123.09 146.98 47.24 Favored 'General case' 0 C--N 1.269 -2.933 0 CA-C-N 111.959 -2.382 . . . . 0.0 111.589 -165.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.437 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 19.4 p -94.91 145.7 24.74 Favored 'General case' 0 N--CA 1.408 -2.531 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.587 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.2 -12.99 57.09 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.964 0.905 . . . . 0.0 112.911 -173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -71.53 -20.09 62.09 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.87 30.6 2.95 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.128 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.0 m -123.85 136.76 54.57 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.342 0.592 . . . . 0.0 112.494 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.449 ' HE1' ' HG3' ' A' ' 15' ' ' LYS . 62.2 t80 -79.95 115.19 19.39 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.6 t -85.75 -61.55 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.9 p -164.38 154.73 14.64 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.434 ' HG3' ' HD2' ' A' ' 15' ' ' LYS . 13.2 tt0 -89.65 155.53 19.17 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 174.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -54.55 113.13 3.18 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.592 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -83.37 -10.53 58.4 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.5 m -95.78 125.72 40.55 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-O 121.403 0.62 . . . . 0.0 110.338 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.71 134.66 37.06 Favored Pre-proline 0 C--N 1.293 -1.89 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.038 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.88 -8.21 17.28 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.074 2.516 . . . . 0.0 114.72 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -63.66 -46.66 84.58 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 117.839 0.29 . . . . 0.0 110.823 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -90.14 138.14 27.54 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.02 95.88 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.882 2.388 . . . . 0.0 110.727 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -88.92 118.94 28.99 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.077 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.8 78.48 1.72 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 96.8 m -79.16 169.16 18.58 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.859 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.414 ' HB ' ' OD1' ' A' ' 40' ' ' ASN . 0.3 OUTLIER -61.73 155.83 21.82 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.61 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.4 mt -94.77 40.87 1.09 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.907 0.861 . . . . 0.0 109.563 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.414 ' OD1' ' HB ' ' A' ' 38' ' ' THR . 8.4 m120 -62.47 122.57 16.07 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 113.793 -1.548 . . . . 0.0 109.307 175.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.839 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 5.2 m -81.26 112.04 18.21 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.186 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -111.09 85.09 4.97 Favored Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 24.4 Cg_exo -63.19 -19.89 69.66 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 123.614 2.876 . . . . 0.0 113.695 -171.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 18' ' ' SER . 3.4 tmm_? -73.36 -9.64 58.91 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.277 0.561 . . . . 0.0 110.486 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.5 mt -101.24 124.49 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 172.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.84 -59.09 1.93 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.643 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -157.36 163.66 38.38 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.469 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.06 127.75 9.2 Favored Glycine 0 N--CA 1.407 -3.292 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.2 t -105.77 103.37 15.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 14.0 m -85.1 152.48 58.7 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -44.57 124.58 5.5 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 123.26 2.64 . . . . 0.0 112.6 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -78.93 68.66 4.94 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.991 0.901 . . . . 0.0 110.481 -177.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.7 m . . . . . 0 C--O 1.257 1.492 0 C-N-CA 124.701 1.2 . . . . 0.0 108.052 178.172 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.238 0.464 0 CA-C-O 120.564 0.221 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -94.51 80.83 3.88 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.162 0.506 . . . . 0.0 109.891 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 tt -65.55 107.06 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.161 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.87 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 22.2 m -119.73 43.21 2.71 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.62 ' HB ' HG23 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -90.74 163.81 14.35 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 170.29 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.633 ' HA ' ' HB3' ' A' ' 42' ' ' ASP . 7.9 p30 -151.42 136.13 17.15 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 119.116 0.871 . . . . 0.0 110.309 170.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 t -60.69 -34.51 74.45 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.277 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 t -74.45 -26.81 60.28 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.328 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.54 -54.39 4.59 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 18.76 -137.38 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 118.669 2.227 . . . . 0.0 118.669 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.506 ' H ' ' HE1' ' A' ' 16' ' ' TYR . 80.4 m -159.98 102.26 1.46 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.743 1.217 . . . . 0.0 109.789 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -46.75 128.11 10.38 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 125.136 1.375 . . . . 0.0 109.979 171.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.42 ' O ' ' HD2' ' A' ' 51' ' ' PRO . . . 111.49 -10.01 28.35 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 30.9 m -132.39 141.66 48.97 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.629 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 55.7 mmtt -82.56 131.02 35.22 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.506 ' HE1' ' H ' ' A' ' 11' ' ' THR . 12.3 m-85 -83.99 119.72 25.26 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.76 144.69 32.73 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.828 0.823 . . . . 0.0 112.369 -169.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.652 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 34.3 p -92.79 139.27 30.72 Favored 'General case' 0 N--CA 1.407 -2.623 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.017 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -62.74 -13.57 34.34 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -171.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -72.61 -15.16 61.74 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 120.833 0.349 . . . . 0.0 110.707 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.31 34.33 2.53 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.964 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.417 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 85.3 m -125.52 124.65 41.78 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.023 0.439 . . . . 0.0 110.88 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.629 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 69.0 t80 -76.97 132.61 39.11 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 175.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.9 t -106.18 -58.57 3.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.223 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.38 154.01 35.84 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.37 0.605 . . . . 0.0 112.46 -176.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -79.85 152.92 29.42 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.113 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.471 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -69.04 93.26 0.32 Allowed Glycine 0 N--CA 1.436 -1.308 0 O-C-N 123.927 0.767 . . . . 0.0 113.752 -175.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -100.25 -41.37 7.11 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.424 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 5.0 m -71.87 102.54 2.91 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -164.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -78.81 124.23 85.07 Favored Pre-proline 0 C--N 1.304 -1.394 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.794 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -87.9 1.9 6.65 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.911 2.407 . . . . 0.0 113.289 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -82.96 -46.59 12.73 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -86.23 156.85 57.0 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 173.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.71 55.8 4.98 Favored 'Trans proline' 0 C--O 1.246 0.91 0 C-N-CA 122.411 2.074 . . . . 0.0 113.426 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.424 ' HE2' ' HA ' ' A' ' 29' ' ' SER . 7.5 ttpt -88.75 97.28 11.05 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.415 0.626 . . . . 0.0 110.356 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.01 146.16 48.77 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.024 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.0 m -125.89 149.66 48.53 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.373 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.0 60.63 0.4 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.858 0.863 . . . . 0.0 112.271 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 tp -137.57 44.15 2.25 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 175.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -62.92 141.05 58.86 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 113.495 -1.684 . . . . 0.0 109.986 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.87 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 35.9 m 63.45 59.64 1.21 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.04 0.924 . . . . 0.0 110.328 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.633 ' HB3' ' HA ' ' A' ' 6' ' ' ASN . 61.3 t0 -82.8 109.43 16.64 Favored Pre-proline 0 C--N 1.312 -1.054 0 C-N-CA 125.45 1.5 . . . . 0.0 108.821 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 11.8 Cg_exo -69.68 -4.47 14.03 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 123.204 2.603 . . . . 0.0 113.616 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.652 ' O ' ' HB3' ' A' ' 18' ' ' SER . 1.6 mmp_? -85.17 -30.48 23.89 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.396 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.62 HG23 ' HB ' ' A' ' 5' ' ' THR . 7.3 tt -99.16 105.4 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.753 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.79 -42.71 23.87 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -167.54 176.44 6.51 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.919 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -109.07 124.74 7.45 Favored Glycine 0 C--N 1.285 -2.275 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.213 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.1 t -94.88 107.65 19.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 13.9 m -80.32 117.41 67.52 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.53 ' HG3' ' HE2' ' A' ' 15' ' ' LYS . 21.0 Cg_endo -58.4 133.01 52.03 Favored 'Trans proline' 0 C--O 1.24 0.613 0 C-N-CA 123.117 2.544 . . . . 0.0 113.614 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.5 ttp85 -136.35 105.18 5.86 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--N 1.291 -1.957 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -177.623 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 43' ' ' PRO . 4.6 p-10 . . . . . 0 C--O 1.218 -0.603 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -83.85 45.93 1.13 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.881 1.218 . . . . 0.0 113.004 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 tp -90.12 137.28 21.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 m -115.11 20.66 14.83 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.405 ' HA ' HD13 ' A' ' 39' ' ' LEU . 1.2 m -90.69 172.79 8.41 Favored 'General case' 0 C--N 1.273 -2.744 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.608 177.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.834 HD21 HD12 ' A' ' 39' ' ' LEU . 9.1 p30 -133.31 156.81 46.93 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.4 t -73.72 -35.59 65.11 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 123.791 0.836 . . . . 0.0 113.105 -174.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 45.7 t -59.5 -56.91 15.99 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.578 0.704 . . . . 0.0 109.801 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.633 ' HB1' ' HB2' ' A' ' 37' ' ' CYS . . . -90.53 26.38 2.01 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.55 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.15 163.68 26.77 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.606 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -53.77 110.83 0.63 Allowed 'General case' 0 C--O 1.241 0.646 0 C-N-CA 125.708 1.603 . . . . 0.0 113.111 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.603 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 27.1 ttpp -55.02 112.96 1.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.215 1.006 . . . . 0.0 111.627 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.01 -26.51 10.45 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.17 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.9 m -87.15 122.09 30.48 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -77.8 113.16 15.4 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.764 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.613 ' HD2' HG22 ' A' ' 45' ' ' ILE . 60.5 m-85 -72.91 106.65 4.92 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.85 145.11 44.03 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.499 -1.682 . . . . 0.0 111.154 -167.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.479 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 4.9 p -92.87 145.57 24.29 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.556 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -64.45 -14.7 58.37 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -170.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.71 8.27 20.36 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.405 0.622 . . . . 0.0 110.444 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.27 28.37 9.87 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 115.522 -0.763 . . . . 0.0 114.251 171.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.479 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 5.3 m -115.74 114.14 24.4 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 118.007 0.903 . . . . 0.0 112.027 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -67.44 116.78 8.57 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 171.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.68 -47.29 16.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.1 p -178.59 -175.58 0.44 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -125.6 144.3 50.64 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -66.36 146.09 48.31 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -130.75 1.75 4.42 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.42 0.629 . . . . 0.0 111.035 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.7 m -121.46 169.39 10.69 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-O 121.974 0.892 . . . . 0.0 112.127 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.482 ' HB3' ' OD1' ' A' ' 33' ' ' ASN . 30.6 t70 -114.43 116.98 43.51 Favored Pre-proline 0 C--N 1.287 -2.132 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 173.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 19.6 Cg_exo -67.79 26.98 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 124.018 3.145 . . . . 0.0 115.334 -173.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -116.79 -32.58 5.08 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.482 ' OD1' ' HB3' ' A' ' 30' ' ' ASP . 3.0 p-10 -90.54 152.14 44.88 Favored Pre-proline 0 C--O 1.245 0.851 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.179 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.79 103.55 0.72 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.228 2.618 . . . . 0.0 112.815 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.18 114.18 19.94 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.57 64.63 4.5 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.552 0.691 . . . . 0.0 112.845 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.633 ' HB2' ' HB1' ' A' ' 9' ' ' ALA . 58.8 m -113.18 118.15 33.91 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 172.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.9 p -65.03 141.01 58.91 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 123.565 0.54 . . . . 0.0 111.226 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.834 HD12 HD21 ' A' ' 6' ' ' ASN . 4.1 mm? -79.54 -74.14 0.31 Allowed 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 60.7 7.65 1.49 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.408 1.483 . . . . 0.0 113.643 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.524 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 60.6 m 58.83 123.58 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 125.416 1.486 . . . . 0.0 111.789 -173.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -110.62 83.64 3.54 Favored Pre-proline 0 C--N 1.323 -0.579 0 O-C-N 121.115 -0.991 . . . . 0.0 109.547 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 23.4 Cg_exo -65.46 -14.09 43.13 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 123.616 2.877 . . . . 0.0 114.11 -172.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -73.71 -25.09 60.04 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.567 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.613 HG22 ' HD2' ' A' ' 16' ' ' TYR . 87.3 mt -82.56 144.33 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.06 -59.69 2.13 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.6 174.04 11.28 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.176 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.73 99.13 2.02 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.94 107.26 12.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.343 0.592 . . . . 0.0 110.876 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.7 m -85.73 136.86 36.36 Favored Pre-proline 0 C--N 1.291 -1.953 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 170.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 16.9 Cg_exo -68.65 66.73 1.19 Allowed 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.446 2.764 . . . . 0.0 113.52 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -134.42 113.07 11.49 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.4 m . . . . . 0 C--N 1.278 -2.51 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.42 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 52.96 47.23 25.11 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.043 1.337 . . . . 0.0 113.662 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 tt -89.76 116.18 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 172.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.453 ' HA ' ' CB ' ' A' ' 41' ' ' CYS 0.252 98.7 m -88.66 19.32 4.03 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -174.156 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.7 m -90.64 136.14 33.25 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 171.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -119.3 158.06 26.83 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.611 ' HB2' HD12 ' A' ' 45' ' ' ILE . 6.9 t -84.86 -17.25 38.56 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.287 -174.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.3 t -67.9 -46.1 72.57 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.53 22.58 3.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.239 0.542 . . . . 0.0 109.593 173.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.71 152.91 37.81 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 115.738 -0.665 . . . . 0.0 114.75 -172.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 m -79.36 114.26 18.16 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 124.768 1.227 . . . . 0.0 110.277 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 26' ' ' GLU . 2.3 tmtp? -64.84 127.34 31.16 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.44 ' H ' ' HG2' ' A' ' 26' ' ' GLU . . . 113.48 -10.11 24.04 Favored Glycine 0 C--N 1.301 -1.372 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -176.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.5 m -105.75 127.54 53.15 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.403 ' HA ' ' HE1' ' A' ' 23' ' ' PHE . 20.7 mmmt -84.84 94.02 8.63 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -178.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -72.51 111.22 7.49 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 175.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -140.91 151.69 44.44 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.794 -164.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.9 t -97.17 138.96 33.86 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.537 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.441 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 3.5 p30 -69.12 -3.59 13.99 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.732 0.813 . . . . 0.0 112.894 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.07 -8.88 59.0 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.765 176.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.45 25.05 6.48 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.93 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 m -122.02 114.91 21.6 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 122.565 -0.374 . . . . 0.0 111.662 -177.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.491 ' HZ ' ' HB2' ' A' ' 26' ' ' GLU . 73.6 t80 -73.34 130.8 40.95 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.91 -62.05 2.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.895 -175.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 p -162.73 155.51 19.34 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.598 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 20.0 tt0 -103.76 44.82 0.99 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.517 0.675 . . . . 0.0 110.461 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.89 -162.8 49.0 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.872 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -112.26 -69.74 0.85 Allowed 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 120.974 0.416 . . . . 0.0 109.988 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.4 m -144.56 -166.49 2.4 Favored 'General case' 0 N--CA 1.407 -2.62 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -177.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.48 133.74 59.28 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.66 1.54 0.39 Allowed 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 123.505 2.803 . . . . 0.0 115.205 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -61.39 -47.91 83.62 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -91.81 117.56 67.81 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 172.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -76.63 121.52 6.0 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 121.551 1.501 . . . . 0.0 111.081 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.93 116.21 24.84 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.59 113.16 20.11 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.376 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.6 m -141.96 -177.68 5.33 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.32 157.39 29.26 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 120.867 0.365 . . . . 0.0 110.616 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.49 32.92 1.9 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.898 0.856 . . . . 0.0 109.838 -175.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -78.14 136.16 37.8 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.188 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.475 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 19.6 m -76.27 123.48 25.97 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -83.78 105.27 5.31 Favored Pre-proline 0 N--CA 1.468 0.454 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.699 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 68.1 Cg_endo -83.45 1.72 8.8 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.929 2.419 . . . . 0.0 111.725 -174.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 ttp-105 -83.04 -20.55 34.78 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.611 HD12 ' HB2' ' A' ' 7' ' ' CYS . 71.8 mt -108.02 152.64 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.491 -1.232 . . . . 0.0 109.018 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.26 -50.58 3.12 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 19' ' ' ASP . 15.9 p90 -159.16 175.54 13.33 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -114.62 112.16 2.71 Favored Glycine 0 N--CA 1.428 -1.894 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.339 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.529 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 56.2 t -82.29 106.29 13.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 85.7 m -105.67 99.29 20.89 Favored Pre-proline 0 C--N 1.298 -1.657 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.231 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 49' ' ' VAL . 3.6 Cg_exo -78.44 66.76 8.44 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.296 2.664 . . . . 0.0 109.594 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -143.1 108.09 4.94 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.253 1.279 0 C-N-CA 125.017 1.327 . . . . 0.0 111.413 179.173 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.5 t0 . . . . . 0 CA--C 1.51 -0.592 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.619 ' HB3' ' SG ' ' A' ' 41' ' ' CYS . 23.8 mmt180 68.63 128.64 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.108 1.363 . . . . 0.0 112.493 176.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 tp -76.47 65.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-O 122.911 1.339 . . . . 0.0 109.769 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.949 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.8 m -88.58 40.83 0.98 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.991 0.901 . . . . 0.0 112.282 -176.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -90.83 127.25 36.29 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 171.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -146.27 178.8 7.97 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.524 -0.871 . . . . 0.0 112.548 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -85.17 -32.93 22.44 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.6 t -66.1 -50.43 64.07 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.933 0.873 . . . . 0.0 108.976 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.37 33.25 0.9 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.527 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.23 136.11 13.06 Favored Glycine 0 N--CA 1.41 -3.076 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.804 HG22 ' HA ' ' A' ' 31' ' ' PRO . 7.2 p -83.85 111.46 19.24 Favored 'General case' 0 C--N 1.268 -2.955 0 CA-C-N 113.924 -1.138 . . . . 0.0 111.834 -175.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -45.79 115.57 1.0 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.704 0.802 . . . . 0.0 110.854 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.49 -36.59 2.53 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 m -95.52 134.71 38.05 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.53 ' HG3' ' HG3' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -88.42 119.96 29.34 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -83.86 105.24 14.59 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 122.896 1.331 . . . . 0.0 108.142 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.593 ' HE1' ' HA2' ' A' ' 21' ' ' GLY . 0.5 OUTLIER -126.52 147.95 49.78 Favored 'General case' 0 N--CA 1.405 -2.684 0 CA-C-N 112.868 -1.969 . . . . 0.0 112.207 -164.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.7 142.58 29.31 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.113 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -58.18 -19.05 30.21 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.867 1.267 . . . . 0.0 114.208 -172.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.07 -8.03 59.17 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.131 0.491 . . . . 0.0 111.02 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.593 ' HA2' ' HE1' ' A' ' 17' ' ' PHE . . . 106.14 24.27 6.95 Favored Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.324 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.2 m -107.04 123.32 48.05 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.291 -0.563 . . . . 0.0 112.142 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -77.94 109.65 12.18 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.21 -52.09 15.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.9 p -174.46 169.54 3.71 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.53 ' HG3' ' HG3' ' A' ' 15' ' ' LYS . 15.8 tt0 -108.27 171.3 7.49 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.67 112.3 1.56 Allowed Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -83.08 -22.67 33.4 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.666 -0.267 . . . . 0.0 111.705 -172.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -130.36 -176.94 4.12 Favored 'General case' 0 N--CA 1.4 -2.962 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.472 -174.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -78.0 140.59 62.27 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.804 ' HA ' HG22 ' A' ' 11' ' ' THR . 1.0 OUTLIER -42.92 -27.07 0.8 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 124.922 3.748 . . . . 0.0 115.725 -179.501 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.465 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 19.5 mmt85 -122.64 46.09 2.23 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 118.409 0.549 . . . . 0.0 110.492 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -73.57 119.9 78.37 Favored Pre-proline 0 C--N 1.304 -1.382 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.525 175.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -87.25 94.21 0.48 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.787 2.324 . . . . 0.0 111.575 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -158.67 155.32 27.92 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.263 0.554 . . . . 0.0 111.478 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.16 131.53 45.13 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 173.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.2 m -115.28 135.51 54.07 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.208 0.528 . . . . 0.0 112.278 -174.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -18.26 62.9 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 123.573 0.749 . . . . 0.0 110.814 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 tp -86.33 25.31 1.21 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.099 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -53.67 121.09 7.13 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.937 176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.949 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 14.9 m 67.36 86.58 0.13 Allowed 'General case' 0 C--N 1.321 -0.661 0 O-C-N 124.504 1.128 . . . . 0.0 111.421 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -96.28 104.5 17.6 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.49 3.87 6.83 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.782 2.321 . . . . 0.0 113.041 -172.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -90.41 -15.57 30.73 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.49 0.662 . . . . 0.0 109.331 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 93.2 mt -101.18 140.94 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.49 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.95 -54.35 3.49 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -167.23 173.3 9.11 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.423 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.43 121.23 7.14 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.5 t -94.14 114.09 30.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 123.021 0.529 . . . . 0.0 109.582 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.6 m -99.84 129.39 28.72 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 32.2 Cg_exo -58.21 116.37 3.19 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 123.324 2.683 . . . . 0.0 112.114 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.0 tpt85 -156.11 -48.59 0.08 Allowed 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.546 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 C--N 1.304 -1.396 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.081 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 . . . . . 0 C--O 1.239 0.504 0 CA-C-O 120.816 0.341 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.7 tpp85 -175.74 -46.13 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.417 ' O ' ' HB3' ' A' ' 41' ' ' CYS . 6.1 tp -71.71 113.6 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 172.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 69.4 m -113.6 40.37 2.42 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.97 0.891 . . . . 0.0 112.781 -173.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 t -90.82 165.81 13.43 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 172.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -160.17 175.86 12.43 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 118.435 0.561 . . . . 0.0 111.11 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.4 t -69.11 -21.2 64.06 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.563 0.745 . . . . 0.0 112.275 -174.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.3 t -91.03 -54.82 3.79 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.56 -0.713 . . . . 0.0 109.965 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.22 37.43 0.1 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.21 175.3 30.67 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 175.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 m -109.48 124.74 51.58 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 117.037 0.419 . . . . 0.0 111.251 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.542 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -54.36 122.58 10.71 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.9 175.152 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.56 -35.52 2.65 Favored Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -176.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.1 m -105.75 151.15 24.82 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -88.28 123.99 33.44 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.515 ' CZ ' ' HA2' ' A' ' 27' ' ' GLY . 1.2 m-30 -77.45 106.89 9.51 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.416 ' CE1' ' HA ' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -141.01 151.74 44.35 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.599 0.714 . . . . 0.0 112.77 -167.192 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.526 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 43.4 p -96.24 129.61 43.52 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 175.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.416 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 4.1 p-10 -62.64 -9.8 10.23 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -20.23 63.79 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.16 -0.19 6.51 Favored Glycine 0 N--CA 1.429 -1.812 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.404 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.526 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 3.8 m -97.45 118.07 33.12 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -76.56 121.77 23.65 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.417 HG22 HG12 ' A' ' 45' ' ' ILE . 23.5 t -95.53 -65.86 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.837 -176.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.56 155.75 43.81 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.964 0.412 . . . . 0.0 111.849 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.07 169.02 10.57 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.542 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -62.48 118.78 15.31 Favored Glycine 0 N--CA 1.439 -1.105 0 O-C-N 123.53 0.519 . . . . 0.0 113.306 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -131.24 1.52 4.19 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.01 0.433 . . . . 0.0 111.638 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.2 m -121.29 115.41 22.92 Favored 'General case' 0 N--CA 1.403 -2.779 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -114.12 140.83 25.42 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.74 -21.02 7.47 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.634 2.889 . . . . 0.0 114.958 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -90.94 -24.99 19.99 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.495 ' HA ' ' HD3' ' A' ' 34' ' ' PRO 0.254 28.5 p30 -91.4 115.28 64.12 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.344 0.592 . . . . 0.0 112.484 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 17.2 Cg_exo -65.43 111.74 1.93 Allowed 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 123.313 2.675 . . . . 0.0 111.573 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -139.45 120.29 14.39 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.61 92.92 7.23 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.525 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.6 m -88.7 165.66 14.6 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.804 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.08 149.68 42.93 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.952 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -95.88 33.22 1.72 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.13 147.19 40.73 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.995 -1.457 . . . . 0.0 111.443 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 35.0 m -106.99 93.77 4.74 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.529 ' OD1' ' HB3' ' A' ' 44' ' ' ARG . 9.9 t70 -80.65 103.2 1.66 Allowed Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 123.871 0.868 . . . . 0.0 110.572 -175.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 52.6 Cg_endo -72.79 -7.12 20.25 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.637 2.225 . . . . 0.0 112.464 -174.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.529 ' HB3' ' OD1' ' A' ' 42' ' ' ASP . 16.9 ttp180 -82.81 -45.94 13.69 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.417 HG12 HG22 ' A' ' 24' ' ' VAL . 79.6 mt -79.72 128.95 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 CA-C-O 121.538 0.685 . . . . 0.0 109.965 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.05 -55.41 3.95 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.898 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -171.38 171.24 5.62 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.03 117.06 4.93 Favored Glycine 0 N--CA 1.423 -2.199 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.7 t -93.08 117.32 36.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.35 0.595 . . . . 0.0 111.419 -176.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.3 m -105.73 102.34 37.89 Favored Pre-proline 0 C--N 1.285 -2.198 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 171.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -36.55 116.32 0.15 Allowed 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 125.092 3.861 . . . . 0.0 114.513 -174.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 -82.22 66.52 7.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.237 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.303 -1.453 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.423 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 40.6 t0 . . . . . 0 CA--C 1.51 -0.593 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -98.51 105.97 18.19 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.457 HG13 ' OG1' ' A' ' 5' ' ' THR . 6.5 tp -77.08 122.09 30.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 121.624 0.726 . . . . 0.0 111.231 -178.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.48 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 19.3 m -136.38 47.16 2.22 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 121.972 0.892 . . . . 0.0 110.3 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.457 ' OG1' HG13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -72.17 160.41 32.49 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.961 178.153 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -158.93 149.25 19.56 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 t -105.79 18.36 22.27 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.357 0.598 . . . . 0.0 112.048 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 t -85.84 -46.01 11.02 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.527 ' HA ' ' OG ' ' A' ' 29' ' ' SER . . . -91.05 -100.01 0.11 Allowed 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.386 173.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.62 -140.3 28.98 Favored Glycine 0 N--CA 1.414 -2.779 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.563 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 m -154.0 119.3 5.12 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.568 ' HD3' ' HB2' ' A' ' 30' ' ' ASP . 15.0 ttpt -57.26 127.05 30.0 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 123.704 0.627 . . . . 0.0 110.613 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.19 -12.83 65.2 Favored Glycine 0 C--N 1.304 -1.201 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.391 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.9 m -99.06 128.65 45.24 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -80.13 92.2 5.63 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.988 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.595 ' HD2' HG23 ' A' ' 45' ' ' ILE . 27.9 m-85 -71.21 115.5 10.44 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.426 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -146.5 151.64 37.71 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.009 -161.747 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.3 t -86.86 137.19 32.61 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.427 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -57.98 -22.45 49.45 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.6 -18.61 60.54 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.181 0.515 . . . . 0.0 110.888 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.426 ' HA2' ' CE2' ' A' ' 17' ' ' PHE . . . 118.65 20.29 4.26 Favored Glycine 0 N--CA 1.425 -2.076 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.404 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 m -104.8 108.33 19.75 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 117.312 0.556 . . . . 0.0 110.173 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.492 ' CZ ' ' HG3' ' A' ' 26' ' ' GLU . 75.1 t80 -68.92 137.15 53.57 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.6 t -108.23 -64.56 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.713 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.3 p -163.35 155.34 17.69 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.492 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 18.3 mt-10 -97.52 39.19 1.21 Allowed 'General case' 0 C--O 1.242 0.676 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -175.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.21 127.74 0.27 Allowed Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.446 -0.797 . . . . 0.0 114.165 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -105.4 27.81 7.97 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 122.377 -0.484 . . . . 0.0 111.036 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.527 ' OG ' ' HA ' ' A' ' 9' ' ' ALA . 4.3 m -141.74 109.1 5.56 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.568 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 21.0 t70 -96.18 130.45 31.08 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 167.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -59.44 50.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.511 2.51 0 C-N-CA 124.859 3.706 . . . . 0.0 116.189 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -128.56 -56.12 1.22 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -90.5 130.06 42.81 Favored Pre-proline 0 N--CA 1.442 -0.85 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 175.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.28 147.75 11.5 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.258 1.972 . . . . 0.0 110.853 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.526 ' HB3' ' SG ' ' A' ' 37' ' ' CYS . 27.6 mmtp -120.28 89.7 3.18 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.477 0.656 . . . . 0.0 109.893 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.99 59.51 5.67 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.178 0.99 . . . . 0.0 110.041 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' SG ' ' HB3' ' A' ' 35' ' ' LYS . 3.4 m -88.46 -178.79 5.94 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.808 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.45 ' C ' ' H ' ' A' ' 40' ' ' ASN . 0.2 OUTLIER -80.48 137.49 36.47 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 174.277 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.9 tp -89.1 43.72 1.16 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.377 1.084 . . . . 0.0 110.105 -174.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.45 ' H ' ' C ' ' A' ' 38' ' ' THR . 3.1 m120 -53.17 122.54 9.67 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 112.837 -1.983 . . . . 0.0 110.926 172.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.524 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 34.8 m -71.94 108.67 5.31 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 175.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -104.88 91.57 4.44 Favored Pre-proline 0 C--N 1.31 -1.123 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 22.9 Cg_exo -64.66 -17.2 58.78 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 124.43 3.42 . . . . 0.0 114.818 -172.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.4 ttp-105 -59.68 -23.65 63.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.564 0.697 . . . . 0.0 110.139 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.595 HG23 ' HD2' ' A' ' 16' ' ' TYR . 95.1 mt -103.82 122.27 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.73 -46.56 8.52 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.143 -177.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -161.09 175.15 12.72 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.965 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -109.59 111.78 3.24 Favored Glycine 0 N--CA 1.415 -2.754 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.7 t -86.31 98.68 7.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.7 m -87.74 157.49 52.03 Favored Pre-proline 0 C--N 1.285 -2.212 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -74.46 66.62 5.51 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.636 2.224 . . . . 0.0 109.709 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -110.19 23.05 14.82 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.67 -174.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.429 -1.515 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.675 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.444 ' OD1' ' HD3' ' A' ' 2' ' ' ARG . 11.4 t0 . . . . . 0 C--O 1.234 0.268 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.444 ' HD3' ' OD1' ' A' ' 1' ' ' ASP . 0.3 OUTLIER -88.63 46.48 1.39 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.639 1.209 . . . . 0.0 110.704 -176.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 tp -76.96 111.08 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.378 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.546 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 90.8 m -96.36 25.65 4.86 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 122.218 1.008 . . . . 0.0 112.317 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.7 m -90.82 141.94 28.28 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 173.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -136.84 167.15 22.02 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.97 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.497 ' HA ' ' CD2' ' A' ' 16' ' ' TYR . 6.4 t -70.95 -34.57 71.59 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 123.447 0.699 . . . . 0.0 112.695 -171.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 1.8 t -77.89 -36.43 49.69 Favored 'General case' 0 N--CA 1.424 -1.754 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.767 -177.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.58 34.28 0.32 Allowed 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.482 0.658 . . . . 0.0 111.09 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.523 ' HA3' ' HE2' ' A' ' 16' ' ' TYR . . . -119.29 168.75 13.49 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.36 143.25 30.77 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 116.929 0.365 . . . . 0.0 111.009 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -50.81 138.66 18.26 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.694 172.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.91 -33.08 6.66 Favored Glycine 0 C--N 1.3 -1.456 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 64.0 m -99.11 138.83 35.65 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.736 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 37.0 mtmt -110.94 127.76 55.59 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -175.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.523 ' HE2' ' HA3' ' A' ' 10' ' ' GLY . 28.6 m-85 -76.47 128.28 34.48 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.335 0.588 . . . . 0.0 110.443 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -148.07 147.05 29.13 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.162 -171.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.547 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 31.5 p -97.74 144.22 27.58 Favored 'General case' 0 N--CA 1.407 -2.588 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.889 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.0 -11.47 57.1 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.737 0.815 . . . . 0.0 113.14 -170.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -74.1 -14.12 60.93 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.68 48.74 1.25 Allowed Glycine 0 N--CA 1.427 -1.962 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.547 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 84.9 m -134.68 121.61 21.06 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.077 0.465 . . . . 0.0 110.803 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.736 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 78.1 t80 -69.67 120.23 15.12 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.3 t -89.57 -53.22 9.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.327 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.4 p -172.33 164.87 5.85 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.986 0.422 . . . . 0.0 110.458 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -88.87 146.05 25.19 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 123.765 0.826 . . . . 0.0 109.265 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.61 109.65 2.49 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 1.1 mm-40 -101.49 23.49 11.03 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 10' ' ' GLY . 5.5 m -113.32 102.7 10.59 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-O 121.285 0.564 . . . . 0.0 111.779 176.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.539 ' HB3' ' ND2' ' A' ' 33' ' ' ASN . 4.6 t70 -113.98 138.7 22.94 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 173.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.34 -19.83 5.06 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.981 3.121 . . . . 0.0 115.549 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -86.88 -37.75 17.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.91 -0.494 . . . . 0.0 111.345 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.539 ' ND2' ' HB3' ' A' ' 30' ' ' ASP . 14.9 p30 -90.44 116.9 67.44 Favored Pre-proline 0 C--N 1.317 -0.834 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.094 -177.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -80.85 117.91 3.35 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.237 1.958 . . . . 0.0 109.208 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.461 ' HE2' ' HB3' ' A' ' 28' ' ' GLU . 25.5 mmtm -109.36 139.89 43.75 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -171.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.55 125.05 30.04 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 166.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 73.0 m -128.94 150.47 50.36 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.785 -170.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 t -68.06 140.88 56.3 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 29.3 mt -106.85 -10.46 16.03 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.07 0.462 . . . . 0.0 110.833 -172.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -110.92 163.95 13.29 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.348 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 2.7 m -45.28 135.33 5.95 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 126.082 1.753 . . . . 0.0 112.596 -177.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -119.85 88.98 41.17 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.4 2.79 2.08 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 123.884 3.056 . . . . 0.0 115.214 -172.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -76.0 -24.54 55.32 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.865 0.84 . . . . 0.0 108.856 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.3 mt -95.89 149.47 4.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.023 -175.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.88 -53.01 2.84 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.42 170.7 18.33 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.883 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -102.45 98.17 1.66 Allowed Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.4 t -79.69 109.2 14.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.292 0.568 . . . . 0.0 109.882 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 3.4 m -80.66 115.08 52.97 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 106.131 -1.804 . . . . 0.0 106.131 173.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.609 ' HG3' ' HE2' ' A' ' 15' ' ' LYS . 24.5 Cg_exo -62.87 121.26 9.09 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 123.365 2.71 . . . . 0.0 114.169 -171.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -92.5 80.62 4.86 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 174.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 C--N 1.298 -1.636 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.901 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.241 0.613 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.453 ' HB3' ' SG ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -170.04 161.04 8.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 -178.359 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 tt -76.6 81.97 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 122.793 1.282 . . . . 0.0 109.361 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.739 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 78.2 m -124.37 43.66 2.95 Favored 'General case' 0 N--CA 1.406 -2.631 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.918 -175.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.401 ' HB ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -77.97 148.64 34.36 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 173.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -128.61 142.97 50.87 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 118.871 -1.131 . . . . 0.0 113.501 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.7 t -98.97 13.03 34.16 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.321 1.057 . . . . 0.0 108.619 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.7 t -85.92 -70.39 0.6 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.773 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.1 -71.5 0.64 Allowed 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.33 -159.62 53.76 Favored Glycine 0 N--CA 1.415 -2.714 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.604 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 m -122.08 98.17 5.81 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.741 ' HE3' ' HB2' ' A' ' 30' ' ' ASP . 0.5 OUTLIER -40.18 122.22 1.49 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.031 0.932 . . . . 0.0 112.103 175.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.02 -42.01 1.92 Allowed Glycine 0 N--CA 1.435 -1.414 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.601 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 70.0 m -89.42 147.43 24.04 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.554 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 18.4 mtpp -97.36 116.19 29.1 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -175.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.826 ' HB3' HG13 ' A' ' 45' ' ' ILE . 10.9 m-85 -77.61 115.94 17.77 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.025 0.917 . . . . 0.0 108.85 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.452 ' HE2' ' HA2' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -135.67 149.05 49.16 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.498 -166.09 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.81 134.06 37.84 Favored 'General case' 0 N--CA 1.41 -2.466 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.42 -20.45 19.74 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -169.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -76.03 -13.77 60.22 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.907 0.385 . . . . 0.0 111.669 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.452 ' HA2' ' HE2' ' A' ' 17' ' ' PHE . . . 114.8 19.11 6.16 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.054 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.6 m -104.53 110.2 22.39 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.837 0.351 . . . . 0.0 110.86 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.554 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 50.3 t80 -73.14 126.14 29.34 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.1 t -96.34 -61.14 2.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 120.842 0.353 . . . . 0.0 110.328 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.4 p -161.63 160.07 28.32 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -176.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -97.3 145.46 26.08 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 174.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -46.65 122.09 6.31 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 124.165 0.916 . . . . 0.0 112.133 -178.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.56 -52.75 6.54 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.898 0.38 . . . . 0.0 111.13 -173.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.7 m -102.69 145.16 30.11 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-O 121.684 0.754 . . . . 0.0 111.963 -170.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.741 ' HB2' ' HE3' ' A' ' 12' ' ' LYS . 11.3 t70 -87.91 139.07 30.9 Favored Pre-proline 0 C--N 1.288 -2.077 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 172.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -49.79 -20.18 4.42 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.233 2.622 . . . . 0.0 114.512 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -83.23 -21.59 33.35 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.28 2.8 p-10 -90.58 118.86 69.02 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.823 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -75.27 73.51 4.45 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 123.637 2.892 . . . . 0.0 116.161 -170.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -130.37 49.91 2.25 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 122.551 1.167 . . . . 0.0 109.639 170.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.47 123.26 27.38 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.439 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.3 m -81.49 171.11 15.1 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.382 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 m -50.18 -64.76 0.71 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.85 -53.6 0.09 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 59.91 79.33 0.24 Allowed 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 124.578 1.174 . . . . 0.0 111.88 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.739 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 61.7 m -81.18 89.8 6.03 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 173.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.601 ' HB3' HG23 ' A' ' 45' ' ' ILE . 7.0 t0 -91.3 108.58 29.79 Favored Pre-proline 0 C--N 1.306 -1.283 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.544 -170.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -71.44 -5.59 17.36 Favored 'Trans proline' 0 C--O 1.24 0.594 0 C-N-CA 123.184 2.589 . . . . 0.0 112.424 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.568 ' HD3' ' OD1' ' A' ' 42' ' ' ASP . 25.8 mtp180 -75.26 -36.59 61.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.025 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.826 HG13 ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -108.98 136.66 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 CA-C-O 121.752 0.787 . . . . 0.0 112.943 -171.552 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.7 -60.53 1.68 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.387 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -153.75 165.22 36.69 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.012 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -98.41 114.56 5.05 Favored Glycine 0 C--N 1.29 -2.003 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t -92.85 114.12 29.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 14.7 m -79.67 137.43 54.8 Favored Pre-proline 0 C--N 1.284 -2.25 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.31 83.35 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.278 3.318 . . . . 0.0 114.466 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.04 26.39 7.55 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 C--N 1.3 -1.565 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -178.487 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 CA--C 1.51 -0.562 0 CA-C-O 121.413 0.625 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -109.74 -161.32 0.75 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 173.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 tp -70.86 108.38 2.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 118.561 -1.255 . . . . 0.0 108.29 174.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.991 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 69.3 m -101.47 34.39 2.61 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-O 122.206 1.003 . . . . 0.0 113.18 -173.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.8 m -91.34 147.07 23.3 Favored 'General case' 0 N--CA 1.408 -2.525 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.44 ' HA ' HD12 ' A' ' 45' ' ' ILE . 8.7 t-20 -159.01 -172.64 3.87 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.476 ' O ' ' HA3' ' A' ' 27' ' ' GLY . 1.1 t -74.14 -30.5 62.31 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 122.055 0.931 . . . . 0.0 108.925 -175.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.518 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 34.3 t -80.32 -44.28 19.79 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.972 176.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.27 49.43 0.2 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.471 1.108 . . . . 0.0 113.375 -176.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.437 ' C ' ' HG1' ' A' ' 11' ' ' THR . . . -151.86 -121.52 0.94 Allowed Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.335 -0.936 . . . . 0.0 111.322 176.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.437 ' HG1' ' C ' ' A' ' 10' ' ' GLY . 7.7 m -159.9 138.17 10.29 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 27' ' ' GLY . 14.9 mtpp -57.4 130.71 47.5 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.72 -32.66 6.24 Favored Glycine 0 C--N 1.291 -1.95 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -174.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.3 m -80.81 123.94 28.66 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 121.1 0.476 . . . . 0.0 109.838 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.683 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 62.0 mttm -87.34 109.91 19.87 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.495 ' HE2' ' N ' ' A' ' 27' ' ' GLY . 51.5 m-85 -71.7 125.68 27.76 Favored 'General case' 0 CA--C 1.472 -2.056 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.48 146.16 32.28 Favored 'General case' 0 N--CA 1.393 -3.314 0 CA-C-N 114.385 -1.28 . . . . 0.0 111.541 -167.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.628 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 28.1 t -93.62 130.47 39.52 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.09 -17.12 50.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.101 0.96 . . . . 0.0 113.038 -172.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.72 -10.19 59.43 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.988 0.423 . . . . 0.0 110.387 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.08 6.05 16.65 Favored Glycine 0 N--CA 1.432 -1.612 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.96 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 8.5 m -90.95 122.66 33.82 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 117.046 0.423 . . . . 0.0 111.694 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.683 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 72.3 t80 -79.04 138.53 38.03 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 174.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.461 HG23 HG12 ' A' ' 45' ' ' ILE . 59.8 t -108.58 -64.51 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.532 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 p -173.02 168.27 4.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.646 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -112.54 117.47 32.44 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 170.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.599 ' O ' ' HG2' ' A' ' 12' ' ' LYS . . . -79.17 176.29 54.76 Favored Glycine 0 C--N 1.296 -1.657 0 N-CA-C 115.351 0.9 . . . . 0.0 115.351 -169.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -103.21 29.02 5.82 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 123.365 0.666 . . . . 0.0 110.96 -176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.431 ' HB3' ' HA ' ' A' ' 11' ' ' THR . 10.0 t -81.94 72.11 8.98 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 122.335 1.064 . . . . 0.0 109.084 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.69 140.33 31.5 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.119 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -35.46 -44.7 0.65 Allowed 'Trans proline' 0 CA--C 1.548 1.196 0 C-N-CA 124.791 3.661 . . . . 0.0 115.892 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.72 9.46 37.13 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -174.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.42 158.07 43.79 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -83.41 85.29 1.53 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.261 1.974 . . . . 0.0 111.072 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.12 55.01 3.14 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 122.143 0.973 . . . . 0.0 111.86 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.32 83.51 1.77 Allowed 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.951 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.2 m -109.99 123.74 50.18 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.387 -175.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.08 46.36 1.38 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.211 0.529 . . . . 0.0 111.359 -175.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.32 23.19 0.48 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.518 ' OD1' ' HB3' ' A' ' 8' ' ' CYS . 37.2 m-20 -90.21 57.14 3.63 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -167.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.991 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 71.0 m -148.29 74.34 1.28 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 173.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -92.82 112.94 58.14 Favored Pre-proline 0 CA--C 1.515 -0.394 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.54 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.76 -11.69 28.05 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 123.053 2.502 . . . . 0.0 113.862 -174.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.9 ptt-85 -90.7 -12.44 36.68 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.55 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.461 HG12 HG23 ' A' ' 24' ' ' VAL . 85.1 mt -97.82 138.0 23.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.82 -59.61 1.7 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.374 0.607 . . . . 0.0 109.622 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.35 161.51 41.04 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -95.51 106.75 3.43 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.3 t -86.91 107.43 16.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.433 0.635 . . . . 0.0 110.931 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.6 m -92.43 124.12 60.2 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 173.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 2.6 Cg_exo -75.96 77.96 3.29 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.086 2.524 . . . . 0.0 113.291 -175.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -79.92 -50.6 10.22 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.421 -1.912 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 176.498 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 C--O 1.238 0.493 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 64.75 52.38 1.68 Allowed 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 -173.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.662 HG12 ' HA ' ' A' ' 43' ' ' PRO . 7.1 tp -75.08 45.39 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.605 0 CA-C-O 122.832 1.301 . . . . 0.0 113.072 -173.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.426 ' HA ' ' CB ' ' A' ' 41' ' ' CYS . 3.3 m -102.45 32.55 3.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.238 1.018 . . . . 0.0 111.162 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.93 162.85 17.46 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 113.921 -1.491 . . . . 0.0 108.222 176.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -132.42 156.58 46.45 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.208 0.528 . . . . 0.0 110.3 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 t -85.09 -16.13 41.64 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 124.263 1.025 . . . . 0.0 112.407 -173.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 8.4 t -90.86 -66.61 0.91 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.594 -1.242 . . . . 0.0 113.788 -175.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.05 48.9 0.42 Allowed 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -167.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.2 -95.13 2.38 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 174.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.4 m -163.78 132.17 3.69 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 123.957 0.903 . . . . 0.0 109.088 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.915 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 19.8 pttp -64.34 143.05 58.18 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.48 -35.47 4.79 Favored Glycine 0 C--N 1.297 -1.619 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.504 -175.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.4 m -80.49 146.33 31.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.692 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 2.1 mmpt? -97.19 113.89 25.54 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.685 ' HE2' ' HA2' ' A' ' 27' ' ' GLY . 90.6 m-85 -71.28 117.6 13.01 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.51 ' CE2' ' HA ' ' A' ' 22' ' ' THR . 16.0 t80 -122.73 144.5 49.12 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-O 122.193 0.997 . . . . 0.0 113.138 -163.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.452 ' HB2' ' CG2' ' A' ' 24' ' ' VAL . 6.4 t -97.19 123.3 40.92 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.4 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -66.76 -30.9 71.24 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -174.112 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -107.06 18.81 21.28 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.252 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -162.7 20.21 0.17 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 118.815 -1.66 . . . . 0.0 115.715 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.51 ' HA ' ' CE2' ' A' ' 17' ' ' PHE . 0.4 OUTLIER 55.91 -170.42 0.08 Allowed 'General case' 0 CA--C 1.587 2.387 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 177.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.692 ' HD1' ' HB3' ' A' ' 15' ' ' LYS . 72.9 t80 -39.79 126.06 1.92 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.253 1.421 . . . . 0.0 113.103 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.452 ' CG2' ' HB2' ' A' ' 18' ' ' SER . 40.2 t -106.49 -58.68 3.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.694 177.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 p -147.28 165.41 30.2 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.402 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 15.7 tt0 -111.21 165.08 12.22 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -178.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.915 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -51.85 134.87 35.17 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 115.976 1.15 . . . . 0.0 115.976 -176.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -123.52 8.85 8.98 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 122.404 1.097 . . . . 0.0 108.946 176.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.2 m -100.98 101.41 12.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.135 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -108.27 143.95 28.46 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.61 -29.0 77.58 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.504 2.136 . . . . 0.0 114.298 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -98.11 -41.67 7.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.503 0.192 . . . . 0.0 111.287 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -57.8 139.3 82.33 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -174.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -67.57 134.8 34.07 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.371 2.047 . . . . 0.0 109.561 175.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 ptpp? -123.51 111.13 15.92 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -173.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.45 81.53 1.56 Allowed 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 172.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 91.4 m -99.62 143.15 30.19 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -172.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.26 115.75 10.77 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 171.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mp -111.2 36.23 3.27 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.55 0.691 . . . . 0.0 110.138 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -92.98 158.98 15.52 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.753 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.426 ' CB ' ' HA ' ' A' ' 4' ' ' CYS . 33.6 m -67.01 105.35 1.62 Allowed 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.809 ' HB3' HG23 ' A' ' 45' ' ' ILE . 12.7 t70 -97.73 110.78 56.76 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.199 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.662 ' HA ' HG12 ' A' ' 3' ' ' ILE . 24.7 Cg_exo -63.56 -9.82 19.6 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.787 2.992 . . . . 0.0 114.854 -176.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.68 -34.97 15.2 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.675 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.809 HG23 ' HB3' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -87.59 100.26 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 122.001 0.905 . . . . 0.0 110.98 -176.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.86 -39.54 30.38 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.545 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -170.65 172.52 5.8 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.21 123.16 7.78 Favored Glycine 0 C--N 1.288 -2.138 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.0 t -96.32 100.83 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 73.1 m -80.94 153.66 72.57 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.56 61.95 1.64 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.348 2.698 . . . . 0.0 113.269 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.455 ' CZ ' ' HA ' ' A' ' 52' ' ' ARG . 0.6 OUTLIER -126.71 11.84 7.3 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 176.38 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.4 m . . . . . 0 N--CA 1.424 -1.747 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.396 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.559 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 1.1 m-20 . . . . . 0 CA--C 1.508 -0.642 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.82 -52.29 2.44 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.6 tt -83.54 56.06 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 123.37 1.557 . . . . 0.0 110.283 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.559 ' SG ' ' HB2' ' A' ' 1' ' ' ASP . 21.0 m -92.61 57.28 2.88 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.985 -178.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.592 ' HB ' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -90.65 -178.67 5.35 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 173.225 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -156.48 142.83 18.33 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 174.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.5 t -61.0 -46.66 89.87 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 123.758 0.661 . . . . 0.0 111.611 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.489 ' HA ' ' HB3' ' A' ' 28' ' ' GLU . 34.2 t -67.89 -51.16 51.18 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.885 -176.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.13 36.94 0.19 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.6 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . -109.35 170.66 14.6 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 176.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -74.77 122.47 23.35 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 117.008 0.404 . . . . 0.0 110.621 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.726 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -57.41 144.49 36.16 Favored 'General case' 0 C--O 1.241 0.606 0 O-C-N 121.902 -0.499 . . . . 0.0 110.048 173.613 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.08 -26.32 19.61 Favored Glycine 0 C--N 1.305 -1.171 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.5 m -91.28 130.92 37.09 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -84.13 103.67 13.53 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.584 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 17.0 m-85 -61.07 122.45 15.02 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.532 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -148.84 149.99 32.24 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.744 -167.214 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.594 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 33.6 t -89.88 133.61 34.66 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -47.46 -33.12 5.79 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.812 1.645 . . . . 0.0 114.155 -174.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -68.77 -19.71 64.33 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.532 ' HA2' ' CE2' ' A' ' 17' ' ' PHE . . . 122.61 18.79 3.22 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.326 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.594 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 69.1 m -103.5 125.49 50.09 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 117.197 0.498 . . . . 0.0 111.302 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -78.2 137.74 38.3 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 45' ' ' ILE . 21.7 t -111.29 -56.07 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.128 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.8 177.99 7.53 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.022 0.529 . . . . 0.0 109.687 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -147.51 103.9 3.58 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 118.776 0.716 . . . . 0.0 112.14 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.726 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . 73.55 84.98 0.26 Allowed Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.979 177.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.489 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 59.2 mm-40 -111.32 -37.38 5.3 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.6 ' HB2' ' O ' ' A' ' 10' ' ' GLY . 3.8 m -105.6 107.48 18.49 Favored 'General case' 0 C--O 1.248 0.992 0 O-C-N 121.877 -0.514 . . . . 0.0 111.331 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.406 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 56.4 t0 -139.88 129.82 13.92 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.406 ' HD2' ' OD1' ' A' ' 30' ' ' ASP . 21.1 Cg_endo -61.73 77.83 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.212 0 C-N-CA 123.004 2.47 . . . . 0.0 114.402 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -141.46 -56.96 0.48 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 173.263 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 1.2 p-10 -82.25 126.3 74.7 Favored Pre-proline 0 N--CA 1.432 -1.351 0 CA-C-O 121.37 0.605 . . . . 0.0 109.832 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 11.5 Cg_exo -70.37 166.26 28.96 Favored 'Trans proline' 0 C--O 1.253 1.271 0 C-N-CA 123.234 2.623 . . . . 0.0 111.534 175.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.747 ' HE3' ' HA ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER 83.09 142.69 0.07 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.311 1.844 . . . . 0.0 111.677 -179.439 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.3 157.75 17.5 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.3 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 24.0 m -85.88 164.4 17.51 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 t -65.66 156.51 32.68 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.309 0.576 . . . . 0.0 110.87 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.68 6.95 45.51 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.368 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -58.06 127.94 34.62 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.978 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 33.0 m -64.21 123.16 18.39 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.456 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -112.34 95.92 33.29 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -72.33 8.82 1.34 Allowed 'Trans proline' 0 N--CA 1.485 0.994 0 C-N-CA 123.267 2.645 . . . . 0.0 113.969 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.5 ttp-105 -90.45 -34.96 15.4 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.592 HG21 ' HB ' ' A' ' 5' ' ' THR . 1.6 tt -94.8 121.13 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.2 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.79 -47.66 8.45 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -167.76 169.3 11.79 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.694 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -97.03 120.35 6.68 Favored Glycine 0 C--N 1.284 -2.334 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.7 t -92.43 107.45 19.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 121.327 0.584 . . . . 0.0 110.364 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.74 153.87 64.59 Favored Pre-proline 0 C--N 1.296 -1.744 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.24 121.61 6.38 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 123.457 2.771 . . . . 0.0 113.231 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -95.7 -36.81 11.06 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.2 m . . . . . 0 N--CA 1.425 -1.679 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 179.815 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 42.3 p-10 . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -114.69 -37.91 4.12 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.824 -0.547 . . . . 0.0 112.233 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.4 tp -82.81 94.45 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-O 121.758 0.79 . . . . 0.0 109.525 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.891 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 6.7 m -126.11 47.95 2.18 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-O 121.667 0.746 . . . . 0.0 112.876 -175.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.54 HG23 ' HA ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -90.24 116.33 28.14 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 172.156 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.452 HD22 ' HB1' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -126.5 156.53 40.6 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -178.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.491 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 45.0 t -88.72 -47.18 8.43 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -172.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.4 t -61.38 -53.93 50.2 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.262 0.553 . . . . 0.0 111.35 -174.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.452 ' HB1' HD22 ' A' ' 6' ' ' ASN . . . -90.48 24.83 2.46 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.588 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.532 ' HA3' ' CE1' ' A' ' 16' ' ' TYR . . . -90.77 149.97 20.35 Favored Glycine 0 N--CA 1.431 -1.671 0 C-N-CA 120.096 -1.05 . . . . 0.0 110.876 177.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.37 117.98 5.45 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 123.477 0.711 . . . . 0.0 111.48 -176.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.718 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 40.2 ttmt -53.31 107.46 0.24 Allowed 'General case' 0 C--O 1.238 0.49 0 O-C-N 123.882 0.738 . . . . 0.0 112.777 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.54 -30.8 3.07 Favored Glycine 0 C--N 1.303 -1.274 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.1 m -86.26 121.86 29.43 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 63.7 mmtt -80.75 108.1 14.12 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.592 ' HD2' HG21 ' A' ' 45' ' ' ILE . 43.1 m-85 -71.25 109.94 5.59 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.02 151.22 50.6 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.567 -165.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.429 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 6.3 t -87.87 129.55 35.18 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.08 -9.18 20.36 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -168.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -79.61 -10.17 59.75 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 122.997 0.519 . . . . 0.0 111.1 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.89 33.11 2.47 Favored Glycine 0 C--N 1.315 -0.611 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.2 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 52.5 m -124.94 106.45 9.98 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 121.021 0.439 . . . . 0.0 110.788 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.415 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 58.2 t80 -70.91 124.14 23.64 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.528 176.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.03 -64.72 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.9 p -170.73 157.74 5.75 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 30.6 tt0 -85.24 138.86 32.07 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.718 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -63.57 135.15 41.69 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 176.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -126.48 34.96 4.72 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.792 -175.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 t -82.96 113.37 20.5 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -104.35 133.41 20.22 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -53.57 -14.94 5.58 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.616 2.877 . . . . 0.0 114.442 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -103.07 -27.08 12.79 Favored 'General case' 0 N--CA 1.441 -0.895 0 O-C-N 121.622 -0.674 . . . . 0.0 111.693 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -91.14 137.42 26.4 Favored Pre-proline 0 C--O 1.239 0.552 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -172.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -82.6 124.08 3.96 Favored 'Trans proline' 0 N--CA 1.442 -1.548 0 C-N-CA 122.461 2.108 . . . . 0.0 110.038 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.9 138.25 47.53 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.656 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.5 93.3 3.9 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.451 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.9 m -142.67 167.2 22.65 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.9 138.11 54.39 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.4 47.65 1.97 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.806 0.812 . . . . 0.0 109.958 -176.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -97.83 18.89 14.75 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.321 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.891 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 55.7 m 65.23 156.72 0.09 Allowed 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 125.701 1.6 . . . . 0.0 112.124 177.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -122.52 112.31 31.14 Favored Pre-proline 0 N--CA 1.466 0.357 0 O-C-N 120.411 -1.431 . . . . 0.0 113.127 -178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.68 -2.88 12.83 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.975 2.45 . . . . 0.0 113.941 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -85.6 -21.75 28.34 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.4 0.619 . . . . 0.0 109.673 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.592 HG21 ' HD2' ' A' ' 16' ' ' TYR . 95.3 mt -95.73 132.47 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.083 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.09 -55.67 3.65 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.692 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.54 ' HA ' HG23 ' A' ' 5' ' ' THR . 2.2 p90 -164.77 164.8 21.08 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.767 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -92.95 111.58 4.12 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.2 t -87.81 115.92 29.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 120.996 0.427 . . . . 0.0 110.3 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.7 m -96.16 105.14 20.02 Favored Pre-proline 0 C--N 1.293 -1.856 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 4.3 Cg_exo -73.32 88.99 0.95 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.202 2.601 . . . . 0.0 112.079 -175.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.46 -53.73 6.6 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.297 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.3 m . . . . . 0 N--CA 1.42 -1.928 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -179.489 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 CA--C 1.499 -1.009 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -147.76 61.52 1.14 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.7 tp -83.36 63.93 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-O 123.154 1.454 . . . . 0.0 109.888 -176.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.972 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.7 m -83.98 48.02 1.4 Allowed 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -176.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -91.17 164.12 14.02 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.455 ' HB3' HD22 ' A' ' 39' ' ' LEU . 1.1 t-20 -160.49 152.37 20.0 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.008 0.822 . . . . 0.0 111.811 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.8 t -67.8 -44.35 77.53 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 46.5 t -59.0 -52.22 66.68 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.163 0.506 . . . . 0.0 109.715 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.446 ' HB3' ' H ' ' A' ' 37' ' ' CYS . . . -86.16 25.58 1.15 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.783 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.51 156.11 22.48 Favored Glycine 0 N--CA 1.423 -2.193 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.911 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.2 m -83.01 109.41 17.08 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 123.008 0.523 . . . . 0.0 111.704 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -47.38 141.11 5.07 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.639 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.73 -44.11 1.56 Allowed Glycine 0 C--N 1.303 -1.298 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.3 m -103.23 140.43 37.39 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.77 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 69.8 mttt -100.01 129.39 46.06 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 121.392 0.615 . . . . 0.0 110.432 -173.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.414 ' HB3' ' CG1' ' A' ' 45' ' ' ILE . 48.7 m-85 -84.14 132.14 34.71 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.241 -176.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.46 148.45 37.76 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.227 -168.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.575 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 29.6 t -91.5 141.14 29.06 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.211 -1.358 . . . . 0.0 109.442 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.2 -14.4 60.55 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.796 1.239 . . . . 0.0 112.388 -176.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.29 -6.65 59.24 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.106 0.479 . . . . 0.0 110.527 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.71 34.17 3.61 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.505 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 25.2 m -118.75 120.03 36.17 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.261 -178.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.77 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 47.7 t80 -74.91 128.91 36.7 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -98.54 -71.71 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.504 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -172.11 165.96 6.12 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -178.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.755 ' HG3' ' HG2' ' A' ' 15' ' ' LYS . 12.0 tt0 -85.35 158.63 20.21 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.19 127.73 29.7 Favored Glycine 0 C--O 1.238 0.367 0 O-C-N 123.602 0.564 . . . . 0.0 112.905 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.595 ' HB2' ' HA ' ' A' ' 8' ' ' CYS . 4.4 mm-40 -79.76 -22.69 42.9 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.494 0.188 . . . . 0.0 111.315 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.3 m -95.89 128.62 42.93 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-O 121.088 0.47 . . . . 0.0 110.047 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -79.53 124.41 83.85 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.43 82.62 0.1 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.488 2.792 . . . . 0.0 112.944 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 mmm180 -146.17 -70.44 0.25 Allowed 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -90.44 151.7 44.6 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.82 66.27 5.86 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.62 2.214 . . . . 0.0 111.781 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -80.38 130.6 35.28 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.145 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -131.76 160.88 34.26 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.285 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.446 ' H ' ' HB3' ' A' ' 9' ' ' ALA . 59.8 m -137.53 166.56 23.58 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.6 m -59.28 110.51 1.09 Allowed 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.455 HD22 ' HB3' ' A' ' 6' ' ' ASN . 12.8 mt -79.39 -62.54 1.66 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.554 -175.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 56.34 31.53 18.82 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.026 0.93 . . . . 0.0 111.253 -177.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.972 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 68.4 m 49.29 76.83 0.12 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.064 -177.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 6.7 t0 -53.27 112.74 3.9 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 123.869 0.868 . . . . 0.0 111.357 -174.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 10.9 Cg_exo -71.35 -11.31 28.42 Favored 'Trans proline' 0 C--O 1.242 0.695 0 C-N-CA 123.0 2.466 . . . . 0.0 112.828 -176.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.754 ' HA ' ' HE ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -91.41 -14.13 31.15 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.513 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.414 ' CG1' ' HB3' ' A' ' 16' ' ' TYR . 1.7 mp -108.85 124.24 65.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.155 0.503 . . . . 0.0 110.765 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.07 -47.76 5.11 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -164.47 166.21 20.7 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.715 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.11 130.5 10.34 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.2 t -109.54 115.88 50.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 25.6 m -82.05 141.19 46.67 Favored Pre-proline 0 C--N 1.288 -2.071 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 12.6 Cg_exo -69.49 61.59 1.59 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.65 2.9 . . . . 0.0 114.01 -174.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.47 ' HB3' ' H ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -100.35 -83.53 0.44 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 175.339 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.47 ' H ' ' HB3' ' A' ' 52' ' ' ARG . 50.7 m . . . . . 0 C--N 1.31 -1.149 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.544 ' OD1' ' HG2' ' A' ' 2' ' ' ARG . 7.1 t70 . . . . . 0 CA--C 1.516 -0.356 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.544 ' HG2' ' OD1' ' A' ' 1' ' ' ASP . 21.5 mmm180 61.78 57.71 2.13 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.711 0.804 . . . . 0.0 111.953 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.542 HG21 ' HA ' ' A' ' 43' ' ' PRO . 6.7 tp -72.97 98.84 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 122.297 1.046 . . . . 0.0 111.169 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.669 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 1.8 m -121.64 22.27 10.62 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 122.015 0.912 . . . . 0.0 111.727 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.37 144.08 26.15 Favored 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.77 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -126.06 151.8 46.67 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 17.2 t -86.59 -16.37 36.97 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 123.743 0.817 . . . . 0.0 111.346 -173.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.0 t -66.31 -43.97 84.72 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.93 0.871 . . . . 0.0 108.764 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' A' ' 36' ' ' ALA . . . -90.9 -102.39 0.1 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.483 172.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.48 -151.16 48.97 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-O 121.521 0.512 . . . . 0.0 113.813 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.795 HG23 ' HD3' ' A' ' 31' ' ' PRO . 95.0 m -143.88 110.96 5.75 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 122.679 0.392 . . . . 0.0 110.189 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.434 ' HE3' ' O ' ' A' ' 27' ' ' GLY . 17.0 ttmt -51.34 116.52 2.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.136 176.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.59 -38.25 1.59 Allowed Glycine 0 N--CA 1.418 -2.544 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.2 m -106.56 112.43 25.43 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.502 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 37.0 mttp -87.47 113.24 23.0 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.755 -175.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -65.79 123.44 19.76 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.174 -177.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -125.06 152.79 43.85 Favored 'General case' 0 N--CA 1.407 -2.605 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.314 -166.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.744 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 1.0 OUTLIER -105.7 127.04 52.83 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 113.221 -1.809 . . . . 0.0 106.325 179.158 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.7 -14.34 20.33 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -167.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.6 -18.14 60.61 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.266 175.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.91 3.12 6.45 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.032 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.744 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 97.7 m -83.13 117.18 22.71 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.97 0.414 . . . . 0.0 111.674 -177.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.502 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 20.4 t80 -76.08 119.14 19.61 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 169.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.4 HG12 ' NH2' ' A' ' 44' ' ' ARG . 18.0 t -87.39 -63.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.497 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 p -169.14 172.58 7.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.866 0.365 . . . . 0.0 111.206 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -97.1 150.52 20.75 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.434 ' O ' ' HE3' ' A' ' 12' ' ' LYS . . . -62.61 118.59 14.69 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -79.91 3.02 21.19 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -175.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.4 m -121.38 141.22 51.17 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-O 121.601 0.715 . . . . 0.0 110.53 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -99.0 145.29 29.73 Favored Pre-proline 0 C--N 1.285 -2.237 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.795 ' HD3' HG23 ' A' ' 11' ' ' THR . 6.6 Cg_endo -50.53 -19.78 5.34 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.37 2.713 . . . . 0.0 115.071 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.458 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 0.8 OUTLIER -82.24 -25.62 33.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.52 138.48 25.31 Favored Pre-proline 0 C--N 1.319 -0.723 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.767 177.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -86.34 -164.18 0.21 Allowed 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.759 2.306 . . . . 0.0 111.195 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt 73.62 164.57 0.28 Allowed 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 125.37 1.468 . . . . 0.0 112.833 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.477 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . . . -155.58 143.28 19.69 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 178.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 55.7 m -79.85 125.19 29.39 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.42 79.44 0.26 Allowed 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 124.079 0.952 . . . . 0.0 112.249 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.6 tp -100.34 -18.91 16.56 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.884 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 65.63 55.12 1.03 Allowed 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 124.389 1.076 . . . . 0.0 110.19 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.669 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 20.7 m 74.78 138.04 0.06 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 125.686 1.594 . . . . 0.0 110.744 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -107.52 91.71 7.49 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.542 ' HA ' HG21 ' A' ' 3' ' ' ILE . 3.5 Cg_exo -77.25 0.67 9.51 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 123.117 2.545 . . . . 0.0 112.325 -175.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.4 ' NH2' HG12 ' A' ' 24' ' ' VAL . 15.3 ttp-105 -85.63 -19.13 31.44 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 74.1 mt -82.42 141.01 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.61 -57.96 2.32 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.433 0.635 . . . . 0.0 109.47 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -160.34 170.7 20.52 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.201 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.03 125.39 8.56 Favored Glycine 0 C--N 1.291 -1.92 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.7 t -95.95 106.19 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 m -93.96 111.9 54.93 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 177.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.89 134.76 64.59 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.177 2.584 . . . . 0.0 112.225 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -111.93 134.64 53.36 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.431 0.634 . . . . 0.0 110.819 -177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.3 m . . . . . 0 C--N 1.279 -2.48 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 176.229 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.497 -1.08 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 53.44 79.19 0.13 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 124.208 0.943 . . . . 0.0 110.712 175.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 1.011 ' HB ' ' HA ' ' A' ' 43' ' ' PRO . 37.5 mm -83.79 92.02 2.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.611 -175.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.6 m -97.32 32.33 2.25 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 122.284 1.04 . . . . 0.0 112.526 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.448 ' HB ' HG22 ' A' ' 45' ' ' ILE . 3.6 m -81.44 140.95 34.35 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 171.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -133.13 148.23 52.11 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.305 -174.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.7 t -83.77 -28.02 28.46 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.564 1.145 . . . . 0.0 110.815 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.1 t -62.94 -59.99 4.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.421 0.629 . . . . 0.0 110.828 -175.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.82 47.86 1.39 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.254 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.794 ' HA3' ' HE1' ' A' ' 16' ' ' TYR . . . -93.04 -110.07 1.95 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.73 175.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.9 m -162.86 127.65 3.11 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 123.857 0.863 . . . . 0.0 108.746 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 1.07 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -64.24 128.95 38.0 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.917 174.313 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.93 -26.42 11.56 Favored Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 m -89.68 127.53 35.94 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.508 ' HG2' ' HG3' ' A' ' 26' ' ' GLU . 43.9 mtpt -86.11 114.61 23.1 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.794 ' HE1' ' HA3' ' A' ' 10' ' ' GLY . 57.3 m-85 -72.85 111.95 8.44 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 178.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.561 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -134.94 147.74 49.85 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.871 -166.307 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.439 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 21.6 p -97.13 148.17 23.32 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.556 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -62.97 -16.7 60.48 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.663 1.185 . . . . 0.0 113.218 -172.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -77.6 -12.01 59.92 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.382 0.61 . . . . 0.0 109.72 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.561 ' HA2' ' CE2' ' A' ' 17' ' ' PHE . . . 101.59 40.93 2.63 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.393 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.439 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 41.6 m -127.26 131.92 50.46 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.612 0.72 . . . . 0.0 111.93 -178.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.601 ' HE1' ' HB2' ' A' ' 26' ' ' GLU . 78.1 t80 -72.51 130.24 40.18 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.245 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 t -106.07 -49.08 8.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 120.911 0.386 . . . . 0.0 109.993 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.1 p -164.77 174.39 10.73 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.601 ' HB2' ' HE1' ' A' ' 23' ' ' PHE . 2.2 tm-20 -153.51 140.78 19.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.834 0.743 . . . . 0.0 111.636 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 1.07 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . 57.27 55.57 29.66 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 116.684 1.433 . . . . 0.0 116.684 171.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -81.58 -44.98 16.52 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.605 0.716 . . . . 0.0 109.614 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.21 78.32 8.85 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.609 -174.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.614 ' HA ' ' HG2' ' A' ' 12' ' ' LYS . 18.8 t0 -89.69 129.29 47.31 Favored Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -64.28 51.19 0.18 Allowed 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 123.921 3.081 . . . . 0.0 113.721 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -147.18 -45.52 0.17 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 125.294 1.437 . . . . 0.0 107.721 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -84.26 124.38 74.01 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -86.88 106.36 0.69 Allowed 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.737 2.292 . . . . 0.0 110.333 173.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.403 ' HE2' ' HB2' ' A' ' 35' ' ' LYS . 17.5 mtmm -115.36 102.83 10.21 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.25 98.9 6.82 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.28 0.562 . . . . 0.0 110.106 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.4 m -114.77 124.69 52.41 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.37 -42.28 71.98 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.0 -175.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.5 tp -158.98 -64.82 0.08 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 m120 61.2 49.29 5.61 Favored 'General case' 0 C--O 1.245 0.867 0 O-C-N 124.197 0.936 . . . . 0.0 112.148 176.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 84.9 m -57.98 120.96 9.46 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.513 ' O ' HG23 ' A' ' 45' ' ' ILE . 2.2 t70 -116.21 100.51 53.55 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -177.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 1.011 ' HA ' ' HB ' ' A' ' 3' ' ' ILE . 44.2 Cg_endo -68.74 -6.48 18.04 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.858 2.372 . . . . 0.0 113.97 -174.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.428 ' O ' ' HB3' ' A' ' 18' ' ' SER . 0.7 OUTLIER -90.55 -25.4 20.24 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 111.755 0.279 . . . . 0.0 111.755 -178.572 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 42' ' ' ASP . 3.8 tt -88.39 147.13 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 121.411 0.624 . . . . 0.0 111.07 -177.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.91 -50.92 4.03 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.77 175.24 4.0 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.234 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.33 121.69 6.82 Favored Glycine 0 N--CA 1.429 -1.825 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.6 t -104.3 103.82 15.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.033 0.444 . . . . 0.0 110.446 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 17.3 m -79.89 112.67 31.69 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 170.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.19 111.18 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 124.29 3.327 . . . . 0.0 114.272 -171.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -80.72 -60.91 2.13 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 N--CA 1.429 -1.485 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 175.944 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 . . . . . 0 C--O 1.233 0.206 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.8 ttt85 -65.16 -39.74 93.39 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.443 ' O ' ' HB3' ' A' ' 41' ' ' CYS . 19.3 tt -75.48 94.33 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 122.207 1.003 . . . . 0.0 112.458 -176.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 97.0 m -128.65 40.36 3.66 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.811 0.815 . . . . 0.0 110.792 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.459 HG21 ' HA ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -62.75 133.67 55.13 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.765 176.678 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -144.84 148.69 34.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.083 0.468 . . . . 0.0 110.164 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 t -75.22 -25.84 58.46 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.839 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.1 t -59.48 -56.06 26.71 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.361 0.601 . . . . 0.0 109.448 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . . . -90.74 23.29 3.15 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.309 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.62 141.85 31.44 Favored Glycine 0 N--CA 1.424 -2.132 0 C-N-CA 120.34 -0.933 . . . . 0.0 111.932 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.0 m -75.4 117.1 16.83 Favored 'General case' 0 C--N 1.273 -2.737 0 O-C-N 123.886 0.404 . . . . 0.0 111.451 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -53.03 120.63 6.1 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.51 0.724 . . . . 0.0 109.129 175.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.92 -31.27 6.16 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.8 m -91.0 126.82 36.2 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 178.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -90.09 109.39 20.44 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.623 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 18.8 m-85 -71.54 115.16 10.4 Favored 'General case' 0 CA--C 1.484 -1.569 0 CA-C-O 121.875 0.845 . . . . 0.0 109.287 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.463 ' HE1' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -133.81 145.19 49.52 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 113.281 -1.781 . . . . 0.0 111.612 -167.227 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.505 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 53.4 p -98.22 148.16 23.89 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -13.16 44.16 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -173.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.7 -0.99 40.75 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.213 0.53 . . . . 0.0 110.453 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.463 ' HA2' ' HE1' ' A' ' 17' ' ' PHE . . . 92.94 36.22 6.11 Favored Glycine 0 N--CA 1.43 -1.735 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.039 176.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.505 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 90.7 m -122.11 121.5 37.06 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.759 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -73.29 124.37 25.57 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.439 HG21 HG12 ' A' ' 45' ' ' ILE . 34.3 t -96.2 -60.76 2.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.515 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.8 p -161.95 161.05 28.49 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.675 -0.41 . . . . 0.0 112.074 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -81.45 149.31 28.83 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 174.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.5 127.38 45.05 Favored Glycine 0 CA--C 1.524 0.64 0 O-C-N 123.587 0.554 . . . . 0.0 113.046 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -83.53 -21.0 32.85 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.6 m -100.86 131.01 46.95 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 121.266 0.555 . . . . 0.0 111.609 -176.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.801 ' HB3' ' HB3' ' A' ' 33' ' ' ASN . 25.1 t70 -79.72 140.23 54.84 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -56.01 -12.41 7.22 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.286 2.657 . . . . 0.0 114.374 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -121.6 7.98 10.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 122.329 0.252 . . . . 0.0 111.325 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.801 ' HB3' ' HB3' ' A' ' 30' ' ' ASP . 2.4 p-10 -90.58 138.16 26.86 Favored Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.729 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -76.46 121.37 5.99 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.706 1.604 . . . . 0.0 108.686 171.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.7 pttm -128.84 162.46 27.43 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 120.822 0.344 . . . . 0.0 111.552 -173.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.41 45.62 1.73 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.103 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 9' ' ' ALA . 89.6 m -79.54 148.67 31.7 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.7 t -79.69 -175.7 4.97 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.488 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.51 39.95 1.88 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.339 0.656 . . . . 0.0 110.269 -175.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -66.08 106.21 1.56 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.156 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 3.3 m -73.08 112.59 9.26 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.447 -178.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -92.6 101.13 4.6 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 3.0 Cg_exo -74.22 -3.53 13.96 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 123.144 2.563 . . . . 0.0 112.526 -174.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -87.8 -34.59 18.23 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.172 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.439 HG12 HG21 ' A' ' 24' ' ' VAL . 79.4 mt -87.05 142.28 13.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.23 -65.46 1.0 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.459 ' HA ' HG21 ' A' ' 5' ' ' THR . 0.5 OUTLIER -161.02 169.17 23.05 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.077 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.623 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -96.11 103.51 2.96 Favored Glycine 0 N--CA 1.429 -1.799 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.515 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 71.4 t -79.9 113.75 19.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.69 102.87 2.92 Favored Pre-proline 0 C--N 1.308 -1.231 0 C-N-CA 122.988 0.515 . . . . 0.0 109.636 175.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 49' ' ' VAL . 9.5 Cg_endo -93.75 141.81 1.7 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 123.0 2.467 . . . . 0.0 111.567 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.98 -44.33 5.52 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.43 -1.433 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 177.707 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 C--O 1.226 -0.183 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -71.06 -19.33 62.49 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.7 tp -70.36 93.69 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 122.148 0.975 . . . . 0.0 110.373 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.813 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 22.4 m -105.26 29.36 6.49 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 122.227 1.013 . . . . 0.0 110.874 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -90.31 135.79 33.46 Favored 'General case' 0 N--CA 1.399 -2.981 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.393 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -126.25 154.75 42.92 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.57 ' HB2' HD12 ' A' ' 45' ' ' ILE . 17.5 t -88.81 -11.58 44.44 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.002 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.0 t -60.8 -49.43 77.5 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 120.91 0.386 . . . . 0.0 109.968 -178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.46 -87.34 0.17 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.06 -144.28 32.19 Favored Glycine 0 N--CA 1.438 -1.192 0 O-C-N 124.093 0.871 . . . . 0.0 114.182 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 4.6 t -147.06 115.44 6.66 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-O 120.951 0.405 . . . . 0.0 110.219 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -47.58 111.09 0.38 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.267 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.0 -35.31 2.32 Favored Glycine 0 N--CA 1.422 -2.292 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.362 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.4 m -96.9 131.59 43.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 117.534 0.667 . . . . 0.0 110.454 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.689 ' HE2' ' HB3' ' A' ' 51' ' ' PRO . 65.4 mttm -79.71 101.5 8.45 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.678 -174.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -70.98 112.32 7.05 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.0 147.97 42.83 Favored 'General case' 0 N--CA 1.407 -2.593 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.161 -167.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.01 137.12 32.62 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.684 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.61 -14.11 62.66 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -171.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.36 -15.18 60.02 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.958 0.409 . . . . 0.0 110.321 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.61 24.82 3.91 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.317 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -112.44 105.81 14.15 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.95 0.405 . . . . 0.0 111.522 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -71.01 130.32 41.26 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.5 t -99.09 -70.46 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -160.05 152.01 20.34 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 15.6 tt0 -93.86 43.26 1.11 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.563 0.697 . . . . 0.0 110.789 -175.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.84 127.39 0.95 Allowed Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.407 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -89.91 -24.88 21.22 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 120.705 -0.398 . . . . 0.0 112.014 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.32 157.91 44.84 Favored 'General case' 0 N--CA 1.424 -1.741 0 O-C-N 121.883 -0.511 . . . . 0.0 111.471 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.42 131.62 37.8 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 42.7 Cg_endo -65.43 -9.87 23.96 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.911 2.407 . . . . 0.0 115.15 -172.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.3 mtm180 -75.85 -23.74 55.73 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -91.25 146.12 32.85 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 172.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -74.1 84.77 1.45 Allowed 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.021 1.814 . . . . 0.0 112.408 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -95.25 127.87 41.64 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.21 100.45 6.97 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.41 0.624 . . . . 0.0 109.812 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.6 m -107.14 -172.9 2.17 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.446 ' C ' ' H ' ' A' ' 40' ' ' ASN . 0.2 OUTLIER -67.8 143.81 55.65 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 172.351 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.67 47.22 1.16 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 38' ' ' THR . 85.0 m-20 -54.0 112.95 1.06 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 112.288 -2.233 . . . . 0.0 110.236 177.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.813 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 60.4 m -81.79 78.42 8.52 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 170.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 45.3 t0 -70.64 111.91 11.26 Favored Pre-proline 0 CA--C 1.51 -0.579 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.377 -169.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 16.6 Cg_exo -70.97 -18.37 31.38 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.976 2.451 . . . . 0.0 110.986 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -70.76 -23.89 62.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.514 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.57 HD12 ' HB2' ' A' ' 7' ' ' CYS . 63.0 mt -95.76 125.62 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.87 -51.02 6.07 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -169.91 166.24 9.47 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.146 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.11 110.58 4.0 Favored Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -84.66 103.95 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 64.1 m -79.07 116.38 59.7 Favored Pre-proline 0 C--N 1.288 -2.076 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.689 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 37.3 Cg_endo -63.23 125.51 15.9 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.35 2.7 . . . . 0.0 114.992 -171.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -144.27 35.17 1.2 Allowed 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 171.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.428 -1.566 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.994 -178.412 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 CA--C 1.511 -0.545 0 N-CA-C 110.636 -0.135 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? 54.93 -116.51 1.06 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.989 1.316 . . . . 0.0 114.034 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.8 tp -82.82 123.73 38.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 121.527 0.68 . . . . 0.0 110.288 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 71.6 m -99.2 56.62 1.03 Allowed 'General case' 0 N--CA 1.422 -1.87 0 CA-C-O 121.93 0.871 . . . . 0.0 111.763 -177.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.8 147.13 23.4 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.7 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -134.25 146.6 50.22 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.511 ' HB2' HD11 ' A' ' 45' ' ' ILE . 8.0 t -101.61 -4.17 27.08 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.033 0.444 . . . . 0.0 110.063 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.1 t -60.41 -54.45 45.5 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.31 -83.31 0.28 Allowed 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.44 175.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . 67.55 173.21 6.54 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.005 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.56 111.76 24.59 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 122.019 -0.695 . . . . 0.0 109.911 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.406 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 1.2 tmmt? -47.46 127.24 10.86 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.315 0.646 . . . . 0.0 110.35 176.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.94 -32.42 6.0 Favored Glycine 0 N--CA 1.436 -1.303 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.7 m -94.35 128.32 40.8 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.631 ' HG2' ' HG2' ' A' ' 26' ' ' GLU . 43.0 mtmt -88.76 112.11 22.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.534 ' HD2' HG23 ' A' ' 45' ' ' ILE . 81.8 m-85 -74.38 114.36 12.66 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.165 0.983 . . . . 0.0 109.279 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.05 147.51 38.74 Favored 'General case' 0 N--CA 1.407 -2.588 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.443 -167.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.451 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 43.1 t -89.0 141.97 28.03 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.955 -1.475 . . . . 0.0 109.014 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -72.89 -8.23 54.61 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.232 0.613 . . . . 0.0 112.335 -174.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.5 -3.37 57.56 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.76 43.47 3.11 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.353 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 13.6 m -131.24 123.38 28.28 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 122.514 -0.404 . . . . 0.0 110.952 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.666 ' HZ ' ' HG3' ' A' ' 26' ' ' GLU . 52.2 t80 -81.42 129.04 34.48 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.5 t -95.17 -67.62 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.99 174.48 4.72 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.666 ' HG3' ' HZ ' ' A' ' 23' ' ' PHE . 32.3 mt-10 -102.35 157.75 16.68 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.2 132.18 45.36 Favored Glycine 0 C--O 1.242 0.625 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -100.47 -27.48 13.42 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.064 0.459 . . . . 0.0 110.568 -175.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.485 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 47.6 m -80.94 128.12 33.33 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 122.355 1.074 . . . . 0.0 112.926 -176.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.87 138.67 13.14 Favored Pre-proline 0 C--N 1.293 -1.879 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -13.2 -51.89 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.247 1 C-N-CA 127.735 5.623 . . . . 0.0 119.31 -175.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.524 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 6.2 tpp180 -63.37 -44.95 93.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.506 0.594 . . . . 0.0 111.275 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.485 ' OD1' ' HA ' ' A' ' 29' ' ' SER . 6.5 p30 -92.8 107.56 25.34 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-O 121.593 0.711 . . . . 0.0 111.22 176.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 32' ' ' ARG . 65.5 Cg_endo -94.35 67.49 0.34 Allowed 'Trans proline' 0 N--CA 1.443 -1.488 0 C-N-CA 123.117 2.544 . . . . 0.0 110.273 175.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 55.2 mtpt -74.94 92.36 2.57 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.889 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.64 82.77 7.88 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.6 m -79.64 159.37 26.77 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.869 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.574 HG22 ' H ' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.18 175.37 1.66 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.138 0.575 . . . . 0.0 112.102 -175.85 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.574 ' H ' HG22 ' A' ' 38' ' ' THR . 3.3 mm? -86.75 37.85 0.77 Allowed 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.393 1.077 . . . . 0.0 110.193 -171.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.436 ' H ' ' C ' ' A' ' 38' ' ' THR . 3.9 m120 -61.88 119.06 8.07 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.649 176.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 24.3 m -96.83 104.01 15.98 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -96.5 104.45 17.86 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.614 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 5.2 Cg_exo -76.85 -3.59 13.96 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 123.483 2.789 . . . . 0.0 111.983 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 18' ' ' SER . 4.6 tpp180 -77.86 -10.84 59.77 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.534 HG23 ' HD2' ' A' ' 16' ' ' TYR . 83.3 mt -102.43 130.45 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.171 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.37 -40.58 9.86 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -176.75 174.01 1.87 Allowed 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.75 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.77 114.0 4.89 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.8 t -79.63 100.69 4.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 121.338 0.589 . . . . 0.0 109.89 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -97.82 150.15 36.47 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 173.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -72.11 67.7 3.32 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.825 2.35 . . . . 0.0 111.869 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -79.83 131.8 35.97 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.157 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.279 -2.485 0 CA-C-O 118.549 -0.739 . . . . 0.0 109.051 -178.839 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 C--O 1.243 0.741 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.78 71.25 0.33 Allowed 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 123.965 0.906 . . . . 0.0 110.847 -177.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -69.09 92.93 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.935 0.874 . . . . 0.0 109.645 177.118 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.77 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 60.5 m -128.59 37.01 4.18 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-O 122.333 1.063 . . . . 0.0 109.684 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.401 HG22 ' HA ' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -81.91 151.7 27.14 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-N 113.788 -1.551 . . . . 0.0 108.704 176.832 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -150.45 175.67 11.65 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.7 t -70.49 -30.09 66.79 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 118.149 0.431 . . . . 0.0 111.809 -174.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 4.4 t -76.09 -41.33 50.71 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.368 -0.832 . . . . 0.0 109.837 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.3 46.24 0.25 Allowed 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.617 ' HA3' ' HE1' ' A' ' 16' ' ' TYR . . . -140.37 -141.23 4.0 Favored Glycine 0 N--CA 1.431 -1.689 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.85 178.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.2 m -151.91 133.34 14.59 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 122.483 -0.422 . . . . 0.0 110.412 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.696 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 29.9 mmtt -50.52 121.89 6.36 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.348 1.059 . . . . 0.0 110.364 175.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 119.57 -34.11 4.37 Favored Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.477 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.2 m -92.85 132.06 37.33 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.563 ' HD3' ' HG2' ' A' ' 26' ' ' GLU . 10.3 mmtp -87.04 117.68 25.92 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -177.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.617 ' HE1' ' HA3' ' A' ' 10' ' ' GLY . 66.0 m-85 -70.18 120.36 15.75 Favored 'General case' 0 CA--C 1.479 -1.777 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -134.57 147.58 50.29 Favored 'General case' 0 N--CA 1.399 -3.017 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.331 -168.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.474 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 12.1 t -93.11 131.96 37.68 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.93 -10.45 53.42 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -170.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.25 -1.9 54.29 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.948 0.404 . . . . 0.0 110.956 176.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.62 59.21 0.75 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.711 175.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 18.9 m -146.8 133.09 19.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 O-C-N 122.484 -0.421 . . . . 0.0 110.426 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -83.92 120.32 25.95 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.9 t -93.56 -51.14 11.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-O 120.699 0.285 . . . . 0.0 110.553 -177.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.4 p -169.85 165.32 9.77 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.563 ' HG2' ' HD3' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -94.44 171.87 8.54 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 176.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.696 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -52.5 128.87 36.51 Favored Glycine 0 N--CA 1.45 -0.431 0 O-C-N 123.703 0.627 . . . . 0.0 114.138 -175.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -100.82 -18.18 16.54 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.963 0.411 . . . . 0.0 110.374 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 m -120.07 107.22 12.79 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -175.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -82.41 109.01 13.63 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 165.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.01 21.94 0.37 Allowed 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 123.49 2.793 . . . . 0.0 115.185 -170.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -83.12 -51.93 7.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -90.34 126.73 55.64 Favored Pre-proline 0 C--O 1.254 1.306 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.81 139.7 81.55 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.606 2.871 . . . . 0.0 113.681 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.39 152.4 27.49 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.53 83.67 1.9 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.032 0.444 . . . . 0.0 111.394 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 78.5 m -83.25 123.2 29.36 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.99 167.53 3.79 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.176 0.99 . . . . 0.0 112.882 -175.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.7 mt -94.4 34.86 1.25 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -61.8 119.55 8.98 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.643 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.77 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 2.7 m -80.27 104.25 10.69 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.046 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -100.48 100.99 13.45 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 19.5 Cg_exo -69.04 -4.56 13.79 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.695 2.93 . . . . 0.0 113.453 -177.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.9 ttp-105 -75.61 -23.92 56.47 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 66.5 mt -110.84 161.6 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.489 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.45 -57.2 2.3 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 173.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.401 ' HA ' HG22 ' A' ' 5' ' ' THR . 0.2 OUTLIER -162.86 179.09 7.86 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.0 178.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -100.5 116.58 5.62 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 177.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.6 t -104.18 122.97 57.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.043 0.449 . . . . 0.0 110.426 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -96.09 104.79 18.21 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 171.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -73.97 -173.22 1.33 Allowed 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 122.982 2.455 . . . . 0.0 113.396 -174.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -78.64 -11.5 59.97 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.816 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.43 -1.43 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.389 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.3 tp . . . . . 0 CA--C 1.552 1.024 0 CA-C-O 122.95 1.357 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.872 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 96.6 m -111.38 33.7 4.54 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-O 122.004 0.907 . . . . 0.0 111.405 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -79.62 145.8 32.86 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.189 -1.369 . . . . 0.0 107.526 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -146.93 168.31 21.8 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -66.9 -28.3 68.2 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.4 t -68.32 -43.03 78.45 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.74 -2.5 23.63 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.328 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.42 161.75 54.33 Favored Glycine 0 N--CA 1.425 -2.093 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.576 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.1 m -116.32 122.55 45.22 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 122.528 0.331 . . . . 0.0 110.72 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 3.2 tttp -43.13 132.4 4.18 Favored 'General case' 0 C--O 1.247 0.973 0 C-N-CA 124.677 1.191 . . . . 0.0 111.464 175.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.98 -28.32 15.22 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.98 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.8 m -103.92 133.37 49.01 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 122.537 -0.39 . . . . 0.0 110.299 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 12.6 mptt -84.62 118.47 24.39 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.815 -177.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -88.56 105.97 18.0 Favored 'General case' 0 CA--C 1.492 -1.284 0 CA-C-O 123.2 1.476 . . . . 0.0 108.727 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -123.09 146.98 47.24 Favored 'General case' 0 C--N 1.269 -2.933 0 CA-C-N 111.959 -2.382 . . . . 0.0 111.589 -165.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 19.4 p -94.91 145.7 24.74 Favored 'General case' 0 N--CA 1.408 -2.531 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.587 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.2 -12.99 57.09 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.964 0.905 . . . . 0.0 112.911 -173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -71.53 -20.09 62.09 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.87 30.6 2.95 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.128 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.0 m -123.85 136.76 54.57 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.342 0.592 . . . . 0.0 112.494 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.457 ' CE1' ' HG3' ' A' ' 15' ' ' LYS . 62.2 t80 -79.95 115.19 19.39 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.6 t -85.75 -61.55 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.9 p -164.38 154.73 14.64 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.433 ' HG3' ' HD2' ' A' ' 15' ' ' LYS . 13.2 tt0 -89.65 155.53 19.17 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 174.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -54.55 113.13 3.18 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.592 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -83.37 -10.53 58.4 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.5 m -95.78 125.72 40.55 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-O 121.403 0.62 . . . . 0.0 110.338 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.71 134.66 37.06 Favored Pre-proline 0 C--N 1.293 -1.89 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.038 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.88 -8.21 17.28 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.074 2.516 . . . . 0.0 114.72 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -63.66 -46.66 84.58 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 117.839 0.29 . . . . 0.0 110.823 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -90.14 138.14 27.54 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.02 95.88 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.882 2.388 . . . . 0.0 110.727 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -88.92 118.94 28.99 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.077 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.8 78.48 1.72 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 96.8 m -79.16 169.16 18.58 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.859 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.422 ' HB ' ' OD1' ' A' ' 40' ' ' ASN . 0.3 OUTLIER -61.73 155.83 21.82 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.61 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.4 mt -94.77 40.87 1.09 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.907 0.861 . . . . 0.0 109.563 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.422 ' OD1' ' HB ' ' A' ' 38' ' ' THR . 8.4 m120 -62.47 122.57 16.07 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 113.793 -1.548 . . . . 0.0 109.307 175.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.872 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 5.2 m -81.26 112.04 18.21 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.186 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -111.09 85.09 4.97 Favored Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 24.4 Cg_exo -63.19 -19.89 69.66 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 123.614 2.876 . . . . 0.0 113.695 -171.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.487 ' O ' ' HB3' ' A' ' 18' ' ' SER . 3.4 tmm_? -73.36 -9.64 58.91 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.277 0.561 . . . . 0.0 110.486 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.5 mt -101.24 124.49 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 172.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.84 -59.09 1.93 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.643 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -157.36 163.66 38.38 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.469 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.06 127.75 9.2 Favored Glycine 0 N--CA 1.407 -3.292 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.2 t -105.77 103.37 15.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 14.0 m -85.1 152.48 58.7 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo . . . . . 0 C--N 1.364 1.372 0 C-N-CA 123.26 2.64 . . . . 0.0 112.6 -178.664 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 tt . . . . . 0 C--O 1.244 0.773 0 CA-C-O 121.594 0.711 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.93 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 22.2 m -119.73 43.21 2.71 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.613 ' HB ' HG23 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -90.74 163.81 14.35 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 170.29 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.689 ' HA ' ' HB3' ' A' ' 42' ' ' ASP . 7.9 p30 -151.42 136.13 17.15 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 119.116 0.871 . . . . 0.0 110.309 170.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 t -60.69 -34.51 74.45 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.277 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 t -74.45 -26.81 60.28 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.328 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.54 -54.39 4.59 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 18.76 -137.38 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 118.669 2.227 . . . . 0.0 118.669 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.569 ' H ' ' HE1' ' A' ' 16' ' ' TYR . 80.4 m -159.98 102.26 1.46 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.743 1.217 . . . . 0.0 109.789 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -46.75 128.11 10.38 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 125.136 1.375 . . . . 0.0 109.979 171.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.431 ' O ' ' HD2' ' A' ' 51' ' ' PRO . . . 111.49 -10.01 28.35 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 30.9 m -132.39 141.66 48.97 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.635 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 55.7 mmtt -82.56 131.02 35.22 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.569 ' HE1' ' H ' ' A' ' 11' ' ' THR . 12.3 m-85 -83.99 119.72 25.26 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.76 144.69 32.73 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.828 0.823 . . . . 0.0 112.369 -169.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.633 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 34.3 p -92.79 139.27 30.72 Favored 'General case' 0 N--CA 1.407 -2.623 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.017 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -62.74 -13.57 34.34 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -171.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -72.61 -15.16 61.74 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 120.833 0.349 . . . . 0.0 110.707 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.31 34.33 2.53 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.964 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.432 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 85.3 m -125.52 124.65 41.78 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.023 0.439 . . . . 0.0 110.88 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.635 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 69.0 t80 -76.97 132.61 39.11 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 175.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.9 t -106.18 -58.57 3.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.223 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.38 154.01 35.84 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.37 0.605 . . . . 0.0 112.46 -176.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -79.85 152.92 29.42 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.113 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.483 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -69.04 93.26 0.32 Allowed Glycine 0 N--CA 1.436 -1.308 0 O-C-N 123.927 0.767 . . . . 0.0 113.752 -175.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -100.25 -41.37 7.11 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 m -71.87 102.54 2.91 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -164.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -78.81 124.23 85.07 Favored Pre-proline 0 C--N 1.304 -1.394 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.794 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -87.9 1.9 6.65 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.911 2.407 . . . . 0.0 113.289 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -82.96 -46.59 12.73 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -86.23 156.85 57.0 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 173.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.71 55.8 4.98 Favored 'Trans proline' 0 C--O 1.246 0.91 0 C-N-CA 122.411 2.074 . . . . 0.0 113.426 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -88.75 97.28 11.05 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.415 0.626 . . . . 0.0 110.356 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.01 146.16 48.77 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.024 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.0 m -125.89 149.66 48.53 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.373 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.0 60.63 0.4 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.858 0.863 . . . . 0.0 112.271 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 tp -137.57 44.15 2.25 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 175.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -62.92 141.05 58.86 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 113.495 -1.684 . . . . 0.0 109.986 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.93 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 35.9 m 63.45 59.64 1.21 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.04 0.924 . . . . 0.0 110.328 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.689 ' HB3' ' HA ' ' A' ' 6' ' ' ASN . 61.3 t0 -82.8 109.43 16.64 Favored Pre-proline 0 C--N 1.312 -1.054 0 C-N-CA 125.45 1.5 . . . . 0.0 108.821 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 11.8 Cg_exo -69.68 -4.47 14.03 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 123.204 2.603 . . . . 0.0 113.616 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.633 ' O ' ' HB3' ' A' ' 18' ' ' SER . 1.6 mmp_? -85.17 -30.48 23.89 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.396 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.613 HG23 ' HB ' ' A' ' 5' ' ' THR . 7.3 tt -99.16 105.4 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.753 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.79 -42.71 23.87 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -167.54 176.44 6.51 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.919 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -109.07 124.74 7.45 Favored Glycine 0 C--N 1.285 -2.275 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.213 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.1 t -94.88 107.65 19.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 13.9 m -80.32 117.41 67.52 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.499 ' HG3' ' HE2' ' A' ' 15' ' ' LYS . 21.0 Cg_endo . . . . . 0 C--O 1.24 0.613 0 C-N-CA 123.117 2.544 . . . . 0.0 113.614 -175.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.45 HG13 ' H ' ' A' ' 5' ' ' THR . 8.7 tp . . . . . 0 N--CA 1.435 -1.186 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.8 m -115.11 20.66 14.83 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.45 ' H ' HG13 ' A' ' 3' ' ' ILE . 1.2 m -90.69 172.79 8.41 Favored 'General case' 0 C--N 1.273 -2.744 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.608 177.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.887 HD22 HD13 ' A' ' 39' ' ' LEU . 9.1 p30 -133.31 156.81 46.93 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.4 t -73.72 -35.59 65.11 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 123.791 0.836 . . . . 0.0 113.105 -174.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 45.7 t -59.5 -56.91 15.99 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.578 0.704 . . . . 0.0 109.801 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.611 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . . . -90.53 26.38 2.01 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.55 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.15 163.68 26.77 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.606 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -53.77 110.83 0.63 Allowed 'General case' 0 C--O 1.241 0.646 0 C-N-CA 125.708 1.603 . . . . 0.0 113.111 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 27.1 ttpp -55.02 112.96 1.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.215 1.006 . . . . 0.0 111.627 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.01 -26.51 10.45 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.17 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.9 m -87.15 122.09 30.48 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.411 ' HE3' ' HG3' ' A' ' 51' ' ' PRO . 65.2 mttt -77.8 113.16 15.4 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.764 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.616 ' HD2' HG21 ' A' ' 45' ' ' ILE . 60.5 m-85 -72.91 106.65 4.92 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.85 145.11 44.03 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.499 -1.682 . . . . 0.0 111.154 -167.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.486 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 4.9 p -92.87 145.57 24.29 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.556 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -64.45 -14.7 58.37 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -170.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.71 8.27 20.36 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.405 0.622 . . . . 0.0 110.444 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.27 28.37 9.87 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 115.522 -0.763 . . . . 0.0 114.251 171.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.486 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 5.3 m -115.74 114.14 24.4 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 118.007 0.903 . . . . 0.0 112.027 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -67.44 116.78 8.57 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 171.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.68 -47.29 16.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.1 p -178.59 -175.58 0.44 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -125.6 144.3 50.64 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -66.36 146.09 48.31 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -130.75 1.75 4.42 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.42 0.629 . . . . 0.0 111.035 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.7 m -121.46 169.39 10.69 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-O 121.974 0.892 . . . . 0.0 112.127 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.491 ' HB3' ' OD1' ' A' ' 33' ' ' ASN . 30.6 t70 -114.43 116.98 43.51 Favored Pre-proline 0 C--N 1.287 -2.132 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 173.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 19.6 Cg_exo -67.79 26.98 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 124.018 3.145 . . . . 0.0 115.334 -173.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -116.79 -32.58 5.08 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' A' ' 30' ' ' ASP . 3.0 p-10 -90.54 152.14 44.88 Favored Pre-proline 0 C--O 1.245 0.851 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.179 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.79 103.55 0.72 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.228 2.618 . . . . 0.0 112.815 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.18 114.18 19.94 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.57 64.63 4.5 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.552 0.691 . . . . 0.0 112.845 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.611 ' HB2' ' HB2' ' A' ' 9' ' ' ALA . 58.8 m -113.18 118.15 33.91 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 172.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.9 p -65.03 141.01 58.91 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 123.565 0.54 . . . . 0.0 111.226 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.887 HD13 HD22 ' A' ' 6' ' ' ASN . 4.1 mm? -79.54 -74.14 0.31 Allowed 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 60.7 7.65 1.49 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.408 1.483 . . . . 0.0 113.643 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 60.6 m 58.83 123.58 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 125.416 1.486 . . . . 0.0 111.789 -173.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -110.62 83.64 3.54 Favored Pre-proline 0 C--N 1.323 -0.579 0 O-C-N 121.115 -0.991 . . . . 0.0 109.547 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 23.4 Cg_exo -65.46 -14.09 43.13 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 123.616 2.877 . . . . 0.0 114.11 -172.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -73.71 -25.09 60.04 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.567 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.616 HG21 ' HD2' ' A' ' 16' ' ' TYR . 87.3 mt -82.56 144.33 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.06 -59.69 2.13 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.6 174.04 11.28 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.176 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.73 99.13 2.02 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.94 107.26 12.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.343 0.592 . . . . 0.0 110.876 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.7 m -85.73 136.86 36.36 Favored Pre-proline 0 C--N 1.291 -1.953 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 170.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 16.9 Cg_exo . . . . . 0 CA--C 1.539 0.734 0 C-N-CA 123.446 2.764 . . . . 0.0 113.52 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 tt . . . . . 0 N--CA 1.427 -1.591 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.464 ' HA ' ' CB ' ' A' ' 41' ' ' CYS 0.252 98.7 m -88.66 19.32 4.03 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -174.156 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.7 m -90.64 136.14 33.25 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 171.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.462 ' HA ' ' HB2' ' A' ' 42' ' ' ASP . 11.4 p30 -119.3 158.06 26.83 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.625 ' HB2' HD11 ' A' ' 45' ' ' ILE . 6.9 t -84.86 -17.25 38.56 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.287 -174.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.3 t -67.9 -46.1 72.57 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 35' ' ' LYS . . . -91.53 22.58 3.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.239 0.542 . . . . 0.0 109.593 173.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.71 152.91 37.81 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 115.738 -0.665 . . . . 0.0 114.75 -172.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 m -79.36 114.26 18.16 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 124.768 1.227 . . . . 0.0 110.277 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.615 ' HA ' ' O ' ' A' ' 26' ' ' GLU . 2.3 tmtp? -64.84 127.34 31.16 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.526 ' H ' ' HG2' ' A' ' 26' ' ' GLU . . . 113.48 -10.11 24.04 Favored Glycine 0 C--N 1.301 -1.372 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -176.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.5 m -105.75 127.54 53.15 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HA ' ' HE1' ' A' ' 23' ' ' PHE . 20.7 mmmt -84.84 94.02 8.63 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -178.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -72.51 111.22 7.49 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 175.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -140.91 151.69 44.44 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.794 -164.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.9 t -97.17 138.96 33.86 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.537 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.454 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 3.5 p30 -69.12 -3.59 13.99 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.732 0.813 . . . . 0.0 112.894 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.07 -8.88 59.0 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.765 176.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.45 25.05 6.48 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.93 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 m -122.02 114.91 21.6 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 122.565 -0.374 . . . . 0.0 111.662 -177.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.496 ' HZ ' ' HB2' ' A' ' 26' ' ' GLU . 73.6 t80 -73.34 130.8 40.95 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.91 -62.05 2.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.895 -175.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 p -162.73 155.51 19.34 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.615 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 20.0 tt0 -103.76 44.82 0.99 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.517 0.675 . . . . 0.0 110.461 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.89 -162.8 49.0 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.872 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -112.26 -69.74 0.85 Allowed 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 120.974 0.416 . . . . 0.0 109.988 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.4 m -144.56 -166.49 2.4 Favored 'General case' 0 N--CA 1.407 -2.62 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -177.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.48 133.74 59.28 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.66 1.54 0.39 Allowed 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 123.505 2.803 . . . . 0.0 115.205 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -61.39 -47.91 83.62 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -91.81 117.56 67.81 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 172.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -76.63 121.52 6.0 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 121.551 1.501 . . . . 0.0 111.081 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -86.93 116.21 24.84 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.32 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.59 113.16 20.11 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.376 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.6 m -141.96 -177.68 5.33 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.32 157.39 29.26 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 120.867 0.365 . . . . 0.0 110.616 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.49 32.92 1.9 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.898 0.856 . . . . 0.0 109.838 -175.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -78.14 136.16 37.8 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.188 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 19.6 m -76.27 123.48 25.97 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 6' ' ' ASN . 6.9 t0 -83.78 105.27 5.31 Favored Pre-proline 0 N--CA 1.468 0.454 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.699 -169.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 68.1 Cg_endo -83.45 1.72 8.8 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.929 2.419 . . . . 0.0 111.725 -174.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 ttp-105 -83.04 -20.55 34.78 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 7' ' ' CYS . 71.8 mt -108.02 152.64 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.491 -1.232 . . . . 0.0 109.018 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.26 -50.58 3.12 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 19' ' ' ASP . 15.9 p90 -159.16 175.54 13.33 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -114.62 112.16 2.71 Favored Glycine 0 N--CA 1.428 -1.894 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.339 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.537 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 56.2 t -82.29 106.29 13.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 85.7 m -105.67 99.29 20.89 Favored Pre-proline 0 C--N 1.298 -1.657 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.231 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 49' ' ' VAL . 3.6 Cg_exo . . . . . 0 N--CA 1.456 -0.703 0 C-N-CA 123.296 2.664 . . . . 0.0 109.594 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 tp . . . . . 0 CA--C 1.551 0.996 0 CA-C-O 122.911 1.339 . . . . 0.0 109.769 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.932 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.8 m -88.58 40.83 0.98 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.991 0.901 . . . . 0.0 112.282 -176.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -90.83 127.25 36.29 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 171.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -146.27 178.8 7.97 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.524 -0.871 . . . . 0.0 112.548 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -85.17 -32.93 22.44 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.6 t -66.1 -50.43 64.07 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.933 0.873 . . . . 0.0 108.976 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.37 33.25 0.9 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.527 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.23 136.11 13.06 Favored Glycine 0 N--CA 1.41 -3.076 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.781 HG22 ' HA ' ' A' ' 31' ' ' PRO . 7.2 p -83.85 111.46 19.24 Favored 'General case' 0 C--N 1.268 -2.955 0 CA-C-N 113.924 -1.138 . . . . 0.0 111.834 -175.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -45.79 115.57 1.0 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.704 0.802 . . . . 0.0 110.854 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.49 -36.59 2.53 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 m -95.52 134.71 38.05 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.532 ' HG3' ' HG3' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -88.42 119.96 29.34 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.441 ' HB3' HD13 ' A' ' 45' ' ' ILE . 67.7 m-85 -83.86 105.24 14.59 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 122.896 1.331 . . . . 0.0 108.142 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.586 ' HE1' ' HA2' ' A' ' 21' ' ' GLY . 0.5 OUTLIER -126.52 147.95 49.78 Favored 'General case' 0 N--CA 1.405 -2.684 0 CA-C-N 112.868 -1.969 . . . . 0.0 112.207 -164.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.7 142.58 29.31 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.113 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -58.18 -19.05 30.21 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.867 1.267 . . . . 0.0 114.208 -172.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.07 -8.03 59.17 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.131 0.491 . . . . 0.0 111.02 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.586 ' HA2' ' HE1' ' A' ' 17' ' ' PHE . . . 106.14 24.27 6.95 Favored Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.324 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.2 m -107.04 123.32 48.05 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.291 -0.563 . . . . 0.0 112.142 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -77.94 109.65 12.18 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.21 -52.09 15.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.9 p -174.46 169.54 3.71 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.532 ' HG3' ' HG3' ' A' ' 15' ' ' LYS . 15.8 tt0 -108.27 171.3 7.49 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.67 112.3 1.56 Allowed Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -83.08 -22.67 33.4 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.666 -0.267 . . . . 0.0 111.705 -172.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -130.36 -176.94 4.12 Favored 'General case' 0 N--CA 1.4 -2.962 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.472 -174.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -78.0 140.59 62.27 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.781 ' HA ' HG22 ' A' ' 11' ' ' THR . 1.0 OUTLIER -42.92 -27.07 0.8 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 124.922 3.748 . . . . 0.0 115.725 -179.501 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.475 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 19.5 mmt85 -122.64 46.09 2.23 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 118.409 0.549 . . . . 0.0 110.492 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -73.57 119.9 78.37 Favored Pre-proline 0 C--N 1.304 -1.382 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.525 175.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -87.25 94.21 0.48 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.787 2.324 . . . . 0.0 111.575 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -158.67 155.32 27.92 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.263 0.554 . . . . 0.0 111.478 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.16 131.53 45.13 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 173.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.2 m -115.28 135.51 54.07 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.208 0.528 . . . . 0.0 112.278 -174.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -18.26 62.9 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 123.573 0.749 . . . . 0.0 110.814 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 tp -86.33 25.31 1.21 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.099 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -53.67 121.09 7.13 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.937 176.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.932 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 14.9 m 67.36 86.58 0.13 Allowed 'General case' 0 C--N 1.321 -0.661 0 O-C-N 124.504 1.128 . . . . 0.0 111.421 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -96.28 104.5 17.6 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.49 3.87 6.83 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.782 2.321 . . . . 0.0 113.041 -172.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -90.41 -15.57 30.73 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.49 0.662 . . . . 0.0 109.331 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.441 HD13 ' HB3' ' A' ' 16' ' ' TYR . 93.2 mt -101.18 140.94 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.49 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.95 -54.35 3.49 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -167.23 173.3 9.11 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.423 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.43 121.23 7.14 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.5 t -94.14 114.09 30.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 123.021 0.529 . . . . 0.0 109.582 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.6 m -99.84 129.39 28.72 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 32.2 Cg_exo . . . . . 0 C--O 1.246 0.883 0 C-N-CA 123.324 2.683 . . . . 0.0 112.114 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.425 ' O ' ' HB3' ' A' ' 41' ' ' CYS . 6.1 tp . . . . . 0 N--CA 1.445 -0.682 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 69.4 m -113.6 40.37 2.42 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.97 0.891 . . . . 0.0 112.781 -173.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 t -90.82 165.81 13.43 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 172.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -160.17 175.86 12.43 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 118.435 0.561 . . . . 0.0 111.11 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.4 t -69.11 -21.2 64.06 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.563 0.745 . . . . 0.0 112.275 -174.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.3 t -91.03 -54.82 3.79 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.56 -0.713 . . . . 0.0 109.965 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.22 37.43 0.1 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.21 175.3 30.67 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 175.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 m -109.48 124.74 51.58 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 117.037 0.419 . . . . 0.0 111.251 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.565 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -54.36 122.58 10.71 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.9 175.152 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.56 -35.52 2.65 Favored Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -176.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.1 m -105.75 151.15 24.82 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -88.28 123.99 33.44 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.519 ' CZ ' ' HA2' ' A' ' 27' ' ' GLY . 1.2 m-30 -77.45 106.89 9.51 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.423 ' CE1' ' HA ' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -141.01 151.74 44.35 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.599 0.714 . . . . 0.0 112.77 -167.192 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.524 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 43.4 p -96.24 129.61 43.52 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 175.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.423 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 4.1 p-10 -62.64 -9.8 10.23 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -20.23 63.79 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.16 -0.19 6.51 Favored Glycine 0 N--CA 1.429 -1.812 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.404 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.524 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 3.8 m -97.45 118.07 33.12 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -76.56 121.77 23.65 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.466 HG21 HG12 ' A' ' 45' ' ' ILE . 23.5 t -95.53 -65.86 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.837 -176.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.56 155.75 43.81 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.964 0.412 . . . . 0.0 111.849 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.07 169.02 10.57 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -62.48 118.78 15.31 Favored Glycine 0 N--CA 1.439 -1.105 0 O-C-N 123.53 0.519 . . . . 0.0 113.306 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -131.24 1.52 4.19 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.01 0.433 . . . . 0.0 111.638 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.2 m -121.29 115.41 22.92 Favored 'General case' 0 N--CA 1.403 -2.779 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -114.12 140.83 25.42 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.74 -21.02 7.47 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.634 2.889 . . . . 0.0 114.958 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -90.94 -24.99 19.99 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.47 ' HA ' ' HD3' ' A' ' 34' ' ' PRO 0.254 28.5 p30 -91.4 115.28 64.12 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.344 0.592 . . . . 0.0 112.484 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 17.2 Cg_exo -65.43 111.74 1.93 Allowed 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 123.313 2.675 . . . . 0.0 111.573 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -139.45 120.29 14.39 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.61 92.92 7.23 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.525 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.6 m -88.7 165.66 14.6 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.804 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.08 149.68 42.93 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.952 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -95.88 33.22 1.72 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.13 147.19 40.73 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.995 -1.457 . . . . 0.0 111.443 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 35.0 m -106.99 93.77 4.74 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.532 ' OD1' ' HB3' ' A' ' 44' ' ' ARG . 9.9 t70 -80.65 103.2 1.66 Allowed Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 123.871 0.868 . . . . 0.0 110.572 -175.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 52.6 Cg_endo -72.79 -7.12 20.25 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.637 2.225 . . . . 0.0 112.464 -174.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.532 ' HB3' ' OD1' ' A' ' 42' ' ' ASP . 16.9 ttp180 -82.81 -45.94 13.69 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.466 HG12 HG21 ' A' ' 24' ' ' VAL . 79.6 mt -79.72 128.95 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 CA-C-O 121.538 0.685 . . . . 0.0 109.965 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.05 -55.41 3.95 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.898 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -171.38 171.24 5.62 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.03 117.06 4.93 Favored Glycine 0 N--CA 1.423 -2.199 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.7 t -93.08 117.32 36.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.35 0.595 . . . . 0.0 111.419 -176.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.3 m -105.73 102.34 37.89 Favored Pre-proline 0 C--N 1.285 -2.198 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 171.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo . . . . . 0 C--N 1.367 1.527 0 C-N-CA 125.092 3.861 . . . . 0.0 114.513 -174.737 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.472 HG13 ' OG1' ' A' ' 5' ' ' THR . 6.5 tp . . . . . 0 N--CA 1.428 -1.543 0 CA-C-O 121.624 0.726 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 19.3 m -136.38 47.16 2.22 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 121.972 0.892 . . . . 0.0 110.3 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.472 ' OG1' HG13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -72.17 160.41 32.49 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.961 178.153 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -158.93 149.25 19.56 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 t -105.79 18.36 22.27 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.357 0.598 . . . . 0.0 112.048 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 t -85.84 -46.01 11.02 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.541 ' HA ' ' OG ' ' A' ' 29' ' ' SER . . . -91.05 -100.01 0.11 Allowed 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.386 173.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.62 -140.3 28.98 Favored Glycine 0 N--CA 1.414 -2.779 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.563 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 m -154.0 119.3 5.12 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.563 ' HD3' ' HB2' ' A' ' 30' ' ' ASP . 15.0 ttpt -57.26 127.05 30.0 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 123.704 0.627 . . . . 0.0 110.613 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.19 -12.83 65.2 Favored Glycine 0 C--N 1.304 -1.201 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.391 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.9 m -99.06 128.65 45.24 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -80.13 92.2 5.63 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.988 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.595 ' HD2' HG21 ' A' ' 45' ' ' ILE . 27.9 m-85 -71.21 115.5 10.44 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.418 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -146.5 151.64 37.71 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.009 -161.747 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.3 t -86.86 137.19 32.61 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.427 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -57.98 -22.45 49.45 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.6 -18.61 60.54 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.181 0.515 . . . . 0.0 110.888 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.418 ' HA2' ' CE2' ' A' ' 17' ' ' PHE . . . 118.65 20.29 4.26 Favored Glycine 0 N--CA 1.425 -2.076 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.404 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 m -104.8 108.33 19.75 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 117.312 0.556 . . . . 0.0 110.173 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.497 ' CZ ' ' HG3' ' A' ' 26' ' ' GLU . 75.1 t80 -68.92 137.15 53.57 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.6 t -108.23 -64.56 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.713 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.3 p -163.35 155.34 17.69 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 18.3 mt-10 -97.52 39.19 1.21 Allowed 'General case' 0 C--O 1.242 0.676 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -175.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.21 127.74 0.27 Allowed Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.446 -0.797 . . . . 0.0 114.165 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -105.4 27.81 7.97 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 122.377 -0.484 . . . . 0.0 111.036 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.541 ' OG ' ' HA ' ' A' ' 9' ' ' ALA . 4.3 m -141.74 109.1 5.56 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.563 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 21.0 t70 -96.18 130.45 31.08 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 167.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -59.44 50.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.511 2.51 0 C-N-CA 124.859 3.706 . . . . 0.0 116.189 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -128.56 -56.12 1.22 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -90.5 130.06 42.81 Favored Pre-proline 0 N--CA 1.442 -0.85 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 175.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.28 147.75 11.5 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.258 1.972 . . . . 0.0 110.853 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.527 ' HB3' ' SG ' ' A' ' 37' ' ' CYS . 27.6 mmtp -120.28 89.7 3.18 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.477 0.656 . . . . 0.0 109.893 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.99 59.51 5.67 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.178 0.99 . . . . 0.0 110.041 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 35' ' ' LYS . 3.4 m -88.46 -178.79 5.94 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.808 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.48 137.49 36.47 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 174.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.9 tp -89.1 43.72 1.16 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.377 1.084 . . . . 0.0 110.105 -174.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -53.17 122.54 9.67 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 112.837 -1.983 . . . . 0.0 110.926 172.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.528 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 34.8 m -71.94 108.67 5.31 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 175.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -104.88 91.57 4.44 Favored Pre-proline 0 C--N 1.31 -1.123 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 22.9 Cg_exo -64.66 -17.2 58.78 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 124.43 3.42 . . . . 0.0 114.818 -172.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.4 ttp-105 -59.68 -23.65 63.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.564 0.697 . . . . 0.0 110.139 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.595 HG21 ' HD2' ' A' ' 16' ' ' TYR . 95.1 mt -103.82 122.27 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.73 -46.56 8.52 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.143 -177.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -161.09 175.15 12.72 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.965 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -109.59 111.78 3.24 Favored Glycine 0 N--CA 1.415 -2.754 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.7 t -86.31 98.68 7.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.7 m -87.74 157.49 52.03 Favored Pre-proline 0 C--N 1.285 -2.212 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo . . . . . 0 CA--C 1.532 0.376 0 C-N-CA 122.636 2.224 . . . . 0.0 109.709 175.921 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 tp . . . . . 0 N--CA 1.426 -1.669 0 CA-C-O 121.949 0.881 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.53 ' HA ' ' CB ' ' A' ' 41' ' ' CYS . 90.8 m -96.36 25.65 4.86 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 122.218 1.008 . . . . 0.0 112.317 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.7 m -90.82 141.94 28.28 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 173.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -136.84 167.15 22.02 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.97 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.505 ' HA ' ' CD2' ' A' ' 16' ' ' TYR . 6.4 t -70.95 -34.57 71.59 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 123.447 0.699 . . . . 0.0 112.695 -171.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -77.89 -36.43 49.69 Favored 'General case' 0 N--CA 1.424 -1.754 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.767 -177.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.58 34.28 0.32 Allowed 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.482 0.658 . . . . 0.0 111.09 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.532 ' HA3' ' HE2' ' A' ' 16' ' ' TYR . . . -119.29 168.75 13.49 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.36 143.25 30.77 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 116.929 0.365 . . . . 0.0 111.009 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -50.81 138.66 18.26 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.694 172.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.91 -33.08 6.66 Favored Glycine 0 C--N 1.3 -1.456 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 64.0 m -99.11 138.83 35.65 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.739 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 37.0 mtmt -110.94 127.76 55.59 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -175.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.532 ' HE2' ' HA3' ' A' ' 10' ' ' GLY . 28.6 m-85 -76.47 128.28 34.48 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.335 0.588 . . . . 0.0 110.443 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -148.07 147.05 29.13 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.162 -171.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.559 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 31.5 p -97.74 144.22 27.58 Favored 'General case' 0 N--CA 1.407 -2.588 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.889 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.0 -11.47 57.1 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.737 0.815 . . . . 0.0 113.14 -170.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -74.1 -14.12 60.93 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.68 48.74 1.25 Allowed Glycine 0 N--CA 1.427 -1.962 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.559 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 84.9 m -134.68 121.61 21.06 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.077 0.465 . . . . 0.0 110.803 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.739 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 78.1 t80 -69.67 120.23 15.12 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.3 t -89.57 -53.22 9.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.327 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.4 p -172.33 164.87 5.85 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.986 0.422 . . . . 0.0 110.458 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -88.87 146.05 25.19 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 123.765 0.826 . . . . 0.0 109.265 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.61 109.65 2.49 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.476 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 1.1 mm-40 -101.49 23.49 11.03 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 10' ' ' GLY . 5.5 m -113.32 102.7 10.59 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-O 121.285 0.564 . . . . 0.0 111.779 176.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.552 ' HB3' ' ND2' ' A' ' 33' ' ' ASN . 4.6 t70 -113.98 138.7 22.94 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 173.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.34 -19.83 5.06 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.981 3.121 . . . . 0.0 115.549 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -86.88 -37.75 17.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.91 -0.494 . . . . 0.0 111.345 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.552 ' ND2' ' HB3' ' A' ' 30' ' ' ASP . 14.9 p30 -90.44 116.9 67.44 Favored Pre-proline 0 C--N 1.317 -0.834 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.094 -177.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -80.85 117.91 3.35 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.237 1.958 . . . . 0.0 109.208 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 28' ' ' GLU . 25.5 mmtm -109.36 139.89 43.75 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -171.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.55 125.05 30.04 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 166.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.0 m -128.94 150.47 50.36 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.785 -170.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 t -68.06 140.88 56.3 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 29.3 mt -106.85 -10.46 16.03 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.07 0.462 . . . . 0.0 110.833 -172.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -110.92 163.95 13.29 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.348 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.53 ' CB ' ' HA ' ' A' ' 4' ' ' CYS . 2.7 m -45.28 135.33 5.95 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 126.082 1.753 . . . . 0.0 112.596 -177.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -119.85 88.98 41.17 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.4 2.79 2.08 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 123.884 3.056 . . . . 0.0 115.214 -172.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -76.0 -24.54 55.32 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.865 0.84 . . . . 0.0 108.856 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.3 mt -95.89 149.47 4.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.023 -175.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.88 -53.01 2.84 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.42 170.7 18.33 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.883 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -102.45 98.17 1.66 Allowed Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.4 t -79.69 109.2 14.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.292 0.568 . . . . 0.0 109.882 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 3.4 m -80.66 115.08 52.97 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 106.131 -1.804 . . . . 0.0 106.131 173.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.623 ' HG3' ' HE2' ' A' ' 15' ' ' LYS . 24.5 Cg_exo . . . . . 0 C--O 1.24 0.615 0 C-N-CA 123.365 2.71 . . . . 0.0 114.169 -171.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 tt . . . . . 0 CA--C 1.543 0.705 0 CA-C-O 122.793 1.282 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.823 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 78.2 m -124.37 43.66 2.95 Favored 'General case' 0 N--CA 1.406 -2.631 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.918 -175.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.453 ' HB ' HG23 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -77.97 148.64 34.36 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 173.617 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -128.61 142.97 50.87 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 118.871 -1.131 . . . . 0.0 113.501 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.7 t -98.97 13.03 34.16 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.321 1.057 . . . . 0.0 108.619 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.7 t -85.92 -70.39 0.6 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.773 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.1 -71.5 0.64 Allowed 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.33 -159.62 53.76 Favored Glycine 0 N--CA 1.415 -2.714 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.604 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 m -122.08 98.17 5.81 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.753 ' HE3' ' HB2' ' A' ' 30' ' ' ASP . 0.5 OUTLIER -40.18 122.22 1.49 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.031 0.932 . . . . 0.0 112.103 175.188 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.02 -42.01 1.92 Allowed Glycine 0 N--CA 1.435 -1.414 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.601 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 70.0 m -89.42 147.43 24.04 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.557 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 18.4 mtpp -97.36 116.19 29.1 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -175.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.82 ' HB3' HG13 ' A' ' 45' ' ' ILE . 10.9 m-85 -77.61 115.94 17.77 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.025 0.917 . . . . 0.0 108.85 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.448 ' HE2' ' HA2' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -135.67 149.05 49.16 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.498 -166.09 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.81 134.06 37.84 Favored 'General case' 0 N--CA 1.41 -2.466 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.42 -20.45 19.74 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -169.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -76.03 -13.77 60.22 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.907 0.385 . . . . 0.0 111.669 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.448 ' HA2' ' HE2' ' A' ' 17' ' ' PHE . . . 114.8 19.11 6.16 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.054 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.6 m -104.53 110.2 22.39 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.837 0.351 . . . . 0.0 110.86 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.557 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 50.3 t80 -73.14 126.14 29.34 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.1 t -96.34 -61.14 2.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 120.842 0.353 . . . . 0.0 110.328 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.4 p -161.63 160.07 28.32 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -176.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -97.3 145.46 26.08 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 174.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -46.65 122.09 6.31 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 124.165 0.916 . . . . 0.0 112.133 -178.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.56 -52.75 6.54 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.898 0.38 . . . . 0.0 111.13 -173.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.7 m -102.69 145.16 30.11 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-O 121.684 0.754 . . . . 0.0 111.963 -170.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.753 ' HB2' ' HE3' ' A' ' 12' ' ' LYS . 11.3 t70 -87.91 139.07 30.9 Favored Pre-proline 0 C--N 1.288 -2.077 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 172.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -49.79 -20.18 4.42 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.233 2.622 . . . . 0.0 114.512 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -83.23 -21.59 33.35 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.28 2.8 p-10 -90.58 118.86 69.02 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.823 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -75.27 73.51 4.45 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 123.637 2.892 . . . . 0.0 116.161 -170.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -130.37 49.91 2.25 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 122.551 1.167 . . . . 0.0 109.639 170.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.47 123.26 27.38 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.439 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.3 m -81.49 171.11 15.1 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.382 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 m -50.18 -64.76 0.71 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.85 -53.6 0.09 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 59.91 79.33 0.24 Allowed 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 124.578 1.174 . . . . 0.0 111.88 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.823 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 61.7 m -81.18 89.8 6.03 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 173.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.598 ' HB3' HG22 ' A' ' 45' ' ' ILE . 7.0 t0 -91.3 108.58 29.79 Favored Pre-proline 0 C--N 1.306 -1.283 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.544 -170.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -71.44 -5.59 17.36 Favored 'Trans proline' 0 C--O 1.24 0.594 0 C-N-CA 123.184 2.589 . . . . 0.0 112.424 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.577 ' HD3' ' OD1' ' A' ' 42' ' ' ASP . 25.8 mtp180 -75.26 -36.59 61.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.025 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.82 HG13 ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -108.98 136.66 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 CA-C-O 121.752 0.787 . . . . 0.0 112.943 -171.552 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.7 -60.53 1.68 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.387 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -153.75 165.22 36.69 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.012 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.41 114.56 5.05 Favored Glycine 0 C--N 1.29 -2.003 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t -92.85 114.12 29.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 14.7 m -79.67 137.43 54.8 Favored Pre-proline 0 C--N 1.284 -2.25 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 176.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo . . . . . 0 CA--C 1.54 0.821 0 C-N-CA 124.278 3.318 . . . . 0.0 114.466 -175.652 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 tp . . . . . 0 CA--C 1.539 0.555 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 1.015 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 69.3 m -101.47 34.39 2.61 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-O 122.206 1.003 . . . . 0.0 113.18 -173.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.8 m -91.34 147.07 23.3 Favored 'General case' 0 N--CA 1.408 -2.525 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.444 ' HA ' HD12 ' A' ' 45' ' ' ILE . 8.7 t-20 -159.01 -172.64 3.87 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.487 ' O ' ' HA3' ' A' ' 27' ' ' GLY . 1.1 t -74.14 -30.5 62.31 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 122.055 0.931 . . . . 0.0 108.925 -175.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.532 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 34.3 t -80.32 -44.28 19.79 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.972 176.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.415 ' HB3' ' H ' ' A' ' 6' ' ' ASN . . . -72.27 49.43 0.2 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.471 1.108 . . . . 0.0 113.375 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' HA3' ' HE1' ' A' ' 16' ' ' TYR . . . -151.86 -121.52 0.94 Allowed Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.335 -0.936 . . . . 0.0 111.322 176.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 29' ' ' SER . 7.7 m -159.9 138.17 10.29 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 27' ' ' GLY . 14.9 mtpp -57.4 130.71 47.5 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.72 -32.66 6.24 Favored Glycine 0 C--N 1.291 -1.95 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -174.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.3 m -80.81 123.94 28.66 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 121.1 0.476 . . . . 0.0 109.838 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.686 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 62.0 mttm -87.34 109.91 19.87 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.507 ' HE2' ' H ' ' A' ' 27' ' ' GLY . 51.5 m-85 -71.7 125.68 27.76 Favored 'General case' 0 CA--C 1.472 -2.056 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.48 146.16 32.28 Favored 'General case' 0 N--CA 1.393 -3.314 0 CA-C-N 114.385 -1.28 . . . . 0.0 111.541 -167.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.649 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 28.1 t -93.62 130.47 39.52 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.09 -17.12 50.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.101 0.96 . . . . 0.0 113.038 -172.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.72 -10.19 59.43 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.988 0.423 . . . . 0.0 110.387 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.08 6.05 16.65 Favored Glycine 0 N--CA 1.432 -1.612 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.96 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.649 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 8.5 m -90.95 122.66 33.82 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 117.046 0.423 . . . . 0.0 111.694 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.686 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 72.3 t80 -79.04 138.53 38.03 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 174.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.5 HG21 HG12 ' A' ' 45' ' ' ILE . 59.8 t -108.58 -64.51 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.532 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 p -173.02 168.27 4.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.646 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -112.54 117.47 32.44 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 170.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.605 ' O ' ' HG2' ' A' ' 12' ' ' LYS . . . -79.17 176.29 54.76 Favored Glycine 0 C--N 1.296 -1.657 0 N-CA-C 115.351 0.9 . . . . 0.0 115.351 -169.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -103.21 29.02 5.82 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 123.365 0.666 . . . . 0.0 110.96 -176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.413 ' HB3' ' HA ' ' A' ' 11' ' ' THR . 10.0 t -81.94 72.11 8.98 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 122.335 1.064 . . . . 0.0 109.084 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.69 140.33 31.5 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.119 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -35.46 -44.7 0.65 Allowed 'Trans proline' 0 CA--C 1.548 1.196 0 C-N-CA 124.791 3.661 . . . . 0.0 115.892 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.72 9.46 37.13 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -174.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.42 158.07 43.79 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -83.41 85.29 1.53 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.261 1.974 . . . . 0.0 111.072 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.12 55.01 3.14 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 122.143 0.973 . . . . 0.0 111.86 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.32 83.51 1.77 Allowed 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.951 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.2 m -109.99 123.74 50.18 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.387 -175.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.08 46.36 1.38 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.211 0.529 . . . . 0.0 111.359 -175.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.32 23.19 0.48 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.532 ' OD1' ' HB3' ' A' ' 8' ' ' CYS . 37.2 m-20 -90.21 57.14 3.63 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -167.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 1.015 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 71.0 m -148.29 74.34 1.28 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 173.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -92.82 112.94 58.14 Favored Pre-proline 0 CA--C 1.515 -0.394 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.54 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.76 -11.69 28.05 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 123.053 2.502 . . . . 0.0 113.862 -174.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.9 ptt-85 -90.7 -12.44 36.68 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.55 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.5 HG12 HG21 ' A' ' 24' ' ' VAL . 85.1 mt -97.82 138.0 23.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.82 -59.61 1.7 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.374 0.607 . . . . 0.0 109.622 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.35 161.51 41.04 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -95.51 106.75 3.43 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.3 t -86.91 107.43 16.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.433 0.635 . . . . 0.0 110.931 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.465 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.6 m -92.43 124.12 60.2 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 173.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 2.6 Cg_exo . . . . . 0 N--CA 1.457 -0.637 0 C-N-CA 123.086 2.524 . . . . 0.0 113.291 -175.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.742 HG12 ' HA ' ' A' ' 43' ' ' PRO . 7.1 tp . . . . . 0 CA--C 1.567 1.605 0 CA-C-O 122.832 1.301 . . . . 0.0 113.072 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.453 ' HA ' ' CB ' ' A' ' 41' ' ' CYS . 3.3 m -102.45 32.55 3.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.238 1.018 . . . . 0.0 111.162 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.93 162.85 17.46 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 113.921 -1.491 . . . . 0.0 108.222 176.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -132.42 156.58 46.45 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.208 0.528 . . . . 0.0 110.3 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 t -85.09 -16.13 41.64 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 124.263 1.025 . . . . 0.0 112.407 -173.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 8.4 t -90.86 -66.61 0.91 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.594 -1.242 . . . . 0.0 113.788 -175.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.05 48.9 0.42 Allowed 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -167.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.2 -95.13 2.38 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 174.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.4 m -163.78 132.17 3.69 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 123.957 0.903 . . . . 0.0 109.088 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.931 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 19.8 pttp -64.34 143.05 58.18 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.48 -35.47 4.79 Favored Glycine 0 C--N 1.297 -1.619 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.504 -175.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.4 m -80.49 146.33 31.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.704 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 2.1 mmpt? -97.19 113.89 25.54 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.686 ' HB3' HG13 ' A' ' 45' ' ' ILE . 90.6 m-85 -71.28 117.6 13.01 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.544 ' CE2' ' HA ' ' A' ' 22' ' ' THR . 16.0 t80 -122.73 144.5 49.12 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-O 122.193 0.997 . . . . 0.0 113.138 -163.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.467 ' HB2' ' CG2' ' A' ' 24' ' ' VAL . 6.4 t -97.19 123.3 40.92 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -30.9 71.24 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -174.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -107.06 18.81 21.28 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.252 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -162.7 20.21 0.17 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 118.815 -1.66 . . . . 0.0 115.715 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.544 ' HA ' ' CE2' ' A' ' 17' ' ' PHE . 0.4 OUTLIER 55.91 -170.42 0.08 Allowed 'General case' 0 CA--C 1.587 2.387 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 177.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.704 ' HD1' ' HB3' ' A' ' 15' ' ' LYS . 72.9 t80 -39.79 126.06 1.92 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.253 1.421 . . . . 0.0 113.103 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 18' ' ' SER . 40.2 t -106.49 -58.68 3.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.694 177.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 p -147.28 165.41 30.2 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.416 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 15.7 tt0 -111.21 165.08 12.22 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -178.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.931 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -51.85 134.87 35.17 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 115.976 1.15 . . . . 0.0 115.976 -176.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -123.52 8.85 8.98 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 122.404 1.097 . . . . 0.0 108.946 176.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.2 m -100.98 101.41 12.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.135 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -108.27 143.95 28.46 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.61 -29.0 77.58 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.504 2.136 . . . . 0.0 114.298 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -98.11 -41.67 7.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.503 0.192 . . . . 0.0 111.287 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -57.8 139.3 82.33 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -174.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -67.57 134.8 34.07 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.371 2.047 . . . . 0.0 109.561 175.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.421 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 4.8 ptpp? -123.51 111.13 15.92 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -173.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.45 81.53 1.56 Allowed 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 172.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 91.4 m -99.62 143.15 30.19 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -172.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.26 115.75 10.77 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 171.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mp -111.2 36.23 3.27 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.55 0.691 . . . . 0.0 110.138 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -92.98 158.98 15.52 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.753 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.453 ' CB ' ' HA ' ' A' ' 4' ' ' CYS . 33.6 m -67.01 105.35 1.62 Allowed 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.78 ' HB3' HG22 ' A' ' 45' ' ' ILE . 12.7 t70 -97.73 110.78 56.76 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.199 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.742 ' HA ' HG12 ' A' ' 3' ' ' ILE . 24.7 Cg_exo -63.56 -9.82 19.6 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.787 2.992 . . . . 0.0 114.854 -176.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.68 -34.97 15.2 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.675 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.78 HG22 ' HB3' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -87.59 100.26 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 122.001 0.905 . . . . 0.0 110.98 -176.437 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.86 -39.54 30.38 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.545 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -170.65 172.52 5.8 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.21 123.16 7.78 Favored Glycine 0 C--N 1.288 -2.138 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.0 t -96.32 100.83 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 73.1 m -80.94 153.66 72.57 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 16.9 Cg_exo . . . . . 0 C--N 1.35 0.614 0 C-N-CA 123.348 2.698 . . . . 0.0 113.269 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 CA--C 1.552 1.039 0 CA-C-O 123.37 1.557 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.0 m -92.61 57.28 2.88 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.985 -178.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.566 ' HB ' HG23 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -90.65 -178.67 5.35 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 173.225 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -156.48 142.83 18.33 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 174.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.5 t -61.0 -46.66 89.87 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 123.758 0.661 . . . . 0.0 111.611 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.512 ' HA ' ' HB3' ' A' ' 28' ' ' GLU . 34.2 t -67.89 -51.16 51.18 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.885 -176.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.13 36.94 0.19 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.605 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . -109.35 170.66 14.6 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 176.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -74.77 122.47 23.35 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 117.008 0.404 . . . . 0.0 110.621 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.772 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -57.41 144.49 36.16 Favored 'General case' 0 C--O 1.241 0.606 0 O-C-N 121.902 -0.499 . . . . 0.0 110.048 173.613 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.08 -26.32 19.61 Favored Glycine 0 C--N 1.305 -1.171 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.5 m -91.28 130.92 37.09 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -84.13 103.67 13.53 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.575 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 17.0 m-85 -61.07 122.45 15.02 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.527 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -148.84 149.99 32.24 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.744 -167.214 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.619 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 33.6 t -89.88 133.61 34.66 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -47.46 -33.12 5.79 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.812 1.645 . . . . 0.0 114.155 -174.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -68.77 -19.71 64.33 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.527 ' HA2' ' CE2' ' A' ' 17' ' ' PHE . . . 122.61 18.79 3.22 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.326 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.619 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 69.1 m -103.5 125.49 50.09 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 117.197 0.498 . . . . 0.0 111.302 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -78.2 137.74 38.3 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.435 HG21 ' HA ' ' A' ' 45' ' ' ILE . 21.7 t -111.29 -56.07 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.128 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.8 177.99 7.53 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.022 0.529 . . . . 0.0 109.687 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -147.51 103.9 3.58 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 118.776 0.716 . . . . 0.0 112.14 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.772 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . 73.55 84.98 0.26 Allowed Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.979 177.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 59.2 mm-40 -111.32 -37.38 5.3 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.605 ' HB2' ' O ' ' A' ' 10' ' ' GLY . 3.8 m -105.6 107.48 18.49 Favored 'General case' 0 C--O 1.248 0.992 0 O-C-N 121.877 -0.514 . . . . 0.0 111.331 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -139.88 129.82 13.92 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.73 77.83 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.212 0 C-N-CA 123.004 2.47 . . . . 0.0 114.402 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.448 ' CZ ' ' HB2' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -141.46 -56.96 0.48 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 173.263 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 1.2 p-10 -82.25 126.3 74.7 Favored Pre-proline 0 N--CA 1.432 -1.351 0 CA-C-O 121.37 0.605 . . . . 0.0 109.832 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 11.5 Cg_exo -70.37 166.26 28.96 Favored 'Trans proline' 0 C--O 1.253 1.271 0 C-N-CA 123.234 2.623 . . . . 0.0 111.534 175.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.778 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER 83.09 142.69 0.07 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.311 1.844 . . . . 0.0 111.677 -179.439 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.3 157.75 17.5 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.3 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 24.0 m -85.88 164.4 17.51 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 t -65.66 156.51 32.68 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.309 0.576 . . . . 0.0 110.87 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.68 6.95 45.51 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.368 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -58.06 127.94 34.62 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.978 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 33.0 m -64.21 123.16 18.39 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.456 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -112.34 95.92 33.29 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -72.33 8.82 1.34 Allowed 'Trans proline' 0 N--CA 1.485 0.994 0 C-N-CA 123.267 2.645 . . . . 0.0 113.969 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.5 ttp-105 -90.45 -34.96 15.4 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.566 HG23 ' HB ' ' A' ' 5' ' ' THR . 1.6 tt -94.8 121.13 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.2 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.79 -47.66 8.45 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -167.76 169.3 11.79 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.694 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -97.03 120.35 6.68 Favored Glycine 0 C--N 1.284 -2.334 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.7 t -92.43 107.45 19.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 121.327 0.584 . . . . 0.0 110.364 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.74 153.87 64.59 Favored Pre-proline 0 C--N 1.296 -1.744 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo . . . . . 0 C--N 1.359 1.087 0 C-N-CA 123.457 2.771 . . . . 0.0 113.231 -178.684 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.402 HG12 ' HA ' ' A' ' 43' ' ' PRO . 6.4 tp . . . . . 0 N--CA 1.442 -0.831 0 CA-C-O 121.758 0.79 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.898 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 6.7 m -126.11 47.95 2.18 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-O 121.667 0.746 . . . . 0.0 112.876 -175.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.551 HG21 ' HA ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -90.24 116.33 28.14 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 172.156 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.428 HD21 ' HB3' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -126.5 156.53 40.6 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -178.738 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.507 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 45.0 t -88.72 -47.18 8.43 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -172.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.4 t -61.38 -53.93 50.2 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.262 0.553 . . . . 0.0 111.35 -174.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.428 ' HB3' HD21 ' A' ' 6' ' ' ASN . . . -90.48 24.83 2.46 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.588 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' CE1' ' A' ' 16' ' ' TYR . . . -90.77 149.97 20.35 Favored Glycine 0 N--CA 1.431 -1.671 0 C-N-CA 120.096 -1.05 . . . . 0.0 110.876 177.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.37 117.98 5.45 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 123.477 0.711 . . . . 0.0 111.48 -176.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.728 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 40.2 ttmt -53.31 107.46 0.24 Allowed 'General case' 0 C--O 1.238 0.49 0 O-C-N 123.882 0.738 . . . . 0.0 112.777 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.54 -30.8 3.07 Favored Glycine 0 C--N 1.303 -1.274 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.1 m -86.26 121.86 29.43 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 63.7 mmtt -80.75 108.1 14.12 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.588 ' HD2' HG21 ' A' ' 45' ' ' ILE . 43.1 m-85 -71.25 109.94 5.59 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.02 151.22 50.6 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.567 -165.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.455 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 6.3 t -87.87 129.55 35.18 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.08 -9.18 20.36 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -168.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -79.61 -10.17 59.75 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 122.997 0.519 . . . . 0.0 111.1 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.89 33.11 2.47 Favored Glycine 0 C--N 1.315 -0.611 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.2 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 52.5 m -124.94 106.45 9.98 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 121.021 0.439 . . . . 0.0 110.788 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 58.2 t80 -70.91 124.14 23.64 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.528 176.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.03 -64.72 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.9 p -170.73 157.74 5.75 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 30.6 tt0 -85.24 138.86 32.07 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.728 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -63.57 135.15 41.69 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 176.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.404 ' HG3' ' HE2' ' A' ' 12' ' ' LYS . 7.6 tt0 -126.48 34.96 4.72 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.792 -175.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 t -82.96 113.37 20.5 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -104.35 133.41 20.22 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -53.57 -14.94 5.58 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.616 2.877 . . . . 0.0 114.442 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -103.07 -27.08 12.79 Favored 'General case' 0 N--CA 1.441 -0.895 0 O-C-N 121.622 -0.674 . . . . 0.0 111.693 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -91.14 137.42 26.4 Favored Pre-proline 0 C--O 1.239 0.552 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -172.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -82.6 124.08 3.96 Favored 'Trans proline' 0 N--CA 1.442 -1.548 0 C-N-CA 122.461 2.108 . . . . 0.0 110.038 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.9 138.25 47.53 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.656 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.5 93.3 3.9 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.451 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.9 m -142.67 167.2 22.65 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.9 138.11 54.39 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.4 47.65 1.97 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.806 0.812 . . . . 0.0 109.958 -176.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -97.83 18.89 14.75 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.321 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.898 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 55.7 m 65.23 156.72 0.09 Allowed 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 125.701 1.6 . . . . 0.0 112.124 177.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -122.52 112.31 31.14 Favored Pre-proline 0 N--CA 1.466 0.357 0 O-C-N 120.411 -1.431 . . . . 0.0 113.127 -178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.402 ' HA ' HG12 ' A' ' 3' ' ' ILE . 59.4 Cg_endo -73.68 -2.88 12.83 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.975 2.45 . . . . 0.0 113.941 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -85.6 -21.75 28.34 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.4 0.619 . . . . 0.0 109.673 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.588 HG21 ' HD2' ' A' ' 16' ' ' TYR . 95.3 mt -95.73 132.47 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.083 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.09 -55.67 3.65 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.692 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.551 ' HA ' HG21 ' A' ' 5' ' ' THR . 2.2 p90 -164.77 164.8 21.08 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.767 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -92.95 111.58 4.12 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.2 t -87.81 115.92 29.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 120.996 0.427 . . . . 0.0 110.3 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -96.16 105.14 20.02 Favored Pre-proline 0 C--N 1.293 -1.856 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo . . . . . 0 C--N 1.35 0.629 0 C-N-CA 123.202 2.601 . . . . 0.0 112.079 -175.764 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.7 tp . . . . . 0 N--CA 1.438 -1.058 0 CA-C-O 123.154 1.454 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.966 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.7 m -83.98 48.02 1.4 Allowed 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -176.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -91.17 164.12 14.02 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.53 ' HB3' HD23 ' A' ' 39' ' ' LEU . 1.1 t-20 -160.49 152.37 20.0 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.008 0.822 . . . . 0.0 111.811 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.8 t -67.8 -44.35 77.53 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.583 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 46.5 t -59.0 -52.22 66.68 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.163 0.506 . . . . 0.0 109.715 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.519 ' HB2' ' H ' ' A' ' 37' ' ' CYS . . . -86.16 25.58 1.15 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.783 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.51 156.11 22.48 Favored Glycine 0 N--CA 1.423 -2.193 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.911 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.2 m -83.01 109.41 17.08 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 123.008 0.523 . . . . 0.0 111.704 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -47.38 141.11 5.07 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.639 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.73 -44.11 1.56 Allowed Glycine 0 C--N 1.303 -1.298 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.3 m -103.23 140.43 37.39 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.775 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 69.8 mttt -100.01 129.39 46.06 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 121.392 0.615 . . . . 0.0 110.432 -173.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.428 ' HB3' ' CG1' ' A' ' 45' ' ' ILE . 48.7 m-85 -84.14 132.14 34.71 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.241 -176.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.46 148.45 37.76 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.227 -168.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.596 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 29.6 t -91.5 141.14 29.06 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.211 -1.358 . . . . 0.0 109.442 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.2 -14.4 60.55 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.796 1.239 . . . . 0.0 112.388 -176.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.29 -6.65 59.24 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.106 0.479 . . . . 0.0 110.527 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.71 34.17 3.61 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.505 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.596 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 25.2 m -118.75 120.03 36.17 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.261 -178.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.775 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 47.7 t80 -74.91 128.91 36.7 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -98.54 -71.71 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.504 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -172.11 165.96 6.12 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -178.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.769 ' HG3' ' HG2' ' A' ' 15' ' ' LYS . 12.0 tt0 -85.35 158.63 20.21 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.19 127.73 29.7 Favored Glycine 0 C--O 1.238 0.367 0 O-C-N 123.602 0.564 . . . . 0.0 112.905 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 8' ' ' CYS . 4.4 mm-40 -79.76 -22.69 42.9 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.494 0.188 . . . . 0.0 111.315 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.3 m -95.89 128.62 42.93 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-O 121.088 0.47 . . . . 0.0 110.047 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -79.53 124.41 83.85 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.43 82.62 0.1 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.488 2.792 . . . . 0.0 112.944 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 mmm180 -146.17 -70.44 0.25 Allowed 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -90.44 151.7 44.6 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.82 66.27 5.86 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.62 2.214 . . . . 0.0 111.781 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -80.38 130.6 35.28 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.145 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -131.76 160.88 34.26 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.285 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.519 ' H ' ' HB2' ' A' ' 9' ' ' ALA . 59.8 m -137.53 166.56 23.58 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.6 m -59.28 110.51 1.09 Allowed 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.53 HD23 ' HB3' ' A' ' 6' ' ' ASN . 12.8 mt -79.39 -62.54 1.66 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.554 -175.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 56.34 31.53 18.82 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.026 0.93 . . . . 0.0 111.253 -177.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.966 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 68.4 m 49.29 76.83 0.12 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.064 -177.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.497 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 6.7 t0 -53.27 112.74 3.9 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 123.869 0.868 . . . . 0.0 111.357 -174.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 10.9 Cg_exo -71.35 -11.31 28.42 Favored 'Trans proline' 0 C--O 1.242 0.695 0 C-N-CA 123.0 2.466 . . . . 0.0 112.828 -176.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.753 ' HA ' ' HE ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -91.41 -14.13 31.15 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.513 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.428 ' CG1' ' HB3' ' A' ' 16' ' ' TYR . 1.7 mp -108.85 124.24 65.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.155 0.503 . . . . 0.0 110.765 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.07 -47.76 5.11 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -164.47 166.21 20.7 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.715 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.11 130.5 10.34 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.2 t -109.54 115.88 50.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.474 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 25.6 m -82.05 141.19 46.67 Favored Pre-proline 0 C--N 1.288 -2.071 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 12.6 Cg_exo . . . . . 0 CA--C 1.54 0.783 0 C-N-CA 123.65 2.9 . . . . 0.0 114.01 -174.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' A' ' 43' ' ' PRO . 6.7 tp . . . . . 0 CA--C 1.547 0.838 0 CA-C-O 122.297 1.046 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.753 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 1.8 m -121.64 22.27 10.62 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 122.015 0.912 . . . . 0.0 111.727 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.37 144.08 26.15 Favored 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.77 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -126.06 151.8 46.67 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 17.2 t -86.59 -16.37 36.97 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 123.743 0.817 . . . . 0.0 111.346 -173.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.0 t -66.31 -43.97 84.72 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.93 0.871 . . . . 0.0 108.764 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . . . -90.9 -102.39 0.1 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.483 172.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.48 -151.16 48.97 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-O 121.521 0.512 . . . . 0.0 113.813 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.814 HG23 ' HD3' ' A' ' 31' ' ' PRO . 95.0 m -143.88 110.96 5.75 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 122.679 0.392 . . . . 0.0 110.189 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' A' ' 27' ' ' GLY . 17.0 ttmt -51.34 116.52 2.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.136 176.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.59 -38.25 1.59 Allowed Glycine 0 N--CA 1.418 -2.544 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.2 m -106.56 112.43 25.43 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.492 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 37.0 mttp -87.47 113.24 23.0 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.755 -175.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -65.79 123.44 19.76 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.174 -177.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -125.06 152.79 43.85 Favored 'General case' 0 N--CA 1.407 -2.605 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.314 -166.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.767 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 1.0 OUTLIER -105.7 127.04 52.83 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 113.221 -1.809 . . . . 0.0 106.325 179.158 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.7 -14.34 20.33 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -167.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.6 -18.14 60.61 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.266 175.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.91 3.12 6.45 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.032 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.767 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 97.7 m -83.13 117.18 22.71 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.97 0.414 . . . . 0.0 111.674 -177.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.492 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 20.4 t80 -76.08 119.14 19.61 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 169.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.408 HG11 ' NH2' ' A' ' 44' ' ' ARG . 18.0 t -87.39 -63.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.497 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 p -169.14 172.58 7.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.866 0.365 . . . . 0.0 111.206 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -97.1 150.52 20.75 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.445 ' O ' ' HE3' ' A' ' 12' ' ' LYS . . . -62.61 118.59 14.69 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -79.91 3.02 21.19 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -175.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.4 m -121.38 141.22 51.17 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-O 121.601 0.715 . . . . 0.0 110.53 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -99.0 145.29 29.73 Favored Pre-proline 0 C--N 1.285 -2.237 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.814 ' HD3' HG23 ' A' ' 11' ' ' THR . 6.6 Cg_endo -50.53 -19.78 5.34 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.37 2.713 . . . . 0.0 115.071 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.472 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 0.8 OUTLIER -82.24 -25.62 33.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.641 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.52 138.48 25.31 Favored Pre-proline 0 C--N 1.319 -0.723 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.767 177.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -86.34 -164.18 0.21 Allowed 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.759 2.306 . . . . 0.0 111.195 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt 73.62 164.57 0.28 Allowed 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 125.37 1.468 . . . . 0.0 112.833 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . . . -155.58 143.28 19.69 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 178.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 55.7 m -79.85 125.19 29.39 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.42 79.44 0.26 Allowed 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 124.079 0.952 . . . . 0.0 112.249 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.6 tp -100.34 -18.91 16.56 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.884 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 65.63 55.12 1.03 Allowed 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 124.389 1.076 . . . . 0.0 110.19 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.753 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 20.7 m 74.78 138.04 0.06 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 125.686 1.594 . . . . 0.0 110.744 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -107.52 91.71 7.49 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.508 ' HA ' HG23 ' A' ' 3' ' ' ILE . 3.5 Cg_exo -77.25 0.67 9.51 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 123.117 2.545 . . . . 0.0 112.325 -175.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.408 ' NH2' HG11 ' A' ' 24' ' ' VAL . 15.3 ttp-105 -85.63 -19.13 31.44 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 74.1 mt -82.42 141.01 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.61 -57.96 2.32 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.433 0.635 . . . . 0.0 109.47 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -160.34 170.7 20.52 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.201 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.03 125.39 8.56 Favored Glycine 0 C--N 1.291 -1.92 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.7 t -95.95 106.19 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 m -93.96 111.9 54.93 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 177.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 C--O 1.236 0.409 0 C-N-CA 123.177 2.584 . . . . 0.0 112.225 -177.372 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.983 ' HB ' ' HA ' ' A' ' 43' ' ' PRO . 37.5 mm . . . . . 0 N--CA 1.428 -1.565 0 CA-C-O 121.293 0.568 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.6 m -97.32 32.33 2.25 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 122.284 1.04 . . . . 0.0 112.526 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.489 ' HB ' HG23 ' A' ' 45' ' ' ILE . 3.6 m -81.44 140.95 34.35 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 171.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -133.13 148.23 52.11 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.305 -174.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.7 t -83.77 -28.02 28.46 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.564 1.145 . . . . 0.0 110.815 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.1 t -62.94 -59.99 4.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.421 0.629 . . . . 0.0 110.828 -175.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.82 47.86 1.39 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.254 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.8 ' HA3' ' HE1' ' A' ' 16' ' ' TYR . . . -93.04 -110.07 1.95 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.73 175.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.9 m -162.86 127.65 3.11 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 123.857 0.863 . . . . 0.0 108.746 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 1.074 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -64.24 128.95 38.0 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.917 174.313 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.93 -26.42 11.56 Favored Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 m -89.68 127.53 35.94 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.533 ' HG2' ' HG3' ' A' ' 26' ' ' GLU . 43.9 mtpt -86.11 114.61 23.1 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.8 ' HE1' ' HA3' ' A' ' 10' ' ' GLY . 57.3 m-85 -72.85 111.95 8.44 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 178.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.563 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -134.94 147.74 49.85 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.871 -166.307 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 21.6 p -97.13 148.17 23.32 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.556 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -62.97 -16.7 60.48 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.663 1.185 . . . . 0.0 113.218 -172.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -77.6 -12.01 59.92 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.382 0.61 . . . . 0.0 109.72 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.563 ' HA2' ' CE2' ' A' ' 17' ' ' PHE . . . 101.59 40.93 2.63 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.393 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.449 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 41.6 m -127.26 131.92 50.46 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.612 0.72 . . . . 0.0 111.93 -178.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.612 ' HE1' ' HB2' ' A' ' 26' ' ' GLU . 78.1 t80 -72.51 130.24 40.18 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.245 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 t -106.07 -49.08 8.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 120.911 0.386 . . . . 0.0 109.993 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.1 p -164.77 174.39 10.73 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.612 ' HB2' ' HE1' ' A' ' 23' ' ' PHE . 2.2 tm-20 -153.51 140.78 19.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.834 0.743 . . . . 0.0 111.636 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 1.074 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . 57.27 55.57 29.66 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 116.684 1.433 . . . . 0.0 116.684 171.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -81.58 -44.98 16.52 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.605 0.716 . . . . 0.0 109.614 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.21 78.32 8.85 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.609 -174.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.653 ' HA ' ' HG2' ' A' ' 12' ' ' LYS . 18.8 t0 -89.69 129.29 47.31 Favored Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -64.28 51.19 0.18 Allowed 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 123.921 3.081 . . . . 0.0 113.721 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -147.18 -45.52 0.17 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 125.294 1.437 . . . . 0.0 107.721 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -84.26 124.38 74.01 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -86.88 106.36 0.69 Allowed 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.737 2.292 . . . . 0.0 110.333 173.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 mtmm -115.36 102.83 10.21 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.25 98.9 6.82 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.28 0.562 . . . . 0.0 110.106 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.4 m -114.77 124.69 52.41 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.37 -42.28 71.98 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.0 -175.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.5 tp -158.98 -64.82 0.08 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 m120 61.2 49.29 5.61 Favored 'General case' 0 C--O 1.245 0.867 0 O-C-N 124.197 0.936 . . . . 0.0 112.148 176.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 84.9 m -57.98 120.96 9.46 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.534 ' HB3' HG22 ' A' ' 45' ' ' ILE . 2.2 t70 -116.21 100.51 53.55 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -177.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.983 ' HA ' ' HB ' ' A' ' 3' ' ' ILE . 44.2 Cg_endo -68.74 -6.48 18.04 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.858 2.372 . . . . 0.0 113.97 -174.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.49 ' O ' ' HB3' ' A' ' 18' ' ' SER . 0.7 OUTLIER -90.55 -25.4 20.24 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 111.755 0.279 . . . . 0.0 111.755 -178.572 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.534 HG22 ' HB3' ' A' ' 42' ' ' ASP . 3.8 tt -88.39 147.13 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 121.411 0.624 . . . . 0.0 111.07 -177.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.91 -50.92 4.03 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.77 175.24 4.0 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.234 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.33 121.69 6.82 Favored Glycine 0 N--CA 1.429 -1.825 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.6 t -104.3 103.82 15.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.033 0.444 . . . . 0.0 110.446 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 17.3 m -79.89 112.67 31.69 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 170.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo . . . . . 0 C--N 1.354 0.859 0 C-N-CA 124.29 3.327 . . . . 0.0 114.272 -171.733 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.45 ' O ' ' HB3' ' A' ' 41' ' ' CYS . 19.3 tt . . . . . 0 CA--C 1.546 0.791 0 CA-C-O 122.207 1.003 . . . . 0.0 112.458 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 97.0 m -128.65 40.36 3.66 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.811 0.815 . . . . 0.0 110.792 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.432 HG21 ' HA ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -62.75 133.67 55.13 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.765 176.678 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -144.84 148.69 34.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.083 0.468 . . . . 0.0 110.164 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 t -75.22 -25.84 58.46 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.839 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.1 t -59.48 -56.06 26.71 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.361 0.601 . . . . 0.0 109.448 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . . . -90.74 23.29 3.15 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.309 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.62 141.85 31.44 Favored Glycine 0 N--CA 1.424 -2.132 0 C-N-CA 120.34 -0.933 . . . . 0.0 111.932 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.0 m -75.4 117.1 16.83 Favored 'General case' 0 C--N 1.273 -2.737 0 O-C-N 123.886 0.404 . . . . 0.0 111.451 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.412 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 34.9 ttmt -53.03 120.63 6.1 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.51 0.724 . . . . 0.0 109.129 175.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.92 -31.27 6.16 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 11.8 m -91.0 126.82 36.2 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -90.09 109.39 20.44 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.6 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 18.8 m-85 -71.54 115.16 10.4 Favored 'General case' 0 CA--C 1.484 -1.569 0 CA-C-O 121.875 0.845 . . . . 0.0 109.287 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.461 ' HE1' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -133.81 145.19 49.52 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 113.281 -1.781 . . . . 0.0 111.612 -167.227 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.518 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 53.4 p -98.22 148.16 23.89 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -13.16 44.16 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -173.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.7 -0.99 40.75 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.213 0.53 . . . . 0.0 110.453 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.461 ' HA2' ' HE1' ' A' ' 17' ' ' PHE . . . 92.94 36.22 6.11 Favored Glycine 0 N--CA 1.43 -1.735 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.039 176.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.518 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 90.7 m -122.11 121.5 37.06 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.759 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -73.29 124.37 25.57 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.506 HG21 HG12 ' A' ' 45' ' ' ILE . 34.3 t -96.2 -60.76 2.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.515 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.8 p -161.95 161.05 28.49 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.675 -0.41 . . . . 0.0 112.074 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -81.45 149.31 28.83 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 174.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.5 127.38 45.05 Favored Glycine 0 CA--C 1.524 0.64 0 O-C-N 123.587 0.554 . . . . 0.0 113.046 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -83.53 -21.0 32.85 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.6 m -100.86 131.01 46.95 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 121.266 0.555 . . . . 0.0 111.609 -176.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.816 ' HB3' ' HB3' ' A' ' 33' ' ' ASN . 25.1 t70 -79.72 140.23 54.84 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 12' ' ' LYS . 78.2 Cg_exo -56.01 -12.41 7.22 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.286 2.657 . . . . 0.0 114.374 179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -121.6 7.98 10.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 122.329 0.252 . . . . 0.0 111.325 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.816 ' HB3' ' HB3' ' A' ' 30' ' ' ASP . 2.4 p-10 -90.58 138.16 26.86 Favored Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.729 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -76.46 121.37 5.99 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.706 1.604 . . . . 0.0 108.686 171.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.7 pttm -128.84 162.46 27.43 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 120.822 0.344 . . . . 0.0 111.552 -173.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.41 45.62 1.73 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.103 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 9' ' ' ALA . 89.6 m -79.54 148.67 31.7 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.7 t -79.69 -175.7 4.97 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.488 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.51 39.95 1.88 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.339 0.656 . . . . 0.0 110.269 -175.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -66.08 106.21 1.56 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.156 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 3.3 m -73.08 112.59 9.26 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.447 -178.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -92.6 101.13 4.6 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 3.0 Cg_exo -74.22 -3.53 13.96 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 123.144 2.563 . . . . 0.0 112.526 -174.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -87.8 -34.59 18.23 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.172 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.506 HG12 HG21 ' A' ' 24' ' ' VAL . 79.4 mt -87.05 142.28 13.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.23 -65.46 1.0 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.432 ' HA ' HG21 ' A' ' 5' ' ' THR . 0.5 OUTLIER -161.02 169.17 23.05 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.077 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -96.11 103.51 2.96 Favored Glycine 0 N--CA 1.429 -1.799 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.497 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 71.4 t -79.9 113.75 19.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 1.6 m -85.69 102.87 2.92 Favored Pre-proline 0 C--N 1.308 -1.231 0 C-N-CA 122.988 0.515 . . . . 0.0 109.636 175.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 49' ' ' VAL . 9.5 Cg_endo . . . . . 0 N--CA 1.441 -1.56 0 C-N-CA 123.0 2.467 . . . . 0.0 111.567 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.7 tp . . . . . 0 CA--C 1.544 0.743 0 CA-C-O 122.148 0.975 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.882 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 22.4 m -105.26 29.36 6.49 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 122.227 1.013 . . . . 0.0 110.874 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -90.31 135.79 33.46 Favored 'General case' 0 N--CA 1.399 -2.981 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.393 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -126.25 154.75 42.92 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.582 ' HB2' HD11 ' A' ' 45' ' ' ILE . 17.5 t -88.81 -11.58 44.44 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.002 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.0 t -60.8 -49.43 77.5 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 120.91 0.386 . . . . 0.0 109.968 -178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.46 -87.34 0.17 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.06 -144.28 32.19 Favored Glycine 0 N--CA 1.438 -1.192 0 O-C-N 124.093 0.871 . . . . 0.0 114.182 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.5 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 4.6 t -147.06 115.44 6.66 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-O 120.951 0.405 . . . . 0.0 110.219 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -47.58 111.09 0.38 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.267 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.0 -35.31 2.32 Favored Glycine 0 N--CA 1.422 -2.292 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.362 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.4 m -96.9 131.59 43.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 117.534 0.667 . . . . 0.0 110.454 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.722 ' HE2' ' HB3' ' A' ' 51' ' ' PRO . 65.4 mttm -79.71 101.5 8.45 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.678 -174.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -70.98 112.32 7.05 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.0 147.97 42.83 Favored 'General case' 0 N--CA 1.407 -2.593 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.161 -167.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.01 137.12 32.62 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.684 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.61 -14.11 62.66 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -171.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.36 -15.18 60.02 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.958 0.409 . . . . 0.0 110.321 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.61 24.82 3.91 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.317 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -112.44 105.81 14.15 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.95 0.405 . . . . 0.0 111.522 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -71.01 130.32 41.26 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.5 t -99.09 -70.46 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -160.05 152.01 20.34 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 15.6 tt0 -93.86 43.26 1.11 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.563 0.697 . . . . 0.0 110.789 -175.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.84 127.39 0.95 Allowed Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.407 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -89.91 -24.88 21.22 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 120.705 -0.398 . . . . 0.0 112.014 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.32 157.91 44.84 Favored 'General case' 0 N--CA 1.424 -1.741 0 O-C-N 121.883 -0.511 . . . . 0.0 111.471 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.42 131.62 37.8 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 42.7 Cg_endo -65.43 -9.87 23.96 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.911 2.407 . . . . 0.0 115.15 -172.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.3 mtm180 -75.85 -23.74 55.73 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -91.25 146.12 32.85 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 172.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -74.1 84.77 1.45 Allowed 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.021 1.814 . . . . 0.0 112.408 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -95.25 127.87 41.64 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.21 100.45 6.97 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.41 0.624 . . . . 0.0 109.812 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.6 m -107.14 -172.9 2.17 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.8 143.81 55.65 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 172.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -94.67 47.22 1.16 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -176.234 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -54.0 112.95 1.06 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 112.288 -2.233 . . . . 0.0 110.236 177.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.882 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 60.4 m -81.79 78.42 8.52 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 170.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 45.3 t0 -70.64 111.91 11.26 Favored Pre-proline 0 CA--C 1.51 -0.579 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.377 -169.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 16.6 Cg_exo -70.97 -18.37 31.38 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.976 2.451 . . . . 0.0 110.986 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -70.76 -23.89 62.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.514 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 7' ' ' CYS . 63.0 mt -95.76 125.62 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.87 -51.02 6.07 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -169.91 166.24 9.47 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.146 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.11 110.58 4.0 Favored Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -84.66 103.95 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 64.1 m -79.07 116.38 59.7 Favored Pre-proline 0 C--N 1.288 -2.076 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.722 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 37.3 Cg_endo . . . . . 0 N--CA 1.455 -0.787 0 C-N-CA 123.35 2.7 . . . . 0.0 114.992 -171.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.8 tp . . . . . 0 N--CA 1.436 -1.148 0 CA-C-O 121.527 0.68 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 71.6 m -99.2 56.62 1.03 Allowed 'General case' 0 N--CA 1.422 -1.87 0 CA-C-O 121.93 0.871 . . . . 0.0 111.763 -177.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.8 147.13 23.4 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.7 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -134.25 146.6 50.22 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.524 ' HB2' HD11 ' A' ' 45' ' ' ILE . 8.0 t -101.61 -4.17 27.08 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.033 0.444 . . . . 0.0 110.063 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.1 t -60.41 -54.45 45.5 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.31 -83.31 0.28 Allowed 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.44 175.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . 67.55 173.21 6.54 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.005 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.56 111.76 24.59 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 122.019 -0.695 . . . . 0.0 109.911 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.411 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 1.2 tmmt? -47.46 127.24 10.86 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.315 0.646 . . . . 0.0 110.35 176.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.94 -32.42 6.0 Favored Glycine 0 N--CA 1.436 -1.303 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.7 m -94.35 128.32 40.8 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.652 ' HG2' ' HG2' ' A' ' 26' ' ' GLU . 43.0 mtmt -88.76 112.11 22.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.547 ' HD2' HG21 ' A' ' 45' ' ' ILE . 81.8 m-85 -74.38 114.36 12.66 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.165 0.983 . . . . 0.0 109.279 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.05 147.51 38.74 Favored 'General case' 0 N--CA 1.407 -2.588 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.443 -167.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.453 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 43.1 t -89.0 141.97 28.03 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.955 -1.475 . . . . 0.0 109.014 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -72.89 -8.23 54.61 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.232 0.613 . . . . 0.0 112.335 -174.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.5 -3.37 57.56 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.76 43.47 3.11 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.353 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.453 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 13.6 m -131.24 123.38 28.28 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 122.514 -0.404 . . . . 0.0 110.952 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.664 ' HZ ' ' HG3' ' A' ' 26' ' ' GLU . 52.2 t80 -81.42 129.04 34.48 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.5 t -95.17 -67.62 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.99 174.48 4.72 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.664 ' HG3' ' HZ ' ' A' ' 23' ' ' PHE . 32.3 mt-10 -102.35 157.75 16.68 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.2 132.18 45.36 Favored Glycine 0 C--O 1.242 0.625 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -100.47 -27.48 13.42 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.064 0.459 . . . . 0.0 110.568 -175.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.493 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 47.6 m -80.94 128.12 33.33 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 122.355 1.074 . . . . 0.0 112.926 -176.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.87 138.67 13.14 Favored Pre-proline 0 C--N 1.293 -1.879 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -13.2 -51.89 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.247 1 C-N-CA 127.735 5.623 . . . . 0.0 119.31 -175.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.522 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 6.2 tpp180 -63.37 -44.95 93.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.506 0.594 . . . . 0.0 111.275 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 29' ' ' SER . 6.5 p30 -92.8 107.56 25.34 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-O 121.593 0.711 . . . . 0.0 111.22 176.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 32' ' ' ARG . 65.5 Cg_endo -94.35 67.49 0.34 Allowed 'Trans proline' 0 N--CA 1.443 -1.488 0 C-N-CA 123.117 2.544 . . . . 0.0 110.273 175.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.415 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 55.2 mtpt -74.94 92.36 2.57 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.889 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.64 82.77 7.88 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.6 m -79.64 159.37 26.77 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.869 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.18 175.37 1.66 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.138 0.575 . . . . 0.0 112.102 -175.85 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.559 ' H ' HG22 ' A' ' 38' ' ' THR . 3.3 mm? -86.75 37.85 0.77 Allowed 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.393 1.077 . . . . 0.0 110.193 -171.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -61.88 119.06 8.07 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.649 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 24.3 m -96.83 104.01 15.98 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -96.5 104.45 17.86 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.614 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 5.2 Cg_exo -76.85 -3.59 13.96 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 123.483 2.789 . . . . 0.0 111.983 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -77.86 -10.84 59.77 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.547 HG21 ' HD2' ' A' ' 16' ' ' TYR . 83.3 mt -102.43 130.45 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.171 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.37 -40.58 9.86 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -176.75 174.01 1.87 Allowed 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.75 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.77 114.0 4.89 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.8 t -79.63 100.69 4.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 121.338 0.589 . . . . 0.0 109.89 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.6 m -97.82 150.15 36.47 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 173.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 11.4 Cg_exo . . . . . 0 CA--C 1.538 0.715 0 C-N-CA 122.825 2.35 . . . . 0.0 111.869 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' A' ' 41' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.648 0 CA-C-O 121.935 0.874 . . . . 0.0 109.645 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.815 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 60.5 m -128.59 37.01 4.18 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-O 122.333 1.063 . . . . 0.0 109.684 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.412 HG21 ' HA ' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -81.91 151.7 27.14 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-N 113.788 -1.551 . . . . 0.0 108.704 176.832 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -150.45 175.67 11.65 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.7 t -70.49 -30.09 66.79 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 118.149 0.431 . . . . 0.0 111.809 -174.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 4.4 t -76.09 -41.33 50.71 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.368 -0.832 . . . . 0.0 109.837 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.3 46.24 0.25 Allowed 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.636 ' HA3' ' HE1' ' A' ' 16' ' ' TYR . . . -140.37 -141.23 4.0 Favored Glycine 0 N--CA 1.431 -1.689 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.85 178.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.2 m -151.91 133.34 14.59 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 122.483 -0.422 . . . . 0.0 110.412 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.72 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 29.9 mmtt -50.52 121.89 6.36 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.348 1.059 . . . . 0.0 110.364 175.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.403 ' O ' ' HE3' ' A' ' 15' ' ' LYS . . . 119.57 -34.11 4.37 Favored Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.477 -178.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.2 m -92.85 132.06 37.33 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.589 ' HD3' ' HG2' ' A' ' 26' ' ' GLU . 10.3 mmtp -87.04 117.68 25.92 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -177.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.636 ' HE1' ' HA3' ' A' ' 10' ' ' GLY . 66.0 m-85 -70.18 120.36 15.75 Favored 'General case' 0 CA--C 1.479 -1.777 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -134.57 147.58 50.29 Favored 'General case' 0 N--CA 1.399 -3.017 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.331 -168.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.482 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 12.1 t -93.11 131.96 37.68 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.93 -10.45 53.42 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -170.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.25 -1.9 54.29 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.948 0.404 . . . . 0.0 110.956 176.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.62 59.21 0.75 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.711 175.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.482 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 18.9 m -146.8 133.09 19.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 O-C-N 122.484 -0.421 . . . . 0.0 110.426 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.401 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 82.8 t80 -83.92 120.32 25.95 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 174.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.446 HG11 HG12 ' A' ' 45' ' ' ILE . 31.9 t -93.56 -51.14 11.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-O 120.699 0.285 . . . . 0.0 110.553 -177.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.4 p -169.85 165.32 9.77 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.589 ' HG2' ' HD3' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -94.44 171.87 8.54 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 176.815 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.72 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -52.5 128.87 36.51 Favored Glycine 0 N--CA 1.45 -0.431 0 O-C-N 123.703 0.627 . . . . 0.0 114.138 -175.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -100.82 -18.18 16.54 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.963 0.411 . . . . 0.0 110.374 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 m -120.07 107.22 12.79 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -175.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -82.41 109.01 13.63 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 165.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.01 21.94 0.37 Allowed 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 123.49 2.793 . . . . 0.0 115.185 -170.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -83.12 -51.93 7.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -90.34 126.73 55.64 Favored Pre-proline 0 C--O 1.254 1.306 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.81 139.7 81.55 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.606 2.871 . . . . 0.0 113.681 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.39 152.4 27.49 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.53 83.67 1.9 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.032 0.444 . . . . 0.0 111.394 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 78.5 m -83.25 123.2 29.36 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.99 167.53 3.79 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.176 0.99 . . . . 0.0 112.882 -175.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.7 mt -94.4 34.86 1.25 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -61.8 119.55 8.98 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.643 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.815 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 2.7 m -80.27 104.25 10.69 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.046 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -100.48 100.99 13.45 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 19.5 Cg_exo -69.04 -4.56 13.79 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.695 2.93 . . . . 0.0 113.453 -177.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.9 ttp-105 -75.61 -23.92 56.47 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.446 HG12 HG11 ' A' ' 24' ' ' VAL . 66.5 mt -110.84 161.6 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.489 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.45 -57.2 2.3 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 173.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.412 ' HA ' HG21 ' A' ' 5' ' ' THR . 0.2 OUTLIER -162.86 179.09 7.86 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.0 178.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -100.5 116.58 5.62 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 177.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.6 t -104.18 122.97 57.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.043 0.449 . . . . 0.0 110.426 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.7 m -96.09 104.79 18.21 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 171.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 5.3 Cg_exo . . . . . 0 C--O 1.241 0.642 0 C-N-CA 122.982 2.455 . . . . 0.0 113.396 -174.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 34.4 t70 . . . . . 0 CA--C 1.517 -0.3 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.495 ' HG3' ' SG ' ' A' ' 4' ' ' CYS . 2.1 tpm_? -151.97 91.84 1.66 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.3 tp -72.61 76.29 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-O 122.95 1.357 . . . . 0.0 111.861 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.872 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 96.6 m -111.38 33.7 4.54 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-O 122.004 0.907 . . . . 0.0 111.405 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -79.62 145.8 32.86 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.189 -1.369 . . . . 0.0 107.526 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -146.93 168.31 21.8 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -66.9 -28.3 68.2 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.4 t -68.32 -43.03 78.45 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.74 -2.5 23.63 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.328 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.42 161.75 54.33 Favored Glycine 0 N--CA 1.425 -2.093 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.576 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.1 m -116.32 122.55 45.22 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 122.528 0.331 . . . . 0.0 110.72 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 3.2 tttp -43.13 132.4 4.18 Favored 'General case' 0 C--O 1.247 0.973 0 C-N-CA 124.677 1.191 . . . . 0.0 111.464 175.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.98 -28.32 15.22 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.98 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.8 m -103.92 133.37 49.01 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 122.537 -0.39 . . . . 0.0 110.299 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 12.6 mptt -84.62 118.47 24.39 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.815 -177.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -88.56 105.97 18.0 Favored 'General case' 0 CA--C 1.492 -1.284 0 CA-C-O 123.2 1.476 . . . . 0.0 108.727 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -123.09 146.98 47.24 Favored 'General case' 0 C--N 1.269 -2.933 0 CA-C-N 111.959 -2.382 . . . . 0.0 111.589 -165.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 19.4 p -94.91 145.7 24.74 Favored 'General case' 0 N--CA 1.408 -2.531 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.587 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.2 -12.99 57.09 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.964 0.905 . . . . 0.0 112.911 -173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -71.53 -20.09 62.09 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.87 30.6 2.95 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.128 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.0 m -123.85 136.76 54.57 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.342 0.592 . . . . 0.0 112.494 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.457 ' CE1' ' HG3' ' A' ' 15' ' ' LYS . 62.2 t80 -79.95 115.19 19.39 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.6 t -85.75 -61.55 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.9 p -164.38 154.73 14.64 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.433 ' HG3' ' HD2' ' A' ' 15' ' ' LYS . 13.2 tt0 -89.65 155.53 19.17 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 174.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -54.55 113.13 3.18 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.592 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -83.37 -10.53 58.4 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.5 m -95.78 125.72 40.55 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-O 121.403 0.62 . . . . 0.0 110.338 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.71 134.66 37.06 Favored Pre-proline 0 C--N 1.293 -1.89 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.038 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.88 -8.21 17.28 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.074 2.516 . . . . 0.0 114.72 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -63.66 -46.66 84.58 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 117.839 0.29 . . . . 0.0 110.823 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -90.14 138.14 27.54 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.02 95.88 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.882 2.388 . . . . 0.0 110.727 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -88.92 118.94 28.99 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.077 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.8 78.48 1.72 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 96.8 m -79.16 169.16 18.58 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.859 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.422 ' HB ' ' OD1' ' A' ' 40' ' ' ASN . 0.3 OUTLIER -61.73 155.83 21.82 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.61 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.4 mt -94.77 40.87 1.09 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.907 0.861 . . . . 0.0 109.563 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.422 ' OD1' ' HB ' ' A' ' 38' ' ' THR . 8.4 m120 -62.47 122.57 16.07 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 113.793 -1.548 . . . . 0.0 109.307 175.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.872 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 5.2 m -81.26 112.04 18.21 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.186 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -111.09 85.09 4.97 Favored Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 24.4 Cg_exo -63.19 -19.89 69.66 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 123.614 2.876 . . . . 0.0 113.695 -171.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.487 ' O ' ' HB3' ' A' ' 18' ' ' SER . 3.4 tmm_? -73.36 -9.64 58.91 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.277 0.561 . . . . 0.0 110.486 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.5 mt -101.24 124.49 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 172.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.84 -59.09 1.93 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.643 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -157.36 163.66 38.38 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.469 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.06 127.75 9.2 Favored Glycine 0 N--CA 1.407 -3.292 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.2 t -105.77 103.37 15.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 14.0 m -85.1 152.48 58.7 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -44.57 124.58 5.5 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 123.26 2.64 . . . . 0.0 112.6 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -78.93 68.66 4.94 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.991 0.901 . . . . 0.0 110.481 -177.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.7 m . . . . . 0 C--O 1.257 1.492 0 C-N-CA 124.701 1.2 . . . . 0.0 108.052 178.172 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.238 0.464 0 CA-C-O 120.564 0.221 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -94.51 80.83 3.88 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.162 0.506 . . . . 0.0 109.891 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 tt -65.55 107.06 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.161 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.93 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 22.2 m -119.73 43.21 2.71 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.613 ' HB ' HG23 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -90.74 163.81 14.35 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 170.29 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.689 ' HA ' ' HB3' ' A' ' 42' ' ' ASP . 7.9 p30 -151.42 136.13 17.15 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 119.116 0.871 . . . . 0.0 110.309 170.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 t -60.69 -34.51 74.45 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.277 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 t -74.45 -26.81 60.28 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.328 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.54 -54.39 4.59 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 18.76 -137.38 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 118.669 2.227 . . . . 0.0 118.669 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.569 ' H ' ' HE1' ' A' ' 16' ' ' TYR . 80.4 m -159.98 102.26 1.46 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.743 1.217 . . . . 0.0 109.789 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -46.75 128.11 10.38 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 125.136 1.375 . . . . 0.0 109.979 171.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.431 ' O ' ' HD2' ' A' ' 51' ' ' PRO . . . 111.49 -10.01 28.35 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 30.9 m -132.39 141.66 48.97 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.635 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 55.7 mmtt -82.56 131.02 35.22 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.569 ' HE1' ' H ' ' A' ' 11' ' ' THR . 12.3 m-85 -83.99 119.72 25.26 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.76 144.69 32.73 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.828 0.823 . . . . 0.0 112.369 -169.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.633 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 34.3 p -92.79 139.27 30.72 Favored 'General case' 0 N--CA 1.407 -2.623 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.017 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -62.74 -13.57 34.34 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -171.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -72.61 -15.16 61.74 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 120.833 0.349 . . . . 0.0 110.707 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.31 34.33 2.53 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.964 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.432 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 85.3 m -125.52 124.65 41.78 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.023 0.439 . . . . 0.0 110.88 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.635 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 69.0 t80 -76.97 132.61 39.11 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 175.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.9 t -106.18 -58.57 3.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.223 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.38 154.01 35.84 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.37 0.605 . . . . 0.0 112.46 -176.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -79.85 152.92 29.42 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.113 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.483 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -69.04 93.26 0.32 Allowed Glycine 0 N--CA 1.436 -1.308 0 O-C-N 123.927 0.767 . . . . 0.0 113.752 -175.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -100.25 -41.37 7.11 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 m -71.87 102.54 2.91 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -164.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -78.81 124.23 85.07 Favored Pre-proline 0 C--N 1.304 -1.394 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.794 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -87.9 1.9 6.65 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.911 2.407 . . . . 0.0 113.289 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -82.96 -46.59 12.73 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -86.23 156.85 57.0 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 173.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.71 55.8 4.98 Favored 'Trans proline' 0 C--O 1.246 0.91 0 C-N-CA 122.411 2.074 . . . . 0.0 113.426 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -88.75 97.28 11.05 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.415 0.626 . . . . 0.0 110.356 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.01 146.16 48.77 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.024 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.0 m -125.89 149.66 48.53 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.373 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.0 60.63 0.4 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.858 0.863 . . . . 0.0 112.271 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 tp -137.57 44.15 2.25 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 175.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -62.92 141.05 58.86 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 113.495 -1.684 . . . . 0.0 109.986 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.93 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 35.9 m 63.45 59.64 1.21 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.04 0.924 . . . . 0.0 110.328 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.689 ' HB3' ' HA ' ' A' ' 6' ' ' ASN . 61.3 t0 -82.8 109.43 16.64 Favored Pre-proline 0 C--N 1.312 -1.054 0 C-N-CA 125.45 1.5 . . . . 0.0 108.821 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 11.8 Cg_exo -69.68 -4.47 14.03 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 123.204 2.603 . . . . 0.0 113.616 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.633 ' O ' ' HB3' ' A' ' 18' ' ' SER . 1.6 mmp_? -85.17 -30.48 23.89 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.396 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.613 HG23 ' HB ' ' A' ' 5' ' ' THR . 7.3 tt -99.16 105.4 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.753 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.79 -42.71 23.87 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -167.54 176.44 6.51 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.919 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -109.07 124.74 7.45 Favored Glycine 0 C--N 1.285 -2.275 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.213 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.1 t -94.88 107.65 19.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 13.9 m -80.32 117.41 67.52 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.499 ' HG3' ' HE2' ' A' ' 15' ' ' LYS . 21.0 Cg_endo -58.4 133.01 52.03 Favored 'Trans proline' 0 C--O 1.24 0.613 0 C-N-CA 123.117 2.544 . . . . 0.0 113.614 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.5 ttp85 -136.35 105.18 5.86 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--N 1.291 -1.957 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -177.623 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 C--O 1.218 -0.603 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -83.85 45.93 1.13 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.881 1.218 . . . . 0.0 113.004 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.45 HG13 ' H ' ' A' ' 5' ' ' THR . 8.7 tp -90.12 137.28 21.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.8 m -115.11 20.66 14.83 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.45 ' H ' HG13 ' A' ' 3' ' ' ILE . 1.2 m -90.69 172.79 8.41 Favored 'General case' 0 C--N 1.273 -2.744 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.608 177.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.887 HD22 HD13 ' A' ' 39' ' ' LEU . 9.1 p30 -133.31 156.81 46.93 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.4 t -73.72 -35.59 65.11 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 123.791 0.836 . . . . 0.0 113.105 -174.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 45.7 t -59.5 -56.91 15.99 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.578 0.704 . . . . 0.0 109.801 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.611 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . . . -90.53 26.38 2.01 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.55 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.15 163.68 26.77 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.606 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -53.77 110.83 0.63 Allowed 'General case' 0 C--O 1.241 0.646 0 C-N-CA 125.708 1.603 . . . . 0.0 113.111 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 27.1 ttpp -55.02 112.96 1.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.215 1.006 . . . . 0.0 111.627 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.01 -26.51 10.45 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.17 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.9 m -87.15 122.09 30.48 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.411 ' HE3' ' HG3' ' A' ' 51' ' ' PRO . 65.2 mttt -77.8 113.16 15.4 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.764 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.616 ' HD2' HG21 ' A' ' 45' ' ' ILE . 60.5 m-85 -72.91 106.65 4.92 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.85 145.11 44.03 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.499 -1.682 . . . . 0.0 111.154 -167.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.486 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 4.9 p -92.87 145.57 24.29 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.556 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -64.45 -14.7 58.37 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -170.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.71 8.27 20.36 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.405 0.622 . . . . 0.0 110.444 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.27 28.37 9.87 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 115.522 -0.763 . . . . 0.0 114.251 171.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.486 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 5.3 m -115.74 114.14 24.4 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 118.007 0.903 . . . . 0.0 112.027 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -67.44 116.78 8.57 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 171.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.68 -47.29 16.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.1 p -178.59 -175.58 0.44 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -125.6 144.3 50.64 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -66.36 146.09 48.31 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -130.75 1.75 4.42 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.42 0.629 . . . . 0.0 111.035 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.7 m -121.46 169.39 10.69 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-O 121.974 0.892 . . . . 0.0 112.127 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.491 ' HB3' ' OD1' ' A' ' 33' ' ' ASN . 30.6 t70 -114.43 116.98 43.51 Favored Pre-proline 0 C--N 1.287 -2.132 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 173.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 19.6 Cg_exo -67.79 26.98 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 124.018 3.145 . . . . 0.0 115.334 -173.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -116.79 -32.58 5.08 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' A' ' 30' ' ' ASP . 3.0 p-10 -90.54 152.14 44.88 Favored Pre-proline 0 C--O 1.245 0.851 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.179 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.79 103.55 0.72 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.228 2.618 . . . . 0.0 112.815 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.18 114.18 19.94 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.57 64.63 4.5 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.552 0.691 . . . . 0.0 112.845 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.611 ' HB2' ' HB2' ' A' ' 9' ' ' ALA . 58.8 m -113.18 118.15 33.91 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 172.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.9 p -65.03 141.01 58.91 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 123.565 0.54 . . . . 0.0 111.226 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.887 HD13 HD22 ' A' ' 6' ' ' ASN . 4.1 mm? -79.54 -74.14 0.31 Allowed 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 60.7 7.65 1.49 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.408 1.483 . . . . 0.0 113.643 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 60.6 m 58.83 123.58 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 125.416 1.486 . . . . 0.0 111.789 -173.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -110.62 83.64 3.54 Favored Pre-proline 0 C--N 1.323 -0.579 0 O-C-N 121.115 -0.991 . . . . 0.0 109.547 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 23.4 Cg_exo -65.46 -14.09 43.13 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 123.616 2.877 . . . . 0.0 114.11 -172.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -73.71 -25.09 60.04 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.567 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.616 HG21 ' HD2' ' A' ' 16' ' ' TYR . 87.3 mt -82.56 144.33 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.06 -59.69 2.13 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.6 174.04 11.28 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.176 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.73 99.13 2.02 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.94 107.26 12.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.343 0.592 . . . . 0.0 110.876 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.7 m -85.73 136.86 36.36 Favored Pre-proline 0 C--N 1.291 -1.953 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 170.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 16.9 Cg_exo -68.65 66.73 1.19 Allowed 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.446 2.764 . . . . 0.0 113.52 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -134.42 113.07 11.49 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.4 m . . . . . 0 C--N 1.278 -2.51 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.42 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 52.96 47.23 25.11 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.043 1.337 . . . . 0.0 113.662 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 tt -89.76 116.18 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 172.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.464 ' HA ' ' CB ' ' A' ' 41' ' ' CYS 0.252 98.7 m -88.66 19.32 4.03 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -174.156 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.7 m -90.64 136.14 33.25 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 171.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.462 ' HA ' ' HB2' ' A' ' 42' ' ' ASP . 11.4 p30 -119.3 158.06 26.83 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.625 ' HB2' HD11 ' A' ' 45' ' ' ILE . 6.9 t -84.86 -17.25 38.56 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.287 -174.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.3 t -67.9 -46.1 72.57 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 35' ' ' LYS . . . -91.53 22.58 3.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.239 0.542 . . . . 0.0 109.593 173.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.71 152.91 37.81 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 115.738 -0.665 . . . . 0.0 114.75 -172.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 m -79.36 114.26 18.16 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 124.768 1.227 . . . . 0.0 110.277 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.615 ' HA ' ' O ' ' A' ' 26' ' ' GLU . 2.3 tmtp? -64.84 127.34 31.16 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.526 ' H ' ' HG2' ' A' ' 26' ' ' GLU . . . 113.48 -10.11 24.04 Favored Glycine 0 C--N 1.301 -1.372 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -176.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.5 m -105.75 127.54 53.15 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HA ' ' HE1' ' A' ' 23' ' ' PHE . 20.7 mmmt -84.84 94.02 8.63 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -178.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -72.51 111.22 7.49 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 175.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -140.91 151.69 44.44 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.794 -164.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.9 t -97.17 138.96 33.86 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.537 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.454 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 3.5 p30 -69.12 -3.59 13.99 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.732 0.813 . . . . 0.0 112.894 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.07 -8.88 59.0 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.765 176.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.45 25.05 6.48 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.93 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 m -122.02 114.91 21.6 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 122.565 -0.374 . . . . 0.0 111.662 -177.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.496 ' HZ ' ' HB2' ' A' ' 26' ' ' GLU . 73.6 t80 -73.34 130.8 40.95 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.91 -62.05 2.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.895 -175.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 p -162.73 155.51 19.34 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.615 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 20.0 tt0 -103.76 44.82 0.99 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.517 0.675 . . . . 0.0 110.461 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.89 -162.8 49.0 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.872 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -112.26 -69.74 0.85 Allowed 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 120.974 0.416 . . . . 0.0 109.988 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.4 m -144.56 -166.49 2.4 Favored 'General case' 0 N--CA 1.407 -2.62 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -177.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.48 133.74 59.28 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.66 1.54 0.39 Allowed 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 123.505 2.803 . . . . 0.0 115.205 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -61.39 -47.91 83.62 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -91.81 117.56 67.81 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 172.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -76.63 121.52 6.0 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 121.551 1.501 . . . . 0.0 111.081 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -86.93 116.21 24.84 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.32 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.59 113.16 20.11 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.376 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.6 m -141.96 -177.68 5.33 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.32 157.39 29.26 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 120.867 0.365 . . . . 0.0 110.616 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.49 32.92 1.9 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.898 0.856 . . . . 0.0 109.838 -175.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -78.14 136.16 37.8 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.188 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 19.6 m -76.27 123.48 25.97 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 6' ' ' ASN . 6.9 t0 -83.78 105.27 5.31 Favored Pre-proline 0 N--CA 1.468 0.454 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.699 -169.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 68.1 Cg_endo -83.45 1.72 8.8 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.929 2.419 . . . . 0.0 111.725 -174.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 ttp-105 -83.04 -20.55 34.78 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 7' ' ' CYS . 71.8 mt -108.02 152.64 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.491 -1.232 . . . . 0.0 109.018 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.26 -50.58 3.12 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 19' ' ' ASP . 15.9 p90 -159.16 175.54 13.33 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -114.62 112.16 2.71 Favored Glycine 0 N--CA 1.428 -1.894 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.339 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.537 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 56.2 t -82.29 106.29 13.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 85.7 m -105.67 99.29 20.89 Favored Pre-proline 0 C--N 1.298 -1.657 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.231 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 49' ' ' VAL . 3.6 Cg_exo -78.44 66.76 8.44 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.296 2.664 . . . . 0.0 109.594 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -143.1 108.09 4.94 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.253 1.279 0 C-N-CA 125.017 1.327 . . . . 0.0 111.413 179.173 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.5 t0 . . . . . 0 CA--C 1.51 -0.592 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.629 ' HB3' ' SG ' ' A' ' 41' ' ' CYS . 23.8 mmt180 68.63 128.64 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.108 1.363 . . . . 0.0 112.493 176.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 tp -76.47 65.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-O 122.911 1.339 . . . . 0.0 109.769 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.932 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.8 m -88.58 40.83 0.98 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.991 0.901 . . . . 0.0 112.282 -176.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -90.83 127.25 36.29 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 171.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -146.27 178.8 7.97 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.524 -0.871 . . . . 0.0 112.548 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -85.17 -32.93 22.44 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.6 t -66.1 -50.43 64.07 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.933 0.873 . . . . 0.0 108.976 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.37 33.25 0.9 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.527 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.23 136.11 13.06 Favored Glycine 0 N--CA 1.41 -3.076 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.781 HG22 ' HA ' ' A' ' 31' ' ' PRO . 7.2 p -83.85 111.46 19.24 Favored 'General case' 0 C--N 1.268 -2.955 0 CA-C-N 113.924 -1.138 . . . . 0.0 111.834 -175.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -45.79 115.57 1.0 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.704 0.802 . . . . 0.0 110.854 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.49 -36.59 2.53 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 m -95.52 134.71 38.05 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.532 ' HG3' ' HG3' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -88.42 119.96 29.34 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.441 ' HB3' HD13 ' A' ' 45' ' ' ILE . 67.7 m-85 -83.86 105.24 14.59 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 122.896 1.331 . . . . 0.0 108.142 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.586 ' HE1' ' HA2' ' A' ' 21' ' ' GLY . 0.5 OUTLIER -126.52 147.95 49.78 Favored 'General case' 0 N--CA 1.405 -2.684 0 CA-C-N 112.868 -1.969 . . . . 0.0 112.207 -164.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.7 142.58 29.31 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.113 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -58.18 -19.05 30.21 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.867 1.267 . . . . 0.0 114.208 -172.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.07 -8.03 59.17 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.131 0.491 . . . . 0.0 111.02 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.586 ' HA2' ' HE1' ' A' ' 17' ' ' PHE . . . 106.14 24.27 6.95 Favored Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.324 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.2 m -107.04 123.32 48.05 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.291 -0.563 . . . . 0.0 112.142 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -77.94 109.65 12.18 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.21 -52.09 15.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.9 p -174.46 169.54 3.71 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.532 ' HG3' ' HG3' ' A' ' 15' ' ' LYS . 15.8 tt0 -108.27 171.3 7.49 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.67 112.3 1.56 Allowed Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -83.08 -22.67 33.4 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.666 -0.267 . . . . 0.0 111.705 -172.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -130.36 -176.94 4.12 Favored 'General case' 0 N--CA 1.4 -2.962 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.472 -174.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -78.0 140.59 62.27 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.781 ' HA ' HG22 ' A' ' 11' ' ' THR . 1.0 OUTLIER -42.92 -27.07 0.8 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 124.922 3.748 . . . . 0.0 115.725 -179.501 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.475 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 19.5 mmt85 -122.64 46.09 2.23 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 118.409 0.549 . . . . 0.0 110.492 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -73.57 119.9 78.37 Favored Pre-proline 0 C--N 1.304 -1.382 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.525 175.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -87.25 94.21 0.48 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.787 2.324 . . . . 0.0 111.575 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -158.67 155.32 27.92 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.263 0.554 . . . . 0.0 111.478 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.16 131.53 45.13 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 173.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.2 m -115.28 135.51 54.07 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.208 0.528 . . . . 0.0 112.278 -174.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -18.26 62.9 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 123.573 0.749 . . . . 0.0 110.814 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 tp -86.33 25.31 1.21 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.099 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -53.67 121.09 7.13 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.937 176.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.932 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 14.9 m 67.36 86.58 0.13 Allowed 'General case' 0 C--N 1.321 -0.661 0 O-C-N 124.504 1.128 . . . . 0.0 111.421 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -96.28 104.5 17.6 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.49 3.87 6.83 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.782 2.321 . . . . 0.0 113.041 -172.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -90.41 -15.57 30.73 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.49 0.662 . . . . 0.0 109.331 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.441 HD13 ' HB3' ' A' ' 16' ' ' TYR . 93.2 mt -101.18 140.94 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.49 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.95 -54.35 3.49 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -167.23 173.3 9.11 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.423 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.43 121.23 7.14 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.5 t -94.14 114.09 30.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 123.021 0.529 . . . . 0.0 109.582 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.6 m -99.84 129.39 28.72 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 32.2 Cg_exo -58.21 116.37 3.19 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 123.324 2.683 . . . . 0.0 112.114 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 12.0 tpt85 -156.11 -48.59 0.08 Allowed 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.546 176.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 C--N 1.304 -1.396 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.081 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 . . . . . 0 C--O 1.239 0.504 0 CA-C-O 120.816 0.341 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.7 tpp85 -175.74 -46.13 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.425 ' O ' ' HB3' ' A' ' 41' ' ' CYS . 6.1 tp -71.71 113.6 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 172.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 69.4 m -113.6 40.37 2.42 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.97 0.891 . . . . 0.0 112.781 -173.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 t -90.82 165.81 13.43 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 172.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -160.17 175.86 12.43 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 118.435 0.561 . . . . 0.0 111.11 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.4 t -69.11 -21.2 64.06 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.563 0.745 . . . . 0.0 112.275 -174.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.3 t -91.03 -54.82 3.79 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.56 -0.713 . . . . 0.0 109.965 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.22 37.43 0.1 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.21 175.3 30.67 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 175.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 m -109.48 124.74 51.58 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 117.037 0.419 . . . . 0.0 111.251 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.565 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -54.36 122.58 10.71 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.9 175.152 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.56 -35.52 2.65 Favored Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -176.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.1 m -105.75 151.15 24.82 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -88.28 123.99 33.44 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.519 ' CZ ' ' HA2' ' A' ' 27' ' ' GLY . 1.2 m-30 -77.45 106.89 9.51 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.423 ' CE1' ' HA ' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -141.01 151.74 44.35 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.599 0.714 . . . . 0.0 112.77 -167.192 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.524 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 43.4 p -96.24 129.61 43.52 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 175.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.423 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 4.1 p-10 -62.64 -9.8 10.23 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -20.23 63.79 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.16 -0.19 6.51 Favored Glycine 0 N--CA 1.429 -1.812 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.404 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.524 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 3.8 m -97.45 118.07 33.12 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -76.56 121.77 23.65 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.466 HG21 HG12 ' A' ' 45' ' ' ILE . 23.5 t -95.53 -65.86 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.837 -176.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.56 155.75 43.81 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.964 0.412 . . . . 0.0 111.849 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.07 169.02 10.57 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -62.48 118.78 15.31 Favored Glycine 0 N--CA 1.439 -1.105 0 O-C-N 123.53 0.519 . . . . 0.0 113.306 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -131.24 1.52 4.19 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.01 0.433 . . . . 0.0 111.638 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.2 m -121.29 115.41 22.92 Favored 'General case' 0 N--CA 1.403 -2.779 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -114.12 140.83 25.42 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.74 -21.02 7.47 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.634 2.889 . . . . 0.0 114.958 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -90.94 -24.99 19.99 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.47 ' HA ' ' HD3' ' A' ' 34' ' ' PRO 0.254 28.5 p30 -91.4 115.28 64.12 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.344 0.592 . . . . 0.0 112.484 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 17.2 Cg_exo -65.43 111.74 1.93 Allowed 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 123.313 2.675 . . . . 0.0 111.573 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -139.45 120.29 14.39 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.61 92.92 7.23 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.525 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.6 m -88.7 165.66 14.6 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.804 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.08 149.68 42.93 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.952 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -95.88 33.22 1.72 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.13 147.19 40.73 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.995 -1.457 . . . . 0.0 111.443 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 35.0 m -106.99 93.77 4.74 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.532 ' OD1' ' HB3' ' A' ' 44' ' ' ARG . 9.9 t70 -80.65 103.2 1.66 Allowed Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 123.871 0.868 . . . . 0.0 110.572 -175.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 52.6 Cg_endo -72.79 -7.12 20.25 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.637 2.225 . . . . 0.0 112.464 -174.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.532 ' HB3' ' OD1' ' A' ' 42' ' ' ASP . 16.9 ttp180 -82.81 -45.94 13.69 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.466 HG12 HG21 ' A' ' 24' ' ' VAL . 79.6 mt -79.72 128.95 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 CA-C-O 121.538 0.685 . . . . 0.0 109.965 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.05 -55.41 3.95 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.898 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -171.38 171.24 5.62 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.03 117.06 4.93 Favored Glycine 0 N--CA 1.423 -2.199 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.7 t -93.08 117.32 36.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.35 0.595 . . . . 0.0 111.419 -176.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.3 m -105.73 102.34 37.89 Favored Pre-proline 0 C--N 1.285 -2.198 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 171.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -36.55 116.32 0.15 Allowed 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 125.092 3.861 . . . . 0.0 114.513 -174.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 -82.22 66.52 7.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.237 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.303 -1.453 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.423 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 40.6 t0 . . . . . 0 CA--C 1.51 -0.593 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -98.51 105.97 18.19 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.472 HG13 ' OG1' ' A' ' 5' ' ' THR . 6.5 tp -77.08 122.09 30.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 121.624 0.726 . . . . 0.0 111.231 -178.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 19.3 m -136.38 47.16 2.22 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 121.972 0.892 . . . . 0.0 110.3 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.472 ' OG1' HG13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -72.17 160.41 32.49 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.961 178.153 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -158.93 149.25 19.56 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 t -105.79 18.36 22.27 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.357 0.598 . . . . 0.0 112.048 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 t -85.84 -46.01 11.02 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.541 ' HA ' ' OG ' ' A' ' 29' ' ' SER . . . -91.05 -100.01 0.11 Allowed 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.386 173.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.62 -140.3 28.98 Favored Glycine 0 N--CA 1.414 -2.779 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.563 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 m -154.0 119.3 5.12 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.563 ' HD3' ' HB2' ' A' ' 30' ' ' ASP . 15.0 ttpt -57.26 127.05 30.0 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 123.704 0.627 . . . . 0.0 110.613 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.19 -12.83 65.2 Favored Glycine 0 C--N 1.304 -1.201 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.391 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.9 m -99.06 128.65 45.24 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -80.13 92.2 5.63 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.988 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.595 ' HD2' HG21 ' A' ' 45' ' ' ILE . 27.9 m-85 -71.21 115.5 10.44 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.418 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -146.5 151.64 37.71 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.009 -161.747 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.3 t -86.86 137.19 32.61 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.427 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -57.98 -22.45 49.45 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.6 -18.61 60.54 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.181 0.515 . . . . 0.0 110.888 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.418 ' HA2' ' CE2' ' A' ' 17' ' ' PHE . . . 118.65 20.29 4.26 Favored Glycine 0 N--CA 1.425 -2.076 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.404 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 m -104.8 108.33 19.75 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 117.312 0.556 . . . . 0.0 110.173 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.497 ' CZ ' ' HG3' ' A' ' 26' ' ' GLU . 75.1 t80 -68.92 137.15 53.57 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.6 t -108.23 -64.56 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.713 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.3 p -163.35 155.34 17.69 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 18.3 mt-10 -97.52 39.19 1.21 Allowed 'General case' 0 C--O 1.242 0.676 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -175.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.21 127.74 0.27 Allowed Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.446 -0.797 . . . . 0.0 114.165 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -105.4 27.81 7.97 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 122.377 -0.484 . . . . 0.0 111.036 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.541 ' OG ' ' HA ' ' A' ' 9' ' ' ALA . 4.3 m -141.74 109.1 5.56 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.563 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 21.0 t70 -96.18 130.45 31.08 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 167.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -59.44 50.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.511 2.51 0 C-N-CA 124.859 3.706 . . . . 0.0 116.189 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -128.56 -56.12 1.22 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -90.5 130.06 42.81 Favored Pre-proline 0 N--CA 1.442 -0.85 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 175.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.28 147.75 11.5 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.258 1.972 . . . . 0.0 110.853 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.527 ' HB3' ' SG ' ' A' ' 37' ' ' CYS . 27.6 mmtp -120.28 89.7 3.18 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.477 0.656 . . . . 0.0 109.893 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.99 59.51 5.67 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.178 0.99 . . . . 0.0 110.041 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 35' ' ' LYS . 3.4 m -88.46 -178.79 5.94 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.808 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.48 137.49 36.47 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 174.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.9 tp -89.1 43.72 1.16 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.377 1.084 . . . . 0.0 110.105 -174.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -53.17 122.54 9.67 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 112.837 -1.983 . . . . 0.0 110.926 172.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.528 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 34.8 m -71.94 108.67 5.31 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 175.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -104.88 91.57 4.44 Favored Pre-proline 0 C--N 1.31 -1.123 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 22.9 Cg_exo -64.66 -17.2 58.78 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 124.43 3.42 . . . . 0.0 114.818 -172.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.4 ttp-105 -59.68 -23.65 63.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.564 0.697 . . . . 0.0 110.139 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.595 HG21 ' HD2' ' A' ' 16' ' ' TYR . 95.1 mt -103.82 122.27 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.73 -46.56 8.52 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.143 -177.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -161.09 175.15 12.72 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.965 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -109.59 111.78 3.24 Favored Glycine 0 N--CA 1.415 -2.754 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.7 t -86.31 98.68 7.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.7 m -87.74 157.49 52.03 Favored Pre-proline 0 C--N 1.285 -2.212 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -74.46 66.62 5.51 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.636 2.224 . . . . 0.0 109.709 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -110.19 23.05 14.82 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.67 -174.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.429 -1.515 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.675 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.464 ' OD1' ' HD3' ' A' ' 2' ' ' ARG . 11.4 t0 . . . . . 0 C--O 1.234 0.268 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.554 ' H ' ' HD3' ' A' ' 2' ' ' ARG . 0.3 OUTLIER -88.63 46.48 1.39 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.639 1.209 . . . . 0.0 110.704 -176.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 tp -76.96 111.08 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.378 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.53 ' HA ' ' CB ' ' A' ' 41' ' ' CYS . 90.8 m -96.36 25.65 4.86 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 122.218 1.008 . . . . 0.0 112.317 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.7 m -90.82 141.94 28.28 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 173.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -136.84 167.15 22.02 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.97 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.505 ' HA ' ' CD2' ' A' ' 16' ' ' TYR . 6.4 t -70.95 -34.57 71.59 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 123.447 0.699 . . . . 0.0 112.695 -171.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -77.89 -36.43 49.69 Favored 'General case' 0 N--CA 1.424 -1.754 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.767 -177.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.58 34.28 0.32 Allowed 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.482 0.658 . . . . 0.0 111.09 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.532 ' HA3' ' HE2' ' A' ' 16' ' ' TYR . . . -119.29 168.75 13.49 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.36 143.25 30.77 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 116.929 0.365 . . . . 0.0 111.009 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -50.81 138.66 18.26 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.694 172.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.91 -33.08 6.66 Favored Glycine 0 C--N 1.3 -1.456 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 64.0 m -99.11 138.83 35.65 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.739 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 37.0 mtmt -110.94 127.76 55.59 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -175.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.532 ' HE2' ' HA3' ' A' ' 10' ' ' GLY . 28.6 m-85 -76.47 128.28 34.48 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.335 0.588 . . . . 0.0 110.443 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -148.07 147.05 29.13 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.162 -171.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.559 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 31.5 p -97.74 144.22 27.58 Favored 'General case' 0 N--CA 1.407 -2.588 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.889 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.0 -11.47 57.1 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.737 0.815 . . . . 0.0 113.14 -170.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -74.1 -14.12 60.93 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.68 48.74 1.25 Allowed Glycine 0 N--CA 1.427 -1.962 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.559 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 84.9 m -134.68 121.61 21.06 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.077 0.465 . . . . 0.0 110.803 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.739 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 78.1 t80 -69.67 120.23 15.12 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.3 t -89.57 -53.22 9.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.327 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.4 p -172.33 164.87 5.85 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.986 0.422 . . . . 0.0 110.458 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -88.87 146.05 25.19 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 123.765 0.826 . . . . 0.0 109.265 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.61 109.65 2.49 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.476 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 1.1 mm-40 -101.49 23.49 11.03 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 10' ' ' GLY . 5.5 m -113.32 102.7 10.59 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-O 121.285 0.564 . . . . 0.0 111.779 176.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.552 ' HB3' ' ND2' ' A' ' 33' ' ' ASN . 4.6 t70 -113.98 138.7 22.94 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 173.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.34 -19.83 5.06 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.981 3.121 . . . . 0.0 115.549 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -86.88 -37.75 17.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.91 -0.494 . . . . 0.0 111.345 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.552 ' ND2' ' HB3' ' A' ' 30' ' ' ASP . 14.9 p30 -90.44 116.9 67.44 Favored Pre-proline 0 C--N 1.317 -0.834 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.094 -177.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -80.85 117.91 3.35 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.237 1.958 . . . . 0.0 109.208 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 28' ' ' GLU . 25.5 mmtm -109.36 139.89 43.75 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -171.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.55 125.05 30.04 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 166.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.0 m -128.94 150.47 50.36 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.785 -170.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 t -68.06 140.88 56.3 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 29.3 mt -106.85 -10.46 16.03 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.07 0.462 . . . . 0.0 110.833 -172.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -110.92 163.95 13.29 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.348 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.53 ' CB ' ' HA ' ' A' ' 4' ' ' CYS . 2.7 m -45.28 135.33 5.95 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 126.082 1.753 . . . . 0.0 112.596 -177.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -119.85 88.98 41.17 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.4 2.79 2.08 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 123.884 3.056 . . . . 0.0 115.214 -172.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -76.0 -24.54 55.32 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.865 0.84 . . . . 0.0 108.856 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.3 mt -95.89 149.47 4.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.023 -175.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.88 -53.01 2.84 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.42 170.7 18.33 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.883 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -102.45 98.17 1.66 Allowed Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.4 t -79.69 109.2 14.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.292 0.568 . . . . 0.0 109.882 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 3.4 m -80.66 115.08 52.97 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 106.131 -1.804 . . . . 0.0 106.131 173.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.623 ' HG3' ' HE2' ' A' ' 15' ' ' LYS . 24.5 Cg_exo -62.87 121.26 9.09 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 123.365 2.71 . . . . 0.0 114.169 -171.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -92.5 80.62 4.86 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 174.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 C--N 1.298 -1.636 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.901 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.241 0.613 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.459 ' HB3' ' SG ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -170.04 161.04 8.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 -178.359 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 tt -76.6 81.97 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 122.793 1.282 . . . . 0.0 109.361 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.823 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 78.2 m -124.37 43.66 2.95 Favored 'General case' 0 N--CA 1.406 -2.631 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.918 -175.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.453 ' HB ' HG23 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -77.97 148.64 34.36 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 173.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -128.61 142.97 50.87 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 118.871 -1.131 . . . . 0.0 113.501 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.7 t -98.97 13.03 34.16 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.321 1.057 . . . . 0.0 108.619 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.7 t -85.92 -70.39 0.6 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.773 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.1 -71.5 0.64 Allowed 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.33 -159.62 53.76 Favored Glycine 0 N--CA 1.415 -2.714 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.604 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 m -122.08 98.17 5.81 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.753 ' HE3' ' HB2' ' A' ' 30' ' ' ASP . 0.5 OUTLIER -40.18 122.22 1.49 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.031 0.932 . . . . 0.0 112.103 175.188 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.02 -42.01 1.92 Allowed Glycine 0 N--CA 1.435 -1.414 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.601 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 70.0 m -89.42 147.43 24.04 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.557 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 18.4 mtpp -97.36 116.19 29.1 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -175.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.82 ' HB3' HG13 ' A' ' 45' ' ' ILE . 10.9 m-85 -77.61 115.94 17.77 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.025 0.917 . . . . 0.0 108.85 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.448 ' HE2' ' HA2' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -135.67 149.05 49.16 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.498 -166.09 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.81 134.06 37.84 Favored 'General case' 0 N--CA 1.41 -2.466 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.42 -20.45 19.74 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -169.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -76.03 -13.77 60.22 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.907 0.385 . . . . 0.0 111.669 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.448 ' HA2' ' HE2' ' A' ' 17' ' ' PHE . . . 114.8 19.11 6.16 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.054 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.6 m -104.53 110.2 22.39 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.837 0.351 . . . . 0.0 110.86 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.557 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 50.3 t80 -73.14 126.14 29.34 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.1 t -96.34 -61.14 2.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 120.842 0.353 . . . . 0.0 110.328 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.4 p -161.63 160.07 28.32 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -176.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -97.3 145.46 26.08 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 174.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -46.65 122.09 6.31 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 124.165 0.916 . . . . 0.0 112.133 -178.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.56 -52.75 6.54 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.898 0.38 . . . . 0.0 111.13 -173.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.7 m -102.69 145.16 30.11 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-O 121.684 0.754 . . . . 0.0 111.963 -170.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.753 ' HB2' ' HE3' ' A' ' 12' ' ' LYS . 11.3 t70 -87.91 139.07 30.9 Favored Pre-proline 0 C--N 1.288 -2.077 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 172.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -49.79 -20.18 4.42 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.233 2.622 . . . . 0.0 114.512 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -83.23 -21.59 33.35 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.28 2.8 p-10 -90.58 118.86 69.02 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.823 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -75.27 73.51 4.45 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 123.637 2.892 . . . . 0.0 116.161 -170.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -130.37 49.91 2.25 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 122.551 1.167 . . . . 0.0 109.639 170.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.47 123.26 27.38 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.439 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.3 m -81.49 171.11 15.1 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.382 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 m -50.18 -64.76 0.71 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.85 -53.6 0.09 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 59.91 79.33 0.24 Allowed 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 124.578 1.174 . . . . 0.0 111.88 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.823 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 61.7 m -81.18 89.8 6.03 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 173.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.598 ' HB3' HG22 ' A' ' 45' ' ' ILE . 7.0 t0 -91.3 108.58 29.79 Favored Pre-proline 0 C--N 1.306 -1.283 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.544 -170.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -71.44 -5.59 17.36 Favored 'Trans proline' 0 C--O 1.24 0.594 0 C-N-CA 123.184 2.589 . . . . 0.0 112.424 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.577 ' HD3' ' OD1' ' A' ' 42' ' ' ASP . 25.8 mtp180 -75.26 -36.59 61.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.025 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.82 HG13 ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -108.98 136.66 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 CA-C-O 121.752 0.787 . . . . 0.0 112.943 -171.552 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.7 -60.53 1.68 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.387 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -153.75 165.22 36.69 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.012 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.41 114.56 5.05 Favored Glycine 0 C--N 1.29 -2.003 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t -92.85 114.12 29.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 14.7 m -79.67 137.43 54.8 Favored Pre-proline 0 C--N 1.284 -2.25 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 176.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.31 83.35 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.278 3.318 . . . . 0.0 114.466 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.04 26.39 7.55 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 C--N 1.3 -1.565 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -178.487 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 CA--C 1.51 -0.562 0 CA-C-O 121.413 0.625 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.413 ' HA ' ' HD2' ' A' ' 2' ' ' ARG . 23.4 mmm180 -109.74 -161.32 0.75 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 173.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 tp -70.86 108.38 2.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 118.561 -1.255 . . . . 0.0 108.29 174.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 1.015 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 69.3 m -101.47 34.39 2.61 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-O 122.206 1.003 . . . . 0.0 113.18 -173.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.8 m -91.34 147.07 23.3 Favored 'General case' 0 N--CA 1.408 -2.525 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.444 ' HA ' HD12 ' A' ' 45' ' ' ILE . 8.7 t-20 -159.01 -172.64 3.87 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.487 ' O ' ' HA3' ' A' ' 27' ' ' GLY . 1.1 t -74.14 -30.5 62.31 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 122.055 0.931 . . . . 0.0 108.925 -175.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.532 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 34.3 t -80.32 -44.28 19.79 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.972 176.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.415 ' HB3' ' H ' ' A' ' 6' ' ' ASN . . . -72.27 49.43 0.2 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.471 1.108 . . . . 0.0 113.375 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' HA3' ' HE1' ' A' ' 16' ' ' TYR . . . -151.86 -121.52 0.94 Allowed Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.335 -0.936 . . . . 0.0 111.322 176.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 29' ' ' SER . 7.7 m -159.9 138.17 10.29 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 27' ' ' GLY . 14.9 mtpp -57.4 130.71 47.5 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.72 -32.66 6.24 Favored Glycine 0 C--N 1.291 -1.95 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -174.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.3 m -80.81 123.94 28.66 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 121.1 0.476 . . . . 0.0 109.838 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.686 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 62.0 mttm -87.34 109.91 19.87 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.507 ' HE2' ' H ' ' A' ' 27' ' ' GLY . 51.5 m-85 -71.7 125.68 27.76 Favored 'General case' 0 CA--C 1.472 -2.056 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.48 146.16 32.28 Favored 'General case' 0 N--CA 1.393 -3.314 0 CA-C-N 114.385 -1.28 . . . . 0.0 111.541 -167.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.649 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 28.1 t -93.62 130.47 39.52 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.09 -17.12 50.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.101 0.96 . . . . 0.0 113.038 -172.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.72 -10.19 59.43 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.988 0.423 . . . . 0.0 110.387 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.08 6.05 16.65 Favored Glycine 0 N--CA 1.432 -1.612 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.96 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.649 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 8.5 m -90.95 122.66 33.82 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 117.046 0.423 . . . . 0.0 111.694 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.686 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 72.3 t80 -79.04 138.53 38.03 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 174.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.5 HG21 HG12 ' A' ' 45' ' ' ILE . 59.8 t -108.58 -64.51 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.532 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 p -173.02 168.27 4.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.646 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -112.54 117.47 32.44 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 170.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.605 ' O ' ' HG2' ' A' ' 12' ' ' LYS . . . -79.17 176.29 54.76 Favored Glycine 0 C--N 1.296 -1.657 0 N-CA-C 115.351 0.9 . . . . 0.0 115.351 -169.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -103.21 29.02 5.82 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 123.365 0.666 . . . . 0.0 110.96 -176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.413 ' HB3' ' HA ' ' A' ' 11' ' ' THR . 10.0 t -81.94 72.11 8.98 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 122.335 1.064 . . . . 0.0 109.084 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.69 140.33 31.5 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.119 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -35.46 -44.7 0.65 Allowed 'Trans proline' 0 CA--C 1.548 1.196 0 C-N-CA 124.791 3.661 . . . . 0.0 115.892 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.72 9.46 37.13 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -174.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.42 158.07 43.79 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -83.41 85.29 1.53 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.261 1.974 . . . . 0.0 111.072 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.12 55.01 3.14 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 122.143 0.973 . . . . 0.0 111.86 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.32 83.51 1.77 Allowed 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.951 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.2 m -109.99 123.74 50.18 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.387 -175.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.08 46.36 1.38 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.211 0.529 . . . . 0.0 111.359 -175.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.32 23.19 0.48 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.532 ' OD1' ' HB3' ' A' ' 8' ' ' CYS . 37.2 m-20 -90.21 57.14 3.63 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -167.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 1.015 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 71.0 m -148.29 74.34 1.28 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 173.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -92.82 112.94 58.14 Favored Pre-proline 0 CA--C 1.515 -0.394 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.54 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.76 -11.69 28.05 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 123.053 2.502 . . . . 0.0 113.862 -174.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.9 ptt-85 -90.7 -12.44 36.68 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.55 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.5 HG12 HG21 ' A' ' 24' ' ' VAL . 85.1 mt -97.82 138.0 23.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.82 -59.61 1.7 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.374 0.607 . . . . 0.0 109.622 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.35 161.51 41.04 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -95.51 106.75 3.43 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.3 t -86.91 107.43 16.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.433 0.635 . . . . 0.0 110.931 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.465 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.6 m -92.43 124.12 60.2 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 173.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 2.6 Cg_exo -75.96 77.96 3.29 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.086 2.524 . . . . 0.0 113.291 -175.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -79.92 -50.6 10.22 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.421 -1.912 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 176.498 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 C--O 1.238 0.493 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 64.75 52.38 1.68 Allowed 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 -173.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.742 HG12 ' HA ' ' A' ' 43' ' ' PRO . 7.1 tp -75.08 45.39 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.605 0 CA-C-O 122.832 1.301 . . . . 0.0 113.072 -173.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.453 ' HA ' ' CB ' ' A' ' 41' ' ' CYS . 3.3 m -102.45 32.55 3.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.238 1.018 . . . . 0.0 111.162 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.93 162.85 17.46 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 113.921 -1.491 . . . . 0.0 108.222 176.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -132.42 156.58 46.45 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.208 0.528 . . . . 0.0 110.3 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 t -85.09 -16.13 41.64 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 124.263 1.025 . . . . 0.0 112.407 -173.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 8.4 t -90.86 -66.61 0.91 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.594 -1.242 . . . . 0.0 113.788 -175.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.05 48.9 0.42 Allowed 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -167.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.2 -95.13 2.38 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 174.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.4 m -163.78 132.17 3.69 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 123.957 0.903 . . . . 0.0 109.088 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.931 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 19.8 pttp -64.34 143.05 58.18 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.48 -35.47 4.79 Favored Glycine 0 C--N 1.297 -1.619 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.504 -175.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.4 m -80.49 146.33 31.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.704 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 2.1 mmpt? -97.19 113.89 25.54 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.686 ' HB3' HG13 ' A' ' 45' ' ' ILE . 90.6 m-85 -71.28 117.6 13.01 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.544 ' CE2' ' HA ' ' A' ' 22' ' ' THR . 16.0 t80 -122.73 144.5 49.12 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-O 122.193 0.997 . . . . 0.0 113.138 -163.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.467 ' HB2' ' CG2' ' A' ' 24' ' ' VAL . 6.4 t -97.19 123.3 40.92 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -30.9 71.24 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -174.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -107.06 18.81 21.28 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.252 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -162.7 20.21 0.17 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 118.815 -1.66 . . . . 0.0 115.715 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.544 ' HA ' ' CE2' ' A' ' 17' ' ' PHE . 0.4 OUTLIER 55.91 -170.42 0.08 Allowed 'General case' 0 CA--C 1.587 2.387 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 177.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.704 ' HD1' ' HB3' ' A' ' 15' ' ' LYS . 72.9 t80 -39.79 126.06 1.92 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.253 1.421 . . . . 0.0 113.103 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 18' ' ' SER . 40.2 t -106.49 -58.68 3.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.694 177.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 p -147.28 165.41 30.2 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.416 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 15.7 tt0 -111.21 165.08 12.22 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -178.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.931 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -51.85 134.87 35.17 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 115.976 1.15 . . . . 0.0 115.976 -176.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -123.52 8.85 8.98 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 122.404 1.097 . . . . 0.0 108.946 176.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.2 m -100.98 101.41 12.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.135 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -108.27 143.95 28.46 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.61 -29.0 77.58 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.504 2.136 . . . . 0.0 114.298 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -98.11 -41.67 7.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.503 0.192 . . . . 0.0 111.287 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -57.8 139.3 82.33 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -174.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -67.57 134.8 34.07 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.371 2.047 . . . . 0.0 109.561 175.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.421 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 4.8 ptpp? -123.51 111.13 15.92 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -173.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.45 81.53 1.56 Allowed 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 172.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 91.4 m -99.62 143.15 30.19 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -172.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.26 115.75 10.77 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 171.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mp -111.2 36.23 3.27 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.55 0.691 . . . . 0.0 110.138 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -92.98 158.98 15.52 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.753 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.453 ' CB ' ' HA ' ' A' ' 4' ' ' CYS . 33.6 m -67.01 105.35 1.62 Allowed 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.78 ' HB3' HG22 ' A' ' 45' ' ' ILE . 12.7 t70 -97.73 110.78 56.76 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.199 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.742 ' HA ' HG12 ' A' ' 3' ' ' ILE . 24.7 Cg_exo -63.56 -9.82 19.6 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.787 2.992 . . . . 0.0 114.854 -176.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.68 -34.97 15.2 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.675 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.78 HG22 ' HB3' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -87.59 100.26 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 122.001 0.905 . . . . 0.0 110.98 -176.437 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.86 -39.54 30.38 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.545 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -170.65 172.52 5.8 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.21 123.16 7.78 Favored Glycine 0 C--N 1.288 -2.138 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.0 t -96.32 100.83 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 73.1 m -80.94 153.66 72.57 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 16.9 Cg_exo -69.56 61.95 1.64 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.348 2.698 . . . . 0.0 113.269 -177.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.483 ' CZ ' ' HA ' ' A' ' 52' ' ' ARG . 0.6 OUTLIER -126.71 11.84 7.3 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 176.38 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.4 m . . . . . 0 N--CA 1.424 -1.747 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.396 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.573 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 1.1 m-20 . . . . . 0 CA--C 1.508 -0.642 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.82 -52.29 2.44 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.6 tt -83.54 56.06 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 123.37 1.557 . . . . 0.0 110.283 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 1' ' ' ASP . 21.0 m -92.61 57.28 2.88 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.985 -178.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.566 ' HB ' HG23 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -90.65 -178.67 5.35 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 173.225 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -156.48 142.83 18.33 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 174.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.5 t -61.0 -46.66 89.87 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 123.758 0.661 . . . . 0.0 111.611 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.512 ' HA ' ' HB3' ' A' ' 28' ' ' GLU . 34.2 t -67.89 -51.16 51.18 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.885 -176.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.13 36.94 0.19 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.605 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . -109.35 170.66 14.6 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 176.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -74.77 122.47 23.35 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 117.008 0.404 . . . . 0.0 110.621 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.772 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -57.41 144.49 36.16 Favored 'General case' 0 C--O 1.241 0.606 0 O-C-N 121.902 -0.499 . . . . 0.0 110.048 173.613 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.08 -26.32 19.61 Favored Glycine 0 C--N 1.305 -1.171 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.5 m -91.28 130.92 37.09 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -84.13 103.67 13.53 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.575 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 17.0 m-85 -61.07 122.45 15.02 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.527 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -148.84 149.99 32.24 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.744 -167.214 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.619 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 33.6 t -89.88 133.61 34.66 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -47.46 -33.12 5.79 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.812 1.645 . . . . 0.0 114.155 -174.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -68.77 -19.71 64.33 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.527 ' HA2' ' CE2' ' A' ' 17' ' ' PHE . . . 122.61 18.79 3.22 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.326 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.619 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 69.1 m -103.5 125.49 50.09 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 117.197 0.498 . . . . 0.0 111.302 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -78.2 137.74 38.3 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.435 HG21 ' HA ' ' A' ' 45' ' ' ILE . 21.7 t -111.29 -56.07 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.128 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.8 177.99 7.53 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.022 0.529 . . . . 0.0 109.687 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -147.51 103.9 3.58 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 118.776 0.716 . . . . 0.0 112.14 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.772 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . 73.55 84.98 0.26 Allowed Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.979 177.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 59.2 mm-40 -111.32 -37.38 5.3 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.605 ' HB2' ' O ' ' A' ' 10' ' ' GLY . 3.8 m -105.6 107.48 18.49 Favored 'General case' 0 C--O 1.248 0.992 0 O-C-N 121.877 -0.514 . . . . 0.0 111.331 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -139.88 129.82 13.92 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.73 77.83 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.212 0 C-N-CA 123.004 2.47 . . . . 0.0 114.402 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.448 ' CZ ' ' HB2' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -141.46 -56.96 0.48 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 173.263 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 1.2 p-10 -82.25 126.3 74.7 Favored Pre-proline 0 N--CA 1.432 -1.351 0 CA-C-O 121.37 0.605 . . . . 0.0 109.832 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 11.5 Cg_exo -70.37 166.26 28.96 Favored 'Trans proline' 0 C--O 1.253 1.271 0 C-N-CA 123.234 2.623 . . . . 0.0 111.534 175.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.778 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER 83.09 142.69 0.07 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.311 1.844 . . . . 0.0 111.677 -179.439 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.3 157.75 17.5 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.3 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 24.0 m -85.88 164.4 17.51 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 t -65.66 156.51 32.68 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.309 0.576 . . . . 0.0 110.87 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.68 6.95 45.51 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.368 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -58.06 127.94 34.62 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.978 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 33.0 m -64.21 123.16 18.39 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.456 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -112.34 95.92 33.29 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -72.33 8.82 1.34 Allowed 'Trans proline' 0 N--CA 1.485 0.994 0 C-N-CA 123.267 2.645 . . . . 0.0 113.969 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.5 ttp-105 -90.45 -34.96 15.4 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.566 HG23 ' HB ' ' A' ' 5' ' ' THR . 1.6 tt -94.8 121.13 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.2 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.79 -47.66 8.45 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -167.76 169.3 11.79 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.694 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -97.03 120.35 6.68 Favored Glycine 0 C--N 1.284 -2.334 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.7 t -92.43 107.45 19.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 121.327 0.584 . . . . 0.0 110.364 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.74 153.87 64.59 Favored Pre-proline 0 C--N 1.296 -1.744 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.24 121.61 6.38 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 123.457 2.771 . . . . 0.0 113.231 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -95.7 -36.81 11.06 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.2 m . . . . . 0 N--CA 1.425 -1.679 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 179.815 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 42.3 p-10 . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -114.69 -37.91 4.12 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.824 -0.547 . . . . 0.0 112.233 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.402 HG12 ' HA ' ' A' ' 43' ' ' PRO . 6.4 tp -82.81 94.45 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-O 121.758 0.79 . . . . 0.0 109.525 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.898 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 6.7 m -126.11 47.95 2.18 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-O 121.667 0.746 . . . . 0.0 112.876 -175.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.551 HG21 ' HA ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -90.24 116.33 28.14 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 172.156 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.428 HD21 ' HB3' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -126.5 156.53 40.6 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -178.738 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.507 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 45.0 t -88.72 -47.18 8.43 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -172.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.4 t -61.38 -53.93 50.2 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.262 0.553 . . . . 0.0 111.35 -174.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.428 ' HB3' HD21 ' A' ' 6' ' ' ASN . . . -90.48 24.83 2.46 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.588 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' CE1' ' A' ' 16' ' ' TYR . . . -90.77 149.97 20.35 Favored Glycine 0 N--CA 1.431 -1.671 0 C-N-CA 120.096 -1.05 . . . . 0.0 110.876 177.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.37 117.98 5.45 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 123.477 0.711 . . . . 0.0 111.48 -176.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.728 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 40.2 ttmt -53.31 107.46 0.24 Allowed 'General case' 0 C--O 1.238 0.49 0 O-C-N 123.882 0.738 . . . . 0.0 112.777 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.54 -30.8 3.07 Favored Glycine 0 C--N 1.303 -1.274 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.1 m -86.26 121.86 29.43 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 63.7 mmtt -80.75 108.1 14.12 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.588 ' HD2' HG21 ' A' ' 45' ' ' ILE . 43.1 m-85 -71.25 109.94 5.59 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.02 151.22 50.6 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.567 -165.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.455 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 6.3 t -87.87 129.55 35.18 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.08 -9.18 20.36 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -168.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -79.61 -10.17 59.75 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 122.997 0.519 . . . . 0.0 111.1 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.89 33.11 2.47 Favored Glycine 0 C--N 1.315 -0.611 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.2 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 52.5 m -124.94 106.45 9.98 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 121.021 0.439 . . . . 0.0 110.788 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 58.2 t80 -70.91 124.14 23.64 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.528 176.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.03 -64.72 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.9 p -170.73 157.74 5.75 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 30.6 tt0 -85.24 138.86 32.07 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.728 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -63.57 135.15 41.69 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 176.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.404 ' HG3' ' HE2' ' A' ' 12' ' ' LYS . 7.6 tt0 -126.48 34.96 4.72 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.792 -175.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 t -82.96 113.37 20.5 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -104.35 133.41 20.22 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -53.57 -14.94 5.58 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.616 2.877 . . . . 0.0 114.442 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -103.07 -27.08 12.79 Favored 'General case' 0 N--CA 1.441 -0.895 0 O-C-N 121.622 -0.674 . . . . 0.0 111.693 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -91.14 137.42 26.4 Favored Pre-proline 0 C--O 1.239 0.552 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -172.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -82.6 124.08 3.96 Favored 'Trans proline' 0 N--CA 1.442 -1.548 0 C-N-CA 122.461 2.108 . . . . 0.0 110.038 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.9 138.25 47.53 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.656 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.5 93.3 3.9 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.451 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.9 m -142.67 167.2 22.65 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.9 138.11 54.39 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.4 47.65 1.97 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.806 0.812 . . . . 0.0 109.958 -176.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -97.83 18.89 14.75 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.321 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.898 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 55.7 m 65.23 156.72 0.09 Allowed 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 125.701 1.6 . . . . 0.0 112.124 177.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -122.52 112.31 31.14 Favored Pre-proline 0 N--CA 1.466 0.357 0 O-C-N 120.411 -1.431 . . . . 0.0 113.127 -178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.402 ' HA ' HG12 ' A' ' 3' ' ' ILE . 59.4 Cg_endo -73.68 -2.88 12.83 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.975 2.45 . . . . 0.0 113.941 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -85.6 -21.75 28.34 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.4 0.619 . . . . 0.0 109.673 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.588 HG21 ' HD2' ' A' ' 16' ' ' TYR . 95.3 mt -95.73 132.47 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.083 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.09 -55.67 3.65 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.692 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.551 ' HA ' HG21 ' A' ' 5' ' ' THR . 2.2 p90 -164.77 164.8 21.08 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.767 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -92.95 111.58 4.12 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.2 t -87.81 115.92 29.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 120.996 0.427 . . . . 0.0 110.3 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -96.16 105.14 20.02 Favored Pre-proline 0 C--N 1.293 -1.856 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -73.32 88.99 0.95 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.202 2.601 . . . . 0.0 112.079 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.46 -53.73 6.6 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.297 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.3 m . . . . . 0 N--CA 1.42 -1.928 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -179.489 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 CA--C 1.499 -1.009 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -147.76 61.52 1.14 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.7 tp -83.36 63.93 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-O 123.154 1.454 . . . . 0.0 109.888 -176.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.966 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.7 m -83.98 48.02 1.4 Allowed 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -176.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -91.17 164.12 14.02 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.53 ' HB3' HD23 ' A' ' 39' ' ' LEU . 1.1 t-20 -160.49 152.37 20.0 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.008 0.822 . . . . 0.0 111.811 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.8 t -67.8 -44.35 77.53 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.583 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 46.5 t -59.0 -52.22 66.68 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.163 0.506 . . . . 0.0 109.715 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.519 ' HB2' ' H ' ' A' ' 37' ' ' CYS . . . -86.16 25.58 1.15 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.783 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.51 156.11 22.48 Favored Glycine 0 N--CA 1.423 -2.193 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.911 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.2 m -83.01 109.41 17.08 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 123.008 0.523 . . . . 0.0 111.704 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -47.38 141.11 5.07 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.639 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.73 -44.11 1.56 Allowed Glycine 0 C--N 1.303 -1.298 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.3 m -103.23 140.43 37.39 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.775 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 69.8 mttt -100.01 129.39 46.06 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 121.392 0.615 . . . . 0.0 110.432 -173.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.428 ' HB3' ' CG1' ' A' ' 45' ' ' ILE . 48.7 m-85 -84.14 132.14 34.71 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.241 -176.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.46 148.45 37.76 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.227 -168.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.596 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 29.6 t -91.5 141.14 29.06 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.211 -1.358 . . . . 0.0 109.442 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.2 -14.4 60.55 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.796 1.239 . . . . 0.0 112.388 -176.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.29 -6.65 59.24 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.106 0.479 . . . . 0.0 110.527 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.71 34.17 3.61 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.505 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.596 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 25.2 m -118.75 120.03 36.17 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.261 -178.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.775 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 47.7 t80 -74.91 128.91 36.7 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -98.54 -71.71 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.504 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -172.11 165.96 6.12 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -178.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.769 ' HG3' ' HG2' ' A' ' 15' ' ' LYS . 12.0 tt0 -85.35 158.63 20.21 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.19 127.73 29.7 Favored Glycine 0 C--O 1.238 0.367 0 O-C-N 123.602 0.564 . . . . 0.0 112.905 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 8' ' ' CYS . 4.4 mm-40 -79.76 -22.69 42.9 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.494 0.188 . . . . 0.0 111.315 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.3 m -95.89 128.62 42.93 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-O 121.088 0.47 . . . . 0.0 110.047 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -79.53 124.41 83.85 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.43 82.62 0.1 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.488 2.792 . . . . 0.0 112.944 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 mmm180 -146.17 -70.44 0.25 Allowed 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -90.44 151.7 44.6 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.82 66.27 5.86 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.62 2.214 . . . . 0.0 111.781 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -80.38 130.6 35.28 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.145 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -131.76 160.88 34.26 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.285 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.519 ' H ' ' HB2' ' A' ' 9' ' ' ALA . 59.8 m -137.53 166.56 23.58 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.6 m -59.28 110.51 1.09 Allowed 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.53 HD23 ' HB3' ' A' ' 6' ' ' ASN . 12.8 mt -79.39 -62.54 1.66 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.554 -175.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 56.34 31.53 18.82 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.026 0.93 . . . . 0.0 111.253 -177.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.966 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 68.4 m 49.29 76.83 0.12 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.064 -177.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.497 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 6.7 t0 -53.27 112.74 3.9 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 123.869 0.868 . . . . 0.0 111.357 -174.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 10.9 Cg_exo -71.35 -11.31 28.42 Favored 'Trans proline' 0 C--O 1.242 0.695 0 C-N-CA 123.0 2.466 . . . . 0.0 112.828 -176.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.753 ' HA ' ' HE ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -91.41 -14.13 31.15 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.513 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.428 ' CG1' ' HB3' ' A' ' 16' ' ' TYR . 1.7 mp -108.85 124.24 65.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.155 0.503 . . . . 0.0 110.765 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.07 -47.76 5.11 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -164.47 166.21 20.7 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.715 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.11 130.5 10.34 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.2 t -109.54 115.88 50.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.474 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 25.6 m -82.05 141.19 46.67 Favored Pre-proline 0 C--N 1.288 -2.071 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 12.6 Cg_exo -69.49 61.59 1.59 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.65 2.9 . . . . 0.0 114.01 -174.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HB3' ' H ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -100.35 -83.53 0.44 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 175.339 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.48 ' H ' ' HB3' ' A' ' 52' ' ' ARG . 50.7 m . . . . . 0 C--N 1.31 -1.149 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.554 ' OD1' ' HG2' ' A' ' 2' ' ' ARG . 7.1 t70 . . . . . 0 CA--C 1.516 -0.356 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.554 ' HG2' ' OD1' ' A' ' 1' ' ' ASP . 21.5 mmm180 61.78 57.71 2.13 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.711 0.804 . . . . 0.0 111.953 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' A' ' 43' ' ' PRO . 6.7 tp -72.97 98.84 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 122.297 1.046 . . . . 0.0 111.169 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.753 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 1.8 m -121.64 22.27 10.62 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 122.015 0.912 . . . . 0.0 111.727 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.37 144.08 26.15 Favored 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.77 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -126.06 151.8 46.67 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 17.2 t -86.59 -16.37 36.97 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 123.743 0.817 . . . . 0.0 111.346 -173.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.0 t -66.31 -43.97 84.72 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.93 0.871 . . . . 0.0 108.764 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . . . -90.9 -102.39 0.1 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.483 172.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.48 -151.16 48.97 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-O 121.521 0.512 . . . . 0.0 113.813 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.814 HG23 ' HD3' ' A' ' 31' ' ' PRO . 95.0 m -143.88 110.96 5.75 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 122.679 0.392 . . . . 0.0 110.189 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' A' ' 27' ' ' GLY . 17.0 ttmt -51.34 116.52 2.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.136 176.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.59 -38.25 1.59 Allowed Glycine 0 N--CA 1.418 -2.544 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.2 m -106.56 112.43 25.43 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.492 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 37.0 mttp -87.47 113.24 23.0 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.755 -175.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -65.79 123.44 19.76 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.174 -177.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -125.06 152.79 43.85 Favored 'General case' 0 N--CA 1.407 -2.605 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.314 -166.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.767 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 1.0 OUTLIER -105.7 127.04 52.83 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 113.221 -1.809 . . . . 0.0 106.325 179.158 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.7 -14.34 20.33 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -167.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.6 -18.14 60.61 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.266 175.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.91 3.12 6.45 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.032 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.767 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 97.7 m -83.13 117.18 22.71 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.97 0.414 . . . . 0.0 111.674 -177.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.492 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 20.4 t80 -76.08 119.14 19.61 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 169.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.408 HG11 ' NH2' ' A' ' 44' ' ' ARG . 18.0 t -87.39 -63.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.497 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 p -169.14 172.58 7.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.866 0.365 . . . . 0.0 111.206 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -97.1 150.52 20.75 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.445 ' O ' ' HE3' ' A' ' 12' ' ' LYS . . . -62.61 118.59 14.69 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -79.91 3.02 21.19 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -175.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.4 m -121.38 141.22 51.17 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-O 121.601 0.715 . . . . 0.0 110.53 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -99.0 145.29 29.73 Favored Pre-proline 0 C--N 1.285 -2.237 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.814 ' HD3' HG23 ' A' ' 11' ' ' THR . 6.6 Cg_endo -50.53 -19.78 5.34 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.37 2.713 . . . . 0.0 115.071 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.472 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 0.8 OUTLIER -82.24 -25.62 33.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.641 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.52 138.48 25.31 Favored Pre-proline 0 C--N 1.319 -0.723 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.767 177.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -86.34 -164.18 0.21 Allowed 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.759 2.306 . . . . 0.0 111.195 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt 73.62 164.57 0.28 Allowed 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 125.37 1.468 . . . . 0.0 112.833 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . . . -155.58 143.28 19.69 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 178.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 55.7 m -79.85 125.19 29.39 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.42 79.44 0.26 Allowed 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 124.079 0.952 . . . . 0.0 112.249 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.6 tp -100.34 -18.91 16.56 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.884 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 65.63 55.12 1.03 Allowed 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 124.389 1.076 . . . . 0.0 110.19 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.753 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 20.7 m 74.78 138.04 0.06 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 125.686 1.594 . . . . 0.0 110.744 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -107.52 91.71 7.49 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.508 ' HA ' HG23 ' A' ' 3' ' ' ILE . 3.5 Cg_exo -77.25 0.67 9.51 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 123.117 2.545 . . . . 0.0 112.325 -175.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.408 ' NH2' HG11 ' A' ' 24' ' ' VAL . 15.3 ttp-105 -85.63 -19.13 31.44 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 74.1 mt -82.42 141.01 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.61 -57.96 2.32 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.433 0.635 . . . . 0.0 109.47 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -160.34 170.7 20.52 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.201 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.03 125.39 8.56 Favored Glycine 0 C--N 1.291 -1.92 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.7 t -95.95 106.19 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 m -93.96 111.9 54.93 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 177.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.89 134.76 64.59 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.177 2.584 . . . . 0.0 112.225 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -111.93 134.64 53.36 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.431 0.634 . . . . 0.0 110.819 -177.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.3 m . . . . . 0 C--N 1.279 -2.48 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 176.229 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.497 -1.08 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 53.44 79.19 0.13 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 124.208 0.943 . . . . 0.0 110.712 175.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.983 ' HB ' ' HA ' ' A' ' 43' ' ' PRO . 37.5 mm -83.79 92.02 2.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.611 -175.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.6 m -97.32 32.33 2.25 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 122.284 1.04 . . . . 0.0 112.526 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.489 ' HB ' HG23 ' A' ' 45' ' ' ILE . 3.6 m -81.44 140.95 34.35 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 171.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -133.13 148.23 52.11 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.305 -174.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.7 t -83.77 -28.02 28.46 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.564 1.145 . . . . 0.0 110.815 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.1 t -62.94 -59.99 4.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.421 0.629 . . . . 0.0 110.828 -175.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.82 47.86 1.39 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.254 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.8 ' HA3' ' HE1' ' A' ' 16' ' ' TYR . . . -93.04 -110.07 1.95 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.73 175.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.9 m -162.86 127.65 3.11 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 123.857 0.863 . . . . 0.0 108.746 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 1.074 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -64.24 128.95 38.0 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.917 174.313 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.93 -26.42 11.56 Favored Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 m -89.68 127.53 35.94 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.533 ' HG2' ' HG3' ' A' ' 26' ' ' GLU . 43.9 mtpt -86.11 114.61 23.1 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.8 ' HE1' ' HA3' ' A' ' 10' ' ' GLY . 57.3 m-85 -72.85 111.95 8.44 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 178.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.563 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -134.94 147.74 49.85 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.871 -166.307 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 21.6 p -97.13 148.17 23.32 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.556 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -62.97 -16.7 60.48 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.663 1.185 . . . . 0.0 113.218 -172.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -77.6 -12.01 59.92 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.382 0.61 . . . . 0.0 109.72 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.563 ' HA2' ' CE2' ' A' ' 17' ' ' PHE . . . 101.59 40.93 2.63 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.393 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.449 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 41.6 m -127.26 131.92 50.46 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.612 0.72 . . . . 0.0 111.93 -178.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.612 ' HE1' ' HB2' ' A' ' 26' ' ' GLU . 78.1 t80 -72.51 130.24 40.18 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.245 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 t -106.07 -49.08 8.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 120.911 0.386 . . . . 0.0 109.993 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.1 p -164.77 174.39 10.73 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.612 ' HB2' ' HE1' ' A' ' 23' ' ' PHE . 2.2 tm-20 -153.51 140.78 19.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.834 0.743 . . . . 0.0 111.636 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 1.074 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . 57.27 55.57 29.66 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 116.684 1.433 . . . . 0.0 116.684 171.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -81.58 -44.98 16.52 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.605 0.716 . . . . 0.0 109.614 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.21 78.32 8.85 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.609 -174.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.653 ' HA ' ' HG2' ' A' ' 12' ' ' LYS . 18.8 t0 -89.69 129.29 47.31 Favored Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -64.28 51.19 0.18 Allowed 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 123.921 3.081 . . . . 0.0 113.721 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -147.18 -45.52 0.17 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 125.294 1.437 . . . . 0.0 107.721 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -84.26 124.38 74.01 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -86.88 106.36 0.69 Allowed 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.737 2.292 . . . . 0.0 110.333 173.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 mtmm -115.36 102.83 10.21 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.25 98.9 6.82 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.28 0.562 . . . . 0.0 110.106 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.4 m -114.77 124.69 52.41 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.37 -42.28 71.98 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.0 -175.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.5 tp -158.98 -64.82 0.08 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 m120 61.2 49.29 5.61 Favored 'General case' 0 C--O 1.245 0.867 0 O-C-N 124.197 0.936 . . . . 0.0 112.148 176.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 84.9 m -57.98 120.96 9.46 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.534 ' HB3' HG22 ' A' ' 45' ' ' ILE . 2.2 t70 -116.21 100.51 53.55 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -177.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.983 ' HA ' ' HB ' ' A' ' 3' ' ' ILE . 44.2 Cg_endo -68.74 -6.48 18.04 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.858 2.372 . . . . 0.0 113.97 -174.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.49 ' O ' ' HB3' ' A' ' 18' ' ' SER . 0.7 OUTLIER -90.55 -25.4 20.24 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 111.755 0.279 . . . . 0.0 111.755 -178.572 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.534 HG22 ' HB3' ' A' ' 42' ' ' ASP . 3.8 tt -88.39 147.13 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 121.411 0.624 . . . . 0.0 111.07 -177.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.91 -50.92 4.03 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.77 175.24 4.0 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.234 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.33 121.69 6.82 Favored Glycine 0 N--CA 1.429 -1.825 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.6 t -104.3 103.82 15.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.033 0.444 . . . . 0.0 110.446 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 17.3 m -79.89 112.67 31.69 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 170.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.19 111.18 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 124.29 3.327 . . . . 0.0 114.272 -171.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -80.72 -60.91 2.13 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 N--CA 1.429 -1.485 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 175.944 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 . . . . . 0 C--O 1.233 0.206 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.8 ttt85 -65.16 -39.74 93.39 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.45 ' O ' ' HB3' ' A' ' 41' ' ' CYS . 19.3 tt -75.48 94.33 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 122.207 1.003 . . . . 0.0 112.458 -176.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 97.0 m -128.65 40.36 3.66 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.811 0.815 . . . . 0.0 110.792 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.432 HG21 ' HA ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -62.75 133.67 55.13 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.765 176.678 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -144.84 148.69 34.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.083 0.468 . . . . 0.0 110.164 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 t -75.22 -25.84 58.46 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.839 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.1 t -59.48 -56.06 26.71 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.361 0.601 . . . . 0.0 109.448 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . . . -90.74 23.29 3.15 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.309 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.62 141.85 31.44 Favored Glycine 0 N--CA 1.424 -2.132 0 C-N-CA 120.34 -0.933 . . . . 0.0 111.932 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.0 m -75.4 117.1 16.83 Favored 'General case' 0 C--N 1.273 -2.737 0 O-C-N 123.886 0.404 . . . . 0.0 111.451 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.412 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 34.9 ttmt -53.03 120.63 6.1 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.51 0.724 . . . . 0.0 109.129 175.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.92 -31.27 6.16 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 11.8 m -91.0 126.82 36.2 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -90.09 109.39 20.44 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.6 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 18.8 m-85 -71.54 115.16 10.4 Favored 'General case' 0 CA--C 1.484 -1.569 0 CA-C-O 121.875 0.845 . . . . 0.0 109.287 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.461 ' HE1' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -133.81 145.19 49.52 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 113.281 -1.781 . . . . 0.0 111.612 -167.227 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.518 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 53.4 p -98.22 148.16 23.89 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -13.16 44.16 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -173.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.7 -0.99 40.75 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.213 0.53 . . . . 0.0 110.453 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.461 ' HA2' ' HE1' ' A' ' 17' ' ' PHE . . . 92.94 36.22 6.11 Favored Glycine 0 N--CA 1.43 -1.735 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.039 176.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.518 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 90.7 m -122.11 121.5 37.06 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.759 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -73.29 124.37 25.57 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.506 HG21 HG12 ' A' ' 45' ' ' ILE . 34.3 t -96.2 -60.76 2.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.515 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.8 p -161.95 161.05 28.49 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.675 -0.41 . . . . 0.0 112.074 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -81.45 149.31 28.83 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 174.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.5 127.38 45.05 Favored Glycine 0 CA--C 1.524 0.64 0 O-C-N 123.587 0.554 . . . . 0.0 113.046 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -83.53 -21.0 32.85 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.6 m -100.86 131.01 46.95 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 121.266 0.555 . . . . 0.0 111.609 -176.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.816 ' HB3' ' HB3' ' A' ' 33' ' ' ASN . 25.1 t70 -79.72 140.23 54.84 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 12' ' ' LYS . 78.2 Cg_exo -56.01 -12.41 7.22 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.286 2.657 . . . . 0.0 114.374 179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -121.6 7.98 10.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 122.329 0.252 . . . . 0.0 111.325 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.816 ' HB3' ' HB3' ' A' ' 30' ' ' ASP . 2.4 p-10 -90.58 138.16 26.86 Favored Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.729 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -76.46 121.37 5.99 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.706 1.604 . . . . 0.0 108.686 171.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.7 pttm -128.84 162.46 27.43 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 120.822 0.344 . . . . 0.0 111.552 -173.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.41 45.62 1.73 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.103 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 9' ' ' ALA . 89.6 m -79.54 148.67 31.7 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.7 t -79.69 -175.7 4.97 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.488 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.51 39.95 1.88 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.339 0.656 . . . . 0.0 110.269 -175.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -66.08 106.21 1.56 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.156 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 3.3 m -73.08 112.59 9.26 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.447 -178.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -92.6 101.13 4.6 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 3.0 Cg_exo -74.22 -3.53 13.96 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 123.144 2.563 . . . . 0.0 112.526 -174.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -87.8 -34.59 18.23 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.172 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.506 HG12 HG21 ' A' ' 24' ' ' VAL . 79.4 mt -87.05 142.28 13.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.23 -65.46 1.0 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.432 ' HA ' HG21 ' A' ' 5' ' ' THR . 0.5 OUTLIER -161.02 169.17 23.05 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.077 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -96.11 103.51 2.96 Favored Glycine 0 N--CA 1.429 -1.799 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.497 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 71.4 t -79.9 113.75 19.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 1.6 m -85.69 102.87 2.92 Favored Pre-proline 0 C--N 1.308 -1.231 0 C-N-CA 122.988 0.515 . . . . 0.0 109.636 175.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 49' ' ' VAL . 9.5 Cg_endo -93.75 141.81 1.7 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 123.0 2.467 . . . . 0.0 111.567 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.98 -44.33 5.52 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.43 -1.433 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 177.707 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 C--O 1.226 -0.183 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -71.06 -19.33 62.49 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.7 tp -70.36 93.69 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 122.148 0.975 . . . . 0.0 110.373 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.882 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 22.4 m -105.26 29.36 6.49 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 122.227 1.013 . . . . 0.0 110.874 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -90.31 135.79 33.46 Favored 'General case' 0 N--CA 1.399 -2.981 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.393 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -126.25 154.75 42.92 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.582 ' HB2' HD11 ' A' ' 45' ' ' ILE . 17.5 t -88.81 -11.58 44.44 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.002 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.0 t -60.8 -49.43 77.5 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 120.91 0.386 . . . . 0.0 109.968 -178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.46 -87.34 0.17 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.06 -144.28 32.19 Favored Glycine 0 N--CA 1.438 -1.192 0 O-C-N 124.093 0.871 . . . . 0.0 114.182 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.5 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 4.6 t -147.06 115.44 6.66 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-O 120.951 0.405 . . . . 0.0 110.219 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -47.58 111.09 0.38 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.267 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.0 -35.31 2.32 Favored Glycine 0 N--CA 1.422 -2.292 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.362 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.4 m -96.9 131.59 43.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 117.534 0.667 . . . . 0.0 110.454 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.722 ' HE2' ' HB3' ' A' ' 51' ' ' PRO . 65.4 mttm -79.71 101.5 8.45 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.678 -174.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -70.98 112.32 7.05 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.0 147.97 42.83 Favored 'General case' 0 N--CA 1.407 -2.593 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.161 -167.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.01 137.12 32.62 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.684 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.61 -14.11 62.66 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -171.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.36 -15.18 60.02 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.958 0.409 . . . . 0.0 110.321 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.61 24.82 3.91 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.317 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -112.44 105.81 14.15 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.95 0.405 . . . . 0.0 111.522 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -71.01 130.32 41.26 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.5 t -99.09 -70.46 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -160.05 152.01 20.34 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 15.6 tt0 -93.86 43.26 1.11 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.563 0.697 . . . . 0.0 110.789 -175.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.84 127.39 0.95 Allowed Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.407 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -89.91 -24.88 21.22 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 120.705 -0.398 . . . . 0.0 112.014 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.32 157.91 44.84 Favored 'General case' 0 N--CA 1.424 -1.741 0 O-C-N 121.883 -0.511 . . . . 0.0 111.471 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.42 131.62 37.8 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 42.7 Cg_endo -65.43 -9.87 23.96 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.911 2.407 . . . . 0.0 115.15 -172.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.3 mtm180 -75.85 -23.74 55.73 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -91.25 146.12 32.85 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 172.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -74.1 84.77 1.45 Allowed 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.021 1.814 . . . . 0.0 112.408 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -95.25 127.87 41.64 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.21 100.45 6.97 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.41 0.624 . . . . 0.0 109.812 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.6 m -107.14 -172.9 2.17 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.8 143.81 55.65 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 172.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -94.67 47.22 1.16 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -176.234 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -54.0 112.95 1.06 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 112.288 -2.233 . . . . 0.0 110.236 177.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.882 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 60.4 m -81.79 78.42 8.52 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 170.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 45.3 t0 -70.64 111.91 11.26 Favored Pre-proline 0 CA--C 1.51 -0.579 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.377 -169.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 16.6 Cg_exo -70.97 -18.37 31.38 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.976 2.451 . . . . 0.0 110.986 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -70.76 -23.89 62.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.514 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 7' ' ' CYS . 63.0 mt -95.76 125.62 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.87 -51.02 6.07 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -169.91 166.24 9.47 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.146 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.11 110.58 4.0 Favored Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -84.66 103.95 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 64.1 m -79.07 116.38 59.7 Favored Pre-proline 0 C--N 1.288 -2.076 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.722 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 37.3 Cg_endo -63.23 125.51 15.9 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.35 2.7 . . . . 0.0 114.992 -171.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 9.1 tpp180 -144.27 35.17 1.2 Allowed 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 171.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.428 -1.566 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.994 -178.412 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 CA--C 1.511 -0.545 0 N-CA-C 110.636 -0.135 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? 54.93 -116.51 1.06 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.989 1.316 . . . . 0.0 114.034 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.8 tp -82.82 123.73 38.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 121.527 0.68 . . . . 0.0 110.288 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 71.6 m -99.2 56.62 1.03 Allowed 'General case' 0 N--CA 1.422 -1.87 0 CA-C-O 121.93 0.871 . . . . 0.0 111.763 -177.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.8 147.13 23.4 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.7 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -134.25 146.6 50.22 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.524 ' HB2' HD11 ' A' ' 45' ' ' ILE . 8.0 t -101.61 -4.17 27.08 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.033 0.444 . . . . 0.0 110.063 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.1 t -60.41 -54.45 45.5 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.31 -83.31 0.28 Allowed 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.44 175.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . 67.55 173.21 6.54 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.005 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.56 111.76 24.59 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 122.019 -0.695 . . . . 0.0 109.911 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.411 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 1.2 tmmt? -47.46 127.24 10.86 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.315 0.646 . . . . 0.0 110.35 176.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.94 -32.42 6.0 Favored Glycine 0 N--CA 1.436 -1.303 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.7 m -94.35 128.32 40.8 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.652 ' HG2' ' HG2' ' A' ' 26' ' ' GLU . 43.0 mtmt -88.76 112.11 22.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.547 ' HD2' HG21 ' A' ' 45' ' ' ILE . 81.8 m-85 -74.38 114.36 12.66 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.165 0.983 . . . . 0.0 109.279 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.05 147.51 38.74 Favored 'General case' 0 N--CA 1.407 -2.588 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.443 -167.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.453 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 43.1 t -89.0 141.97 28.03 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.955 -1.475 . . . . 0.0 109.014 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -72.89 -8.23 54.61 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.232 0.613 . . . . 0.0 112.335 -174.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.5 -3.37 57.56 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.76 43.47 3.11 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.353 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.453 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 13.6 m -131.24 123.38 28.28 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 122.514 -0.404 . . . . 0.0 110.952 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.664 ' HZ ' ' HG3' ' A' ' 26' ' ' GLU . 52.2 t80 -81.42 129.04 34.48 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.5 t -95.17 -67.62 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.99 174.48 4.72 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.664 ' HG3' ' HZ ' ' A' ' 23' ' ' PHE . 32.3 mt-10 -102.35 157.75 16.68 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.2 132.18 45.36 Favored Glycine 0 C--O 1.242 0.625 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -100.47 -27.48 13.42 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.064 0.459 . . . . 0.0 110.568 -175.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.493 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 47.6 m -80.94 128.12 33.33 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 122.355 1.074 . . . . 0.0 112.926 -176.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.87 138.67 13.14 Favored Pre-proline 0 C--N 1.293 -1.879 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -13.2 -51.89 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.247 1 C-N-CA 127.735 5.623 . . . . 0.0 119.31 -175.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.522 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 6.2 tpp180 -63.37 -44.95 93.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.506 0.594 . . . . 0.0 111.275 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 29' ' ' SER . 6.5 p30 -92.8 107.56 25.34 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-O 121.593 0.711 . . . . 0.0 111.22 176.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 32' ' ' ARG . 65.5 Cg_endo -94.35 67.49 0.34 Allowed 'Trans proline' 0 N--CA 1.443 -1.488 0 C-N-CA 123.117 2.544 . . . . 0.0 110.273 175.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.415 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 55.2 mtpt -74.94 92.36 2.57 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.889 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.64 82.77 7.88 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.6 m -79.64 159.37 26.77 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.869 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.18 175.37 1.66 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.138 0.575 . . . . 0.0 112.102 -175.85 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.559 ' H ' HG22 ' A' ' 38' ' ' THR . 3.3 mm? -86.75 37.85 0.77 Allowed 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.393 1.077 . . . . 0.0 110.193 -171.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -61.88 119.06 8.07 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.649 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 24.3 m -96.83 104.01 15.98 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -96.5 104.45 17.86 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.614 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 5.2 Cg_exo -76.85 -3.59 13.96 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 123.483 2.789 . . . . 0.0 111.983 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -77.86 -10.84 59.77 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.547 HG21 ' HD2' ' A' ' 16' ' ' TYR . 83.3 mt -102.43 130.45 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.171 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.37 -40.58 9.86 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -176.75 174.01 1.87 Allowed 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.75 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.77 114.0 4.89 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.8 t -79.63 100.69 4.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 121.338 0.589 . . . . 0.0 109.89 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.6 m -97.82 150.15 36.47 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 173.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 11.4 Cg_exo -72.11 67.7 3.32 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.825 2.35 . . . . 0.0 111.869 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -79.83 131.8 35.97 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.157 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.279 -2.485 0 CA-C-O 118.549 -0.739 . . . . 0.0 109.051 -178.839 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 C--O 1.243 0.741 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.78 71.25 0.33 Allowed 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 123.965 0.906 . . . . 0.0 110.847 -177.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -69.09 92.93 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.935 0.874 . . . . 0.0 109.645 177.118 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.815 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 60.5 m -128.59 37.01 4.18 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-O 122.333 1.063 . . . . 0.0 109.684 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.412 HG21 ' HA ' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -81.91 151.7 27.14 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-N 113.788 -1.551 . . . . 0.0 108.704 176.832 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -150.45 175.67 11.65 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.7 t -70.49 -30.09 66.79 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 118.149 0.431 . . . . 0.0 111.809 -174.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 4.4 t -76.09 -41.33 50.71 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.368 -0.832 . . . . 0.0 109.837 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.3 46.24 0.25 Allowed 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.636 ' HA3' ' HE1' ' A' ' 16' ' ' TYR . . . -140.37 -141.23 4.0 Favored Glycine 0 N--CA 1.431 -1.689 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.85 178.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.2 m -151.91 133.34 14.59 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 122.483 -0.422 . . . . 0.0 110.412 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.72 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 29.9 mmtt -50.52 121.89 6.36 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.348 1.059 . . . . 0.0 110.364 175.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.403 ' O ' ' HE3' ' A' ' 15' ' ' LYS . . . 119.57 -34.11 4.37 Favored Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.477 -178.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.2 m -92.85 132.06 37.33 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.589 ' HD3' ' HG2' ' A' ' 26' ' ' GLU . 10.3 mmtp -87.04 117.68 25.92 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -177.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.636 ' HE1' ' HA3' ' A' ' 10' ' ' GLY . 66.0 m-85 -70.18 120.36 15.75 Favored 'General case' 0 CA--C 1.479 -1.777 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -134.57 147.58 50.29 Favored 'General case' 0 N--CA 1.399 -3.017 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.331 -168.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.482 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 12.1 t -93.11 131.96 37.68 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.93 -10.45 53.42 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -170.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.25 -1.9 54.29 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.948 0.404 . . . . 0.0 110.956 176.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.62 59.21 0.75 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.711 175.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.482 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 18.9 m -146.8 133.09 19.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 O-C-N 122.484 -0.421 . . . . 0.0 110.426 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.401 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 82.8 t80 -83.92 120.32 25.95 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 174.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.446 HG11 HG12 ' A' ' 45' ' ' ILE . 31.9 t -93.56 -51.14 11.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-O 120.699 0.285 . . . . 0.0 110.553 -177.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.4 p -169.85 165.32 9.77 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.589 ' HG2' ' HD3' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -94.44 171.87 8.54 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 176.815 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.72 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -52.5 128.87 36.51 Favored Glycine 0 N--CA 1.45 -0.431 0 O-C-N 123.703 0.627 . . . . 0.0 114.138 -175.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -100.82 -18.18 16.54 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.963 0.411 . . . . 0.0 110.374 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 m -120.07 107.22 12.79 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -175.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -82.41 109.01 13.63 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 165.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.01 21.94 0.37 Allowed 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 123.49 2.793 . . . . 0.0 115.185 -170.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -83.12 -51.93 7.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -90.34 126.73 55.64 Favored Pre-proline 0 C--O 1.254 1.306 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.81 139.7 81.55 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.606 2.871 . . . . 0.0 113.681 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.39 152.4 27.49 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.53 83.67 1.9 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.032 0.444 . . . . 0.0 111.394 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 78.5 m -83.25 123.2 29.36 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.99 167.53 3.79 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.176 0.99 . . . . 0.0 112.882 -175.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.7 mt -94.4 34.86 1.25 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -61.8 119.55 8.98 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.643 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.815 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 2.7 m -80.27 104.25 10.69 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.046 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -100.48 100.99 13.45 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 19.5 Cg_exo -69.04 -4.56 13.79 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.695 2.93 . . . . 0.0 113.453 -177.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.9 ttp-105 -75.61 -23.92 56.47 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.446 HG12 HG11 ' A' ' 24' ' ' VAL . 66.5 mt -110.84 161.6 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.489 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.45 -57.2 2.3 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 173.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.412 ' HA ' HG21 ' A' ' 5' ' ' THR . 0.2 OUTLIER -162.86 179.09 7.86 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.0 178.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -100.5 116.58 5.62 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 177.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.6 t -104.18 122.97 57.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.043 0.449 . . . . 0.0 110.426 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.7 m -96.09 104.79 18.21 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 171.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 5.3 Cg_exo -73.97 -173.22 1.33 Allowed 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 122.982 2.455 . . . . 0.0 113.396 -174.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -78.64 -11.5 59.97 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.816 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.43 -1.43 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.389 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.3 tp . . . . . 0 CA--C 1.552 1.024 0 CA-C-O 122.95 1.357 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.872 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 96.6 m -111.38 33.7 4.54 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-O 122.004 0.907 . . . . 0.0 111.405 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -79.62 145.8 32.86 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.189 -1.369 . . . . 0.0 107.526 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -146.93 168.31 21.8 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -66.9 -28.3 68.2 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.4 t -68.32 -43.03 78.45 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.74 -2.5 23.63 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.328 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.42 161.75 54.33 Favored Glycine 0 N--CA 1.425 -2.093 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.576 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.1 m -116.32 122.55 45.22 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 122.528 0.331 . . . . 0.0 110.72 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 3.2 tttp -43.13 132.4 4.18 Favored 'General case' 0 C--O 1.247 0.973 0 C-N-CA 124.677 1.191 . . . . 0.0 111.464 175.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.98 -28.32 15.22 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.98 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.8 m -103.92 133.37 49.01 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 122.537 -0.39 . . . . 0.0 110.299 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 12.6 mptt -84.62 118.47 24.39 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.815 -177.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -88.56 105.97 18.0 Favored 'General case' 0 CA--C 1.492 -1.284 0 CA-C-O 123.2 1.476 . . . . 0.0 108.727 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -123.09 146.98 47.24 Favored 'General case' 0 C--N 1.269 -2.933 0 CA-C-N 111.959 -2.382 . . . . 0.0 111.589 -165.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 19.4 p -94.91 145.7 24.74 Favored 'General case' 0 N--CA 1.408 -2.531 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.587 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.2 -12.99 57.09 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.964 0.905 . . . . 0.0 112.911 -173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -71.53 -20.09 62.09 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.87 30.6 2.95 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.128 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.0 m -123.85 136.76 54.57 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.342 0.592 . . . . 0.0 112.494 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.457 ' CE1' ' HG3' ' A' ' 15' ' ' LYS . 62.2 t80 -79.95 115.19 19.39 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.6 t -85.75 -61.55 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.9 p -164.38 154.73 14.64 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.433 ' HG3' ' HD2' ' A' ' 15' ' ' LYS . 13.2 tt0 -89.65 155.53 19.17 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 174.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -54.55 113.13 3.18 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.592 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -83.37 -10.53 58.4 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.5 m -95.78 125.72 40.55 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-O 121.403 0.62 . . . . 0.0 110.338 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.71 134.66 37.06 Favored Pre-proline 0 C--N 1.293 -1.89 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.038 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.88 -8.21 17.28 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.074 2.516 . . . . 0.0 114.72 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -63.66 -46.66 84.58 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 117.839 0.29 . . . . 0.0 110.823 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -90.14 138.14 27.54 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.02 95.88 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.882 2.388 . . . . 0.0 110.727 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -88.92 118.94 28.99 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.077 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.8 78.48 1.72 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 96.8 m -79.16 169.16 18.58 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.859 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.422 ' HB ' ' OD1' ' A' ' 40' ' ' ASN . 0.3 OUTLIER -61.73 155.83 21.82 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.61 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.4 mt -94.77 40.87 1.09 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.907 0.861 . . . . 0.0 109.563 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.422 ' OD1' ' HB ' ' A' ' 38' ' ' THR . 8.4 m120 -62.47 122.57 16.07 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 113.793 -1.548 . . . . 0.0 109.307 175.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.872 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 5.2 m -81.26 112.04 18.21 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.186 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -111.09 85.09 4.97 Favored Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 24.4 Cg_exo -63.19 -19.89 69.66 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 123.614 2.876 . . . . 0.0 113.695 -171.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.487 ' O ' ' HB3' ' A' ' 18' ' ' SER . 3.4 tmm_? -73.36 -9.64 58.91 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.277 0.561 . . . . 0.0 110.486 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.5 mt -101.24 124.49 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 172.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.84 -59.09 1.93 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.643 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -157.36 163.66 38.38 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.469 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.06 127.75 9.2 Favored Glycine 0 N--CA 1.407 -3.292 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.2 t -105.77 103.37 15.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 14.0 m -85.1 152.48 58.7 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo . . . . . 0 C--N 1.364 1.372 0 C-N-CA 123.26 2.64 . . . . 0.0 112.6 -178.664 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 tt . . . . . 0 C--O 1.244 0.773 0 CA-C-O 121.594 0.711 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.93 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 22.2 m -119.73 43.21 2.71 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.613 ' HB ' HG23 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -90.74 163.81 14.35 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 170.29 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.689 ' HA ' ' HB3' ' A' ' 42' ' ' ASP . 7.9 p30 -151.42 136.13 17.15 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 119.116 0.871 . . . . 0.0 110.309 170.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 t -60.69 -34.51 74.45 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.277 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 t -74.45 -26.81 60.28 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.328 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.54 -54.39 4.59 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 18.76 -137.38 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 118.669 2.227 . . . . 0.0 118.669 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.569 ' H ' ' HE1' ' A' ' 16' ' ' TYR . 80.4 m -159.98 102.26 1.46 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.743 1.217 . . . . 0.0 109.789 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -46.75 128.11 10.38 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 125.136 1.375 . . . . 0.0 109.979 171.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.431 ' O ' ' HD2' ' A' ' 51' ' ' PRO . . . 111.49 -10.01 28.35 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 30.9 m -132.39 141.66 48.97 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.635 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 55.7 mmtt -82.56 131.02 35.22 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.569 ' HE1' ' H ' ' A' ' 11' ' ' THR . 12.3 m-85 -83.99 119.72 25.26 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.76 144.69 32.73 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.828 0.823 . . . . 0.0 112.369 -169.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.633 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 34.3 p -92.79 139.27 30.72 Favored 'General case' 0 N--CA 1.407 -2.623 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.017 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -62.74 -13.57 34.34 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -171.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -72.61 -15.16 61.74 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 120.833 0.349 . . . . 0.0 110.707 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.31 34.33 2.53 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.964 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.432 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 85.3 m -125.52 124.65 41.78 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.023 0.439 . . . . 0.0 110.88 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.635 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 69.0 t80 -76.97 132.61 39.11 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 175.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.9 t -106.18 -58.57 3.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.223 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.38 154.01 35.84 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.37 0.605 . . . . 0.0 112.46 -176.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -79.85 152.92 29.42 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.113 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.483 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -69.04 93.26 0.32 Allowed Glycine 0 N--CA 1.436 -1.308 0 O-C-N 123.927 0.767 . . . . 0.0 113.752 -175.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -100.25 -41.37 7.11 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 m -71.87 102.54 2.91 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -164.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -78.81 124.23 85.07 Favored Pre-proline 0 C--N 1.304 -1.394 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.794 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -87.9 1.9 6.65 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.911 2.407 . . . . 0.0 113.289 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -82.96 -46.59 12.73 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -86.23 156.85 57.0 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 173.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.71 55.8 4.98 Favored 'Trans proline' 0 C--O 1.246 0.91 0 C-N-CA 122.411 2.074 . . . . 0.0 113.426 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -88.75 97.28 11.05 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.415 0.626 . . . . 0.0 110.356 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.01 146.16 48.77 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.024 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.0 m -125.89 149.66 48.53 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.373 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.0 60.63 0.4 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.858 0.863 . . . . 0.0 112.271 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 tp -137.57 44.15 2.25 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 175.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -62.92 141.05 58.86 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 113.495 -1.684 . . . . 0.0 109.986 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.93 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 35.9 m 63.45 59.64 1.21 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.04 0.924 . . . . 0.0 110.328 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.689 ' HB3' ' HA ' ' A' ' 6' ' ' ASN . 61.3 t0 -82.8 109.43 16.64 Favored Pre-proline 0 C--N 1.312 -1.054 0 C-N-CA 125.45 1.5 . . . . 0.0 108.821 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 11.8 Cg_exo -69.68 -4.47 14.03 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 123.204 2.603 . . . . 0.0 113.616 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.633 ' O ' ' HB3' ' A' ' 18' ' ' SER . 1.6 mmp_? -85.17 -30.48 23.89 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.396 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.613 HG23 ' HB ' ' A' ' 5' ' ' THR . 7.3 tt -99.16 105.4 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.753 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.79 -42.71 23.87 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -167.54 176.44 6.51 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.919 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -109.07 124.74 7.45 Favored Glycine 0 C--N 1.285 -2.275 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.213 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.1 t -94.88 107.65 19.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 13.9 m -80.32 117.41 67.52 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.499 ' HG3' ' HE2' ' A' ' 15' ' ' LYS . 21.0 Cg_endo . . . . . 0 C--O 1.24 0.613 0 C-N-CA 123.117 2.544 . . . . 0.0 113.614 -175.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.45 HG13 ' H ' ' A' ' 5' ' ' THR . 8.7 tp . . . . . 0 N--CA 1.435 -1.186 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.8 m -115.11 20.66 14.83 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.45 ' H ' HG13 ' A' ' 3' ' ' ILE . 1.2 m -90.69 172.79 8.41 Favored 'General case' 0 C--N 1.273 -2.744 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.608 177.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.887 HD22 HD13 ' A' ' 39' ' ' LEU . 9.1 p30 -133.31 156.81 46.93 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.4 t -73.72 -35.59 65.11 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 123.791 0.836 . . . . 0.0 113.105 -174.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 45.7 t -59.5 -56.91 15.99 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.578 0.704 . . . . 0.0 109.801 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.611 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . . . -90.53 26.38 2.01 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.55 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.15 163.68 26.77 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.606 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -53.77 110.83 0.63 Allowed 'General case' 0 C--O 1.241 0.646 0 C-N-CA 125.708 1.603 . . . . 0.0 113.111 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 27.1 ttpp -55.02 112.96 1.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.215 1.006 . . . . 0.0 111.627 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.01 -26.51 10.45 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.17 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.9 m -87.15 122.09 30.48 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.411 ' HE3' ' HG3' ' A' ' 51' ' ' PRO . 65.2 mttt -77.8 113.16 15.4 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.764 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.616 ' HD2' HG21 ' A' ' 45' ' ' ILE . 60.5 m-85 -72.91 106.65 4.92 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.85 145.11 44.03 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.499 -1.682 . . . . 0.0 111.154 -167.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.486 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 4.9 p -92.87 145.57 24.29 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.556 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -64.45 -14.7 58.37 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -170.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.71 8.27 20.36 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.405 0.622 . . . . 0.0 110.444 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.27 28.37 9.87 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 115.522 -0.763 . . . . 0.0 114.251 171.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.486 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 5.3 m -115.74 114.14 24.4 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 118.007 0.903 . . . . 0.0 112.027 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -67.44 116.78 8.57 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 171.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.68 -47.29 16.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.1 p -178.59 -175.58 0.44 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -125.6 144.3 50.64 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -66.36 146.09 48.31 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -130.75 1.75 4.42 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.42 0.629 . . . . 0.0 111.035 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.7 m -121.46 169.39 10.69 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-O 121.974 0.892 . . . . 0.0 112.127 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.491 ' HB3' ' OD1' ' A' ' 33' ' ' ASN . 30.6 t70 -114.43 116.98 43.51 Favored Pre-proline 0 C--N 1.287 -2.132 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 173.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 19.6 Cg_exo -67.79 26.98 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 124.018 3.145 . . . . 0.0 115.334 -173.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -116.79 -32.58 5.08 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' A' ' 30' ' ' ASP . 3.0 p-10 -90.54 152.14 44.88 Favored Pre-proline 0 C--O 1.245 0.851 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.179 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.79 103.55 0.72 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.228 2.618 . . . . 0.0 112.815 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.18 114.18 19.94 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.57 64.63 4.5 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.552 0.691 . . . . 0.0 112.845 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.611 ' HB2' ' HB2' ' A' ' 9' ' ' ALA . 58.8 m -113.18 118.15 33.91 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 172.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.9 p -65.03 141.01 58.91 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 123.565 0.54 . . . . 0.0 111.226 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.887 HD13 HD22 ' A' ' 6' ' ' ASN . 4.1 mm? -79.54 -74.14 0.31 Allowed 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 60.7 7.65 1.49 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.408 1.483 . . . . 0.0 113.643 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 60.6 m 58.83 123.58 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 125.416 1.486 . . . . 0.0 111.789 -173.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -110.62 83.64 3.54 Favored Pre-proline 0 C--N 1.323 -0.579 0 O-C-N 121.115 -0.991 . . . . 0.0 109.547 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 23.4 Cg_exo -65.46 -14.09 43.13 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 123.616 2.877 . . . . 0.0 114.11 -172.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -73.71 -25.09 60.04 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.567 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.616 HG21 ' HD2' ' A' ' 16' ' ' TYR . 87.3 mt -82.56 144.33 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.06 -59.69 2.13 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.6 174.04 11.28 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.176 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.73 99.13 2.02 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.94 107.26 12.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.343 0.592 . . . . 0.0 110.876 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.7 m -85.73 136.86 36.36 Favored Pre-proline 0 C--N 1.291 -1.953 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 170.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 16.9 Cg_exo . . . . . 0 CA--C 1.539 0.734 0 C-N-CA 123.446 2.764 . . . . 0.0 113.52 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 tt . . . . . 0 N--CA 1.427 -1.591 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.464 ' HA ' ' CB ' ' A' ' 41' ' ' CYS 0.252 98.7 m -88.66 19.32 4.03 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -174.156 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.7 m -90.64 136.14 33.25 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 171.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.462 ' HA ' ' HB2' ' A' ' 42' ' ' ASP . 11.4 p30 -119.3 158.06 26.83 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.625 ' HB2' HD11 ' A' ' 45' ' ' ILE . 6.9 t -84.86 -17.25 38.56 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.287 -174.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.3 t -67.9 -46.1 72.57 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 35' ' ' LYS . . . -91.53 22.58 3.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.239 0.542 . . . . 0.0 109.593 173.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.71 152.91 37.81 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 115.738 -0.665 . . . . 0.0 114.75 -172.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 m -79.36 114.26 18.16 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 124.768 1.227 . . . . 0.0 110.277 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.615 ' HA ' ' O ' ' A' ' 26' ' ' GLU . 2.3 tmtp? -64.84 127.34 31.16 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.526 ' H ' ' HG2' ' A' ' 26' ' ' GLU . . . 113.48 -10.11 24.04 Favored Glycine 0 C--N 1.301 -1.372 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -176.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.5 m -105.75 127.54 53.15 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HA ' ' HE1' ' A' ' 23' ' ' PHE . 20.7 mmmt -84.84 94.02 8.63 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -178.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -72.51 111.22 7.49 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 175.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -140.91 151.69 44.44 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.794 -164.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.9 t -97.17 138.96 33.86 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.537 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.454 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 3.5 p30 -69.12 -3.59 13.99 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.732 0.813 . . . . 0.0 112.894 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.07 -8.88 59.0 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.765 176.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.45 25.05 6.48 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.93 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 m -122.02 114.91 21.6 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 122.565 -0.374 . . . . 0.0 111.662 -177.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.496 ' HZ ' ' HB2' ' A' ' 26' ' ' GLU . 73.6 t80 -73.34 130.8 40.95 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.91 -62.05 2.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.895 -175.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 p -162.73 155.51 19.34 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.615 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 20.0 tt0 -103.76 44.82 0.99 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.517 0.675 . . . . 0.0 110.461 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.89 -162.8 49.0 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.872 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -112.26 -69.74 0.85 Allowed 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 120.974 0.416 . . . . 0.0 109.988 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.4 m -144.56 -166.49 2.4 Favored 'General case' 0 N--CA 1.407 -2.62 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -177.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.48 133.74 59.28 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.66 1.54 0.39 Allowed 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 123.505 2.803 . . . . 0.0 115.205 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -61.39 -47.91 83.62 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -91.81 117.56 67.81 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 172.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -76.63 121.52 6.0 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 121.551 1.501 . . . . 0.0 111.081 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -86.93 116.21 24.84 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.59 113.16 20.11 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.376 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.6 m -141.96 -177.68 5.33 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.32 157.39 29.26 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 120.867 0.365 . . . . 0.0 110.616 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.49 32.92 1.9 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.898 0.856 . . . . 0.0 109.838 -175.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -78.14 136.16 37.8 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.188 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 19.6 m -76.27 123.48 25.97 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 6' ' ' ASN . 6.9 t0 -83.78 105.27 5.31 Favored Pre-proline 0 N--CA 1.468 0.454 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.699 -169.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 68.1 Cg_endo -83.45 1.72 8.8 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.929 2.419 . . . . 0.0 111.725 -174.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 ttp-105 -83.04 -20.55 34.78 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 7' ' ' CYS . 71.8 mt -108.02 152.64 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.491 -1.232 . . . . 0.0 109.018 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.26 -50.58 3.12 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 19' ' ' ASP . 15.9 p90 -159.16 175.54 13.33 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -114.62 112.16 2.71 Favored Glycine 0 N--CA 1.428 -1.894 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.339 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.537 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 56.2 t -82.29 106.29 13.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 85.7 m -105.67 99.29 20.89 Favored Pre-proline 0 C--N 1.298 -1.657 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.231 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 49' ' ' VAL . 3.6 Cg_exo . . . . . 0 N--CA 1.456 -0.703 0 C-N-CA 123.296 2.664 . . . . 0.0 109.594 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 tp . . . . . 0 CA--C 1.551 0.996 0 CA-C-O 122.911 1.339 . . . . 0.0 109.769 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.932 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.8 m -88.58 40.83 0.98 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.991 0.901 . . . . 0.0 112.282 -176.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -90.83 127.25 36.29 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 171.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -146.27 178.8 7.97 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.524 -0.871 . . . . 0.0 112.548 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -85.17 -32.93 22.44 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.6 t -66.1 -50.43 64.07 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.933 0.873 . . . . 0.0 108.976 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.37 33.25 0.9 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.527 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.23 136.11 13.06 Favored Glycine 0 N--CA 1.41 -3.076 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.781 HG22 ' HA ' ' A' ' 31' ' ' PRO . 7.2 p -83.85 111.46 19.24 Favored 'General case' 0 C--N 1.268 -2.955 0 CA-C-N 113.924 -1.138 . . . . 0.0 111.834 -175.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -45.79 115.57 1.0 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.704 0.802 . . . . 0.0 110.854 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.49 -36.59 2.53 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 m -95.52 134.71 38.05 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.532 ' HG3' ' HG3' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -88.42 119.96 29.34 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.441 ' HB3' HD13 ' A' ' 45' ' ' ILE . 67.7 m-85 -83.86 105.24 14.59 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 122.896 1.331 . . . . 0.0 108.142 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.586 ' HE1' ' HA2' ' A' ' 21' ' ' GLY . 0.5 OUTLIER -126.52 147.95 49.78 Favored 'General case' 0 N--CA 1.405 -2.684 0 CA-C-N 112.868 -1.969 . . . . 0.0 112.207 -164.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.7 142.58 29.31 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.113 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -58.18 -19.05 30.21 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.867 1.267 . . . . 0.0 114.208 -172.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.07 -8.03 59.17 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.131 0.491 . . . . 0.0 111.02 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.586 ' HA2' ' HE1' ' A' ' 17' ' ' PHE . . . 106.14 24.27 6.95 Favored Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.324 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.2 m -107.04 123.32 48.05 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.291 -0.563 . . . . 0.0 112.142 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -77.94 109.65 12.18 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.21 -52.09 15.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.9 p -174.46 169.54 3.71 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.532 ' HG3' ' HG3' ' A' ' 15' ' ' LYS . 15.8 tt0 -108.27 171.3 7.49 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.67 112.3 1.56 Allowed Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -83.08 -22.67 33.4 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.666 -0.267 . . . . 0.0 111.705 -172.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -130.36 -176.94 4.12 Favored 'General case' 0 N--CA 1.4 -2.962 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.472 -174.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -78.0 140.59 62.27 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.781 ' HA ' HG22 ' A' ' 11' ' ' THR . 1.0 OUTLIER -42.92 -27.07 0.8 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 124.922 3.748 . . . . 0.0 115.725 -179.501 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.475 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 19.5 mmt85 -122.64 46.09 2.23 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 118.409 0.549 . . . . 0.0 110.492 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -73.57 119.9 78.37 Favored Pre-proline 0 C--N 1.304 -1.382 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.525 175.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -87.25 94.21 0.48 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.787 2.324 . . . . 0.0 111.575 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -158.67 155.32 27.92 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.263 0.554 . . . . 0.0 111.478 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.16 131.53 45.13 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 173.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.2 m -115.28 135.51 54.07 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.208 0.528 . . . . 0.0 112.278 -174.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -18.26 62.9 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 123.573 0.749 . . . . 0.0 110.814 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 tp -86.33 25.31 1.21 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.099 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -53.67 121.09 7.13 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.937 176.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.932 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 14.9 m 67.36 86.58 0.13 Allowed 'General case' 0 C--N 1.321 -0.661 0 O-C-N 124.504 1.128 . . . . 0.0 111.421 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -96.28 104.5 17.6 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.49 3.87 6.83 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.782 2.321 . . . . 0.0 113.041 -172.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -90.41 -15.57 30.73 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.49 0.662 . . . . 0.0 109.331 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.441 HD13 ' HB3' ' A' ' 16' ' ' TYR . 93.2 mt -101.18 140.94 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.49 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.95 -54.35 3.49 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -167.23 173.3 9.11 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.423 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.43 121.23 7.14 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.5 t -94.14 114.09 30.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 123.021 0.529 . . . . 0.0 109.582 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.6 m -99.84 129.39 28.72 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 32.2 Cg_exo . . . . . 0 C--O 1.246 0.883 0 C-N-CA 123.324 2.683 . . . . 0.0 112.114 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.425 ' O ' ' HB3' ' A' ' 41' ' ' CYS . 6.1 tp . . . . . 0 N--CA 1.445 -0.682 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 69.4 m -113.6 40.37 2.42 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.97 0.891 . . . . 0.0 112.781 -173.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 t -90.82 165.81 13.43 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 172.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -160.17 175.86 12.43 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 118.435 0.561 . . . . 0.0 111.11 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.4 t -69.11 -21.2 64.06 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.563 0.745 . . . . 0.0 112.275 -174.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.3 t -91.03 -54.82 3.79 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.56 -0.713 . . . . 0.0 109.965 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.22 37.43 0.1 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.21 175.3 30.67 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 175.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 m -109.48 124.74 51.58 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 117.037 0.419 . . . . 0.0 111.251 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.565 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -54.36 122.58 10.71 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.9 175.152 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.56 -35.52 2.65 Favored Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -176.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.1 m -105.75 151.15 24.82 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -88.28 123.99 33.44 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.519 ' CZ ' ' HA2' ' A' ' 27' ' ' GLY . 1.2 m-30 -77.45 106.89 9.51 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.423 ' CE1' ' HA ' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -141.01 151.74 44.35 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.599 0.714 . . . . 0.0 112.77 -167.192 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.524 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 43.4 p -96.24 129.61 43.52 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 175.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.423 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 4.1 p-10 -62.64 -9.8 10.23 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -20.23 63.79 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.16 -0.19 6.51 Favored Glycine 0 N--CA 1.429 -1.812 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.404 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.524 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 3.8 m -97.45 118.07 33.12 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -76.56 121.77 23.65 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.466 HG21 HG12 ' A' ' 45' ' ' ILE . 23.5 t -95.53 -65.86 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.837 -176.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.56 155.75 43.81 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.964 0.412 . . . . 0.0 111.849 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.07 169.02 10.57 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -62.48 118.78 15.31 Favored Glycine 0 N--CA 1.439 -1.105 0 O-C-N 123.53 0.519 . . . . 0.0 113.306 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -131.24 1.52 4.19 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.01 0.433 . . . . 0.0 111.638 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.2 m -121.29 115.41 22.92 Favored 'General case' 0 N--CA 1.403 -2.779 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -114.12 140.83 25.42 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.74 -21.02 7.47 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.634 2.889 . . . . 0.0 114.958 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -90.94 -24.99 19.99 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.47 ' HA ' ' HD3' ' A' ' 34' ' ' PRO 0.254 28.5 p30 -91.4 115.28 64.12 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.344 0.592 . . . . 0.0 112.484 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 17.2 Cg_exo -65.43 111.74 1.93 Allowed 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 123.313 2.675 . . . . 0.0 111.573 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -139.45 120.29 14.39 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.61 92.92 7.23 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.525 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.6 m -88.7 165.66 14.6 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.804 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.08 149.68 42.93 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.952 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -95.88 33.22 1.72 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.13 147.19 40.73 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.995 -1.457 . . . . 0.0 111.443 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 35.0 m -106.99 93.77 4.74 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.532 ' OD1' ' HB3' ' A' ' 44' ' ' ARG . 9.9 t70 -80.65 103.2 1.66 Allowed Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 123.871 0.868 . . . . 0.0 110.572 -175.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 52.6 Cg_endo -72.79 -7.12 20.25 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.637 2.225 . . . . 0.0 112.464 -174.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.532 ' HB3' ' OD1' ' A' ' 42' ' ' ASP . 16.9 ttp180 -82.81 -45.94 13.69 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.466 HG12 HG21 ' A' ' 24' ' ' VAL . 79.6 mt -79.72 128.95 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 CA-C-O 121.538 0.685 . . . . 0.0 109.965 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.05 -55.41 3.95 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.898 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -171.38 171.24 5.62 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.03 117.06 4.93 Favored Glycine 0 N--CA 1.423 -2.199 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.7 t -93.08 117.32 36.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.35 0.595 . . . . 0.0 111.419 -176.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.3 m -105.73 102.34 37.89 Favored Pre-proline 0 C--N 1.285 -2.198 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 171.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo . . . . . 0 C--N 1.367 1.527 0 C-N-CA 125.092 3.861 . . . . 0.0 114.513 -174.737 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.472 HG13 ' OG1' ' A' ' 5' ' ' THR . 6.5 tp . . . . . 0 N--CA 1.428 -1.543 0 CA-C-O 121.624 0.726 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 19.3 m -136.38 47.16 2.22 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 121.972 0.892 . . . . 0.0 110.3 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.472 ' OG1' HG13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -72.17 160.41 32.49 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.961 178.153 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -158.93 149.25 19.56 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 t -105.79 18.36 22.27 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.357 0.598 . . . . 0.0 112.048 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 t -85.84 -46.01 11.02 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.541 ' HA ' ' OG ' ' A' ' 29' ' ' SER . . . -91.05 -100.01 0.11 Allowed 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.386 173.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.62 -140.3 28.98 Favored Glycine 0 N--CA 1.414 -2.779 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.563 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 m -154.0 119.3 5.12 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.563 ' HD3' ' HB2' ' A' ' 30' ' ' ASP . 15.0 ttpt -57.26 127.05 30.0 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 123.704 0.627 . . . . 0.0 110.613 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.19 -12.83 65.2 Favored Glycine 0 C--N 1.304 -1.201 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.391 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.9 m -99.06 128.65 45.24 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -80.13 92.2 5.63 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.988 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.595 ' HD2' HG21 ' A' ' 45' ' ' ILE . 27.9 m-85 -71.21 115.5 10.44 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.418 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -146.5 151.64 37.71 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.009 -161.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.3 t -86.86 137.19 32.61 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.427 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -57.98 -22.45 49.45 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.6 -18.61 60.54 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.181 0.515 . . . . 0.0 110.888 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.418 ' HA2' ' CE2' ' A' ' 17' ' ' PHE . . . 118.65 20.29 4.26 Favored Glycine 0 N--CA 1.425 -2.076 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.404 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 m -104.8 108.33 19.75 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 117.312 0.556 . . . . 0.0 110.173 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.497 ' CZ ' ' HG3' ' A' ' 26' ' ' GLU . 75.1 t80 -68.92 137.15 53.57 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.6 t -108.23 -64.56 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.713 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.3 p -163.35 155.34 17.69 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 18.3 mt-10 -97.52 39.19 1.21 Allowed 'General case' 0 C--O 1.242 0.676 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -175.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.21 127.74 0.27 Allowed Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.446 -0.797 . . . . 0.0 114.165 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -105.4 27.81 7.97 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 122.377 -0.484 . . . . 0.0 111.036 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.541 ' OG ' ' HA ' ' A' ' 9' ' ' ALA . 4.3 m -141.74 109.1 5.56 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.563 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 21.0 t70 -96.18 130.45 31.08 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 167.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -59.44 50.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.511 2.51 0 C-N-CA 124.859 3.706 . . . . 0.0 116.189 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -128.56 -56.12 1.22 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -90.5 130.06 42.81 Favored Pre-proline 0 N--CA 1.442 -0.85 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 175.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.28 147.75 11.5 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.258 1.972 . . . . 0.0 110.853 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.527 ' HB3' ' SG ' ' A' ' 37' ' ' CYS . 27.6 mmtp -120.28 89.7 3.18 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.477 0.656 . . . . 0.0 109.893 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.99 59.51 5.67 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.178 0.99 . . . . 0.0 110.041 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 35' ' ' LYS . 3.4 m -88.46 -178.79 5.94 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.808 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.48 137.49 36.47 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 174.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.9 tp -89.1 43.72 1.16 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.377 1.084 . . . . 0.0 110.105 -174.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -53.17 122.54 9.67 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 112.837 -1.983 . . . . 0.0 110.926 172.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.528 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 34.8 m -71.94 108.67 5.31 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 175.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -104.88 91.57 4.44 Favored Pre-proline 0 C--N 1.31 -1.123 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 22.9 Cg_exo -64.66 -17.2 58.78 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 124.43 3.42 . . . . 0.0 114.818 -172.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.4 ttp-105 -59.68 -23.65 63.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.564 0.697 . . . . 0.0 110.139 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.595 HG21 ' HD2' ' A' ' 16' ' ' TYR . 95.1 mt -103.82 122.27 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.73 -46.56 8.52 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.143 -177.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -161.09 175.15 12.72 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.965 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -109.59 111.78 3.24 Favored Glycine 0 N--CA 1.415 -2.754 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.7 t -86.31 98.68 7.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.7 m -87.74 157.49 52.03 Favored Pre-proline 0 C--N 1.285 -2.212 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo . . . . . 0 CA--C 1.532 0.376 0 C-N-CA 122.636 2.224 . . . . 0.0 109.709 175.921 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 tp . . . . . 0 N--CA 1.426 -1.669 0 CA-C-O 121.949 0.881 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.53 ' HA ' ' CB ' ' A' ' 41' ' ' CYS . 90.8 m -96.36 25.65 4.86 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 122.218 1.008 . . . . 0.0 112.317 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.7 m -90.82 141.94 28.28 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 173.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -136.84 167.15 22.02 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.97 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.505 ' HA ' ' CD2' ' A' ' 16' ' ' TYR . 6.4 t -70.95 -34.57 71.59 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 123.447 0.699 . . . . 0.0 112.695 -171.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -77.89 -36.43 49.69 Favored 'General case' 0 N--CA 1.424 -1.754 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.767 -177.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.58 34.28 0.32 Allowed 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.482 0.658 . . . . 0.0 111.09 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.532 ' HA3' ' HE2' ' A' ' 16' ' ' TYR . . . -119.29 168.75 13.49 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.36 143.25 30.77 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 116.929 0.365 . . . . 0.0 111.009 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -50.81 138.66 18.26 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.694 172.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.91 -33.08 6.66 Favored Glycine 0 C--N 1.3 -1.456 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 64.0 m -99.11 138.83 35.65 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.739 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 37.0 mtmt -110.94 127.76 55.59 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -175.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.532 ' HE2' ' HA3' ' A' ' 10' ' ' GLY . 28.6 m-85 -76.47 128.28 34.48 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.335 0.588 . . . . 0.0 110.443 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -148.07 147.05 29.13 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.162 -171.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.559 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 31.5 p -97.74 144.22 27.58 Favored 'General case' 0 N--CA 1.407 -2.588 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.889 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.0 -11.47 57.1 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.737 0.815 . . . . 0.0 113.14 -170.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -74.1 -14.12 60.93 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.68 48.74 1.25 Allowed Glycine 0 N--CA 1.427 -1.962 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.559 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 84.9 m -134.68 121.61 21.06 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.077 0.465 . . . . 0.0 110.803 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.739 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 78.1 t80 -69.67 120.23 15.12 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.3 t -89.57 -53.22 9.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.327 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.4 p -172.33 164.87 5.85 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.986 0.422 . . . . 0.0 110.458 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -88.87 146.05 25.19 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 123.765 0.826 . . . . 0.0 109.265 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.61 109.65 2.49 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.476 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 1.1 mm-40 -101.49 23.49 11.03 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 10' ' ' GLY . 5.5 m -113.32 102.7 10.59 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-O 121.285 0.564 . . . . 0.0 111.779 176.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.552 ' HB3' ' ND2' ' A' ' 33' ' ' ASN . 4.6 t70 -113.98 138.7 22.94 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 173.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.34 -19.83 5.06 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.981 3.121 . . . . 0.0 115.549 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -86.88 -37.75 17.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.91 -0.494 . . . . 0.0 111.345 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.552 ' ND2' ' HB3' ' A' ' 30' ' ' ASP . 14.9 p30 -90.44 116.9 67.44 Favored Pre-proline 0 C--N 1.317 -0.834 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.094 -177.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -80.85 117.91 3.35 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.237 1.958 . . . . 0.0 109.208 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 28' ' ' GLU . 25.5 mmtm -109.36 139.89 43.75 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -171.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.55 125.05 30.04 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 166.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.0 m -128.94 150.47 50.36 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.785 -170.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 t -68.06 140.88 56.3 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 29.3 mt -106.85 -10.46 16.03 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.07 0.462 . . . . 0.0 110.833 -172.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -110.92 163.95 13.29 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.348 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.53 ' CB ' ' HA ' ' A' ' 4' ' ' CYS . 2.7 m -45.28 135.33 5.95 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 126.082 1.753 . . . . 0.0 112.596 -177.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -119.85 88.98 41.17 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.4 2.79 2.08 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 123.884 3.056 . . . . 0.0 115.214 -172.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -76.0 -24.54 55.32 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.865 0.84 . . . . 0.0 108.856 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.3 mt -95.89 149.47 4.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.023 -175.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.88 -53.01 2.84 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.42 170.7 18.33 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.883 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -102.45 98.17 1.66 Allowed Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.4 t -79.69 109.2 14.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.292 0.568 . . . . 0.0 109.882 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 3.4 m -80.66 115.08 52.97 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 106.131 -1.804 . . . . 0.0 106.131 173.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.623 ' HG3' ' HE2' ' A' ' 15' ' ' LYS . 24.5 Cg_exo . . . . . 0 C--O 1.24 0.615 0 C-N-CA 123.365 2.71 . . . . 0.0 114.169 -171.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 tt . . . . . 0 CA--C 1.543 0.705 0 CA-C-O 122.793 1.282 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.823 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 78.2 m -124.37 43.66 2.95 Favored 'General case' 0 N--CA 1.406 -2.631 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.918 -175.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.453 ' HB ' HG23 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -77.97 148.64 34.36 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 173.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -128.61 142.97 50.87 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 118.871 -1.131 . . . . 0.0 113.501 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.7 t -98.97 13.03 34.16 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.321 1.057 . . . . 0.0 108.619 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.7 t -85.92 -70.39 0.6 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.773 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.1 -71.5 0.64 Allowed 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.33 -159.62 53.76 Favored Glycine 0 N--CA 1.415 -2.714 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.604 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 m -122.08 98.17 5.81 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.753 ' HE3' ' HB2' ' A' ' 30' ' ' ASP . 0.5 OUTLIER -40.18 122.22 1.49 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.031 0.932 . . . . 0.0 112.103 175.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.02 -42.01 1.92 Allowed Glycine 0 N--CA 1.435 -1.414 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.601 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 70.0 m -89.42 147.43 24.04 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.557 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 18.4 mtpp -97.36 116.19 29.1 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -175.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.82 ' HB3' HG13 ' A' ' 45' ' ' ILE . 10.9 m-85 -77.61 115.94 17.77 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.025 0.917 . . . . 0.0 108.85 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.448 ' HE2' ' HA2' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -135.67 149.05 49.16 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.498 -166.09 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.81 134.06 37.84 Favored 'General case' 0 N--CA 1.41 -2.466 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.42 -20.45 19.74 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -169.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -76.03 -13.77 60.22 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.907 0.385 . . . . 0.0 111.669 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.448 ' HA2' ' HE2' ' A' ' 17' ' ' PHE . . . 114.8 19.11 6.16 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.054 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.6 m -104.53 110.2 22.39 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.837 0.351 . . . . 0.0 110.86 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.557 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 50.3 t80 -73.14 126.14 29.34 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.1 t -96.34 -61.14 2.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 120.842 0.353 . . . . 0.0 110.328 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.4 p -161.63 160.07 28.32 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -176.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -97.3 145.46 26.08 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 174.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -46.65 122.09 6.31 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 124.165 0.916 . . . . 0.0 112.133 -178.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.56 -52.75 6.54 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.898 0.38 . . . . 0.0 111.13 -173.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.7 m -102.69 145.16 30.11 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-O 121.684 0.754 . . . . 0.0 111.963 -170.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.753 ' HB2' ' HE3' ' A' ' 12' ' ' LYS . 11.3 t70 -87.91 139.07 30.9 Favored Pre-proline 0 C--N 1.288 -2.077 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 172.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -49.79 -20.18 4.42 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.233 2.622 . . . . 0.0 114.512 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -83.23 -21.59 33.35 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.28 2.8 p-10 -90.58 118.86 69.02 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.823 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -75.27 73.51 4.45 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 123.637 2.892 . . . . 0.0 116.161 -170.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -130.37 49.91 2.25 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 122.551 1.167 . . . . 0.0 109.639 170.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.47 123.26 27.38 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.439 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.3 m -81.49 171.11 15.1 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.382 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 m -50.18 -64.76 0.71 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.85 -53.6 0.09 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 59.91 79.33 0.24 Allowed 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 124.578 1.174 . . . . 0.0 111.88 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.823 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 61.7 m -81.18 89.8 6.03 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 173.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.598 ' HB3' HG22 ' A' ' 45' ' ' ILE . 7.0 t0 -91.3 108.58 29.79 Favored Pre-proline 0 C--N 1.306 -1.283 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.544 -170.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -71.44 -5.59 17.36 Favored 'Trans proline' 0 C--O 1.24 0.594 0 C-N-CA 123.184 2.589 . . . . 0.0 112.424 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.577 ' HD3' ' OD1' ' A' ' 42' ' ' ASP . 25.8 mtp180 -75.26 -36.59 61.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.025 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.82 HG13 ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -108.98 136.66 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 CA-C-O 121.752 0.787 . . . . 0.0 112.943 -171.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.7 -60.53 1.68 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.387 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -153.75 165.22 36.69 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.012 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.41 114.56 5.05 Favored Glycine 0 C--N 1.29 -2.003 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t -92.85 114.12 29.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 14.7 m -79.67 137.43 54.8 Favored Pre-proline 0 C--N 1.284 -2.25 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 176.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo . . . . . 0 CA--C 1.54 0.821 0 C-N-CA 124.278 3.318 . . . . 0.0 114.466 -175.652 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 tp . . . . . 0 CA--C 1.539 0.555 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 1.015 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 69.3 m -101.47 34.39 2.61 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-O 122.206 1.003 . . . . 0.0 113.18 -173.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.8 m -91.34 147.07 23.3 Favored 'General case' 0 N--CA 1.408 -2.525 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.444 ' HA ' HD12 ' A' ' 45' ' ' ILE . 8.7 t-20 -159.01 -172.64 3.87 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.487 ' O ' ' HA3' ' A' ' 27' ' ' GLY . 1.1 t -74.14 -30.5 62.31 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 122.055 0.931 . . . . 0.0 108.925 -175.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.532 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 34.3 t -80.32 -44.28 19.79 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.972 176.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.415 ' HB3' ' H ' ' A' ' 6' ' ' ASN . . . -72.27 49.43 0.2 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.471 1.108 . . . . 0.0 113.375 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' HA3' ' HE1' ' A' ' 16' ' ' TYR . . . -151.86 -121.52 0.94 Allowed Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.335 -0.936 . . . . 0.0 111.322 176.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 29' ' ' SER . 7.7 m -159.9 138.17 10.29 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 27' ' ' GLY . 14.9 mtpp -57.4 130.71 47.5 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.72 -32.66 6.24 Favored Glycine 0 C--N 1.291 -1.95 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -174.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.3 m -80.81 123.94 28.66 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 121.1 0.476 . . . . 0.0 109.838 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.686 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 62.0 mttm -87.34 109.91 19.87 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.507 ' HE2' ' H ' ' A' ' 27' ' ' GLY . 51.5 m-85 -71.7 125.68 27.76 Favored 'General case' 0 CA--C 1.472 -2.056 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.48 146.16 32.28 Favored 'General case' 0 N--CA 1.393 -3.314 0 CA-C-N 114.385 -1.28 . . . . 0.0 111.541 -167.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.649 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 28.1 t -93.62 130.47 39.52 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.09 -17.12 50.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.101 0.96 . . . . 0.0 113.038 -172.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.72 -10.19 59.43 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.988 0.423 . . . . 0.0 110.387 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.08 6.05 16.65 Favored Glycine 0 N--CA 1.432 -1.612 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.96 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.649 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 8.5 m -90.95 122.66 33.82 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 117.046 0.423 . . . . 0.0 111.694 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.686 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 72.3 t80 -79.04 138.53 38.03 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 174.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.5 HG21 HG12 ' A' ' 45' ' ' ILE . 59.8 t -108.58 -64.51 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.532 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 p -173.02 168.27 4.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.646 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -112.54 117.47 32.44 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 170.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.605 ' O ' ' HG2' ' A' ' 12' ' ' LYS . . . -79.17 176.29 54.76 Favored Glycine 0 C--N 1.296 -1.657 0 N-CA-C 115.351 0.9 . . . . 0.0 115.351 -169.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -103.21 29.02 5.82 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 123.365 0.666 . . . . 0.0 110.96 -176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.413 ' HB3' ' HA ' ' A' ' 11' ' ' THR . 10.0 t -81.94 72.11 8.98 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 122.335 1.064 . . . . 0.0 109.084 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.69 140.33 31.5 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.119 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -35.46 -44.7 0.65 Allowed 'Trans proline' 0 CA--C 1.548 1.196 0 C-N-CA 124.791 3.661 . . . . 0.0 115.892 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.72 9.46 37.13 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -174.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.42 158.07 43.79 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -83.41 85.29 1.53 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.261 1.974 . . . . 0.0 111.072 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.12 55.01 3.14 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 122.143 0.973 . . . . 0.0 111.86 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.32 83.51 1.77 Allowed 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.951 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.2 m -109.99 123.74 50.18 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.387 -175.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.08 46.36 1.38 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.211 0.529 . . . . 0.0 111.359 -175.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.32 23.19 0.48 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.532 ' OD1' ' HB3' ' A' ' 8' ' ' CYS . 37.2 m-20 -90.21 57.14 3.63 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -167.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 1.015 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 71.0 m -148.29 74.34 1.28 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 173.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -92.82 112.94 58.14 Favored Pre-proline 0 CA--C 1.515 -0.394 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.54 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.76 -11.69 28.05 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 123.053 2.502 . . . . 0.0 113.862 -174.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.9 ptt-85 -90.7 -12.44 36.68 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.55 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.5 HG12 HG21 ' A' ' 24' ' ' VAL . 85.1 mt -97.82 138.0 23.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.82 -59.61 1.7 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.374 0.607 . . . . 0.0 109.622 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.35 161.51 41.04 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -95.51 106.75 3.43 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.3 t -86.91 107.43 16.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.433 0.635 . . . . 0.0 110.931 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.465 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.6 m -92.43 124.12 60.2 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 173.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 2.6 Cg_exo . . . . . 0 N--CA 1.457 -0.637 0 C-N-CA 123.086 2.524 . . . . 0.0 113.291 -175.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.742 HG12 ' HA ' ' A' ' 43' ' ' PRO . 7.1 tp . . . . . 0 CA--C 1.567 1.605 0 CA-C-O 122.832 1.301 . . . . 0.0 113.072 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.453 ' HA ' ' CB ' ' A' ' 41' ' ' CYS . 3.3 m -102.45 32.55 3.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.238 1.018 . . . . 0.0 111.162 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.93 162.85 17.46 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 113.921 -1.491 . . . . 0.0 108.222 176.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -132.42 156.58 46.45 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.208 0.528 . . . . 0.0 110.3 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 t -85.09 -16.13 41.64 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 124.263 1.025 . . . . 0.0 112.407 -173.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 8.4 t -90.86 -66.61 0.91 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.594 -1.242 . . . . 0.0 113.788 -175.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.05 48.9 0.42 Allowed 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -167.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.2 -95.13 2.38 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 174.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.4 m -163.78 132.17 3.69 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 123.957 0.903 . . . . 0.0 109.088 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.931 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 19.8 pttp -64.34 143.05 58.18 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.48 -35.47 4.79 Favored Glycine 0 C--N 1.297 -1.619 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.504 -175.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.4 m -80.49 146.33 31.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.704 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 2.1 mmpt? -97.19 113.89 25.54 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.686 ' HB3' HG13 ' A' ' 45' ' ' ILE . 90.6 m-85 -71.28 117.6 13.01 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.544 ' CE2' ' HA ' ' A' ' 22' ' ' THR . 16.0 t80 -122.73 144.5 49.12 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-O 122.193 0.997 . . . . 0.0 113.138 -163.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.467 ' HB2' ' CG2' ' A' ' 24' ' ' VAL . 6.4 t -97.19 123.3 40.92 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -30.9 71.24 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -174.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -107.06 18.81 21.28 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.252 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -162.7 20.21 0.17 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 118.815 -1.66 . . . . 0.0 115.715 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.544 ' HA ' ' CE2' ' A' ' 17' ' ' PHE . 0.4 OUTLIER 55.91 -170.42 0.08 Allowed 'General case' 0 CA--C 1.587 2.387 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 177.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.704 ' HD1' ' HB3' ' A' ' 15' ' ' LYS . 72.9 t80 -39.79 126.06 1.92 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.253 1.421 . . . . 0.0 113.103 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 18' ' ' SER . 40.2 t -106.49 -58.68 3.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.694 177.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 p -147.28 165.41 30.2 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.416 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 15.7 tt0 -111.21 165.08 12.22 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -178.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.931 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -51.85 134.87 35.17 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 115.976 1.15 . . . . 0.0 115.976 -176.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -123.52 8.85 8.98 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 122.404 1.097 . . . . 0.0 108.946 176.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.2 m -100.98 101.41 12.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.135 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -108.27 143.95 28.46 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.61 -29.0 77.58 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.504 2.136 . . . . 0.0 114.298 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -98.11 -41.67 7.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.503 0.192 . . . . 0.0 111.287 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -57.8 139.3 82.33 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -174.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -67.57 134.8 34.07 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.371 2.047 . . . . 0.0 109.561 175.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.421 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 4.8 ptpp? -123.51 111.13 15.92 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -173.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.45 81.53 1.56 Allowed 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 172.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 91.4 m -99.62 143.15 30.19 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -172.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.26 115.75 10.77 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 171.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mp -111.2 36.23 3.27 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.55 0.691 . . . . 0.0 110.138 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -92.98 158.98 15.52 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.753 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.453 ' CB ' ' HA ' ' A' ' 4' ' ' CYS . 33.6 m -67.01 105.35 1.62 Allowed 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.78 ' HB3' HG22 ' A' ' 45' ' ' ILE . 12.7 t70 -97.73 110.78 56.76 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.199 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.742 ' HA ' HG12 ' A' ' 3' ' ' ILE . 24.7 Cg_exo -63.56 -9.82 19.6 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.787 2.992 . . . . 0.0 114.854 -176.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.68 -34.97 15.2 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.675 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.78 HG22 ' HB3' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -87.59 100.26 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 122.001 0.905 . . . . 0.0 110.98 -176.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.86 -39.54 30.38 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.545 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -170.65 172.52 5.8 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.21 123.16 7.78 Favored Glycine 0 C--N 1.288 -2.138 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.0 t -96.32 100.83 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 73.1 m -80.94 153.66 72.57 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 16.9 Cg_exo . . . . . 0 C--N 1.35 0.614 0 C-N-CA 123.348 2.698 . . . . 0.0 113.269 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 CA--C 1.552 1.039 0 CA-C-O 123.37 1.557 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.0 m -92.61 57.28 2.88 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.985 -178.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.566 ' HB ' HG23 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -90.65 -178.67 5.35 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 173.225 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -156.48 142.83 18.33 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 174.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.5 t -61.0 -46.66 89.87 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 123.758 0.661 . . . . 0.0 111.611 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.512 ' HA ' ' HB3' ' A' ' 28' ' ' GLU . 34.2 t -67.89 -51.16 51.18 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.885 -176.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.13 36.94 0.19 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.605 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . -109.35 170.66 14.6 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 176.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -74.77 122.47 23.35 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 117.008 0.404 . . . . 0.0 110.621 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.772 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -57.41 144.49 36.16 Favored 'General case' 0 C--O 1.241 0.606 0 O-C-N 121.902 -0.499 . . . . 0.0 110.048 173.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.08 -26.32 19.61 Favored Glycine 0 C--N 1.305 -1.171 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.5 m -91.28 130.92 37.09 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -84.13 103.67 13.53 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.575 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 17.0 m-85 -61.07 122.45 15.02 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.527 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -148.84 149.99 32.24 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.744 -167.214 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.619 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 33.6 t -89.88 133.61 34.66 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -47.46 -33.12 5.79 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.812 1.645 . . . . 0.0 114.155 -174.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -68.77 -19.71 64.33 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.527 ' HA2' ' CE2' ' A' ' 17' ' ' PHE . . . 122.61 18.79 3.22 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.326 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.619 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 69.1 m -103.5 125.49 50.09 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 117.197 0.498 . . . . 0.0 111.302 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -78.2 137.74 38.3 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.435 HG21 ' HA ' ' A' ' 45' ' ' ILE . 21.7 t -111.29 -56.07 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.128 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.8 177.99 7.53 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.022 0.529 . . . . 0.0 109.687 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -147.51 103.9 3.58 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 118.776 0.716 . . . . 0.0 112.14 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.772 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . 73.55 84.98 0.26 Allowed Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.979 177.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 59.2 mm-40 -111.32 -37.38 5.3 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.605 ' HB2' ' O ' ' A' ' 10' ' ' GLY . 3.8 m -105.6 107.48 18.49 Favored 'General case' 0 C--O 1.248 0.992 0 O-C-N 121.877 -0.514 . . . . 0.0 111.331 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -139.88 129.82 13.92 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.73 77.83 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.212 0 C-N-CA 123.004 2.47 . . . . 0.0 114.402 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.448 ' CZ ' ' HB2' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -141.46 -56.96 0.48 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 173.263 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 1.2 p-10 -82.25 126.3 74.7 Favored Pre-proline 0 N--CA 1.432 -1.351 0 CA-C-O 121.37 0.605 . . . . 0.0 109.832 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 11.5 Cg_exo -70.37 166.26 28.96 Favored 'Trans proline' 0 C--O 1.253 1.271 0 C-N-CA 123.234 2.623 . . . . 0.0 111.534 175.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.778 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER 83.09 142.69 0.07 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.311 1.844 . . . . 0.0 111.677 -179.439 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.3 157.75 17.5 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.3 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 24.0 m -85.88 164.4 17.51 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 t -65.66 156.51 32.68 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.309 0.576 . . . . 0.0 110.87 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.68 6.95 45.51 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.368 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -58.06 127.94 34.62 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.978 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 33.0 m -64.21 123.16 18.39 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.456 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -112.34 95.92 33.29 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -72.33 8.82 1.34 Allowed 'Trans proline' 0 N--CA 1.485 0.994 0 C-N-CA 123.267 2.645 . . . . 0.0 113.969 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.5 ttp-105 -90.45 -34.96 15.4 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.566 HG23 ' HB ' ' A' ' 5' ' ' THR . 1.6 tt -94.8 121.13 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.2 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.79 -47.66 8.45 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -167.76 169.3 11.79 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.694 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -97.03 120.35 6.68 Favored Glycine 0 C--N 1.284 -2.334 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.7 t -92.43 107.45 19.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 121.327 0.584 . . . . 0.0 110.364 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.74 153.87 64.59 Favored Pre-proline 0 C--N 1.296 -1.744 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo . . . . . 0 C--N 1.359 1.087 0 C-N-CA 123.457 2.771 . . . . 0.0 113.231 -178.684 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.402 HG12 ' HA ' ' A' ' 43' ' ' PRO . 6.4 tp . . . . . 0 N--CA 1.442 -0.831 0 CA-C-O 121.758 0.79 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.898 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 6.7 m -126.11 47.95 2.18 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-O 121.667 0.746 . . . . 0.0 112.876 -175.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.551 HG21 ' HA ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -90.24 116.33 28.14 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 172.156 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.428 HD21 ' HB3' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -126.5 156.53 40.6 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -178.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.507 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 45.0 t -88.72 -47.18 8.43 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -172.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.4 t -61.38 -53.93 50.2 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.262 0.553 . . . . 0.0 111.35 -174.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.428 ' HB3' HD21 ' A' ' 6' ' ' ASN . . . -90.48 24.83 2.46 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.588 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' CE1' ' A' ' 16' ' ' TYR . . . -90.77 149.97 20.35 Favored Glycine 0 N--CA 1.431 -1.671 0 C-N-CA 120.096 -1.05 . . . . 0.0 110.876 177.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.37 117.98 5.45 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 123.477 0.711 . . . . 0.0 111.48 -176.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.728 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 40.2 ttmt -53.31 107.46 0.24 Allowed 'General case' 0 C--O 1.238 0.49 0 O-C-N 123.882 0.738 . . . . 0.0 112.777 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.54 -30.8 3.07 Favored Glycine 0 C--N 1.303 -1.274 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.1 m -86.26 121.86 29.43 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 63.7 mmtt -80.75 108.1 14.12 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.588 ' HD2' HG21 ' A' ' 45' ' ' ILE . 43.1 m-85 -71.25 109.94 5.59 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.02 151.22 50.6 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.567 -165.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.455 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 6.3 t -87.87 129.55 35.18 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.08 -9.18 20.36 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -168.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -79.61 -10.17 59.75 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 122.997 0.519 . . . . 0.0 111.1 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.89 33.11 2.47 Favored Glycine 0 C--N 1.315 -0.611 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.2 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 52.5 m -124.94 106.45 9.98 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 121.021 0.439 . . . . 0.0 110.788 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 58.2 t80 -70.91 124.14 23.64 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.528 176.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.03 -64.72 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.9 p -170.73 157.74 5.75 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 30.6 tt0 -85.24 138.86 32.07 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.728 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -63.57 135.15 41.69 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 176.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.404 ' HG3' ' HE2' ' A' ' 12' ' ' LYS . 7.6 tt0 -126.48 34.96 4.72 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.792 -175.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 t -82.96 113.37 20.5 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -104.35 133.41 20.22 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -53.57 -14.94 5.58 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.616 2.877 . . . . 0.0 114.442 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -103.07 -27.08 12.79 Favored 'General case' 0 N--CA 1.441 -0.895 0 O-C-N 121.622 -0.674 . . . . 0.0 111.693 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -91.14 137.42 26.4 Favored Pre-proline 0 C--O 1.239 0.552 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -172.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -82.6 124.08 3.96 Favored 'Trans proline' 0 N--CA 1.442 -1.548 0 C-N-CA 122.461 2.108 . . . . 0.0 110.038 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.9 138.25 47.53 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.656 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.5 93.3 3.9 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.451 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.9 m -142.67 167.2 22.65 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.9 138.11 54.39 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.4 47.65 1.97 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.806 0.812 . . . . 0.0 109.958 -176.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -97.83 18.89 14.75 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.321 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.898 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 55.7 m 65.23 156.72 0.09 Allowed 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 125.701 1.6 . . . . 0.0 112.124 177.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -122.52 112.31 31.14 Favored Pre-proline 0 N--CA 1.466 0.357 0 O-C-N 120.411 -1.431 . . . . 0.0 113.127 -178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.402 ' HA ' HG12 ' A' ' 3' ' ' ILE . 59.4 Cg_endo -73.68 -2.88 12.83 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.975 2.45 . . . . 0.0 113.941 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -85.6 -21.75 28.34 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.4 0.619 . . . . 0.0 109.673 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.588 HG21 ' HD2' ' A' ' 16' ' ' TYR . 95.3 mt -95.73 132.47 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.083 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.09 -55.67 3.65 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.692 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.551 ' HA ' HG21 ' A' ' 5' ' ' THR . 2.2 p90 -164.77 164.8 21.08 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.767 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -92.95 111.58 4.12 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.2 t -87.81 115.92 29.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 120.996 0.427 . . . . 0.0 110.3 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -96.16 105.14 20.02 Favored Pre-proline 0 C--N 1.293 -1.856 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo . . . . . 0 C--N 1.35 0.629 0 C-N-CA 123.202 2.601 . . . . 0.0 112.079 -175.764 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.7 tp . . . . . 0 N--CA 1.438 -1.058 0 CA-C-O 123.154 1.454 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.966 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.7 m -83.98 48.02 1.4 Allowed 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -176.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -91.17 164.12 14.02 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.53 ' HB3' HD23 ' A' ' 39' ' ' LEU . 1.1 t-20 -160.49 152.37 20.0 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.008 0.822 . . . . 0.0 111.811 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.8 t -67.8 -44.35 77.53 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.583 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 46.5 t -59.0 -52.22 66.68 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.163 0.506 . . . . 0.0 109.715 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.519 ' HB2' ' H ' ' A' ' 37' ' ' CYS . . . -86.16 25.58 1.15 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.783 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.51 156.11 22.48 Favored Glycine 0 N--CA 1.423 -2.193 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.911 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.2 m -83.01 109.41 17.08 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 123.008 0.523 . . . . 0.0 111.704 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -47.38 141.11 5.07 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.639 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.73 -44.11 1.56 Allowed Glycine 0 C--N 1.303 -1.298 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.3 m -103.23 140.43 37.39 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.775 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 69.8 mttt -100.01 129.39 46.06 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 121.392 0.615 . . . . 0.0 110.432 -173.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.428 ' HB3' ' CG1' ' A' ' 45' ' ' ILE . 48.7 m-85 -84.14 132.14 34.71 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.241 -176.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.46 148.45 37.76 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.227 -168.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.596 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 29.6 t -91.5 141.14 29.06 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.211 -1.358 . . . . 0.0 109.442 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.2 -14.4 60.55 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.796 1.239 . . . . 0.0 112.388 -176.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.29 -6.65 59.24 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.106 0.479 . . . . 0.0 110.527 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.71 34.17 3.61 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.505 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.596 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 25.2 m -118.75 120.03 36.17 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.261 -178.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.775 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 47.7 t80 -74.91 128.91 36.7 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -98.54 -71.71 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.504 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -172.11 165.96 6.12 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -178.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.769 ' HG3' ' HG2' ' A' ' 15' ' ' LYS . 12.0 tt0 -85.35 158.63 20.21 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.19 127.73 29.7 Favored Glycine 0 C--O 1.238 0.367 0 O-C-N 123.602 0.564 . . . . 0.0 112.905 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 8' ' ' CYS . 4.4 mm-40 -79.76 -22.69 42.9 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.494 0.188 . . . . 0.0 111.315 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.3 m -95.89 128.62 42.93 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-O 121.088 0.47 . . . . 0.0 110.047 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -79.53 124.41 83.85 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.43 82.62 0.1 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.488 2.792 . . . . 0.0 112.944 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 mmm180 -146.17 -70.44 0.25 Allowed 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -90.44 151.7 44.6 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.82 66.27 5.86 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.62 2.214 . . . . 0.0 111.781 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -80.38 130.6 35.28 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.145 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -131.76 160.88 34.26 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.285 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.519 ' H ' ' HB2' ' A' ' 9' ' ' ALA . 59.8 m -137.53 166.56 23.58 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.6 m -59.28 110.51 1.09 Allowed 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.53 HD23 ' HB3' ' A' ' 6' ' ' ASN . 12.8 mt -79.39 -62.54 1.66 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.554 -175.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 56.34 31.53 18.82 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.026 0.93 . . . . 0.0 111.253 -177.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.966 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 68.4 m 49.29 76.83 0.12 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.064 -177.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.497 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 6.7 t0 -53.27 112.74 3.9 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 123.869 0.868 . . . . 0.0 111.357 -174.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 10.9 Cg_exo -71.35 -11.31 28.42 Favored 'Trans proline' 0 C--O 1.242 0.695 0 C-N-CA 123.0 2.466 . . . . 0.0 112.828 -176.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.753 ' HA ' ' HE ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -91.41 -14.13 31.15 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.513 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.428 ' CG1' ' HB3' ' A' ' 16' ' ' TYR . 1.7 mp -108.85 124.24 65.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.155 0.503 . . . . 0.0 110.765 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.07 -47.76 5.11 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -164.47 166.21 20.7 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.715 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.11 130.5 10.34 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.2 t -109.54 115.88 50.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.474 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 25.6 m -82.05 141.19 46.67 Favored Pre-proline 0 C--N 1.288 -2.071 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 12.6 Cg_exo . . . . . 0 CA--C 1.54 0.783 0 C-N-CA 123.65 2.9 . . . . 0.0 114.01 -174.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' A' ' 43' ' ' PRO . 6.7 tp . . . . . 0 CA--C 1.547 0.838 0 CA-C-O 122.297 1.046 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.753 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 1.8 m -121.64 22.27 10.62 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 122.015 0.912 . . . . 0.0 111.727 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.37 144.08 26.15 Favored 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.77 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -126.06 151.8 46.67 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 17.2 t -86.59 -16.37 36.97 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 123.743 0.817 . . . . 0.0 111.346 -173.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.0 t -66.31 -43.97 84.72 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.93 0.871 . . . . 0.0 108.764 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . . . -90.9 -102.39 0.1 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.483 172.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.48 -151.16 48.97 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-O 121.521 0.512 . . . . 0.0 113.813 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.814 HG23 ' HD3' ' A' ' 31' ' ' PRO . 95.0 m -143.88 110.96 5.75 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 122.679 0.392 . . . . 0.0 110.189 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' A' ' 27' ' ' GLY . 17.0 ttmt -51.34 116.52 2.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.136 176.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.59 -38.25 1.59 Allowed Glycine 0 N--CA 1.418 -2.544 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.2 m -106.56 112.43 25.43 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.492 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 37.0 mttp -87.47 113.24 23.0 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.755 -175.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -65.79 123.44 19.76 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.174 -177.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -125.06 152.79 43.85 Favored 'General case' 0 N--CA 1.407 -2.605 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.314 -166.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.767 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 1.0 OUTLIER -105.7 127.04 52.83 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 113.221 -1.809 . . . . 0.0 106.325 179.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.7 -14.34 20.33 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -167.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.6 -18.14 60.61 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.266 175.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.91 3.12 6.45 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.032 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.767 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 97.7 m -83.13 117.18 22.71 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.97 0.414 . . . . 0.0 111.674 -177.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.492 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 20.4 t80 -76.08 119.14 19.61 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 169.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.408 HG11 ' NH2' ' A' ' 44' ' ' ARG . 18.0 t -87.39 -63.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.497 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 p -169.14 172.58 7.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.866 0.365 . . . . 0.0 111.206 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -97.1 150.52 20.75 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.445 ' O ' ' HE3' ' A' ' 12' ' ' LYS . . . -62.61 118.59 14.69 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -79.91 3.02 21.19 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -175.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.4 m -121.38 141.22 51.17 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-O 121.601 0.715 . . . . 0.0 110.53 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -99.0 145.29 29.73 Favored Pre-proline 0 C--N 1.285 -2.237 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.814 ' HD3' HG23 ' A' ' 11' ' ' THR . 6.6 Cg_endo -50.53 -19.78 5.34 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.37 2.713 . . . . 0.0 115.071 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.472 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 0.8 OUTLIER -82.24 -25.62 33.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.52 138.48 25.31 Favored Pre-proline 0 C--N 1.319 -0.723 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.767 177.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -86.34 -164.18 0.21 Allowed 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.759 2.306 . . . . 0.0 111.195 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt 73.62 164.57 0.28 Allowed 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 125.37 1.468 . . . . 0.0 112.833 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . . . -155.58 143.28 19.69 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 178.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 55.7 m -79.85 125.19 29.39 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.42 79.44 0.26 Allowed 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 124.079 0.952 . . . . 0.0 112.249 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.6 tp -100.34 -18.91 16.56 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.884 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 65.63 55.12 1.03 Allowed 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 124.389 1.076 . . . . 0.0 110.19 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.753 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 20.7 m 74.78 138.04 0.06 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 125.686 1.594 . . . . 0.0 110.744 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -107.52 91.71 7.49 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.508 ' HA ' HG23 ' A' ' 3' ' ' ILE . 3.5 Cg_exo -77.25 0.67 9.51 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 123.117 2.545 . . . . 0.0 112.325 -175.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.408 ' NH2' HG11 ' A' ' 24' ' ' VAL . 15.3 ttp-105 -85.63 -19.13 31.44 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 74.1 mt -82.42 141.01 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.61 -57.96 2.32 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.433 0.635 . . . . 0.0 109.47 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -160.34 170.7 20.52 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.201 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.03 125.39 8.56 Favored Glycine 0 C--N 1.291 -1.92 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.7 t -95.95 106.19 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 m -93.96 111.9 54.93 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 177.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 C--O 1.236 0.409 0 C-N-CA 123.177 2.584 . . . . 0.0 112.225 -177.372 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.983 ' HB ' ' HA ' ' A' ' 43' ' ' PRO . 37.5 mm . . . . . 0 N--CA 1.428 -1.565 0 CA-C-O 121.293 0.568 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.6 m -97.32 32.33 2.25 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 122.284 1.04 . . . . 0.0 112.526 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.489 ' HB ' HG23 ' A' ' 45' ' ' ILE . 3.6 m -81.44 140.95 34.35 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 171.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -133.13 148.23 52.11 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.305 -174.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.7 t -83.77 -28.02 28.46 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.564 1.145 . . . . 0.0 110.815 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.1 t -62.94 -59.99 4.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.421 0.629 . . . . 0.0 110.828 -175.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.82 47.86 1.39 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.254 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.8 ' HA3' ' HE1' ' A' ' 16' ' ' TYR . . . -93.04 -110.07 1.95 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.73 175.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.9 m -162.86 127.65 3.11 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 123.857 0.863 . . . . 0.0 108.746 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 1.074 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -64.24 128.95 38.0 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.917 174.313 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.93 -26.42 11.56 Favored Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 m -89.68 127.53 35.94 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.533 ' HG2' ' HG3' ' A' ' 26' ' ' GLU . 43.9 mtpt -86.11 114.61 23.1 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.8 ' HE1' ' HA3' ' A' ' 10' ' ' GLY . 57.3 m-85 -72.85 111.95 8.44 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 178.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.563 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -134.94 147.74 49.85 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.871 -166.307 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 21.6 p -97.13 148.17 23.32 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.556 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -62.97 -16.7 60.48 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.663 1.185 . . . . 0.0 113.218 -172.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -77.6 -12.01 59.92 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.382 0.61 . . . . 0.0 109.72 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.563 ' HA2' ' CE2' ' A' ' 17' ' ' PHE . . . 101.59 40.93 2.63 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.393 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.449 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 41.6 m -127.26 131.92 50.46 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.612 0.72 . . . . 0.0 111.93 -178.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.612 ' HE1' ' HB2' ' A' ' 26' ' ' GLU . 78.1 t80 -72.51 130.24 40.18 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.245 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 t -106.07 -49.08 8.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 120.911 0.386 . . . . 0.0 109.993 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.1 p -164.77 174.39 10.73 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.612 ' HB2' ' HE1' ' A' ' 23' ' ' PHE . 2.2 tm-20 -153.51 140.78 19.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.834 0.743 . . . . 0.0 111.636 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 1.074 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . 57.27 55.57 29.66 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 116.684 1.433 . . . . 0.0 116.684 171.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -81.58 -44.98 16.52 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.605 0.716 . . . . 0.0 109.614 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.21 78.32 8.85 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.609 -174.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.653 ' HA ' ' HG2' ' A' ' 12' ' ' LYS . 18.8 t0 -89.69 129.29 47.31 Favored Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -64.28 51.19 0.18 Allowed 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 123.921 3.081 . . . . 0.0 113.721 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -147.18 -45.52 0.17 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 125.294 1.437 . . . . 0.0 107.721 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -84.26 124.38 74.01 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -86.88 106.36 0.69 Allowed 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.737 2.292 . . . . 0.0 110.333 173.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 mtmm -115.36 102.83 10.21 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.25 98.9 6.82 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.28 0.562 . . . . 0.0 110.106 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.4 m -114.77 124.69 52.41 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.37 -42.28 71.98 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.0 -175.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.5 tp -158.98 -64.82 0.08 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 m120 61.2 49.29 5.61 Favored 'General case' 0 C--O 1.245 0.867 0 O-C-N 124.197 0.936 . . . . 0.0 112.148 176.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 84.9 m -57.98 120.96 9.46 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.534 ' HB3' HG22 ' A' ' 45' ' ' ILE . 2.2 t70 -116.21 100.51 53.55 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -177.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.983 ' HA ' ' HB ' ' A' ' 3' ' ' ILE . 44.2 Cg_endo -68.74 -6.48 18.04 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.858 2.372 . . . . 0.0 113.97 -174.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.49 ' O ' ' HB3' ' A' ' 18' ' ' SER . 0.7 OUTLIER -90.55 -25.4 20.24 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 111.755 0.279 . . . . 0.0 111.755 -178.572 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.534 HG22 ' HB3' ' A' ' 42' ' ' ASP . 3.8 tt -88.39 147.13 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 121.411 0.624 . . . . 0.0 111.07 -177.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.91 -50.92 4.03 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.77 175.24 4.0 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.234 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.33 121.69 6.82 Favored Glycine 0 N--CA 1.429 -1.825 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.6 t -104.3 103.82 15.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.033 0.444 . . . . 0.0 110.446 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 17.3 m -79.89 112.67 31.69 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 170.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo . . . . . 0 C--N 1.354 0.859 0 C-N-CA 124.29 3.327 . . . . 0.0 114.272 -171.733 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.45 ' O ' ' HB3' ' A' ' 41' ' ' CYS . 19.3 tt . . . . . 0 CA--C 1.546 0.791 0 CA-C-O 122.207 1.003 . . . . 0.0 112.458 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 97.0 m -128.65 40.36 3.66 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.811 0.815 . . . . 0.0 110.792 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.432 HG21 ' HA ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -62.75 133.67 55.13 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.765 176.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -144.84 148.69 34.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.083 0.468 . . . . 0.0 110.164 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 t -75.22 -25.84 58.46 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.839 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.1 t -59.48 -56.06 26.71 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.361 0.601 . . . . 0.0 109.448 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . . . -90.74 23.29 3.15 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.309 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.62 141.85 31.44 Favored Glycine 0 N--CA 1.424 -2.132 0 C-N-CA 120.34 -0.933 . . . . 0.0 111.932 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.0 m -75.4 117.1 16.83 Favored 'General case' 0 C--N 1.273 -2.737 0 O-C-N 123.886 0.404 . . . . 0.0 111.451 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.412 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 34.9 ttmt -53.03 120.63 6.1 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.51 0.724 . . . . 0.0 109.129 175.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.92 -31.27 6.16 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 11.8 m -91.0 126.82 36.2 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -90.09 109.39 20.44 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.6 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 18.8 m-85 -71.54 115.16 10.4 Favored 'General case' 0 CA--C 1.484 -1.569 0 CA-C-O 121.875 0.845 . . . . 0.0 109.287 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.461 ' HE1' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -133.81 145.19 49.52 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 113.281 -1.781 . . . . 0.0 111.612 -167.227 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.518 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 53.4 p -98.22 148.16 23.89 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -13.16 44.16 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -173.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.7 -0.99 40.75 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.213 0.53 . . . . 0.0 110.453 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.461 ' HA2' ' HE1' ' A' ' 17' ' ' PHE . . . 92.94 36.22 6.11 Favored Glycine 0 N--CA 1.43 -1.735 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.039 176.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.518 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 90.7 m -122.11 121.5 37.06 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.759 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -73.29 124.37 25.57 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.506 HG21 HG12 ' A' ' 45' ' ' ILE . 34.3 t -96.2 -60.76 2.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.515 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.8 p -161.95 161.05 28.49 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.675 -0.41 . . . . 0.0 112.074 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -81.45 149.31 28.83 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 174.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.5 127.38 45.05 Favored Glycine 0 CA--C 1.524 0.64 0 O-C-N 123.587 0.554 . . . . 0.0 113.046 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -83.53 -21.0 32.85 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.6 m -100.86 131.01 46.95 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 121.266 0.555 . . . . 0.0 111.609 -176.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.816 ' HB3' ' HB3' ' A' ' 33' ' ' ASN . 25.1 t70 -79.72 140.23 54.84 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 12' ' ' LYS . 78.2 Cg_exo -56.01 -12.41 7.22 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.286 2.657 . . . . 0.0 114.374 179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -121.6 7.98 10.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 122.329 0.252 . . . . 0.0 111.325 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.816 ' HB3' ' HB3' ' A' ' 30' ' ' ASP . 2.4 p-10 -90.58 138.16 26.86 Favored Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.729 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -76.46 121.37 5.99 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.706 1.604 . . . . 0.0 108.686 171.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.7 pttm -128.84 162.46 27.43 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 120.822 0.344 . . . . 0.0 111.552 -173.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.41 45.62 1.73 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.103 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 9' ' ' ALA . 89.6 m -79.54 148.67 31.7 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.7 t -79.69 -175.7 4.97 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.488 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.51 39.95 1.88 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.339 0.656 . . . . 0.0 110.269 -175.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -66.08 106.21 1.56 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.156 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 3.3 m -73.08 112.59 9.26 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.447 -178.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -92.6 101.13 4.6 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 3.0 Cg_exo -74.22 -3.53 13.96 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 123.144 2.563 . . . . 0.0 112.526 -174.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -87.8 -34.59 18.23 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.172 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.506 HG12 HG21 ' A' ' 24' ' ' VAL . 79.4 mt -87.05 142.28 13.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.23 -65.46 1.0 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.432 ' HA ' HG21 ' A' ' 5' ' ' THR . 0.5 OUTLIER -161.02 169.17 23.05 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.077 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -96.11 103.51 2.96 Favored Glycine 0 N--CA 1.429 -1.799 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.497 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 71.4 t -79.9 113.75 19.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 1.6 m -85.69 102.87 2.92 Favored Pre-proline 0 C--N 1.308 -1.231 0 C-N-CA 122.988 0.515 . . . . 0.0 109.636 175.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 49' ' ' VAL . 9.5 Cg_endo . . . . . 0 N--CA 1.441 -1.56 0 C-N-CA 123.0 2.467 . . . . 0.0 111.567 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.7 tp . . . . . 0 CA--C 1.544 0.743 0 CA-C-O 122.148 0.975 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.882 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 22.4 m -105.26 29.36 6.49 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 122.227 1.013 . . . . 0.0 110.874 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -90.31 135.79 33.46 Favored 'General case' 0 N--CA 1.399 -2.981 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.393 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -126.25 154.75 42.92 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.582 ' HB2' HD11 ' A' ' 45' ' ' ILE . 17.5 t -88.81 -11.58 44.44 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.002 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.0 t -60.8 -49.43 77.5 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 120.91 0.386 . . . . 0.0 109.968 -178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.46 -87.34 0.17 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.06 -144.28 32.19 Favored Glycine 0 N--CA 1.438 -1.192 0 O-C-N 124.093 0.871 . . . . 0.0 114.182 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.5 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 4.6 t -147.06 115.44 6.66 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-O 120.951 0.405 . . . . 0.0 110.219 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -47.58 111.09 0.38 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.267 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.0 -35.31 2.32 Favored Glycine 0 N--CA 1.422 -2.292 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.362 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.4 m -96.9 131.59 43.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 117.534 0.667 . . . . 0.0 110.454 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.722 ' HE2' ' HB3' ' A' ' 51' ' ' PRO . 65.4 mttm -79.71 101.5 8.45 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.678 -174.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -70.98 112.32 7.05 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.0 147.97 42.83 Favored 'General case' 0 N--CA 1.407 -2.593 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.161 -167.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.01 137.12 32.62 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.684 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.61 -14.11 62.66 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -171.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.36 -15.18 60.02 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.958 0.409 . . . . 0.0 110.321 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.61 24.82 3.91 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.317 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -112.44 105.81 14.15 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.95 0.405 . . . . 0.0 111.522 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -71.01 130.32 41.26 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.5 t -99.09 -70.46 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -160.05 152.01 20.34 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 15.6 tt0 -93.86 43.26 1.11 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.563 0.697 . . . . 0.0 110.789 -175.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.84 127.39 0.95 Allowed Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.407 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -89.91 -24.88 21.22 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 120.705 -0.398 . . . . 0.0 112.014 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.32 157.91 44.84 Favored 'General case' 0 N--CA 1.424 -1.741 0 O-C-N 121.883 -0.511 . . . . 0.0 111.471 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.42 131.62 37.8 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 42.7 Cg_endo -65.43 -9.87 23.96 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.911 2.407 . . . . 0.0 115.15 -172.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.3 mtm180 -75.85 -23.74 55.73 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -91.25 146.12 32.85 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 172.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -74.1 84.77 1.45 Allowed 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.021 1.814 . . . . 0.0 112.408 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -95.25 127.87 41.64 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.21 100.45 6.97 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.41 0.624 . . . . 0.0 109.812 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.6 m -107.14 -172.9 2.17 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.8 143.81 55.65 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 172.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -94.67 47.22 1.16 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -176.234 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -54.0 112.95 1.06 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 112.288 -2.233 . . . . 0.0 110.236 177.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.882 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 60.4 m -81.79 78.42 8.52 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 170.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 45.3 t0 -70.64 111.91 11.26 Favored Pre-proline 0 CA--C 1.51 -0.579 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.377 -169.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 16.6 Cg_exo -70.97 -18.37 31.38 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.976 2.451 . . . . 0.0 110.986 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -70.76 -23.89 62.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.514 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 7' ' ' CYS . 63.0 mt -95.76 125.62 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.87 -51.02 6.07 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -169.91 166.24 9.47 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.146 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.11 110.58 4.0 Favored Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -84.66 103.95 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 64.1 m -79.07 116.38 59.7 Favored Pre-proline 0 C--N 1.288 -2.076 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.722 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 37.3 Cg_endo . . . . . 0 N--CA 1.455 -0.787 0 C-N-CA 123.35 2.7 . . . . 0.0 114.992 -171.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.8 tp . . . . . 0 N--CA 1.436 -1.148 0 CA-C-O 121.527 0.68 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 71.6 m -99.2 56.62 1.03 Allowed 'General case' 0 N--CA 1.422 -1.87 0 CA-C-O 121.93 0.871 . . . . 0.0 111.763 -177.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.8 147.13 23.4 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.7 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -134.25 146.6 50.22 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.524 ' HB2' HD11 ' A' ' 45' ' ' ILE . 8.0 t -101.61 -4.17 27.08 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.033 0.444 . . . . 0.0 110.063 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.1 t -60.41 -54.45 45.5 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.31 -83.31 0.28 Allowed 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.44 175.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . 67.55 173.21 6.54 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.005 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.56 111.76 24.59 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 122.019 -0.695 . . . . 0.0 109.911 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.411 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 1.2 tmmt? -47.46 127.24 10.86 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.315 0.646 . . . . 0.0 110.35 176.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.94 -32.42 6.0 Favored Glycine 0 N--CA 1.436 -1.303 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.7 m -94.35 128.32 40.8 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.652 ' HG2' ' HG2' ' A' ' 26' ' ' GLU . 43.0 mtmt -88.76 112.11 22.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.547 ' HD2' HG21 ' A' ' 45' ' ' ILE . 81.8 m-85 -74.38 114.36 12.66 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.165 0.983 . . . . 0.0 109.279 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.05 147.51 38.74 Favored 'General case' 0 N--CA 1.407 -2.588 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.443 -167.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.453 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 43.1 t -89.0 141.97 28.03 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.955 -1.475 . . . . 0.0 109.014 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -72.89 -8.23 54.61 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.232 0.613 . . . . 0.0 112.335 -174.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.5 -3.37 57.56 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.76 43.47 3.11 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.353 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.453 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 13.6 m -131.24 123.38 28.28 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 122.514 -0.404 . . . . 0.0 110.952 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.664 ' HZ ' ' HG3' ' A' ' 26' ' ' GLU . 52.2 t80 -81.42 129.04 34.48 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.5 t -95.17 -67.62 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.99 174.48 4.72 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.664 ' HG3' ' HZ ' ' A' ' 23' ' ' PHE . 32.3 mt-10 -102.35 157.75 16.68 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.2 132.18 45.36 Favored Glycine 0 C--O 1.242 0.625 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -100.47 -27.48 13.42 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.064 0.459 . . . . 0.0 110.568 -175.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.493 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 47.6 m -80.94 128.12 33.33 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 122.355 1.074 . . . . 0.0 112.926 -176.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.87 138.67 13.14 Favored Pre-proline 0 C--N 1.293 -1.879 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -13.2 -51.89 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.247 1 C-N-CA 127.735 5.623 . . . . 0.0 119.31 -175.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.522 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 6.2 tpp180 -63.37 -44.95 93.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.506 0.594 . . . . 0.0 111.275 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 29' ' ' SER . 6.5 p30 -92.8 107.56 25.34 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-O 121.593 0.711 . . . . 0.0 111.22 176.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 32' ' ' ARG . 65.5 Cg_endo -94.35 67.49 0.34 Allowed 'Trans proline' 0 N--CA 1.443 -1.488 0 C-N-CA 123.117 2.544 . . . . 0.0 110.273 175.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.415 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 55.2 mtpt -74.94 92.36 2.57 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.889 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.64 82.77 7.88 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.6 m -79.64 159.37 26.77 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.869 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.18 175.37 1.66 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.138 0.575 . . . . 0.0 112.102 -175.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.559 ' H ' HG22 ' A' ' 38' ' ' THR . 3.3 mm? -86.75 37.85 0.77 Allowed 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.393 1.077 . . . . 0.0 110.193 -171.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -61.88 119.06 8.07 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.649 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 24.3 m -96.83 104.01 15.98 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -96.5 104.45 17.86 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.614 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 5.2 Cg_exo -76.85 -3.59 13.96 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 123.483 2.789 . . . . 0.0 111.983 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -77.86 -10.84 59.77 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.547 HG21 ' HD2' ' A' ' 16' ' ' TYR . 83.3 mt -102.43 130.45 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.171 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.37 -40.58 9.86 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -176.75 174.01 1.87 Allowed 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.75 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.77 114.0 4.89 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.8 t -79.63 100.69 4.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 121.338 0.589 . . . . 0.0 109.89 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.6 m -97.82 150.15 36.47 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 173.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 11.4 Cg_exo . . . . . 0 CA--C 1.538 0.715 0 C-N-CA 122.825 2.35 . . . . 0.0 111.869 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' A' ' 41' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.648 0 CA-C-O 121.935 0.874 . . . . 0.0 109.645 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.815 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 60.5 m -128.59 37.01 4.18 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-O 122.333 1.063 . . . . 0.0 109.684 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.412 HG21 ' HA ' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -81.91 151.7 27.14 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-N 113.788 -1.551 . . . . 0.0 108.704 176.832 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -150.45 175.67 11.65 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.7 t -70.49 -30.09 66.79 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 118.149 0.431 . . . . 0.0 111.809 -174.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 4.4 t -76.09 -41.33 50.71 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.368 -0.832 . . . . 0.0 109.837 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.3 46.24 0.25 Allowed 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.636 ' HA3' ' HE1' ' A' ' 16' ' ' TYR . . . -140.37 -141.23 4.0 Favored Glycine 0 N--CA 1.431 -1.689 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.85 178.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.2 m -151.91 133.34 14.59 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 122.483 -0.422 . . . . 0.0 110.412 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.72 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 29.9 mmtt -50.52 121.89 6.36 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.348 1.059 . . . . 0.0 110.364 175.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.403 ' O ' ' HE3' ' A' ' 15' ' ' LYS . . . 119.57 -34.11 4.37 Favored Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.477 -178.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.2 m -92.85 132.06 37.33 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.589 ' HD3' ' HG2' ' A' ' 26' ' ' GLU . 10.3 mmtp -87.04 117.68 25.92 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -177.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.636 ' HE1' ' HA3' ' A' ' 10' ' ' GLY . 66.0 m-85 -70.18 120.36 15.75 Favored 'General case' 0 CA--C 1.479 -1.777 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -134.57 147.58 50.29 Favored 'General case' 0 N--CA 1.399 -3.017 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.331 -168.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.482 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 12.1 t -93.11 131.96 37.68 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.93 -10.45 53.42 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -170.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.25 -1.9 54.29 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.948 0.404 . . . . 0.0 110.956 176.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.62 59.21 0.75 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.711 175.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.482 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 18.9 m -146.8 133.09 19.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 O-C-N 122.484 -0.421 . . . . 0.0 110.426 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.401 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 82.8 t80 -83.92 120.32 25.95 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 174.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.446 HG11 HG12 ' A' ' 45' ' ' ILE . 31.9 t -93.56 -51.14 11.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-O 120.699 0.285 . . . . 0.0 110.553 -177.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.4 p -169.85 165.32 9.77 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.589 ' HG2' ' HD3' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -94.44 171.87 8.54 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 176.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.72 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -52.5 128.87 36.51 Favored Glycine 0 N--CA 1.45 -0.431 0 O-C-N 123.703 0.627 . . . . 0.0 114.138 -175.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -100.82 -18.18 16.54 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.963 0.411 . . . . 0.0 110.374 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 m -120.07 107.22 12.79 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -175.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -82.41 109.01 13.63 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 165.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.01 21.94 0.37 Allowed 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 123.49 2.793 . . . . 0.0 115.185 -170.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -83.12 -51.93 7.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -90.34 126.73 55.64 Favored Pre-proline 0 C--O 1.254 1.306 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.81 139.7 81.55 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.606 2.871 . . . . 0.0 113.681 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.39 152.4 27.49 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.53 83.67 1.9 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.032 0.444 . . . . 0.0 111.394 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 78.5 m -83.25 123.2 29.36 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.99 167.53 3.79 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.176 0.99 . . . . 0.0 112.882 -175.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.7 mt -94.4 34.86 1.25 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -61.8 119.55 8.98 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.643 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.815 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 2.7 m -80.27 104.25 10.69 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.046 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -100.48 100.99 13.45 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 19.5 Cg_exo -69.04 -4.56 13.79 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.695 2.93 . . . . 0.0 113.453 -177.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.9 ttp-105 -75.61 -23.92 56.47 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.446 HG12 HG11 ' A' ' 24' ' ' VAL . 66.5 mt -110.84 161.6 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.489 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.45 -57.2 2.3 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 173.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.412 ' HA ' HG21 ' A' ' 5' ' ' THR . 0.2 OUTLIER -162.86 179.09 7.86 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.0 178.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -100.5 116.58 5.62 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 177.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.6 t -104.18 122.97 57.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.043 0.449 . . . . 0.0 110.426 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.7 m -96.09 104.79 18.21 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 171.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 5.3 Cg_exo . . . . . 0 C--O 1.241 0.642 0 C-N-CA 122.982 2.455 . . . . 0.0 113.396 -174.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 34.4 t70 . . . . . 0 CA--C 1.517 -0.3 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.495 ' HG3' ' SG ' ' A' ' 4' ' ' CYS . 2.1 tpm_? -151.97 91.84 1.66 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.3 tp -72.61 76.29 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-O 122.95 1.357 . . . . 0.0 111.861 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.872 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 96.6 m -111.38 33.7 4.54 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-O 122.004 0.907 . . . . 0.0 111.405 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -79.62 145.8 32.86 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.189 -1.369 . . . . 0.0 107.526 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -146.93 168.31 21.8 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -66.9 -28.3 68.2 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.4 t -68.32 -43.03 78.45 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.74 -2.5 23.63 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.328 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.42 161.75 54.33 Favored Glycine 0 N--CA 1.425 -2.093 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.576 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.1 m -116.32 122.55 45.22 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 122.528 0.331 . . . . 0.0 110.72 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 3.2 tttp -43.13 132.4 4.18 Favored 'General case' 0 C--O 1.247 0.973 0 C-N-CA 124.677 1.191 . . . . 0.0 111.464 175.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.98 -28.32 15.22 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.98 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.8 m -103.92 133.37 49.01 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 122.537 -0.39 . . . . 0.0 110.299 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 12.6 mptt -84.62 118.47 24.39 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.815 -177.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -88.56 105.97 18.0 Favored 'General case' 0 CA--C 1.492 -1.284 0 CA-C-O 123.2 1.476 . . . . 0.0 108.727 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -123.09 146.98 47.24 Favored 'General case' 0 C--N 1.269 -2.933 0 CA-C-N 111.959 -2.382 . . . . 0.0 111.589 -165.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 19.4 p -94.91 145.7 24.74 Favored 'General case' 0 N--CA 1.408 -2.531 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.587 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.2 -12.99 57.09 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.964 0.905 . . . . 0.0 112.911 -173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -71.53 -20.09 62.09 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.87 30.6 2.95 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.128 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.0 m -123.85 136.76 54.57 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.342 0.592 . . . . 0.0 112.494 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.457 ' CE1' ' HG3' ' A' ' 15' ' ' LYS . 62.2 t80 -79.95 115.19 19.39 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.6 t -85.75 -61.55 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.9 p -164.38 154.73 14.64 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.433 ' HG3' ' HD2' ' A' ' 15' ' ' LYS . 13.2 tt0 -89.65 155.53 19.17 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 174.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -54.55 113.13 3.18 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.592 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -83.37 -10.53 58.4 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.5 m -95.78 125.72 40.55 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-O 121.403 0.62 . . . . 0.0 110.338 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.71 134.66 37.06 Favored Pre-proline 0 C--N 1.293 -1.89 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.038 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.88 -8.21 17.28 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.074 2.516 . . . . 0.0 114.72 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -63.66 -46.66 84.58 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 117.839 0.29 . . . . 0.0 110.823 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -90.14 138.14 27.54 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.02 95.88 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.882 2.388 . . . . 0.0 110.727 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -88.92 118.94 28.99 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.077 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.8 78.48 1.72 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 96.8 m -79.16 169.16 18.58 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.859 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.422 ' HB ' ' OD1' ' A' ' 40' ' ' ASN . 0.3 OUTLIER -61.73 155.83 21.82 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.61 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.4 mt -94.77 40.87 1.09 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.907 0.861 . . . . 0.0 109.563 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.422 ' OD1' ' HB ' ' A' ' 38' ' ' THR . 8.4 m120 -62.47 122.57 16.07 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 113.793 -1.548 . . . . 0.0 109.307 175.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.872 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 5.2 m -81.26 112.04 18.21 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.186 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -111.09 85.09 4.97 Favored Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 24.4 Cg_exo -63.19 -19.89 69.66 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 123.614 2.876 . . . . 0.0 113.695 -171.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.487 ' O ' ' HB3' ' A' ' 18' ' ' SER . 3.4 tmm_? -73.36 -9.64 58.91 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.277 0.561 . . . . 0.0 110.486 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.5 mt -101.24 124.49 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 172.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.84 -59.09 1.93 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.643 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -157.36 163.66 38.38 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.469 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.06 127.75 9.2 Favored Glycine 0 N--CA 1.407 -3.292 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.2 t -105.77 103.37 15.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 14.0 m -85.1 152.48 58.7 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -44.57 124.58 5.5 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 123.26 2.64 . . . . 0.0 112.6 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -78.93 68.66 4.94 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.991 0.901 . . . . 0.0 110.481 -177.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.7 m . . . . . 0 C--O 1.257 1.492 0 C-N-CA 124.701 1.2 . . . . 0.0 108.052 178.172 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.238 0.464 0 CA-C-O 120.564 0.221 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -94.51 80.83 3.88 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.162 0.506 . . . . 0.0 109.891 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 tt -65.55 107.06 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.161 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.93 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 22.2 m -119.73 43.21 2.71 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.613 ' HB ' HG23 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -90.74 163.81 14.35 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 170.29 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.689 ' HA ' ' HB3' ' A' ' 42' ' ' ASP . 7.9 p30 -151.42 136.13 17.15 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 119.116 0.871 . . . . 0.0 110.309 170.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 t -60.69 -34.51 74.45 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.277 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 t -74.45 -26.81 60.28 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.328 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.54 -54.39 4.59 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 18.76 -137.38 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 118.669 2.227 . . . . 0.0 118.669 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.569 ' H ' ' HE1' ' A' ' 16' ' ' TYR . 80.4 m -159.98 102.26 1.46 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.743 1.217 . . . . 0.0 109.789 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -46.75 128.11 10.38 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 125.136 1.375 . . . . 0.0 109.979 171.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.431 ' O ' ' HD2' ' A' ' 51' ' ' PRO . . . 111.49 -10.01 28.35 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 30.9 m -132.39 141.66 48.97 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.635 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 55.7 mmtt -82.56 131.02 35.22 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.569 ' HE1' ' H ' ' A' ' 11' ' ' THR . 12.3 m-85 -83.99 119.72 25.26 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.76 144.69 32.73 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.828 0.823 . . . . 0.0 112.369 -169.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.633 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 34.3 p -92.79 139.27 30.72 Favored 'General case' 0 N--CA 1.407 -2.623 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.017 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -62.74 -13.57 34.34 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -171.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -72.61 -15.16 61.74 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 120.833 0.349 . . . . 0.0 110.707 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.31 34.33 2.53 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.964 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.432 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 85.3 m -125.52 124.65 41.78 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.023 0.439 . . . . 0.0 110.88 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.635 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 69.0 t80 -76.97 132.61 39.11 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 175.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.9 t -106.18 -58.57 3.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.223 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.38 154.01 35.84 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.37 0.605 . . . . 0.0 112.46 -176.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -79.85 152.92 29.42 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.113 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.483 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -69.04 93.26 0.32 Allowed Glycine 0 N--CA 1.436 -1.308 0 O-C-N 123.927 0.767 . . . . 0.0 113.752 -175.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -100.25 -41.37 7.11 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 m -71.87 102.54 2.91 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -164.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -78.81 124.23 85.07 Favored Pre-proline 0 C--N 1.304 -1.394 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.794 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -87.9 1.9 6.65 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.911 2.407 . . . . 0.0 113.289 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -82.96 -46.59 12.73 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -86.23 156.85 57.0 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 173.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.71 55.8 4.98 Favored 'Trans proline' 0 C--O 1.246 0.91 0 C-N-CA 122.411 2.074 . . . . 0.0 113.426 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -88.75 97.28 11.05 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.415 0.626 . . . . 0.0 110.356 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.01 146.16 48.77 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.024 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.0 m -125.89 149.66 48.53 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.373 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.0 60.63 0.4 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.858 0.863 . . . . 0.0 112.271 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 tp -137.57 44.15 2.25 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 175.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -62.92 141.05 58.86 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 113.495 -1.684 . . . . 0.0 109.986 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.93 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 35.9 m 63.45 59.64 1.21 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.04 0.924 . . . . 0.0 110.328 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.689 ' HB3' ' HA ' ' A' ' 6' ' ' ASN . 61.3 t0 -82.8 109.43 16.64 Favored Pre-proline 0 C--N 1.312 -1.054 0 C-N-CA 125.45 1.5 . . . . 0.0 108.821 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 11.8 Cg_exo -69.68 -4.47 14.03 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 123.204 2.603 . . . . 0.0 113.616 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.633 ' O ' ' HB3' ' A' ' 18' ' ' SER . 1.6 mmp_? -85.17 -30.48 23.89 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.396 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.613 HG23 ' HB ' ' A' ' 5' ' ' THR . 7.3 tt -99.16 105.4 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.753 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.79 -42.71 23.87 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -167.54 176.44 6.51 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.919 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -109.07 124.74 7.45 Favored Glycine 0 C--N 1.285 -2.275 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.213 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.1 t -94.88 107.65 19.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 13.9 m -80.32 117.41 67.52 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.499 ' HG3' ' HE2' ' A' ' 15' ' ' LYS . 21.0 Cg_endo -58.4 133.01 52.03 Favored 'Trans proline' 0 C--O 1.24 0.613 0 C-N-CA 123.117 2.544 . . . . 0.0 113.614 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.5 ttp85 -136.35 105.18 5.86 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--N 1.291 -1.957 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -177.623 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 C--O 1.218 -0.603 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -83.85 45.93 1.13 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.881 1.218 . . . . 0.0 113.004 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.45 HG13 ' H ' ' A' ' 5' ' ' THR . 8.7 tp -90.12 137.28 21.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.8 m -115.11 20.66 14.83 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.45 ' H ' HG13 ' A' ' 3' ' ' ILE . 1.2 m -90.69 172.79 8.41 Favored 'General case' 0 C--N 1.273 -2.744 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.608 177.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.887 HD22 HD13 ' A' ' 39' ' ' LEU . 9.1 p30 -133.31 156.81 46.93 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.4 t -73.72 -35.59 65.11 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 123.791 0.836 . . . . 0.0 113.105 -174.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 45.7 t -59.5 -56.91 15.99 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.578 0.704 . . . . 0.0 109.801 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.611 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . . . -90.53 26.38 2.01 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.55 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.15 163.68 26.77 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.606 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -53.77 110.83 0.63 Allowed 'General case' 0 C--O 1.241 0.646 0 C-N-CA 125.708 1.603 . . . . 0.0 113.111 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 27.1 ttpp -55.02 112.96 1.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.215 1.006 . . . . 0.0 111.627 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.01 -26.51 10.45 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.17 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.9 m -87.15 122.09 30.48 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.411 ' HE3' ' HG3' ' A' ' 51' ' ' PRO . 65.2 mttt -77.8 113.16 15.4 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.764 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.616 ' HD2' HG21 ' A' ' 45' ' ' ILE . 60.5 m-85 -72.91 106.65 4.92 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.85 145.11 44.03 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.499 -1.682 . . . . 0.0 111.154 -167.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.486 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 4.9 p -92.87 145.57 24.29 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.556 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -64.45 -14.7 58.37 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -170.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.71 8.27 20.36 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.405 0.622 . . . . 0.0 110.444 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.27 28.37 9.87 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 115.522 -0.763 . . . . 0.0 114.251 171.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.486 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 5.3 m -115.74 114.14 24.4 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 118.007 0.903 . . . . 0.0 112.027 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -67.44 116.78 8.57 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 171.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.68 -47.29 16.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.1 p -178.59 -175.58 0.44 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -125.6 144.3 50.64 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -66.36 146.09 48.31 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -130.75 1.75 4.42 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.42 0.629 . . . . 0.0 111.035 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.7 m -121.46 169.39 10.69 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-O 121.974 0.892 . . . . 0.0 112.127 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.491 ' HB3' ' OD1' ' A' ' 33' ' ' ASN . 30.6 t70 -114.43 116.98 43.51 Favored Pre-proline 0 C--N 1.287 -2.132 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 173.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 19.6 Cg_exo -67.79 26.98 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 124.018 3.145 . . . . 0.0 115.334 -173.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -116.79 -32.58 5.08 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' A' ' 30' ' ' ASP . 3.0 p-10 -90.54 152.14 44.88 Favored Pre-proline 0 C--O 1.245 0.851 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.179 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.79 103.55 0.72 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.228 2.618 . . . . 0.0 112.815 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.18 114.18 19.94 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.57 64.63 4.5 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.552 0.691 . . . . 0.0 112.845 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.611 ' HB2' ' HB2' ' A' ' 9' ' ' ALA . 58.8 m -113.18 118.15 33.91 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 172.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.9 p -65.03 141.01 58.91 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 123.565 0.54 . . . . 0.0 111.226 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.887 HD13 HD22 ' A' ' 6' ' ' ASN . 4.1 mm? -79.54 -74.14 0.31 Allowed 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 60.7 7.65 1.49 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.408 1.483 . . . . 0.0 113.643 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 60.6 m 58.83 123.58 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 125.416 1.486 . . . . 0.0 111.789 -173.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -110.62 83.64 3.54 Favored Pre-proline 0 C--N 1.323 -0.579 0 O-C-N 121.115 -0.991 . . . . 0.0 109.547 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 23.4 Cg_exo -65.46 -14.09 43.13 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 123.616 2.877 . . . . 0.0 114.11 -172.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -73.71 -25.09 60.04 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.567 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.616 HG21 ' HD2' ' A' ' 16' ' ' TYR . 87.3 mt -82.56 144.33 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.06 -59.69 2.13 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.6 174.04 11.28 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.176 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.73 99.13 2.02 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.94 107.26 12.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.343 0.592 . . . . 0.0 110.876 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.7 m -85.73 136.86 36.36 Favored Pre-proline 0 C--N 1.291 -1.953 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 170.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 16.9 Cg_exo -68.65 66.73 1.19 Allowed 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.446 2.764 . . . . 0.0 113.52 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -134.42 113.07 11.49 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.4 m . . . . . 0 C--N 1.278 -2.51 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.42 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 52.96 47.23 25.11 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.043 1.337 . . . . 0.0 113.662 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 tt -89.76 116.18 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 172.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.464 ' HA ' ' CB ' ' A' ' 41' ' ' CYS 0.252 98.7 m -88.66 19.32 4.03 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -174.156 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.7 m -90.64 136.14 33.25 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 171.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.462 ' HA ' ' HB2' ' A' ' 42' ' ' ASP . 11.4 p30 -119.3 158.06 26.83 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.625 ' HB2' HD11 ' A' ' 45' ' ' ILE . 6.9 t -84.86 -17.25 38.56 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.287 -174.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.3 t -67.9 -46.1 72.57 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 35' ' ' LYS . . . -91.53 22.58 3.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.239 0.542 . . . . 0.0 109.593 173.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.71 152.91 37.81 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 115.738 -0.665 . . . . 0.0 114.75 -172.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 m -79.36 114.26 18.16 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 124.768 1.227 . . . . 0.0 110.277 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.615 ' HA ' ' O ' ' A' ' 26' ' ' GLU . 2.3 tmtp? -64.84 127.34 31.16 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.526 ' H ' ' HG2' ' A' ' 26' ' ' GLU . . . 113.48 -10.11 24.04 Favored Glycine 0 C--N 1.301 -1.372 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -176.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.5 m -105.75 127.54 53.15 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HA ' ' HE1' ' A' ' 23' ' ' PHE . 20.7 mmmt -84.84 94.02 8.63 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -178.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -72.51 111.22 7.49 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 175.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -140.91 151.69 44.44 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.794 -164.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.9 t -97.17 138.96 33.86 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.537 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.454 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 3.5 p30 -69.12 -3.59 13.99 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.732 0.813 . . . . 0.0 112.894 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.07 -8.88 59.0 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.765 176.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.45 25.05 6.48 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.93 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 m -122.02 114.91 21.6 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 122.565 -0.374 . . . . 0.0 111.662 -177.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.496 ' HZ ' ' HB2' ' A' ' 26' ' ' GLU . 73.6 t80 -73.34 130.8 40.95 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.91 -62.05 2.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.895 -175.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 p -162.73 155.51 19.34 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.615 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 20.0 tt0 -103.76 44.82 0.99 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.517 0.675 . . . . 0.0 110.461 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.89 -162.8 49.0 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.872 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -112.26 -69.74 0.85 Allowed 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 120.974 0.416 . . . . 0.0 109.988 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.4 m -144.56 -166.49 2.4 Favored 'General case' 0 N--CA 1.407 -2.62 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -177.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.48 133.74 59.28 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.66 1.54 0.39 Allowed 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 123.505 2.803 . . . . 0.0 115.205 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -61.39 -47.91 83.62 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -91.81 117.56 67.81 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 172.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -76.63 121.52 6.0 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 121.551 1.501 . . . . 0.0 111.081 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -86.93 116.21 24.84 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.59 113.16 20.11 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.376 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.6 m -141.96 -177.68 5.33 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.32 157.39 29.26 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 120.867 0.365 . . . . 0.0 110.616 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.49 32.92 1.9 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.898 0.856 . . . . 0.0 109.838 -175.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -78.14 136.16 37.8 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.188 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 19.6 m -76.27 123.48 25.97 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 6' ' ' ASN . 6.9 t0 -83.78 105.27 5.31 Favored Pre-proline 0 N--CA 1.468 0.454 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.699 -169.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 68.1 Cg_endo -83.45 1.72 8.8 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.929 2.419 . . . . 0.0 111.725 -174.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 ttp-105 -83.04 -20.55 34.78 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 7' ' ' CYS . 71.8 mt -108.02 152.64 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.491 -1.232 . . . . 0.0 109.018 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.26 -50.58 3.12 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 19' ' ' ASP . 15.9 p90 -159.16 175.54 13.33 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -114.62 112.16 2.71 Favored Glycine 0 N--CA 1.428 -1.894 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.339 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.537 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 56.2 t -82.29 106.29 13.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 85.7 m -105.67 99.29 20.89 Favored Pre-proline 0 C--N 1.298 -1.657 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.231 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 49' ' ' VAL . 3.6 Cg_exo -78.44 66.76 8.44 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.296 2.664 . . . . 0.0 109.594 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -143.1 108.09 4.94 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.253 1.279 0 C-N-CA 125.017 1.327 . . . . 0.0 111.413 179.173 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.5 t0 . . . . . 0 CA--C 1.51 -0.592 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.629 ' HB3' ' SG ' ' A' ' 41' ' ' CYS . 23.8 mmt180 68.63 128.64 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.108 1.363 . . . . 0.0 112.493 176.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 tp -76.47 65.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-O 122.911 1.339 . . . . 0.0 109.769 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.932 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.8 m -88.58 40.83 0.98 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.991 0.901 . . . . 0.0 112.282 -176.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -90.83 127.25 36.29 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 171.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -146.27 178.8 7.97 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.524 -0.871 . . . . 0.0 112.548 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -85.17 -32.93 22.44 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.6 t -66.1 -50.43 64.07 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.933 0.873 . . . . 0.0 108.976 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.37 33.25 0.9 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.527 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.23 136.11 13.06 Favored Glycine 0 N--CA 1.41 -3.076 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.781 HG22 ' HA ' ' A' ' 31' ' ' PRO . 7.2 p -83.85 111.46 19.24 Favored 'General case' 0 C--N 1.268 -2.955 0 CA-C-N 113.924 -1.138 . . . . 0.0 111.834 -175.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -45.79 115.57 1.0 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.704 0.802 . . . . 0.0 110.854 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.49 -36.59 2.53 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 m -95.52 134.71 38.05 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.532 ' HG3' ' HG3' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -88.42 119.96 29.34 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.441 ' HB3' HD13 ' A' ' 45' ' ' ILE . 67.7 m-85 -83.86 105.24 14.59 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 122.896 1.331 . . . . 0.0 108.142 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.586 ' HE1' ' HA2' ' A' ' 21' ' ' GLY . 0.5 OUTLIER -126.52 147.95 49.78 Favored 'General case' 0 N--CA 1.405 -2.684 0 CA-C-N 112.868 -1.969 . . . . 0.0 112.207 -164.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.7 142.58 29.31 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.113 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -58.18 -19.05 30.21 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.867 1.267 . . . . 0.0 114.208 -172.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.07 -8.03 59.17 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.131 0.491 . . . . 0.0 111.02 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.586 ' HA2' ' HE1' ' A' ' 17' ' ' PHE . . . 106.14 24.27 6.95 Favored Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.324 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.2 m -107.04 123.32 48.05 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.291 -0.563 . . . . 0.0 112.142 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -77.94 109.65 12.18 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.21 -52.09 15.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.9 p -174.46 169.54 3.71 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.532 ' HG3' ' HG3' ' A' ' 15' ' ' LYS . 15.8 tt0 -108.27 171.3 7.49 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.67 112.3 1.56 Allowed Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -83.08 -22.67 33.4 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.666 -0.267 . . . . 0.0 111.705 -172.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -130.36 -176.94 4.12 Favored 'General case' 0 N--CA 1.4 -2.962 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.472 -174.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -78.0 140.59 62.27 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.781 ' HA ' HG22 ' A' ' 11' ' ' THR . 1.0 OUTLIER -42.92 -27.07 0.8 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 124.922 3.748 . . . . 0.0 115.725 -179.501 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.475 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 19.5 mmt85 -122.64 46.09 2.23 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 118.409 0.549 . . . . 0.0 110.492 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -73.57 119.9 78.37 Favored Pre-proline 0 C--N 1.304 -1.382 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.525 175.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -87.25 94.21 0.48 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.787 2.324 . . . . 0.0 111.575 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -158.67 155.32 27.92 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.263 0.554 . . . . 0.0 111.478 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.16 131.53 45.13 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 173.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.2 m -115.28 135.51 54.07 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.208 0.528 . . . . 0.0 112.278 -174.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -18.26 62.9 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 123.573 0.749 . . . . 0.0 110.814 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 tp -86.33 25.31 1.21 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.099 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -53.67 121.09 7.13 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.937 176.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.932 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 14.9 m 67.36 86.58 0.13 Allowed 'General case' 0 C--N 1.321 -0.661 0 O-C-N 124.504 1.128 . . . . 0.0 111.421 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -96.28 104.5 17.6 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.49 3.87 6.83 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.782 2.321 . . . . 0.0 113.041 -172.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -90.41 -15.57 30.73 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.49 0.662 . . . . 0.0 109.331 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.441 HD13 ' HB3' ' A' ' 16' ' ' TYR . 93.2 mt -101.18 140.94 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.49 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.95 -54.35 3.49 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -167.23 173.3 9.11 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.423 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.43 121.23 7.14 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.5 t -94.14 114.09 30.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 123.021 0.529 . . . . 0.0 109.582 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.6 m -99.84 129.39 28.72 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 32.2 Cg_exo -58.21 116.37 3.19 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 123.324 2.683 . . . . 0.0 112.114 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 12.0 tpt85 -156.11 -48.59 0.08 Allowed 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.546 176.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 C--N 1.304 -1.396 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.081 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 . . . . . 0 C--O 1.239 0.504 0 CA-C-O 120.816 0.341 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.7 tpp85 -175.74 -46.13 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.425 ' O ' ' HB3' ' A' ' 41' ' ' CYS . 6.1 tp -71.71 113.6 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 172.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 69.4 m -113.6 40.37 2.42 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.97 0.891 . . . . 0.0 112.781 -173.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 t -90.82 165.81 13.43 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 172.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -160.17 175.86 12.43 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 118.435 0.561 . . . . 0.0 111.11 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.4 t -69.11 -21.2 64.06 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.563 0.745 . . . . 0.0 112.275 -174.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.3 t -91.03 -54.82 3.79 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.56 -0.713 . . . . 0.0 109.965 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.22 37.43 0.1 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.21 175.3 30.67 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 175.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 m -109.48 124.74 51.58 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 117.037 0.419 . . . . 0.0 111.251 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.565 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -54.36 122.58 10.71 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.9 175.152 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.56 -35.52 2.65 Favored Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -176.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.1 m -105.75 151.15 24.82 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -88.28 123.99 33.44 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.519 ' CZ ' ' HA2' ' A' ' 27' ' ' GLY . 1.2 m-30 -77.45 106.89 9.51 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.423 ' CE1' ' HA ' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -141.01 151.74 44.35 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.599 0.714 . . . . 0.0 112.77 -167.192 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.524 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 43.4 p -96.24 129.61 43.52 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 175.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.423 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 4.1 p-10 -62.64 -9.8 10.23 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -20.23 63.79 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.16 -0.19 6.51 Favored Glycine 0 N--CA 1.429 -1.812 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.404 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.524 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 3.8 m -97.45 118.07 33.12 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -76.56 121.77 23.65 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.466 HG21 HG12 ' A' ' 45' ' ' ILE . 23.5 t -95.53 -65.86 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.837 -176.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.56 155.75 43.81 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.964 0.412 . . . . 0.0 111.849 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.07 169.02 10.57 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -62.48 118.78 15.31 Favored Glycine 0 N--CA 1.439 -1.105 0 O-C-N 123.53 0.519 . . . . 0.0 113.306 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -131.24 1.52 4.19 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.01 0.433 . . . . 0.0 111.638 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.2 m -121.29 115.41 22.92 Favored 'General case' 0 N--CA 1.403 -2.779 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -114.12 140.83 25.42 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.74 -21.02 7.47 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.634 2.889 . . . . 0.0 114.958 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -90.94 -24.99 19.99 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.47 ' HA ' ' HD3' ' A' ' 34' ' ' PRO 0.254 28.5 p30 -91.4 115.28 64.12 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.344 0.592 . . . . 0.0 112.484 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 17.2 Cg_exo -65.43 111.74 1.93 Allowed 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 123.313 2.675 . . . . 0.0 111.573 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -139.45 120.29 14.39 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.61 92.92 7.23 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.525 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.6 m -88.7 165.66 14.6 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.804 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.08 149.68 42.93 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.952 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -95.88 33.22 1.72 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.13 147.19 40.73 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.995 -1.457 . . . . 0.0 111.443 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 35.0 m -106.99 93.77 4.74 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.532 ' OD1' ' HB3' ' A' ' 44' ' ' ARG . 9.9 t70 -80.65 103.2 1.66 Allowed Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 123.871 0.868 . . . . 0.0 110.572 -175.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 52.6 Cg_endo -72.79 -7.12 20.25 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.637 2.225 . . . . 0.0 112.464 -174.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.532 ' HB3' ' OD1' ' A' ' 42' ' ' ASP . 16.9 ttp180 -82.81 -45.94 13.69 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.466 HG12 HG21 ' A' ' 24' ' ' VAL . 79.6 mt -79.72 128.95 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 CA-C-O 121.538 0.685 . . . . 0.0 109.965 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.05 -55.41 3.95 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.898 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -171.38 171.24 5.62 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.03 117.06 4.93 Favored Glycine 0 N--CA 1.423 -2.199 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.7 t -93.08 117.32 36.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.35 0.595 . . . . 0.0 111.419 -176.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.3 m -105.73 102.34 37.89 Favored Pre-proline 0 C--N 1.285 -2.198 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 171.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -36.55 116.32 0.15 Allowed 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 125.092 3.861 . . . . 0.0 114.513 -174.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 -82.22 66.52 7.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.237 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.303 -1.453 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.423 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 40.6 t0 . . . . . 0 CA--C 1.51 -0.593 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -98.51 105.97 18.19 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.472 HG13 ' OG1' ' A' ' 5' ' ' THR . 6.5 tp -77.08 122.09 30.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 121.624 0.726 . . . . 0.0 111.231 -178.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 19.3 m -136.38 47.16 2.22 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 121.972 0.892 . . . . 0.0 110.3 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.472 ' OG1' HG13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -72.17 160.41 32.49 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.961 178.153 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -158.93 149.25 19.56 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 t -105.79 18.36 22.27 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.357 0.598 . . . . 0.0 112.048 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 t -85.84 -46.01 11.02 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.541 ' HA ' ' OG ' ' A' ' 29' ' ' SER . . . -91.05 -100.01 0.11 Allowed 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.386 173.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.62 -140.3 28.98 Favored Glycine 0 N--CA 1.414 -2.779 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.563 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 m -154.0 119.3 5.12 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.563 ' HD3' ' HB2' ' A' ' 30' ' ' ASP . 15.0 ttpt -57.26 127.05 30.0 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 123.704 0.627 . . . . 0.0 110.613 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.19 -12.83 65.2 Favored Glycine 0 C--N 1.304 -1.201 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.391 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.9 m -99.06 128.65 45.24 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -80.13 92.2 5.63 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.988 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.595 ' HD2' HG21 ' A' ' 45' ' ' ILE . 27.9 m-85 -71.21 115.5 10.44 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.418 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -146.5 151.64 37.71 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.009 -161.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.3 t -86.86 137.19 32.61 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.427 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -57.98 -22.45 49.45 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.6 -18.61 60.54 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.181 0.515 . . . . 0.0 110.888 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.418 ' HA2' ' CE2' ' A' ' 17' ' ' PHE . . . 118.65 20.29 4.26 Favored Glycine 0 N--CA 1.425 -2.076 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.404 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 m -104.8 108.33 19.75 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 117.312 0.556 . . . . 0.0 110.173 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.497 ' CZ ' ' HG3' ' A' ' 26' ' ' GLU . 75.1 t80 -68.92 137.15 53.57 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.6 t -108.23 -64.56 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.713 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.3 p -163.35 155.34 17.69 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 18.3 mt-10 -97.52 39.19 1.21 Allowed 'General case' 0 C--O 1.242 0.676 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -175.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.21 127.74 0.27 Allowed Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.446 -0.797 . . . . 0.0 114.165 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -105.4 27.81 7.97 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 122.377 -0.484 . . . . 0.0 111.036 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.541 ' OG ' ' HA ' ' A' ' 9' ' ' ALA . 4.3 m -141.74 109.1 5.56 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.563 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 21.0 t70 -96.18 130.45 31.08 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 167.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -59.44 50.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.511 2.51 0 C-N-CA 124.859 3.706 . . . . 0.0 116.189 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -128.56 -56.12 1.22 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -90.5 130.06 42.81 Favored Pre-proline 0 N--CA 1.442 -0.85 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 175.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.28 147.75 11.5 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.258 1.972 . . . . 0.0 110.853 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.527 ' HB3' ' SG ' ' A' ' 37' ' ' CYS . 27.6 mmtp -120.28 89.7 3.18 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.477 0.656 . . . . 0.0 109.893 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.99 59.51 5.67 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.178 0.99 . . . . 0.0 110.041 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 35' ' ' LYS . 3.4 m -88.46 -178.79 5.94 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.808 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.48 137.49 36.47 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 174.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.9 tp -89.1 43.72 1.16 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.377 1.084 . . . . 0.0 110.105 -174.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -53.17 122.54 9.67 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 112.837 -1.983 . . . . 0.0 110.926 172.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.528 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 34.8 m -71.94 108.67 5.31 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 175.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -104.88 91.57 4.44 Favored Pre-proline 0 C--N 1.31 -1.123 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 22.9 Cg_exo -64.66 -17.2 58.78 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 124.43 3.42 . . . . 0.0 114.818 -172.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.4 ttp-105 -59.68 -23.65 63.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.564 0.697 . . . . 0.0 110.139 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.595 HG21 ' HD2' ' A' ' 16' ' ' TYR . 95.1 mt -103.82 122.27 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.73 -46.56 8.52 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.143 -177.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -161.09 175.15 12.72 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.965 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -109.59 111.78 3.24 Favored Glycine 0 N--CA 1.415 -2.754 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.7 t -86.31 98.68 7.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.7 m -87.74 157.49 52.03 Favored Pre-proline 0 C--N 1.285 -2.212 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -74.46 66.62 5.51 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.636 2.224 . . . . 0.0 109.709 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -110.19 23.05 14.82 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.67 -174.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.429 -1.515 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.675 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.464 ' OD1' ' HD3' ' A' ' 2' ' ' ARG . 11.4 t0 . . . . . 0 C--O 1.234 0.268 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.554 ' H ' ' HD3' ' A' ' 2' ' ' ARG . 0.3 OUTLIER -88.63 46.48 1.39 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.639 1.209 . . . . 0.0 110.704 -176.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 tp -76.96 111.08 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.378 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.53 ' HA ' ' CB ' ' A' ' 41' ' ' CYS . 90.8 m -96.36 25.65 4.86 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 122.218 1.008 . . . . 0.0 112.317 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.7 m -90.82 141.94 28.28 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 173.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -136.84 167.15 22.02 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.97 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.505 ' HA ' ' CD2' ' A' ' 16' ' ' TYR . 6.4 t -70.95 -34.57 71.59 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 123.447 0.699 . . . . 0.0 112.695 -171.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -77.89 -36.43 49.69 Favored 'General case' 0 N--CA 1.424 -1.754 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.767 -177.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.58 34.28 0.32 Allowed 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.482 0.658 . . . . 0.0 111.09 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.532 ' HA3' ' HE2' ' A' ' 16' ' ' TYR . . . -119.29 168.75 13.49 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.36 143.25 30.77 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 116.929 0.365 . . . . 0.0 111.009 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -50.81 138.66 18.26 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.694 172.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.91 -33.08 6.66 Favored Glycine 0 C--N 1.3 -1.456 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 64.0 m -99.11 138.83 35.65 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.739 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 37.0 mtmt -110.94 127.76 55.59 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -175.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.532 ' HE2' ' HA3' ' A' ' 10' ' ' GLY . 28.6 m-85 -76.47 128.28 34.48 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.335 0.588 . . . . 0.0 110.443 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -148.07 147.05 29.13 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.162 -171.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.559 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 31.5 p -97.74 144.22 27.58 Favored 'General case' 0 N--CA 1.407 -2.588 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.889 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.0 -11.47 57.1 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.737 0.815 . . . . 0.0 113.14 -170.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -74.1 -14.12 60.93 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.68 48.74 1.25 Allowed Glycine 0 N--CA 1.427 -1.962 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.559 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 84.9 m -134.68 121.61 21.06 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.077 0.465 . . . . 0.0 110.803 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.739 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 78.1 t80 -69.67 120.23 15.12 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.3 t -89.57 -53.22 9.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.327 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.4 p -172.33 164.87 5.85 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.986 0.422 . . . . 0.0 110.458 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -88.87 146.05 25.19 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 123.765 0.826 . . . . 0.0 109.265 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.61 109.65 2.49 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.476 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 1.1 mm-40 -101.49 23.49 11.03 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 10' ' ' GLY . 5.5 m -113.32 102.7 10.59 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-O 121.285 0.564 . . . . 0.0 111.779 176.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.552 ' HB3' ' ND2' ' A' ' 33' ' ' ASN . 4.6 t70 -113.98 138.7 22.94 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 173.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.34 -19.83 5.06 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.981 3.121 . . . . 0.0 115.549 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -86.88 -37.75 17.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.91 -0.494 . . . . 0.0 111.345 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.552 ' ND2' ' HB3' ' A' ' 30' ' ' ASP . 14.9 p30 -90.44 116.9 67.44 Favored Pre-proline 0 C--N 1.317 -0.834 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.094 -177.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -80.85 117.91 3.35 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.237 1.958 . . . . 0.0 109.208 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 28' ' ' GLU . 25.5 mmtm -109.36 139.89 43.75 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -171.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.55 125.05 30.04 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 166.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.0 m -128.94 150.47 50.36 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.785 -170.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 t -68.06 140.88 56.3 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 29.3 mt -106.85 -10.46 16.03 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.07 0.462 . . . . 0.0 110.833 -172.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -110.92 163.95 13.29 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.348 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.53 ' CB ' ' HA ' ' A' ' 4' ' ' CYS . 2.7 m -45.28 135.33 5.95 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 126.082 1.753 . . . . 0.0 112.596 -177.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -119.85 88.98 41.17 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.4 2.79 2.08 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 123.884 3.056 . . . . 0.0 115.214 -172.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -76.0 -24.54 55.32 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.865 0.84 . . . . 0.0 108.856 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.3 mt -95.89 149.47 4.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.023 -175.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.88 -53.01 2.84 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.42 170.7 18.33 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.883 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -102.45 98.17 1.66 Allowed Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.4 t -79.69 109.2 14.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.292 0.568 . . . . 0.0 109.882 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 3.4 m -80.66 115.08 52.97 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 106.131 -1.804 . . . . 0.0 106.131 173.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.623 ' HG3' ' HE2' ' A' ' 15' ' ' LYS . 24.5 Cg_exo -62.87 121.26 9.09 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 123.365 2.71 . . . . 0.0 114.169 -171.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -92.5 80.62 4.86 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 174.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 C--N 1.298 -1.636 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.901 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.241 0.613 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.459 ' HB3' ' SG ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -170.04 161.04 8.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 -178.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 tt -76.6 81.97 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 122.793 1.282 . . . . 0.0 109.361 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.823 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 78.2 m -124.37 43.66 2.95 Favored 'General case' 0 N--CA 1.406 -2.631 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.918 -175.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.453 ' HB ' HG23 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -77.97 148.64 34.36 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 173.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -128.61 142.97 50.87 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 118.871 -1.131 . . . . 0.0 113.501 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.7 t -98.97 13.03 34.16 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.321 1.057 . . . . 0.0 108.619 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.7 t -85.92 -70.39 0.6 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.773 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.1 -71.5 0.64 Allowed 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.33 -159.62 53.76 Favored Glycine 0 N--CA 1.415 -2.714 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.604 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 m -122.08 98.17 5.81 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.753 ' HE3' ' HB2' ' A' ' 30' ' ' ASP . 0.5 OUTLIER -40.18 122.22 1.49 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.031 0.932 . . . . 0.0 112.103 175.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.02 -42.01 1.92 Allowed Glycine 0 N--CA 1.435 -1.414 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.601 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 70.0 m -89.42 147.43 24.04 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.557 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 18.4 mtpp -97.36 116.19 29.1 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -175.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.82 ' HB3' HG13 ' A' ' 45' ' ' ILE . 10.9 m-85 -77.61 115.94 17.77 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.025 0.917 . . . . 0.0 108.85 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.448 ' HE2' ' HA2' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -135.67 149.05 49.16 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.498 -166.09 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.81 134.06 37.84 Favored 'General case' 0 N--CA 1.41 -2.466 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.42 -20.45 19.74 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -169.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -76.03 -13.77 60.22 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.907 0.385 . . . . 0.0 111.669 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.448 ' HA2' ' HE2' ' A' ' 17' ' ' PHE . . . 114.8 19.11 6.16 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.054 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.6 m -104.53 110.2 22.39 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.837 0.351 . . . . 0.0 110.86 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.557 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 50.3 t80 -73.14 126.14 29.34 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.1 t -96.34 -61.14 2.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 120.842 0.353 . . . . 0.0 110.328 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.4 p -161.63 160.07 28.32 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -176.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -97.3 145.46 26.08 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 174.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -46.65 122.09 6.31 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 124.165 0.916 . . . . 0.0 112.133 -178.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.56 -52.75 6.54 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.898 0.38 . . . . 0.0 111.13 -173.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.7 m -102.69 145.16 30.11 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-O 121.684 0.754 . . . . 0.0 111.963 -170.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.753 ' HB2' ' HE3' ' A' ' 12' ' ' LYS . 11.3 t70 -87.91 139.07 30.9 Favored Pre-proline 0 C--N 1.288 -2.077 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 172.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -49.79 -20.18 4.42 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.233 2.622 . . . . 0.0 114.512 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -83.23 -21.59 33.35 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.28 2.8 p-10 -90.58 118.86 69.02 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.823 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -75.27 73.51 4.45 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 123.637 2.892 . . . . 0.0 116.161 -170.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -130.37 49.91 2.25 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 122.551 1.167 . . . . 0.0 109.639 170.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.47 123.26 27.38 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.439 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.3 m -81.49 171.11 15.1 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.382 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 m -50.18 -64.76 0.71 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.85 -53.6 0.09 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 59.91 79.33 0.24 Allowed 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 124.578 1.174 . . . . 0.0 111.88 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.823 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 61.7 m -81.18 89.8 6.03 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 173.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.598 ' HB3' HG22 ' A' ' 45' ' ' ILE . 7.0 t0 -91.3 108.58 29.79 Favored Pre-proline 0 C--N 1.306 -1.283 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.544 -170.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -71.44 -5.59 17.36 Favored 'Trans proline' 0 C--O 1.24 0.594 0 C-N-CA 123.184 2.589 . . . . 0.0 112.424 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.577 ' HD3' ' OD1' ' A' ' 42' ' ' ASP . 25.8 mtp180 -75.26 -36.59 61.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.025 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.82 HG13 ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -108.98 136.66 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 CA-C-O 121.752 0.787 . . . . 0.0 112.943 -171.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.7 -60.53 1.68 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.387 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -153.75 165.22 36.69 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.012 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.41 114.56 5.05 Favored Glycine 0 C--N 1.29 -2.003 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t -92.85 114.12 29.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 14.7 m -79.67 137.43 54.8 Favored Pre-proline 0 C--N 1.284 -2.25 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 176.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.31 83.35 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.278 3.318 . . . . 0.0 114.466 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.04 26.39 7.55 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 C--N 1.3 -1.565 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -178.487 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 CA--C 1.51 -0.562 0 CA-C-O 121.413 0.625 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.413 ' HA ' ' HD2' ' A' ' 2' ' ' ARG . 23.4 mmm180 -109.74 -161.32 0.75 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 173.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 tp -70.86 108.38 2.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 118.561 -1.255 . . . . 0.0 108.29 174.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 1.015 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 69.3 m -101.47 34.39 2.61 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-O 122.206 1.003 . . . . 0.0 113.18 -173.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.8 m -91.34 147.07 23.3 Favored 'General case' 0 N--CA 1.408 -2.525 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.444 ' HA ' HD12 ' A' ' 45' ' ' ILE . 8.7 t-20 -159.01 -172.64 3.87 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.487 ' O ' ' HA3' ' A' ' 27' ' ' GLY . 1.1 t -74.14 -30.5 62.31 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 122.055 0.931 . . . . 0.0 108.925 -175.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.532 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 34.3 t -80.32 -44.28 19.79 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.972 176.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.415 ' HB3' ' H ' ' A' ' 6' ' ' ASN . . . -72.27 49.43 0.2 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.471 1.108 . . . . 0.0 113.375 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' HA3' ' HE1' ' A' ' 16' ' ' TYR . . . -151.86 -121.52 0.94 Allowed Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.335 -0.936 . . . . 0.0 111.322 176.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 29' ' ' SER . 7.7 m -159.9 138.17 10.29 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 27' ' ' GLY . 14.9 mtpp -57.4 130.71 47.5 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.72 -32.66 6.24 Favored Glycine 0 C--N 1.291 -1.95 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -174.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.3 m -80.81 123.94 28.66 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 121.1 0.476 . . . . 0.0 109.838 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.686 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 62.0 mttm -87.34 109.91 19.87 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.507 ' HE2' ' H ' ' A' ' 27' ' ' GLY . 51.5 m-85 -71.7 125.68 27.76 Favored 'General case' 0 CA--C 1.472 -2.056 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.48 146.16 32.28 Favored 'General case' 0 N--CA 1.393 -3.314 0 CA-C-N 114.385 -1.28 . . . . 0.0 111.541 -167.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.649 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 28.1 t -93.62 130.47 39.52 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.09 -17.12 50.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.101 0.96 . . . . 0.0 113.038 -172.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.72 -10.19 59.43 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.988 0.423 . . . . 0.0 110.387 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.08 6.05 16.65 Favored Glycine 0 N--CA 1.432 -1.612 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.96 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.649 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 8.5 m -90.95 122.66 33.82 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 117.046 0.423 . . . . 0.0 111.694 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.686 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 72.3 t80 -79.04 138.53 38.03 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 174.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.5 HG21 HG12 ' A' ' 45' ' ' ILE . 59.8 t -108.58 -64.51 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.532 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 p -173.02 168.27 4.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.646 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -112.54 117.47 32.44 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 170.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.605 ' O ' ' HG2' ' A' ' 12' ' ' LYS . . . -79.17 176.29 54.76 Favored Glycine 0 C--N 1.296 -1.657 0 N-CA-C 115.351 0.9 . . . . 0.0 115.351 -169.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -103.21 29.02 5.82 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 123.365 0.666 . . . . 0.0 110.96 -176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.413 ' HB3' ' HA ' ' A' ' 11' ' ' THR . 10.0 t -81.94 72.11 8.98 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 122.335 1.064 . . . . 0.0 109.084 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.69 140.33 31.5 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.119 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -35.46 -44.7 0.65 Allowed 'Trans proline' 0 CA--C 1.548 1.196 0 C-N-CA 124.791 3.661 . . . . 0.0 115.892 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.72 9.46 37.13 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -174.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.42 158.07 43.79 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -83.41 85.29 1.53 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.261 1.974 . . . . 0.0 111.072 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.12 55.01 3.14 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 122.143 0.973 . . . . 0.0 111.86 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.32 83.51 1.77 Allowed 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.951 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.2 m -109.99 123.74 50.18 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.387 -175.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.08 46.36 1.38 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.211 0.529 . . . . 0.0 111.359 -175.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.32 23.19 0.48 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.532 ' OD1' ' HB3' ' A' ' 8' ' ' CYS . 37.2 m-20 -90.21 57.14 3.63 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -167.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 1.015 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 71.0 m -148.29 74.34 1.28 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 173.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -92.82 112.94 58.14 Favored Pre-proline 0 CA--C 1.515 -0.394 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.54 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.76 -11.69 28.05 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 123.053 2.502 . . . . 0.0 113.862 -174.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.9 ptt-85 -90.7 -12.44 36.68 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.55 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.5 HG12 HG21 ' A' ' 24' ' ' VAL . 85.1 mt -97.82 138.0 23.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.82 -59.61 1.7 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.374 0.607 . . . . 0.0 109.622 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.35 161.51 41.04 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -95.51 106.75 3.43 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.3 t -86.91 107.43 16.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.433 0.635 . . . . 0.0 110.931 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.465 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.6 m -92.43 124.12 60.2 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 173.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 2.6 Cg_exo -75.96 77.96 3.29 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.086 2.524 . . . . 0.0 113.291 -175.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -79.92 -50.6 10.22 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.421 -1.912 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 176.498 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 C--O 1.238 0.493 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 64.75 52.38 1.68 Allowed 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 -173.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.742 HG12 ' HA ' ' A' ' 43' ' ' PRO . 7.1 tp -75.08 45.39 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.605 0 CA-C-O 122.832 1.301 . . . . 0.0 113.072 -173.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.453 ' HA ' ' CB ' ' A' ' 41' ' ' CYS . 3.3 m -102.45 32.55 3.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.238 1.018 . . . . 0.0 111.162 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.93 162.85 17.46 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 113.921 -1.491 . . . . 0.0 108.222 176.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -132.42 156.58 46.45 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.208 0.528 . . . . 0.0 110.3 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 t -85.09 -16.13 41.64 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 124.263 1.025 . . . . 0.0 112.407 -173.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 8.4 t -90.86 -66.61 0.91 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.594 -1.242 . . . . 0.0 113.788 -175.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.05 48.9 0.42 Allowed 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -167.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.2 -95.13 2.38 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 174.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.4 m -163.78 132.17 3.69 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 123.957 0.903 . . . . 0.0 109.088 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.931 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 19.8 pttp -64.34 143.05 58.18 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.48 -35.47 4.79 Favored Glycine 0 C--N 1.297 -1.619 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.504 -175.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.4 m -80.49 146.33 31.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.704 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 2.1 mmpt? -97.19 113.89 25.54 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.686 ' HB3' HG13 ' A' ' 45' ' ' ILE . 90.6 m-85 -71.28 117.6 13.01 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.544 ' CE2' ' HA ' ' A' ' 22' ' ' THR . 16.0 t80 -122.73 144.5 49.12 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-O 122.193 0.997 . . . . 0.0 113.138 -163.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.467 ' HB2' ' CG2' ' A' ' 24' ' ' VAL . 6.4 t -97.19 123.3 40.92 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -30.9 71.24 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -174.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -107.06 18.81 21.28 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.252 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -162.7 20.21 0.17 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 118.815 -1.66 . . . . 0.0 115.715 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.544 ' HA ' ' CE2' ' A' ' 17' ' ' PHE . 0.4 OUTLIER 55.91 -170.42 0.08 Allowed 'General case' 0 CA--C 1.587 2.387 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 177.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.704 ' HD1' ' HB3' ' A' ' 15' ' ' LYS . 72.9 t80 -39.79 126.06 1.92 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.253 1.421 . . . . 0.0 113.103 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 18' ' ' SER . 40.2 t -106.49 -58.68 3.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.694 177.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 p -147.28 165.41 30.2 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.416 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 15.7 tt0 -111.21 165.08 12.22 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -178.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.931 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -51.85 134.87 35.17 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 115.976 1.15 . . . . 0.0 115.976 -176.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -123.52 8.85 8.98 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 122.404 1.097 . . . . 0.0 108.946 176.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.2 m -100.98 101.41 12.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.135 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -108.27 143.95 28.46 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.61 -29.0 77.58 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.504 2.136 . . . . 0.0 114.298 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -98.11 -41.67 7.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.503 0.192 . . . . 0.0 111.287 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -57.8 139.3 82.33 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -174.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -67.57 134.8 34.07 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.371 2.047 . . . . 0.0 109.561 175.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.421 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 4.8 ptpp? -123.51 111.13 15.92 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -173.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.45 81.53 1.56 Allowed 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 172.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 91.4 m -99.62 143.15 30.19 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -172.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.26 115.75 10.77 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 171.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mp -111.2 36.23 3.27 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.55 0.691 . . . . 0.0 110.138 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -92.98 158.98 15.52 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.753 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.453 ' CB ' ' HA ' ' A' ' 4' ' ' CYS . 33.6 m -67.01 105.35 1.62 Allowed 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.78 ' HB3' HG22 ' A' ' 45' ' ' ILE . 12.7 t70 -97.73 110.78 56.76 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.199 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.742 ' HA ' HG12 ' A' ' 3' ' ' ILE . 24.7 Cg_exo -63.56 -9.82 19.6 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.787 2.992 . . . . 0.0 114.854 -176.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.68 -34.97 15.2 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.675 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.78 HG22 ' HB3' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -87.59 100.26 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 122.001 0.905 . . . . 0.0 110.98 -176.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.86 -39.54 30.38 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.545 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -170.65 172.52 5.8 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.21 123.16 7.78 Favored Glycine 0 C--N 1.288 -2.138 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.0 t -96.32 100.83 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 73.1 m -80.94 153.66 72.57 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 16.9 Cg_exo -69.56 61.95 1.64 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.348 2.698 . . . . 0.0 113.269 -177.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.483 ' CZ ' ' HA ' ' A' ' 52' ' ' ARG . 0.6 OUTLIER -126.71 11.84 7.3 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 176.38 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.4 m . . . . . 0 N--CA 1.424 -1.747 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.396 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.573 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 1.1 m-20 . . . . . 0 CA--C 1.508 -0.642 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.82 -52.29 2.44 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.6 tt -83.54 56.06 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 123.37 1.557 . . . . 0.0 110.283 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 1' ' ' ASP . 21.0 m -92.61 57.28 2.88 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.985 -178.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.566 ' HB ' HG23 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -90.65 -178.67 5.35 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 173.225 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -156.48 142.83 18.33 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 174.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.5 t -61.0 -46.66 89.87 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 123.758 0.661 . . . . 0.0 111.611 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.512 ' HA ' ' HB3' ' A' ' 28' ' ' GLU . 34.2 t -67.89 -51.16 51.18 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.885 -176.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.13 36.94 0.19 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.605 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . -109.35 170.66 14.6 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 176.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -74.77 122.47 23.35 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 117.008 0.404 . . . . 0.0 110.621 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.772 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -57.41 144.49 36.16 Favored 'General case' 0 C--O 1.241 0.606 0 O-C-N 121.902 -0.499 . . . . 0.0 110.048 173.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.08 -26.32 19.61 Favored Glycine 0 C--N 1.305 -1.171 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.5 m -91.28 130.92 37.09 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -84.13 103.67 13.53 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.575 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 17.0 m-85 -61.07 122.45 15.02 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.527 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -148.84 149.99 32.24 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.744 -167.214 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.619 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 33.6 t -89.88 133.61 34.66 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -47.46 -33.12 5.79 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.812 1.645 . . . . 0.0 114.155 -174.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -68.77 -19.71 64.33 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.527 ' HA2' ' CE2' ' A' ' 17' ' ' PHE . . . 122.61 18.79 3.22 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.326 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.619 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 69.1 m -103.5 125.49 50.09 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 117.197 0.498 . . . . 0.0 111.302 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -78.2 137.74 38.3 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.435 HG21 ' HA ' ' A' ' 45' ' ' ILE . 21.7 t -111.29 -56.07 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.128 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.8 177.99 7.53 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.022 0.529 . . . . 0.0 109.687 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -147.51 103.9 3.58 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 118.776 0.716 . . . . 0.0 112.14 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.772 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . 73.55 84.98 0.26 Allowed Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.979 177.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 59.2 mm-40 -111.32 -37.38 5.3 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.605 ' HB2' ' O ' ' A' ' 10' ' ' GLY . 3.8 m -105.6 107.48 18.49 Favored 'General case' 0 C--O 1.248 0.992 0 O-C-N 121.877 -0.514 . . . . 0.0 111.331 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -139.88 129.82 13.92 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.73 77.83 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.212 0 C-N-CA 123.004 2.47 . . . . 0.0 114.402 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.448 ' CZ ' ' HB2' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -141.46 -56.96 0.48 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 173.263 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 1.2 p-10 -82.25 126.3 74.7 Favored Pre-proline 0 N--CA 1.432 -1.351 0 CA-C-O 121.37 0.605 . . . . 0.0 109.832 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 11.5 Cg_exo -70.37 166.26 28.96 Favored 'Trans proline' 0 C--O 1.253 1.271 0 C-N-CA 123.234 2.623 . . . . 0.0 111.534 175.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.778 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER 83.09 142.69 0.07 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.311 1.844 . . . . 0.0 111.677 -179.439 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.3 157.75 17.5 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.3 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 24.0 m -85.88 164.4 17.51 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 t -65.66 156.51 32.68 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.309 0.576 . . . . 0.0 110.87 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.68 6.95 45.51 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.368 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -58.06 127.94 34.62 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.978 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 33.0 m -64.21 123.16 18.39 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.456 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -112.34 95.92 33.29 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -72.33 8.82 1.34 Allowed 'Trans proline' 0 N--CA 1.485 0.994 0 C-N-CA 123.267 2.645 . . . . 0.0 113.969 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.5 ttp-105 -90.45 -34.96 15.4 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.566 HG23 ' HB ' ' A' ' 5' ' ' THR . 1.6 tt -94.8 121.13 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.2 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.79 -47.66 8.45 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -167.76 169.3 11.79 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.694 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -97.03 120.35 6.68 Favored Glycine 0 C--N 1.284 -2.334 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.7 t -92.43 107.45 19.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 121.327 0.584 . . . . 0.0 110.364 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.74 153.87 64.59 Favored Pre-proline 0 C--N 1.296 -1.744 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.24 121.61 6.38 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 123.457 2.771 . . . . 0.0 113.231 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -95.7 -36.81 11.06 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.2 m . . . . . 0 N--CA 1.425 -1.679 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 179.815 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 42.3 p-10 . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -114.69 -37.91 4.12 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.824 -0.547 . . . . 0.0 112.233 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.402 HG12 ' HA ' ' A' ' 43' ' ' PRO . 6.4 tp -82.81 94.45 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-O 121.758 0.79 . . . . 0.0 109.525 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.898 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 6.7 m -126.11 47.95 2.18 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-O 121.667 0.746 . . . . 0.0 112.876 -175.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.551 HG21 ' HA ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -90.24 116.33 28.14 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 172.156 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.428 HD21 ' HB3' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -126.5 156.53 40.6 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -178.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.507 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 45.0 t -88.72 -47.18 8.43 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -172.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.4 t -61.38 -53.93 50.2 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.262 0.553 . . . . 0.0 111.35 -174.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.428 ' HB3' HD21 ' A' ' 6' ' ' ASN . . . -90.48 24.83 2.46 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.588 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' CE1' ' A' ' 16' ' ' TYR . . . -90.77 149.97 20.35 Favored Glycine 0 N--CA 1.431 -1.671 0 C-N-CA 120.096 -1.05 . . . . 0.0 110.876 177.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.37 117.98 5.45 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 123.477 0.711 . . . . 0.0 111.48 -176.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.728 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 40.2 ttmt -53.31 107.46 0.24 Allowed 'General case' 0 C--O 1.238 0.49 0 O-C-N 123.882 0.738 . . . . 0.0 112.777 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.54 -30.8 3.07 Favored Glycine 0 C--N 1.303 -1.274 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.1 m -86.26 121.86 29.43 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 63.7 mmtt -80.75 108.1 14.12 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.588 ' HD2' HG21 ' A' ' 45' ' ' ILE . 43.1 m-85 -71.25 109.94 5.59 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.02 151.22 50.6 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.567 -165.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.455 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 6.3 t -87.87 129.55 35.18 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.08 -9.18 20.36 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -168.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -79.61 -10.17 59.75 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 122.997 0.519 . . . . 0.0 111.1 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.89 33.11 2.47 Favored Glycine 0 C--N 1.315 -0.611 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.2 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 52.5 m -124.94 106.45 9.98 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 121.021 0.439 . . . . 0.0 110.788 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 58.2 t80 -70.91 124.14 23.64 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.528 176.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.03 -64.72 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.9 p -170.73 157.74 5.75 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 30.6 tt0 -85.24 138.86 32.07 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.728 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -63.57 135.15 41.69 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 176.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.404 ' HG3' ' HE2' ' A' ' 12' ' ' LYS . 7.6 tt0 -126.48 34.96 4.72 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.792 -175.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 t -82.96 113.37 20.5 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -104.35 133.41 20.22 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -53.57 -14.94 5.58 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.616 2.877 . . . . 0.0 114.442 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -103.07 -27.08 12.79 Favored 'General case' 0 N--CA 1.441 -0.895 0 O-C-N 121.622 -0.674 . . . . 0.0 111.693 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -91.14 137.42 26.4 Favored Pre-proline 0 C--O 1.239 0.552 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -172.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -82.6 124.08 3.96 Favored 'Trans proline' 0 N--CA 1.442 -1.548 0 C-N-CA 122.461 2.108 . . . . 0.0 110.038 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.9 138.25 47.53 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.656 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.5 93.3 3.9 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.451 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.9 m -142.67 167.2 22.65 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.9 138.11 54.39 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.4 47.65 1.97 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.806 0.812 . . . . 0.0 109.958 -176.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -97.83 18.89 14.75 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.321 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.898 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 55.7 m 65.23 156.72 0.09 Allowed 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 125.701 1.6 . . . . 0.0 112.124 177.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -122.52 112.31 31.14 Favored Pre-proline 0 N--CA 1.466 0.357 0 O-C-N 120.411 -1.431 . . . . 0.0 113.127 -178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.402 ' HA ' HG12 ' A' ' 3' ' ' ILE . 59.4 Cg_endo -73.68 -2.88 12.83 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.975 2.45 . . . . 0.0 113.941 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -85.6 -21.75 28.34 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.4 0.619 . . . . 0.0 109.673 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.588 HG21 ' HD2' ' A' ' 16' ' ' TYR . 95.3 mt -95.73 132.47 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.083 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.09 -55.67 3.65 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.692 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.551 ' HA ' HG21 ' A' ' 5' ' ' THR . 2.2 p90 -164.77 164.8 21.08 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.767 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -92.95 111.58 4.12 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.2 t -87.81 115.92 29.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 120.996 0.427 . . . . 0.0 110.3 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -96.16 105.14 20.02 Favored Pre-proline 0 C--N 1.293 -1.856 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -73.32 88.99 0.95 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.202 2.601 . . . . 0.0 112.079 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.46 -53.73 6.6 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.297 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.3 m . . . . . 0 N--CA 1.42 -1.928 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -179.489 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 CA--C 1.499 -1.009 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -147.76 61.52 1.14 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.7 tp -83.36 63.93 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-O 123.154 1.454 . . . . 0.0 109.888 -176.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.966 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.7 m -83.98 48.02 1.4 Allowed 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -176.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -91.17 164.12 14.02 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.53 ' HB3' HD23 ' A' ' 39' ' ' LEU . 1.1 t-20 -160.49 152.37 20.0 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.008 0.822 . . . . 0.0 111.811 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.8 t -67.8 -44.35 77.53 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.583 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 46.5 t -59.0 -52.22 66.68 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.163 0.506 . . . . 0.0 109.715 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.519 ' HB2' ' H ' ' A' ' 37' ' ' CYS . . . -86.16 25.58 1.15 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.783 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.51 156.11 22.48 Favored Glycine 0 N--CA 1.423 -2.193 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.911 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.2 m -83.01 109.41 17.08 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 123.008 0.523 . . . . 0.0 111.704 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -47.38 141.11 5.07 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.639 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.73 -44.11 1.56 Allowed Glycine 0 C--N 1.303 -1.298 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.3 m -103.23 140.43 37.39 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.775 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 69.8 mttt -100.01 129.39 46.06 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 121.392 0.615 . . . . 0.0 110.432 -173.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.428 ' HB3' ' CG1' ' A' ' 45' ' ' ILE . 48.7 m-85 -84.14 132.14 34.71 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.241 -176.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.46 148.45 37.76 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.227 -168.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.596 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 29.6 t -91.5 141.14 29.06 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.211 -1.358 . . . . 0.0 109.442 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.2 -14.4 60.55 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.796 1.239 . . . . 0.0 112.388 -176.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.29 -6.65 59.24 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.106 0.479 . . . . 0.0 110.527 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.71 34.17 3.61 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.505 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.596 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 25.2 m -118.75 120.03 36.17 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.261 -178.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.775 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 47.7 t80 -74.91 128.91 36.7 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -98.54 -71.71 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.504 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -172.11 165.96 6.12 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -178.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.769 ' HG3' ' HG2' ' A' ' 15' ' ' LYS . 12.0 tt0 -85.35 158.63 20.21 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.19 127.73 29.7 Favored Glycine 0 C--O 1.238 0.367 0 O-C-N 123.602 0.564 . . . . 0.0 112.905 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 8' ' ' CYS . 4.4 mm-40 -79.76 -22.69 42.9 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.494 0.188 . . . . 0.0 111.315 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.3 m -95.89 128.62 42.93 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-O 121.088 0.47 . . . . 0.0 110.047 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -79.53 124.41 83.85 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.43 82.62 0.1 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.488 2.792 . . . . 0.0 112.944 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 mmm180 -146.17 -70.44 0.25 Allowed 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -90.44 151.7 44.6 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.82 66.27 5.86 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.62 2.214 . . . . 0.0 111.781 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -80.38 130.6 35.28 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.145 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -131.76 160.88 34.26 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.285 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.519 ' H ' ' HB2' ' A' ' 9' ' ' ALA . 59.8 m -137.53 166.56 23.58 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.6 m -59.28 110.51 1.09 Allowed 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.53 HD23 ' HB3' ' A' ' 6' ' ' ASN . 12.8 mt -79.39 -62.54 1.66 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.554 -175.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 56.34 31.53 18.82 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.026 0.93 . . . . 0.0 111.253 -177.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.966 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 68.4 m 49.29 76.83 0.12 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.064 -177.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.497 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 6.7 t0 -53.27 112.74 3.9 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 123.869 0.868 . . . . 0.0 111.357 -174.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 10.9 Cg_exo -71.35 -11.31 28.42 Favored 'Trans proline' 0 C--O 1.242 0.695 0 C-N-CA 123.0 2.466 . . . . 0.0 112.828 -176.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.753 ' HA ' ' HE ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -91.41 -14.13 31.15 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.513 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.428 ' CG1' ' HB3' ' A' ' 16' ' ' TYR . 1.7 mp -108.85 124.24 65.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.155 0.503 . . . . 0.0 110.765 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.07 -47.76 5.11 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -164.47 166.21 20.7 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.715 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.11 130.5 10.34 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.2 t -109.54 115.88 50.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.474 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 25.6 m -82.05 141.19 46.67 Favored Pre-proline 0 C--N 1.288 -2.071 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 12.6 Cg_exo -69.49 61.59 1.59 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.65 2.9 . . . . 0.0 114.01 -174.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HB3' ' H ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -100.35 -83.53 0.44 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 175.339 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.48 ' H ' ' HB3' ' A' ' 52' ' ' ARG . 50.7 m . . . . . 0 C--N 1.31 -1.149 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.554 ' OD1' ' HG2' ' A' ' 2' ' ' ARG . 7.1 t70 . . . . . 0 CA--C 1.516 -0.356 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.554 ' HG2' ' OD1' ' A' ' 1' ' ' ASP . 21.5 mmm180 61.78 57.71 2.13 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.711 0.804 . . . . 0.0 111.953 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' A' ' 43' ' ' PRO . 6.7 tp -72.97 98.84 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 122.297 1.046 . . . . 0.0 111.169 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.753 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 1.8 m -121.64 22.27 10.62 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 122.015 0.912 . . . . 0.0 111.727 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.37 144.08 26.15 Favored 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.77 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -126.06 151.8 46.67 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 17.2 t -86.59 -16.37 36.97 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 123.743 0.817 . . . . 0.0 111.346 -173.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.0 t -66.31 -43.97 84.72 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.93 0.871 . . . . 0.0 108.764 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . . . -90.9 -102.39 0.1 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.483 172.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.48 -151.16 48.97 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-O 121.521 0.512 . . . . 0.0 113.813 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.814 HG23 ' HD3' ' A' ' 31' ' ' PRO . 95.0 m -143.88 110.96 5.75 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 122.679 0.392 . . . . 0.0 110.189 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' A' ' 27' ' ' GLY . 17.0 ttmt -51.34 116.52 2.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.136 176.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.59 -38.25 1.59 Allowed Glycine 0 N--CA 1.418 -2.544 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.2 m -106.56 112.43 25.43 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.492 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 37.0 mttp -87.47 113.24 23.0 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.755 -175.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -65.79 123.44 19.76 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.174 -177.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -125.06 152.79 43.85 Favored 'General case' 0 N--CA 1.407 -2.605 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.314 -166.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.767 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 1.0 OUTLIER -105.7 127.04 52.83 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 113.221 -1.809 . . . . 0.0 106.325 179.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.7 -14.34 20.33 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -167.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.6 -18.14 60.61 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.266 175.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.91 3.12 6.45 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.032 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.767 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 97.7 m -83.13 117.18 22.71 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.97 0.414 . . . . 0.0 111.674 -177.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.492 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 20.4 t80 -76.08 119.14 19.61 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 169.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.408 HG11 ' NH2' ' A' ' 44' ' ' ARG . 18.0 t -87.39 -63.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.497 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 p -169.14 172.58 7.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.866 0.365 . . . . 0.0 111.206 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -97.1 150.52 20.75 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.445 ' O ' ' HE3' ' A' ' 12' ' ' LYS . . . -62.61 118.59 14.69 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -79.91 3.02 21.19 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -175.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.4 m -121.38 141.22 51.17 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-O 121.601 0.715 . . . . 0.0 110.53 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -99.0 145.29 29.73 Favored Pre-proline 0 C--N 1.285 -2.237 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.814 ' HD3' HG23 ' A' ' 11' ' ' THR . 6.6 Cg_endo -50.53 -19.78 5.34 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.37 2.713 . . . . 0.0 115.071 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.472 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 0.8 OUTLIER -82.24 -25.62 33.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.52 138.48 25.31 Favored Pre-proline 0 C--N 1.319 -0.723 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.767 177.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -86.34 -164.18 0.21 Allowed 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.759 2.306 . . . . 0.0 111.195 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt 73.62 164.57 0.28 Allowed 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 125.37 1.468 . . . . 0.0 112.833 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . . . -155.58 143.28 19.69 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 178.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 55.7 m -79.85 125.19 29.39 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.42 79.44 0.26 Allowed 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 124.079 0.952 . . . . 0.0 112.249 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.6 tp -100.34 -18.91 16.56 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.884 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 65.63 55.12 1.03 Allowed 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 124.389 1.076 . . . . 0.0 110.19 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.753 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 20.7 m 74.78 138.04 0.06 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 125.686 1.594 . . . . 0.0 110.744 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -107.52 91.71 7.49 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.508 ' HA ' HG23 ' A' ' 3' ' ' ILE . 3.5 Cg_exo -77.25 0.67 9.51 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 123.117 2.545 . . . . 0.0 112.325 -175.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.408 ' NH2' HG11 ' A' ' 24' ' ' VAL . 15.3 ttp-105 -85.63 -19.13 31.44 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 74.1 mt -82.42 141.01 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.61 -57.96 2.32 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.433 0.635 . . . . 0.0 109.47 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -160.34 170.7 20.52 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.201 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.03 125.39 8.56 Favored Glycine 0 C--N 1.291 -1.92 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.7 t -95.95 106.19 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 m -93.96 111.9 54.93 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 177.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.89 134.76 64.59 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.177 2.584 . . . . 0.0 112.225 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -111.93 134.64 53.36 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.431 0.634 . . . . 0.0 110.819 -177.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.3 m . . . . . 0 C--N 1.279 -2.48 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 176.229 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.497 -1.08 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 53.44 79.19 0.13 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 124.208 0.943 . . . . 0.0 110.712 175.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.983 ' HB ' ' HA ' ' A' ' 43' ' ' PRO . 37.5 mm -83.79 92.02 2.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.611 -175.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.6 m -97.32 32.33 2.25 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 122.284 1.04 . . . . 0.0 112.526 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.489 ' HB ' HG23 ' A' ' 45' ' ' ILE . 3.6 m -81.44 140.95 34.35 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 171.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -133.13 148.23 52.11 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.305 -174.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.7 t -83.77 -28.02 28.46 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.564 1.145 . . . . 0.0 110.815 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.1 t -62.94 -59.99 4.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.421 0.629 . . . . 0.0 110.828 -175.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.82 47.86 1.39 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.254 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.8 ' HA3' ' HE1' ' A' ' 16' ' ' TYR . . . -93.04 -110.07 1.95 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.73 175.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.9 m -162.86 127.65 3.11 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 123.857 0.863 . . . . 0.0 108.746 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 1.074 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -64.24 128.95 38.0 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.917 174.313 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.93 -26.42 11.56 Favored Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 m -89.68 127.53 35.94 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.533 ' HG2' ' HG3' ' A' ' 26' ' ' GLU . 43.9 mtpt -86.11 114.61 23.1 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.8 ' HE1' ' HA3' ' A' ' 10' ' ' GLY . 57.3 m-85 -72.85 111.95 8.44 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 178.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.563 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -134.94 147.74 49.85 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.871 -166.307 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 21.6 p -97.13 148.17 23.32 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.556 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -62.97 -16.7 60.48 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.663 1.185 . . . . 0.0 113.218 -172.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -77.6 -12.01 59.92 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.382 0.61 . . . . 0.0 109.72 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.563 ' HA2' ' CE2' ' A' ' 17' ' ' PHE . . . 101.59 40.93 2.63 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.393 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.449 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 41.6 m -127.26 131.92 50.46 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.612 0.72 . . . . 0.0 111.93 -178.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.612 ' HE1' ' HB2' ' A' ' 26' ' ' GLU . 78.1 t80 -72.51 130.24 40.18 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.245 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 t -106.07 -49.08 8.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 120.911 0.386 . . . . 0.0 109.993 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.1 p -164.77 174.39 10.73 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.612 ' HB2' ' HE1' ' A' ' 23' ' ' PHE . 2.2 tm-20 -153.51 140.78 19.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.834 0.743 . . . . 0.0 111.636 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 1.074 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . 57.27 55.57 29.66 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 116.684 1.433 . . . . 0.0 116.684 171.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -81.58 -44.98 16.52 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.605 0.716 . . . . 0.0 109.614 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.21 78.32 8.85 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.609 -174.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.653 ' HA ' ' HG2' ' A' ' 12' ' ' LYS . 18.8 t0 -89.69 129.29 47.31 Favored Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -64.28 51.19 0.18 Allowed 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 123.921 3.081 . . . . 0.0 113.721 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -147.18 -45.52 0.17 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 125.294 1.437 . . . . 0.0 107.721 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -84.26 124.38 74.01 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -86.88 106.36 0.69 Allowed 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.737 2.292 . . . . 0.0 110.333 173.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 mtmm -115.36 102.83 10.21 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.25 98.9 6.82 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.28 0.562 . . . . 0.0 110.106 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.4 m -114.77 124.69 52.41 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.37 -42.28 71.98 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.0 -175.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.5 tp -158.98 -64.82 0.08 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 m120 61.2 49.29 5.61 Favored 'General case' 0 C--O 1.245 0.867 0 O-C-N 124.197 0.936 . . . . 0.0 112.148 176.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 84.9 m -57.98 120.96 9.46 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.534 ' HB3' HG22 ' A' ' 45' ' ' ILE . 2.2 t70 -116.21 100.51 53.55 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -177.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.983 ' HA ' ' HB ' ' A' ' 3' ' ' ILE . 44.2 Cg_endo -68.74 -6.48 18.04 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.858 2.372 . . . . 0.0 113.97 -174.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.49 ' O ' ' HB3' ' A' ' 18' ' ' SER . 0.7 OUTLIER -90.55 -25.4 20.24 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 111.755 0.279 . . . . 0.0 111.755 -178.572 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.534 HG22 ' HB3' ' A' ' 42' ' ' ASP . 3.8 tt -88.39 147.13 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 121.411 0.624 . . . . 0.0 111.07 -177.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.91 -50.92 4.03 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.77 175.24 4.0 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.234 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.33 121.69 6.82 Favored Glycine 0 N--CA 1.429 -1.825 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.6 t -104.3 103.82 15.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.033 0.444 . . . . 0.0 110.446 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 17.3 m -79.89 112.67 31.69 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 170.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.19 111.18 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 124.29 3.327 . . . . 0.0 114.272 -171.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -80.72 -60.91 2.13 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 N--CA 1.429 -1.485 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 175.944 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 . . . . . 0 C--O 1.233 0.206 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.8 ttt85 -65.16 -39.74 93.39 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.45 ' O ' ' HB3' ' A' ' 41' ' ' CYS . 19.3 tt -75.48 94.33 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 122.207 1.003 . . . . 0.0 112.458 -176.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 97.0 m -128.65 40.36 3.66 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.811 0.815 . . . . 0.0 110.792 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.432 HG21 ' HA ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -62.75 133.67 55.13 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.765 176.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -144.84 148.69 34.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.083 0.468 . . . . 0.0 110.164 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 t -75.22 -25.84 58.46 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.839 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.1 t -59.48 -56.06 26.71 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.361 0.601 . . . . 0.0 109.448 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . . . -90.74 23.29 3.15 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.309 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.62 141.85 31.44 Favored Glycine 0 N--CA 1.424 -2.132 0 C-N-CA 120.34 -0.933 . . . . 0.0 111.932 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.0 m -75.4 117.1 16.83 Favored 'General case' 0 C--N 1.273 -2.737 0 O-C-N 123.886 0.404 . . . . 0.0 111.451 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.412 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 34.9 ttmt -53.03 120.63 6.1 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.51 0.724 . . . . 0.0 109.129 175.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.92 -31.27 6.16 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 11.8 m -91.0 126.82 36.2 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -90.09 109.39 20.44 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.6 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 18.8 m-85 -71.54 115.16 10.4 Favored 'General case' 0 CA--C 1.484 -1.569 0 CA-C-O 121.875 0.845 . . . . 0.0 109.287 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.461 ' HE1' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -133.81 145.19 49.52 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 113.281 -1.781 . . . . 0.0 111.612 -167.227 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.518 ' OG ' ' HB ' ' A' ' 22' ' ' THR . 53.4 p -98.22 148.16 23.89 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -13.16 44.16 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -173.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.7 -0.99 40.75 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.213 0.53 . . . . 0.0 110.453 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.461 ' HA2' ' HE1' ' A' ' 17' ' ' PHE . . . 92.94 36.22 6.11 Favored Glycine 0 N--CA 1.43 -1.735 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.039 176.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.518 ' HB ' ' OG ' ' A' ' 18' ' ' SER . 90.7 m -122.11 121.5 37.06 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.759 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -73.29 124.37 25.57 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.506 HG21 HG12 ' A' ' 45' ' ' ILE . 34.3 t -96.2 -60.76 2.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.515 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.8 p -161.95 161.05 28.49 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.675 -0.41 . . . . 0.0 112.074 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -81.45 149.31 28.83 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 174.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.5 127.38 45.05 Favored Glycine 0 CA--C 1.524 0.64 0 O-C-N 123.587 0.554 . . . . 0.0 113.046 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -83.53 -21.0 32.85 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.6 m -100.86 131.01 46.95 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 121.266 0.555 . . . . 0.0 111.609 -176.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.816 ' HB3' ' HB3' ' A' ' 33' ' ' ASN . 25.1 t70 -79.72 140.23 54.84 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 12' ' ' LYS . 78.2 Cg_exo -56.01 -12.41 7.22 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.286 2.657 . . . . 0.0 114.374 179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -121.6 7.98 10.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 122.329 0.252 . . . . 0.0 111.325 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.816 ' HB3' ' HB3' ' A' ' 30' ' ' ASP . 2.4 p-10 -90.58 138.16 26.86 Favored Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.729 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -76.46 121.37 5.99 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.706 1.604 . . . . 0.0 108.686 171.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.7 pttm -128.84 162.46 27.43 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 120.822 0.344 . . . . 0.0 111.552 -173.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.41 45.62 1.73 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.103 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 9' ' ' ALA . 89.6 m -79.54 148.67 31.7 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.7 t -79.69 -175.7 4.97 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.488 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.51 39.95 1.88 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.339 0.656 . . . . 0.0 110.269 -175.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -66.08 106.21 1.56 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.156 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 3.3 m -73.08 112.59 9.26 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.447 -178.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -92.6 101.13 4.6 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 3.0 Cg_exo -74.22 -3.53 13.96 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 123.144 2.563 . . . . 0.0 112.526 -174.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -87.8 -34.59 18.23 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.172 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.506 HG12 HG21 ' A' ' 24' ' ' VAL . 79.4 mt -87.05 142.28 13.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.23 -65.46 1.0 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.432 ' HA ' HG21 ' A' ' 5' ' ' THR . 0.5 OUTLIER -161.02 169.17 23.05 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.077 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -96.11 103.51 2.96 Favored Glycine 0 N--CA 1.429 -1.799 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.497 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 71.4 t -79.9 113.75 19.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 1.6 m -85.69 102.87 2.92 Favored Pre-proline 0 C--N 1.308 -1.231 0 C-N-CA 122.988 0.515 . . . . 0.0 109.636 175.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 49' ' ' VAL . 9.5 Cg_endo -93.75 141.81 1.7 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 123.0 2.467 . . . . 0.0 111.567 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.98 -44.33 5.52 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.43 -1.433 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 177.707 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 C--O 1.226 -0.183 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -71.06 -19.33 62.49 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.7 tp -70.36 93.69 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 122.148 0.975 . . . . 0.0 110.373 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.882 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 22.4 m -105.26 29.36 6.49 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 122.227 1.013 . . . . 0.0 110.874 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -90.31 135.79 33.46 Favored 'General case' 0 N--CA 1.399 -2.981 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.393 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -126.25 154.75 42.92 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.582 ' HB2' HD11 ' A' ' 45' ' ' ILE . 17.5 t -88.81 -11.58 44.44 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.002 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.0 t -60.8 -49.43 77.5 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 120.91 0.386 . . . . 0.0 109.968 -178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.46 -87.34 0.17 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.06 -144.28 32.19 Favored Glycine 0 N--CA 1.438 -1.192 0 O-C-N 124.093 0.871 . . . . 0.0 114.182 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.5 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 4.6 t -147.06 115.44 6.66 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-O 120.951 0.405 . . . . 0.0 110.219 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -47.58 111.09 0.38 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.267 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.0 -35.31 2.32 Favored Glycine 0 N--CA 1.422 -2.292 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.362 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.4 m -96.9 131.59 43.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 117.534 0.667 . . . . 0.0 110.454 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.722 ' HE2' ' HB3' ' A' ' 51' ' ' PRO . 65.4 mttm -79.71 101.5 8.45 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.678 -174.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -70.98 112.32 7.05 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.0 147.97 42.83 Favored 'General case' 0 N--CA 1.407 -2.593 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.161 -167.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.01 137.12 32.62 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.684 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.61 -14.11 62.66 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -171.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.36 -15.18 60.02 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.958 0.409 . . . . 0.0 110.321 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.61 24.82 3.91 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.317 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -112.44 105.81 14.15 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.95 0.405 . . . . 0.0 111.522 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -71.01 130.32 41.26 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.5 t -99.09 -70.46 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -160.05 152.01 20.34 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 15.6 tt0 -93.86 43.26 1.11 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.563 0.697 . . . . 0.0 110.789 -175.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.84 127.39 0.95 Allowed Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.407 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -89.91 -24.88 21.22 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 120.705 -0.398 . . . . 0.0 112.014 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.32 157.91 44.84 Favored 'General case' 0 N--CA 1.424 -1.741 0 O-C-N 121.883 -0.511 . . . . 0.0 111.471 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.42 131.62 37.8 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 42.7 Cg_endo -65.43 -9.87 23.96 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.911 2.407 . . . . 0.0 115.15 -172.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.3 mtm180 -75.85 -23.74 55.73 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -91.25 146.12 32.85 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 172.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -74.1 84.77 1.45 Allowed 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.021 1.814 . . . . 0.0 112.408 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -95.25 127.87 41.64 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.21 100.45 6.97 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.41 0.624 . . . . 0.0 109.812 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.6 m -107.14 -172.9 2.17 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.8 143.81 55.65 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 172.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -94.67 47.22 1.16 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -176.234 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -54.0 112.95 1.06 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 112.288 -2.233 . . . . 0.0 110.236 177.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.882 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 60.4 m -81.79 78.42 8.52 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 170.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 45.3 t0 -70.64 111.91 11.26 Favored Pre-proline 0 CA--C 1.51 -0.579 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.377 -169.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 16.6 Cg_exo -70.97 -18.37 31.38 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.976 2.451 . . . . 0.0 110.986 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -70.76 -23.89 62.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.514 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 7' ' ' CYS . 63.0 mt -95.76 125.62 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.87 -51.02 6.07 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -169.91 166.24 9.47 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.146 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.11 110.58 4.0 Favored Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -84.66 103.95 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 64.1 m -79.07 116.38 59.7 Favored Pre-proline 0 C--N 1.288 -2.076 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.722 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 37.3 Cg_endo -63.23 125.51 15.9 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.35 2.7 . . . . 0.0 114.992 -171.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 9.1 tpp180 -144.27 35.17 1.2 Allowed 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 171.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.428 -1.566 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.994 -178.412 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 CA--C 1.511 -0.545 0 N-CA-C 110.636 -0.135 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? 54.93 -116.51 1.06 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.989 1.316 . . . . 0.0 114.034 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.8 tp -82.82 123.73 38.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 121.527 0.68 . . . . 0.0 110.288 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 71.6 m -99.2 56.62 1.03 Allowed 'General case' 0 N--CA 1.422 -1.87 0 CA-C-O 121.93 0.871 . . . . 0.0 111.763 -177.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.8 147.13 23.4 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.7 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -134.25 146.6 50.22 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.524 ' HB2' HD11 ' A' ' 45' ' ' ILE . 8.0 t -101.61 -4.17 27.08 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.033 0.444 . . . . 0.0 110.063 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.1 t -60.41 -54.45 45.5 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.31 -83.31 0.28 Allowed 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.44 175.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . 67.55 173.21 6.54 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.005 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.56 111.76 24.59 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 122.019 -0.695 . . . . 0.0 109.911 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.411 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 1.2 tmmt? -47.46 127.24 10.86 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.315 0.646 . . . . 0.0 110.35 176.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.94 -32.42 6.0 Favored Glycine 0 N--CA 1.436 -1.303 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.7 m -94.35 128.32 40.8 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.652 ' HG2' ' HG2' ' A' ' 26' ' ' GLU . 43.0 mtmt -88.76 112.11 22.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.547 ' HD2' HG21 ' A' ' 45' ' ' ILE . 81.8 m-85 -74.38 114.36 12.66 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.165 0.983 . . . . 0.0 109.279 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.05 147.51 38.74 Favored 'General case' 0 N--CA 1.407 -2.588 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.443 -167.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.453 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 43.1 t -89.0 141.97 28.03 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.955 -1.475 . . . . 0.0 109.014 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -72.89 -8.23 54.61 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.232 0.613 . . . . 0.0 112.335 -174.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.5 -3.37 57.56 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.76 43.47 3.11 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.353 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.453 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 13.6 m -131.24 123.38 28.28 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 122.514 -0.404 . . . . 0.0 110.952 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.664 ' HZ ' ' HG3' ' A' ' 26' ' ' GLU . 52.2 t80 -81.42 129.04 34.48 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.5 t -95.17 -67.62 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.99 174.48 4.72 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.664 ' HG3' ' HZ ' ' A' ' 23' ' ' PHE . 32.3 mt-10 -102.35 157.75 16.68 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.2 132.18 45.36 Favored Glycine 0 C--O 1.242 0.625 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -100.47 -27.48 13.42 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.064 0.459 . . . . 0.0 110.568 -175.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.493 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 47.6 m -80.94 128.12 33.33 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 122.355 1.074 . . . . 0.0 112.926 -176.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.87 138.67 13.14 Favored Pre-proline 0 C--N 1.293 -1.879 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -13.2 -51.89 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.247 1 C-N-CA 127.735 5.623 . . . . 0.0 119.31 -175.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.522 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 6.2 tpp180 -63.37 -44.95 93.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.506 0.594 . . . . 0.0 111.275 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 29' ' ' SER . 6.5 p30 -92.8 107.56 25.34 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-O 121.593 0.711 . . . . 0.0 111.22 176.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 32' ' ' ARG . 65.5 Cg_endo -94.35 67.49 0.34 Allowed 'Trans proline' 0 N--CA 1.443 -1.488 0 C-N-CA 123.117 2.544 . . . . 0.0 110.273 175.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.415 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 55.2 mtpt -74.94 92.36 2.57 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.889 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.64 82.77 7.88 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.6 m -79.64 159.37 26.77 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.869 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.18 175.37 1.66 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.138 0.575 . . . . 0.0 112.102 -175.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.559 ' H ' HG22 ' A' ' 38' ' ' THR . 3.3 mm? -86.75 37.85 0.77 Allowed 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.393 1.077 . . . . 0.0 110.193 -171.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -61.88 119.06 8.07 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.649 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 24.3 m -96.83 104.01 15.98 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -96.5 104.45 17.86 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.614 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 5.2 Cg_exo -76.85 -3.59 13.96 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 123.483 2.789 . . . . 0.0 111.983 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -77.86 -10.84 59.77 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.547 HG21 ' HD2' ' A' ' 16' ' ' TYR . 83.3 mt -102.43 130.45 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.171 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.37 -40.58 9.86 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -176.75 174.01 1.87 Allowed 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.75 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.77 114.0 4.89 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.8 t -79.63 100.69 4.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 121.338 0.589 . . . . 0.0 109.89 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.6 m -97.82 150.15 36.47 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 173.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 11.4 Cg_exo -72.11 67.7 3.32 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.825 2.35 . . . . 0.0 111.869 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -79.83 131.8 35.97 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.157 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.279 -2.485 0 CA-C-O 118.549 -0.739 . . . . 0.0 109.051 -178.839 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 C--O 1.243 0.741 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.78 71.25 0.33 Allowed 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 123.965 0.906 . . . . 0.0 110.847 -177.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -69.09 92.93 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.935 0.874 . . . . 0.0 109.645 177.118 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.815 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 60.5 m -128.59 37.01 4.18 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-O 122.333 1.063 . . . . 0.0 109.684 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.412 HG21 ' HA ' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -81.91 151.7 27.14 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-N 113.788 -1.551 . . . . 0.0 108.704 176.832 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -150.45 175.67 11.65 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.7 t -70.49 -30.09 66.79 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 118.149 0.431 . . . . 0.0 111.809 -174.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 4.4 t -76.09 -41.33 50.71 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.368 -0.832 . . . . 0.0 109.837 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.3 46.24 0.25 Allowed 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.636 ' HA3' ' HE1' ' A' ' 16' ' ' TYR . . . -140.37 -141.23 4.0 Favored Glycine 0 N--CA 1.431 -1.689 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.85 178.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.2 m -151.91 133.34 14.59 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 122.483 -0.422 . . . . 0.0 110.412 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.72 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 29.9 mmtt -50.52 121.89 6.36 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.348 1.059 . . . . 0.0 110.364 175.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.403 ' O ' ' HE3' ' A' ' 15' ' ' LYS . . . 119.57 -34.11 4.37 Favored Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.477 -178.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.2 m -92.85 132.06 37.33 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.589 ' HD3' ' HG2' ' A' ' 26' ' ' GLU . 10.3 mmtp -87.04 117.68 25.92 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -177.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.636 ' HE1' ' HA3' ' A' ' 10' ' ' GLY . 66.0 m-85 -70.18 120.36 15.75 Favored 'General case' 0 CA--C 1.479 -1.777 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -134.57 147.58 50.29 Favored 'General case' 0 N--CA 1.399 -3.017 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.331 -168.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.482 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 12.1 t -93.11 131.96 37.68 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.93 -10.45 53.42 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -170.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.25 -1.9 54.29 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.948 0.404 . . . . 0.0 110.956 176.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.62 59.21 0.75 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.711 175.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.482 ' HB ' ' HB3' ' A' ' 18' ' ' SER . 18.9 m -146.8 133.09 19.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 O-C-N 122.484 -0.421 . . . . 0.0 110.426 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.401 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 82.8 t80 -83.92 120.32 25.95 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 174.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.446 HG11 HG12 ' A' ' 45' ' ' ILE . 31.9 t -93.56 -51.14 11.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-O 120.699 0.285 . . . . 0.0 110.553 -177.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.4 p -169.85 165.32 9.77 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.589 ' HG2' ' HD3' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -94.44 171.87 8.54 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 176.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.72 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -52.5 128.87 36.51 Favored Glycine 0 N--CA 1.45 -0.431 0 O-C-N 123.703 0.627 . . . . 0.0 114.138 -175.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -100.82 -18.18 16.54 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.963 0.411 . . . . 0.0 110.374 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 m -120.07 107.22 12.79 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -175.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -82.41 109.01 13.63 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 165.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.01 21.94 0.37 Allowed 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 123.49 2.793 . . . . 0.0 115.185 -170.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -83.12 -51.93 7.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -90.34 126.73 55.64 Favored Pre-proline 0 C--O 1.254 1.306 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.81 139.7 81.55 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.606 2.871 . . . . 0.0 113.681 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.39 152.4 27.49 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.53 83.67 1.9 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.032 0.444 . . . . 0.0 111.394 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 78.5 m -83.25 123.2 29.36 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.99 167.53 3.79 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.176 0.99 . . . . 0.0 112.882 -175.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.7 mt -94.4 34.86 1.25 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -61.8 119.55 8.98 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.643 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.815 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 2.7 m -80.27 104.25 10.69 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.046 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -100.48 100.99 13.45 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 41' ' ' CYS . 19.5 Cg_exo -69.04 -4.56 13.79 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.695 2.93 . . . . 0.0 113.453 -177.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.9 ttp-105 -75.61 -23.92 56.47 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.446 HG12 HG11 ' A' ' 24' ' ' VAL . 66.5 mt -110.84 161.6 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.489 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.45 -57.2 2.3 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 173.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.412 ' HA ' HG21 ' A' ' 5' ' ' THR . 0.2 OUTLIER -162.86 179.09 7.86 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.0 178.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -100.5 116.58 5.62 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 177.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.6 t -104.18 122.97 57.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.043 0.449 . . . . 0.0 110.426 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 1.7 m -96.09 104.79 18.21 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 171.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 5.3 Cg_exo -73.97 -173.22 1.33 Allowed 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 122.982 2.455 . . . . 0.0 113.396 -174.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -78.64 -11.5 59.97 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.816 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.43 -1.43 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.389 . . . . . . . . 0 0 . 1 stop_ save_